0001385613-21-000120.txt : 20211103 0001385613-21-000120.hdr.sgml : 20211103 20211103163959 ACCESSION NUMBER: 0001385613-21-000120 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 74 CONFORMED PERIOD OF REPORT: 20210930 FILED AS OF DATE: 20211103 DATE AS OF CHANGE: 20211103 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GREENLIGHT CAPITAL RE, LTD. CENTRAL INDEX KEY: 0001385613 STANDARD INDUSTRIAL CLASSIFICATION: FIRE, MARINE & CASUALTY INSURANCE [6331] IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-33493 FILM NUMBER: 211376109 BUSINESS ADDRESS: STREET 1: 65 MARKET STREET, SUITE 1207, STREET 2: CAMANA BAY, P.O. BOX 31110 CITY: GRAND CAYMAN STATE: E9 ZIP: KY1-1205 BUSINESS PHONE: 345 943 4573 MAIL ADDRESS: STREET 1: 65 MARKET STREET, SUITE 1207, STREET 2: CAMANA BAY, P.O. BOX 31110 CITY: GRAND CAYMAN STATE: E9 ZIP: KY1-1205 FORMER COMPANY: FORMER CONFORMED NAME: Greenlight Capital Re, Ltd. DATE OF NAME CHANGE: 20070109 10-Q 1 glre-20210930.htm 10-Q glre-20210930
000138561312/312021Q3falsehttp://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate201613MemberP3D00013856132021-01-012021-09-30xbrli:shares0001385613us-gaap:CommonClassAMember2021-10-290001385613us-gaap:CommonClassBMember2021-10-29iso4217:USD00013856132021-09-3000013856132020-12-31iso4217:USDxbrli:shares0001385613us-gaap:CommonClassAMember2021-09-300001385613us-gaap:CommonClassAMember2020-12-310001385613us-gaap:CommonClassBMember2021-09-300001385613us-gaap:CommonClassBMember2020-12-3100013856132021-07-012021-09-3000013856132020-07-012020-09-3000013856132020-01-012020-09-300001385613us-gaap:CommonStockMember2021-06-300001385613us-gaap:CommonStockMember2020-06-300001385613us-gaap:CommonStockMember2020-12-310001385613us-gaap:CommonStockMember2019-12-310001385613us-gaap:CommonStockMember2021-07-012021-09-300001385613us-gaap:CommonStockMember2020-07-012020-09-300001385613us-gaap:CommonStockMember2021-01-012021-09-300001385613us-gaap:CommonStockMember2020-01-012020-09-300001385613us-gaap:CommonStockMember2021-09-300001385613us-gaap:CommonStockMember2020-09-300001385613us-gaap:AdditionalPaidInCapitalMember2021-06-300001385613us-gaap:AdditionalPaidInCapitalMember2020-06-300001385613us-gaap:AdditionalPaidInCapitalMember2020-12-310001385613us-gaap:AdditionalPaidInCapitalMember2019-12-310001385613us-gaap:AdditionalPaidInCapitalMember2021-07-012021-09-300001385613us-gaap:AdditionalPaidInCapitalMember2020-07-012020-09-300001385613us-gaap:AdditionalPaidInCapitalMember2021-01-012021-09-300001385613us-gaap:AdditionalPaidInCapitalMember2020-01-012020-09-300001385613us-gaap:AdditionalPaidInCapitalMember2021-09-300001385613us-gaap:AdditionalPaidInCapitalMember2020-09-300001385613us-gaap:RetainedEarningsMember2021-06-300001385613us-gaap:RetainedEarningsMember2020-06-300001385613us-gaap:RetainedEarningsMember2020-12-310001385613us-gaap:RetainedEarningsMember2019-12-3100013856132019-01-012019-12-310001385613srt:CumulativeEffectPeriodOfAdoptionAdjustmentMemberus-gaap:RetainedEarningsMember2019-12-310001385613us-gaap:RetainedEarningsMember2021-07-012021-09-300001385613us-gaap:RetainedEarningsMember2020-07-012020-09-300001385613us-gaap:RetainedEarningsMember2021-01-012021-09-300001385613us-gaap:RetainedEarningsMember2020-01-012020-09-300001385613us-gaap:RetainedEarningsMember2021-09-300001385613us-gaap:RetainedEarningsMember2020-09-3000013856132020-09-3000013856132019-12-310001385613us-gaap:EmployeeStockOptionMember2021-07-012021-09-300001385613us-gaap:EmployeeStockOptionMember2020-07-012020-09-300001385613us-gaap:EmployeeStockOptionMember2021-01-012021-09-300001385613us-gaap:EmployeeStockOptionMember2020-01-012020-09-300001385613us-gaap:RestrictedStockMember2021-07-012021-09-300001385613us-gaap:RestrictedStockMember2020-07-012020-09-300001385613us-gaap:RestrictedStockMember2021-01-012021-09-300001385613us-gaap:RestrictedStockMember2020-01-012020-09-300001385613srt:ScenarioForecastMemberus-gaap:AccountingStandardsUpdate202006Member2021-12-310001385613srt:ScenarioForecastMemberus-gaap:AccountingStandardsUpdate202006Member2021-01-012021-12-310001385613glre:SILPMemberglre:GreenlightCapitalReLimitedPartnersMember2021-09-300001385613glre:SILPMemberglre:GreenlightCapitalReLimitedPartnersMember2020-12-31xbrli:pure0001385613us-gaap:GeneralPartnerMember2021-09-300001385613us-gaap:GeneralPartnerMember2020-12-310001385613glre:LimitedPartnershipAgreementMember2021-01-012021-09-300001385613us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMemberglre:SolasglasInvestmentLPSILPMember2021-09-300001385613us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMemberglre:SolasglasInvestmentLPSILPMember2020-12-310001385613glre:SolasglasInvestmentLPSILPMember2021-07-012021-09-300001385613glre:SolasglasInvestmentLPSILPMember2020-07-012020-09-300001385613glre:SolasglasInvestmentLPSILPMember2021-01-012021-09-300001385613glre:SolasglasInvestmentLPSILPMember2020-01-012020-09-300001385613glre:PrivateAndUnlistedEquitySecuritiesMember2021-09-300001385613glre:DerivativeFinancialInstrumentsMember2021-09-300001385613glre:PrivateAndUnlistedEquitySecuritiesMember2020-12-310001385613glre:DerivativeFinancialInstrumentsMember2020-12-310001385613us-gaap:OtherInvestmentsMember2020-12-310001385613us-gaap:EquityMethodInvestmentsMember2020-12-310001385613glre:PrivateAndUnlistedEquitySecuritiesMember2021-07-012021-09-300001385613glre:PrivateAndUnlistedEquitySecuritiesMember2021-01-012021-09-300001385613glre:PrivateAndUnlistedEquitySecuritiesMember2020-07-012020-09-300001385613glre:PrivateAndUnlistedEquitySecuritiesMember2020-01-012020-09-300001385613glre:AccuRiskHoldingsLLCMemberus-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember2021-01-012021-09-300001385613us-gaap:HealthInsuranceProductLineMember2020-12-310001385613us-gaap:HealthInsuranceProductLineMember2019-12-310001385613us-gaap:HealthInsuranceProductLineMember2021-01-012021-09-300001385613us-gaap:HealthInsuranceProductLineMember2020-01-012020-09-300001385613us-gaap:HealthInsuranceProductLineMember2021-09-300001385613us-gaap:HealthInsuranceProductLineMember2020-09-300001385613glre:UnratedMemberus-gaap:CededCreditRiskUnsecuredMember2021-09-300001385613glre:UnratedMemberus-gaap:CededCreditRiskUnsecuredMember2020-12-310001385613glre:UnratedMemberus-gaap:CededCreditRiskSecuredMember2021-09-300001385613glre:UnratedMemberus-gaap:CededCreditRiskSecuredMember2020-12-310001385613srt:AMBestAMinusRatingMember2021-09-300001385613srt:AMBestAMinusRatingMember2020-12-310001385613glre:SeniorUnsecuredConvertibleNotesMemberus-gaap:SeniorNotesMember2018-08-070001385613glre:SeniorUnsecuredConvertibleNotesMemberus-gaap:SeniorNotesMember2021-09-300001385613glre:SeniorUnsecuredConvertibleNotesMemberus-gaap:SeniorNotesMember2020-12-310001385613glre:SeniorUnsecuredConvertibleNotesMemberus-gaap:SeniorNotesMemberus-gaap:AdditionalPaidInCapitalMember2021-09-300001385613glre:SeniorUnsecuredConvertibleNotesMemberus-gaap:SeniorNotesMember2021-07-012021-09-300001385613glre:SeniorUnsecuredConvertibleNotesMemberus-gaap:SeniorNotesMember2021-01-012021-09-300001385613glre:SeniorUnsecuredConvertibleNotesMemberus-gaap:SeniorNotesMember2020-07-012020-09-300001385613glre:SeniorUnsecuredConvertibleNotesMemberus-gaap:SeniorNotesMember2020-01-012020-09-300001385613us-gaap:CommonClassAMemberus-gaap:StockCompensationPlanMember2020-10-290001385613us-gaap:CommonClassAMembersrt:MinimumMemberus-gaap:StockCompensationPlanMember2020-10-290001385613us-gaap:CommonClassAMembersrt:MaximumMemberus-gaap:StockCompensationPlanMember2020-10-290001385613us-gaap:CommonClassAMember2020-03-260001385613glre:SeniorUnsecuredConvertibleNotesMemberus-gaap:SeniorNotesMember2020-03-260001385613glre:SeniorUnsecuredConvertibleNotesMemberus-gaap:SeniorNotesMember2021-05-040001385613us-gaap:CommonClassAMember2021-01-012021-09-300001385613us-gaap:CommonClassAMember2019-12-310001385613us-gaap:CommonClassBMember2019-12-310001385613us-gaap:CommonClassBMember2021-01-012021-09-300001385613us-gaap:CommonClassAMember2020-01-012020-09-300001385613us-gaap:CommonClassBMember2020-01-012020-09-300001385613us-gaap:CommonClassAMember2020-09-300001385613us-gaap:CommonClassBMember2020-09-300001385613us-gaap:CommonClassAMemberus-gaap:RestrictedStockMember2021-01-012021-09-300001385613us-gaap:CommonClassAMemberus-gaap:RestrictedStockMember2020-01-012020-09-300001385613us-gaap:RestrictedStockMember2021-01-012021-09-300001385613us-gaap:RestrictedStockMember2020-01-012020-09-300001385613us-gaap:RestrictedStockMember2021-09-300001385613us-gaap:RestrictedStockMember2020-12-310001385613us-gaap:RestrictedStockMember2021-09-302021-09-300001385613us-gaap:RestrictedStockMember2020-12-312020-12-310001385613us-gaap:CommonClassAMemberglre:NonEmployeeDirectorMemberMemberus-gaap:RestrictedStockUnitsRSUMember2021-01-012021-09-300001385613us-gaap:CommonClassAMemberglre:NonEmployeeDirectorMemberMemberus-gaap:RestrictedStockUnitsRSUMember2020-01-012020-09-300001385613us-gaap:CommonClassAMembersrt:ChiefExecutiveOfficerMemberus-gaap:EmployeeStockOptionMember2020-01-012020-09-300001385613us-gaap:CommonClassAMembersrt:ChiefExecutiveOfficerMemberus-gaap:EmployeeStockOptionMember2021-01-012021-09-300001385613us-gaap:EmployeeStockOptionMember2021-01-012021-09-300001385613us-gaap:EmployeeStockOptionMember2020-01-012020-09-300001385613us-gaap:EmployeeStockOptionMember2021-09-300001385613us-gaap:EmployeeStockOptionMember2020-12-310001385613us-gaap:EmployeeStockOptionMember2020-01-012020-12-310001385613us-gaap:RestrictedStockUnitsRSUMember2021-01-012021-09-300001385613us-gaap:CommonClassAMemberus-gaap:RestrictedStockUnitsRSUMember2021-01-012021-09-300001385613us-gaap:RestrictedStockUnitsRSUMember2020-01-012020-09-300001385613us-gaap:RestrictedStockUnitsRSUMember2021-09-300001385613us-gaap:RestrictedStockUnitsRSUMember2020-09-300001385613us-gaap:RestrictedStockUnitsRSUMember2020-12-310001385613us-gaap:RestrictedStockMembersrt:ChiefExecutiveOfficerMember2021-01-012021-09-300001385613us-gaap:RestrictedStockMembersrt:ChiefExecutiveOfficerMember2021-09-300001385613us-gaap:RestrictedStockMembersrt:ChiefExecutiveOfficerMember2020-12-310001385613us-gaap:GeneralAndAdministrativeExpenseMember2021-01-012021-09-300001385613us-gaap:GeneralAndAdministrativeExpenseMember2020-01-012020-09-300001385613us-gaap:OtherAssetsMember2021-09-300001385613us-gaap:OtherAssetsMember2020-09-300001385613srt:BoardOfDirectorsChairmanMemberglre:LimitedPartnershipAgreementMember2018-09-012018-09-010001385613srt:BoardOfDirectorsChairmanMemberglre:LimitedPartnershipAgreementMember2021-01-012021-09-300001385613srt:BoardOfDirectorsChairmanMemberglre:InvestmentAdvisoryAgreementMember2018-09-012018-09-010001385613glre:GreenBricksPartnersIncGRBKMembersrt:AffiliatedEntityMember2021-09-300001385613srt:BoardOfDirectorsChairmanMemberglre:ServiceAgreementMember2021-01-012021-09-300001385613glre:CollateralAssetsInvestementManagementAgreementMembersrt:BoardOfDirectorsChairmanMember2019-01-012019-01-01glre:facility0001385613glre:CitibankEuropePlcMemberus-gaap:FinancialStandbyLetterOfCreditMember2021-09-300001385613glre:CitibankEuropePlcMemberus-gaap:FinancialStandbyLetterOfCreditMember2021-01-012021-09-300001385613srt:MinimumMember2021-01-012021-09-300001385613srt:MaximumMember2021-01-012021-09-300001385613us-gaap:ConvertibleDebtMember2021-09-30glre:segment0001385613us-gaap:PropertyAndCasualtyCommercialInsuranceProductLineMember2021-07-012021-09-300001385613us-gaap:PropertyAndCasualtyCommercialInsuranceProductLineMember2020-07-012020-09-300001385613us-gaap:PropertyAndCasualtyCommercialInsuranceProductLineMember2021-01-012021-09-300001385613us-gaap:PropertyAndCasualtyCommercialInsuranceProductLineMember2020-01-012020-09-300001385613glre:MotorVehiclePhysicalDamageProductLineMember2021-07-012021-09-300001385613glre:MotorVehiclePhysicalDamageProductLineMember2020-07-012020-09-300001385613glre:MotorVehiclePhysicalDamageProductLineMember2021-01-012021-09-300001385613glre:MotorVehiclePhysicalDamageProductLineMember2020-01-012020-09-300001385613us-gaap:PropertyAndCasualtyPersonalInsuranceProductLineMember2021-07-012021-09-300001385613us-gaap:PropertyAndCasualtyPersonalInsuranceProductLineMember2020-07-012020-09-300001385613us-gaap:PropertyAndCasualtyPersonalInsuranceProductLineMember2021-01-012021-09-300001385613us-gaap:PropertyAndCasualtyPersonalInsuranceProductLineMember2020-01-012020-09-300001385613us-gaap:PropertyInsuranceProductLineMember2021-07-012021-09-300001385613us-gaap:PropertyInsuranceProductLineMember2020-07-012020-09-300001385613us-gaap:PropertyInsuranceProductLineMember2021-01-012021-09-300001385613us-gaap:PropertyInsuranceProductLineMember2020-01-012020-09-300001385613us-gaap:GeneralLiabilityMember2021-07-012021-09-300001385613us-gaap:GeneralLiabilityMember2020-07-012020-09-300001385613us-gaap:GeneralLiabilityMember2021-01-012021-09-300001385613us-gaap:GeneralLiabilityMember2020-01-012020-09-300001385613glre:MotorVehicleLiabilityCasualtyProductLineMember2021-07-012021-09-300001385613glre:MotorVehicleLiabilityCasualtyProductLineMember2020-07-012020-09-300001385613glre:MotorVehicleLiabilityCasualtyProductLineMember2021-01-012021-09-300001385613glre:MotorVehicleLiabilityCasualtyProductLineMember2020-01-012020-09-300001385613us-gaap:ProfessionalMalpracticeLiabilityMember2021-07-012021-09-300001385613us-gaap:ProfessionalMalpracticeLiabilityMember2020-07-012020-09-300001385613us-gaap:ProfessionalMalpracticeLiabilityMember2021-01-012021-09-300001385613us-gaap:ProfessionalMalpracticeLiabilityMember2020-01-012020-09-300001385613glre:WorkersCompensationInsuranceProductLineMember2021-07-012021-09-300001385613glre:WorkersCompensationInsuranceProductLineMember2020-07-012020-09-300001385613glre:WorkersCompensationInsuranceProductLineMember2021-01-012021-09-300001385613glre:WorkersCompensationInsuranceProductLineMember2020-01-012020-09-300001385613glre:MultilineMember2021-07-012021-09-300001385613glre:MultilineMember2020-07-012020-09-300001385613glre:MultilineMember2021-01-012021-09-300001385613glre:MultilineMember2020-01-012020-09-300001385613glre:LiabilityandCasualtyInsuranceProductLineMember2021-07-012021-09-300001385613glre:LiabilityandCasualtyInsuranceProductLineMember2020-07-012020-09-300001385613glre:LiabilityandCasualtyInsuranceProductLineMember2021-01-012021-09-300001385613glre:LiabilityandCasualtyInsuranceProductLineMember2020-01-012020-09-300001385613us-gaap:HealthInsuranceProductLineMember2021-07-012021-09-300001385613us-gaap:HealthInsuranceProductLineMember2020-07-012020-09-300001385613glre:FinancialGuaranteeInsuranceandSuretyProductLineMember2021-07-012021-09-300001385613glre:FinancialGuaranteeInsuranceandSuretyProductLineMember2020-07-012020-09-300001385613glre:FinancialGuaranteeInsuranceandSuretyProductLineMember2021-01-012021-09-300001385613glre:FinancialGuaranteeInsuranceandSuretyProductLineMember2020-01-012020-09-300001385613glre:MarineCasualtyInsuranceMember2021-07-012021-09-300001385613glre:MarineCasualtyInsuranceMember2020-07-012020-09-300001385613glre:MarineCasualtyInsuranceMember2021-01-012021-09-300001385613glre:MarineCasualtyInsuranceMember2020-01-012020-09-300001385613us-gaap:OtherInsuranceProductLineMember2021-07-012021-09-300001385613us-gaap:OtherInsuranceProductLineMember2020-07-012020-09-300001385613us-gaap:OtherInsuranceProductLineMember2021-01-012021-09-300001385613us-gaap:OtherInsuranceProductLineMember2020-01-012020-09-300001385613glre:TotalSpecialtyDomain2021-07-012021-09-300001385613glre:TotalSpecialtyDomain2020-07-012020-09-300001385613glre:TotalSpecialtyDomain2021-01-012021-09-300001385613glre:TotalSpecialtyDomain2020-01-012020-09-300001385613srt:NorthAmericaMember2021-07-012021-09-300001385613srt:NorthAmericaMember2020-07-012020-09-300001385613srt:NorthAmericaMember2021-01-012021-09-300001385613srt:NorthAmericaMember2020-01-012020-09-300001385613glre:WorldwideMember2021-07-012021-09-300001385613glre:WorldwideMember2020-07-012020-09-300001385613glre:WorldwideMember2021-01-012021-09-300001385613glre:WorldwideMember2020-01-012020-09-300001385613srt:EuropeMember2021-07-012021-09-300001385613srt:EuropeMember2020-07-012020-09-300001385613srt:EuropeMember2021-01-012021-09-300001385613srt:EuropeMember2020-01-012020-09-300001385613srt:AsiaMember2021-07-012021-09-300001385613srt:AsiaMember2020-07-012020-09-300001385613srt:AsiaMember2021-01-012021-09-300001385613srt:AsiaMember2020-01-012020-09-30

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 
__________________________
FORM 10-Q 
__________________________
(Mark One)
☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2021

or
☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to
Commission file number 001-33493
____________________________________________________________________________________
GREENLIGHT CAPITAL RE, LTD.
(Exact name of registrant as specified in its charter)
____________________________________________________________________________________
Cayman IslandsN/A
(State or other jurisdiction of incorporation or organization)(I.R.S. employer identification no.)
65 Market Street
Suite 1207, Jasmine Court
P.O. Box 31110
Camana Bay
Grand Cayman
Cayman IslandsKY1-1205
(Address of principal executive offices)(Zip code)

(345) 943-4573
(Registrant’s telephone number, including area code)

Not Applicable
(Former name, former address and former fiscal year, if changed since last report) 

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Class A Ordinary SharesGLRENasdaq Global Select Market

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. 
Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). 
Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one): 
Large accelerated filer ☐          Accelerated filer ☒          Non-accelerated filer ☐          Smaller reporting company ☐          Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act) 
Yes ☐ No ☒

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.
Class A Ordinary Shares, $0.10 par value27,589,731
Class B Ordinary Shares, $0.10 par value6,254,715
(Class)Outstanding as of October 29, 2021


GREENLIGHT CAPITAL RE, LTD.
 
TABLE OF CONTENTS
 
  Page
 Condensed Consolidated Balance Sheets as of September 30, 2021 and December 31, 2020 (unaudited)
 Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2021 and 2020 (unaudited)
 Condensed Consolidated Statements of Changes in Shareholders' Equity for the three and nine months ended September 30, 2021 and 2020 (unaudited)
 Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2021 and 2020 (unaudited)
 Notes to the Condensed Consolidated Financial Statements (unaudited)


 
2
PART I — FINANCIAL INFORMATION
Item 1. FINANCIAL STATEMENTS 
GREENLIGHT CAPITAL RE, LTD.
CONDENSED CONSOLIDATED BALANCE SHEETS
(UNAUDITED) 

September 30, 2021 and December 31, 2020
(expressed in thousands of U.S. dollars, except per share and share amounts)
 September 30, 2021December 31, 2020
Assets  
Investments  
Investment in related party investment fund$180,239 $166,735 
Other investments42,480 29,418 
Total investments222,719 196,153 
Cash and cash equivalents37,380 8,935 
Restricted cash and cash equivalents692,542 745,371 
Reinsurance balances receivable (net of allowance for expected credit losses of $89 and $89)
380,417 330,232 
Loss and loss adjustment expenses recoverable (net of allowance for expected credit losses of $47 and $47)
13,082 16,851 
Deferred acquisition costs 60,634 51,014 
Unearned premiums ceded26 — 
Notes receivable— 6,101 
Other assets6,737 2,993 
Total assets$1,413,537 $1,357,650 
Liabilities and equity 
Liabilities 
Loss and loss adjustment expense reserves$540,779 $494,179 
Unearned premium reserves237,926 201,089 
Reinsurance balances payable77,525 92,247 
Funds withheld5,087 4,475 
Other liabilities5,228 5,009 
Convertible senior notes payable96,478 95,794 
Total liabilities963,023 892,793 
Shareholders' equity 
Preferred share capital (par value $0.10; authorized, 50,000,000; none issued)
— — 
Ordinary share capital (Class A: par value $0.10; authorized, 100,000,000; issued and outstanding, 27,589,731 (2020: 28,260,075): Class B: par value $0.10; authorized, 25,000,000; issued and outstanding, 6,254,715 (2020: 6,254,715))
3,384 3,452 
Additional paid-in capital480,939 488,488 
Retained earnings (deficit)(33,809)(27,083)
Total shareholders' equity450,514 464,857 
Total liabilities and equity$1,413,537 $1,357,650 
 
  The accompanying Notes to the Condensed Consolidated Financial Statements are an
integral part of the Condensed Consolidated Financial Statements.
3
GREENLIGHT CAPITAL RE, LTD.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(UNAUDITED)
 
For the three and nine months ended September 30, 2021 and 2020
(expressed in thousands of U.S. dollars, except per share and share amounts)
Three months ended September 30Nine months ended September 30
 2021202020212020
Revenues 
Gross premiums written$128,735 $135,596 $440,249 $362,072 
Gross premiums ceded(60)(1,464)(6)(2,274)
Net premiums written128,675 134,132 440,243 359,798 
Change in net unearned premium reserves6,849 (18,613)(36,844)(24,844)
Net premiums earned135,524 115,519 403,399 334,954 
Income (loss) from investment in related party investment fund (net of related party expenses of $659 and $2,632 (three and nine months ended September 30, 2020: $703 and $1,981, respectively))
(6,214)6,431 (4,196)(34,086)
Net investment income (loss)10,303 466 28,999 11,237 
Other income (expense), net(380)1,569 (4,033)2,570 
Total revenues139,233 123,985 424,169 314,675 
Expenses
Net loss and loss adjustment expenses incurred110,400 88,053 295,078 252,944 
Acquisition costs35,048 27,018 106,060 76,660 
General and administrative expenses6,060 5,152 21,340 18,095 
Interest expense1,578 1,579 4,684 4,702 
Total expenses153,086 121,802 427,162 352,401 
Income (loss) before income tax(13,853)2,183 (2,993)(37,726)
Income tax (expense) benefit— — (3,733)(424)
Net income (loss)$(13,853)$2,183 $(6,726)$(38,150)
Earnings (loss) per share
Basic$(0.42)$0.06 $(0.20)$(1.07)
Diluted$(0.42)$0.06 $(0.20)$(1.07)
Weighted average number of ordinary shares used in the determination of earnings and loss per share
Basic32,929,097 35,677,554 33,507,060 35,569,292 
Diluted32,929,097 35,779,703 33,507,060 35,569,292 
 

 
The accompanying Notes to the Condensed Consolidated Financial Statements are an
integral part of the Condensed Consolidated Financial Statements. 


 
 
4
GREENLIGHT CAPITAL RE, LTD.
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY
(UNAUDITED)
 
For the three and nine months ended September 30, 2021 and 2020
(expressed in thousands of U.S. dollars)

Three months ended September 30Nine months ended September 30
2021202020212020
Ordinary share capital
Balance - beginning of period$3,417 $3,627 $3,452 $3,699 
Issue of Class A ordinary shares, net of forfeitures3 (19)41 25 
Repurchase of Class A ordinary shares(36)(71)(109)(187)
Balance - end of period3,384 3,537 3,384 3,537 
Additional paid-in capital
Balance - beginning of period483,365 497,559 488,488 503,547 
Repurchase of Class A ordinary shares(3,216)(4,828)(9,891)(12,484)
Share-based compensation expense790 (302)2,342 1,366 
Balance - end of period480,939 492,429 480,939 492,429 
Retained earnings (deficit)
Balance - beginning of period(19,956)(71,282)(27,083)(30,063)
Cumulative effect of adoption of accounting guidance for expected credit losses at January 1, 2020
— — — (886)
Net income (loss)(13,853)2,183 (6,726)(38,150)
Balance - end of period(33,809)(69,099)(33,809)(69,099)
Total shareholders' equity$450,514 $426,867 $450,514 $426,867 


The accompanying Notes to the Condensed Consolidated Financial Statements are an
integral part of the Condensed Consolidated Financial Statements. 


 
5
GREENLIGHT CAPITAL RE, LTD.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)
For the nine months ended September 30, 2021 and 2020
(expressed in thousands of U.S. dollars) 
Nine months ended September 30
 20212020
Cash provided by (used in) operating activities 
Net income (loss)$(6,726)$(38,150)
Adjustments to reconcile net income or loss to net cash provided by (used in) operating activities
Loss (income) from investments in related party investment fund4,196 34,086 
Loss (income) from investment accounted for under the equity method— (870)
Net change in unrealized gains and losses on investments and notes receivable(14,860)(19,153)
Net realized (gains) losses on investments and notes receivable(14,210)15,000 
Foreign exchange (gains) losses on investments14 232 
Current expected credit losses recognized on notes receivable and reinsurance assets — 250 
Share-based compensation expense2,383 1,391 
Amortization and interest expense, net of change in accruals684 702 
Depreciation expense16 21 
Net change in
Reinsurance balances receivable(50,185)(33,932)
Loss and loss adjustment expenses recoverable3,769 7,535 
Deferred acquisition costs(9,620)(2,031)
Unearned premiums ceded(26)901 
Other assets, excluding depreciation(3,760)(1,121)
Loss and loss adjustment expense reserves46,600 11,182 
Unearned premium reserves36,837 24,395 
Reinsurance balances payable(14,722)(42,301)
Funds withheld612 274 
Other liabilities219 (3,069)
Net cash provided by (used in) operating activities(18,779)(44,658)
Investing activities
Proceeds from redemptions from related party investment fund51,904 69,108 
Contributions to related party investment fund(69,604)(48,094)
Purchases of investments(4,761)(944)
Sales of investments20,755 — 
Net change in notes receivable6,101 741 
Net cash provided by (used in) investing activities4,395 20,811 
Financing activities
Repurchase of Class A ordinary shares(10,000)(12,671)
Net cash provided by (used in) financing activities(10,000)(12,671)
Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash— (122)
Net increase (decrease) in cash, cash equivalents and restricted cash(24,384)(36,640)
Cash, cash equivalents and restricted cash at beginning of the period 754,306 767,906 
Cash, cash equivalents and restricted cash at end of the period $729,922 $731,266 
Supplementary information 
Interest paid in cash$4,000 $4,000 
Income tax paid in cash3,700 — 

The accompanying Notes to the Condensed Consolidated Financial Statements are an
integral part of the Condensed Consolidated Financial Statements. 
6
GREENLIGHT CAPITAL RE, LTD.
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
 
September 30, 2021
 
 
1. ORGANIZATION AND BASIS OF PRESENTATION
 
Greenlight Capital Re, Ltd. (“GLRE”) was incorporated as an exempted company under the Companies Law of the Cayman Islands on July 13, 2004. GLRE’s wholly-owned subsidiary, Greenlight Reinsurance, Ltd. (“Greenlight Re”), provides global specialty property and casualty reinsurance. Greenlight Re has a Class D insurer license issued in accordance with the terms of The Insurance Act, 2010 (as amended) and underlying regulations thereto (the “Act”) and is subject to regulation by the Cayman Islands Monetary Authority, in terms of the Act. Greenlight Re commenced underwriting in April 2006. Verdant Holding Company, Ltd. (“Verdant”), a wholly-owned subsidiary of GLRE, was incorporated in 2008 in the state of Delaware. During 2010, GLRE established Greenlight Reinsurance Ireland, Designated Activity Company (“GRIL”), a wholly-owned reinsurance subsidiary based in Dublin, Ireland. GRIL is authorized as a non-life reinsurance undertaking in accordance with the provisions of the European Union (Insurance and Reinsurance) Regulations 2015. GRIL provides multi-line property and casualty reinsurance capacity to the European broker market and provides GLRE with an additional platform to serve clients located in Europe and North America.  In 2020, GLRE established Greenlight Re Marketing (UK) Limited (“Greenlight Re UK”) as a wholly-owned subsidiary to increase the Company’s presence in the London market. As used herein, the “Company” refers collectively to GLRE and its consolidated subsidiaries.

The Class A ordinary shares of GLRE are listed on Nasdaq Global Select Market under the symbol “GLRE.”

These unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information, and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all the information and footnotes required by U.S. GAAP for complete financial statements. In addition, the year-end balance sheet data was derived from audited financial statements but does not include all disclosures required by U.S. GAAP. These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020, as filed with the U.S. Securities and Exchange Commission on March 10, 2021.

In the opinion of management, these unaudited condensed consolidated financial statements reflect all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation of the Company’s financial position and results of operations as at the end of and for the periods presented.

Significant estimates used in the preparation of the Company’s condensed consolidated financial statements, including those associated with premiums and the estimations of loss and loss adjustment expense reserves, including losses arising from the novel coronavirus (the “COVID-19 pandemic”), may be subject to significant adjustments in future periods. (See Note 5 for the significant assumptions that served as the basis for the Company's estimates of reserves for the COVID-19 pandemic). All significant intercompany accounts and transactions have been eliminated.

The results of operations and cash flows for any interim period will not necessarily be indicative of the results of operations and cash flows for the full fiscal year or subsequent periods.

2. SIGNIFICANT ACCOUNTING POLICIES
 
There have been no material changes to the Company’s significant accounting policies as described in its Annual Report on Form 10-K for the year ended December 31, 2020.

Use of Estimates
 
The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the period. Actual results could differ from these estimates. The significant estimates reflected in the Company’s condensed consolidated financial statements include, but are not limited to, loss and loss adjustment expense reserves,
7
premiums written, earned and receivable, variability underlying risk transfer assessments, allowances for credit losses, bonus accruals, share-based compensation, valuation allowances associated with deferred tax assets and investment impairments.

Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
 
The Company maintains cash and cash equivalent balances to collateralize regulatory trusts and letters of credit issued to cedents (see Note 12). The following table reconciles the cash, cash equivalents, and restricted cash reported within the condensed consolidated balance sheets to the total presented in the condensed consolidated statements of cash flows:

 September 30, 2021December 31, 2020
 ($ in thousands)
Cash and cash equivalents$37,380 $8,935 
Restricted cash and cash equivalents692,542 745,371 
Total cash, cash equivalents and restricted cash presented in the condensed consolidated statements of cash flows$729,922 $754,306 

Funds Held by Cedents

The caption “Reinsurance balances receivable” in the Company’s condensed consolidated balance sheets includes amounts held by cedents. Such amounts include premiums and funds held at Lloyd’s, which is held in trust at Lloyd's as security for members’ underwriting activities. At September 30, 2021, funds held by cedents were $201.3 million (December 31, 2020: $127.6 million).
 
Reinsurance Assets

The Company calculates an allowance for expected credit losses for its reinsurance balances receivable and loss and loss adjustment expenses recoverable by applying a Probability of Default (“PD”) / Loss Given Default (“LGD”) model. The PD / LGD approach considers the Company’s collectibility history on its reinsurance assets and representative external loss history. In calculating the probability of default, the Company also considers the estimated duration of its reinsurance assets.

The Company evaluates each counterparty’s creditworthiness based on credit ratings that independent agencies assign to the counterparty. The Company manages its credit risk in its reinsurance assets by transacting only with insurers and reinsurers that it considers financially sound.

For its retrocessional counterparties that are unrated, the Company may hold collateral in the form of funds withheld, trust accounts, or irrevocable letters of credit. In evaluating credit risk associated with reinsurance balances receivable, the Company considers its right to offset loss obligations against premiums receivable. The Company regularly evaluates its net credit exposure to assess the ability of cedents and retrocessionaires to honor their respective obligations.

At September 30, 2021, the Company has recorded an allowance for expected credit loss on its Reinsurance Assets of $0.1 million (December 31, 2020: $0.1 million).

Deposit Assets and Liabilities
 
The Company applies deposit accounting to reinsurance contracts that do not transfer sufficient insurance risk to merit reinsurance accounting. Under deposit accounting, the Company recognizes an asset or liability based on its paid or received consideration. The deposit asset or liability balance is subsequently adjusted using the interest method with the corresponding income or expense recorded in the Company’s condensed consolidated statements of operations under the caption “Other income (expense).” The Company records deposit assets and liabilities in its condensed consolidated balance sheets in the caption “Reinsurance balances receivable” and “Reinsurance balances payable,” respectively. At September 30, 2021, deposit assets and deposit liabilities were $4.9 million and $14.0 million, respectively (December 31, 2020: $4.6 million and $31.0 million, respectively). For the three and nine months ended September 30, 2021, and 2020, the interest income and (expense) on deposit accounted contracts were as follows:
8
 Three months ended September 30Nine months ended September 30
 2021202020212020
($ in thousands)($ in thousands)
Deposit interest income$— $560 $— $1,812 
Deposit interest expense$(38)$— $(2,957)$— 
Deposit interest income/(expense), net$(38)$560 $(2,957)$1,812 

Derivative instruments

The Company recognizes derivative financial instruments in the condensed consolidated balance sheets at their fair values. It includes any realized gains and losses and changes in unrealized gains and losses in the caption “Net investment income (loss)” in the condensed consolidated statements of operations.

The Company’s derivatives do not qualify as hedges for financial reporting purposes. The Company records the associated assets and liabilities in its condensed consolidated balance sheets on a gross basis. The Company does not offset these balances against collateral pledged or received.

Other Assets

The caption “Other assets” in the Company’s condensed consolidated balance sheets consists primarily of prepaid expenses, fixed assets, right-of-use lease assets, other receivables, and deferred tax assets.

Other Liabilities

The caption “Other liabilities” in the Company’s condensed consolidated balance sheets consists primarily of accruals for legal and other professional fees, employee bonuses, taxes payable, and lease liabilities.

Earnings (Loss) Per Share
 
The Company’s unvested restricted stock awards, which contain non-forfeitable rights to dividends or dividend equivalents, whether paid or unpaid, are considered “participating securities” for the purposes of calculating earnings (loss) per share. Basic earnings per share is calculated on the basis of the weighted average number of common shares and participating securities outstanding during the period. Diluted earnings (or loss) per share includes the dilutive effect of the following:

•Restricted Stock Units (“RSUs”) issued that would convert to common shares upon vesting;
•additional potential common shares issuable when in-the-money stock options are exercised, determined using the treasury stock method; and
•those common shares with the potential to be issued in connection with convertible debt and other such convertible instruments, determined using the treasury stock method.

Diluted earnings (or loss) per share contemplates a conversion to common shares of all convertible instruments only if they are dilutive with regards to earnings per share. In the event of a net loss, all RSUs, stock options, convertible debt, and participating securities are excluded from the calculation of both basic and diluted loss per share as their inclusion would be anti-dilutive.

9
The table below presents the shares outstanding for the calculation of earnings (loss) per share for the three and nine months ended September 30, 2021 and 2020:
 Three months ended September 30Nine months ended September 30
 2021202020212020
Weighted average shares outstanding - basic32,929,097 35,677,554 33,507,060 35,569,292 
Effect of dilutive employee and director share-based awards— 102,149 — — 
Weighted average shares outstanding - diluted32,929,097 35,779,703 33,507,060 35,569,292 
Anti-dilutive stock options outstanding735,627 835,627 735,627 835,627 
Participating securities excluded from calculation of loss per share 946,556 — 946,556 878,498 

Taxation
 
Under current Cayman Islands law, no corporate entity, including GLRE and Greenlight Re, is obligated to pay taxes in the Cayman Islands on either income or capital gains. The Company has an undertaking from the Governor-in-Cabinet of the Cayman Islands, pursuant to the provisions of the Tax Concessions Law, as amended, that, in the event that the Cayman Islands enacts any legislation that imposes tax on profits, income, gains or appreciations, or any tax in the nature of estate duty or inheritance tax, such tax will not be applicable to GLRE, Greenlight Re nor their respective operations, or to the Class A or Class B ordinary shares or related obligations, before February 1, 2025.
 
Verdant is incorporated in Delaware and therefore is subject to taxes in accordance with the U.S. federal rates and regulations prescribed by the U.S. Internal Revenue Service (“IRS”). Verdant’s taxable income is generally expected to be taxed at a marginal rate of 21% (2020: 21%). Verdant’s tax years 2017 and beyond remain open and subject to examination by the IRS.

GRIL is incorporated in Ireland and therefore is subject to the Irish corporation tax rate of 12.5% on its trading income and 25% on its non-trading income.

The Company records a valuation allowance to the extent that the Company considers it more likely than not that all or a portion of the deferred tax asset will not be realized in the future. Other than this valuation allowance, the Company has not taken any income tax positions subject to significant uncertainty that is reasonably likely to have a material impact on the Company. 

Recent Accounting Pronouncements

Recently Issued Accounting Standards Adopted

In January 2020, the FASB issued ASU No. 2020-01, Investments - Equity Securities (Topic 321), Investments - Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815) - Clarifying the Interactions between Topic 321, Topic 323, and Topic 815 (a consensus of the Emerging Issues Task Force) (“ASU 2020-01”). ASU 2020-01 clarifies interactions between the accounting guidance for (i) certain equity securities under Topic 321, (ii) investments under the equity method of accounting in Topic 323, and (iii) certain derivative instruments in Topic 815. ASU 2020-01 is effective for public business entities for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years. The adoption of ASU 2020-01 during the first quarter of 2021 had no material impact on the Company’s consolidated financial statements.

Recently Issued Accounting Standards Not Yet Adopted

In August 2020, the FASB issued ASU No. 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity's Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity's Own Equity (“ASU 2020-06”). ASU 2020-06 is designed to simplify the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments. The amendments remove the separation models in Subtopic 470-20 for certain contracts. As a result, entities will no longer present embedded conversion features separately in equity; rather, the convertible debt instrument will be accounted for as a single liability measured at its amortized cost. ASU 2020-06 also addresses the computation of earnings per share for convertible debt instruments, requiring
10
the application of the if-converted method when calculating diluted earnings per share. The Company intends to adopt ASU 2020-06 during the first quarter of 2022, using the “modified retrospective” transition method.

The Company expects that its adoption of ASU 2020-06 will impact the accounting for its senior convertible notes (see Note 7) and will lead to a decrease in its opening shareholders’ equity of approximately $2.5 million, with a corresponding increase in the carrying value of the senior convertible notes. The Company expects that in the periods in which the Company reports a net income, the number of shares outstanding for the diluted earnings per share calculation will be approximately 5.8 million higher under the if-converted method. The Company does not expect the adoption of ASU 2020-06 to have a material impact on net income, cash flows, or any other balances.

3. INVESTMENT IN RELATED PARTY INVESTMENT FUND

On September 1, 2018, the Company entered into an amended and restated exempted limited partnership agreement (as amended by the letter agreement dated as of August 5, 2020, (the “Previous SILP LPA”) of Solasglas Investments, LP (“SILP”), with DME Advisors II, LLC (“DME II”), as General Partner, Greenlight Re, and GRIL, (together the “GLRE Limited Partners”), and the initial limited partner (each, a “Partner”). On September 1, 2018, SILP also entered into a SILP investment advisory agreement (“IAA”) with DME Advisors. LP (“DME Advisors”) pursuant to which DME Advisors is the investment manager for SILP. DME II and DME Advisors are related to the Company, and each is an affiliate of David Einhorn, Chairman of the Company’s Board of Directors.

On January 7, 2021, the Company and DME II entered into the Second Amended and Restated Exempted Limited Partnership Agreement, effective as of January 1, 2021 (the “SILP LPA”). The SILP LPA amends, restates, supersedes, and incorporates all material terms of the Previous SILP LPA, as amended as of February 26, 2019, and the letter agreements dated June 18, 2019, December 27, 2019, and August 5, 2020 (collectively, the “Amendments”). The SILP LPA agreement also amended the definition of “Additional Investment Ratio” and each of the defined terms “Greenlight Re Surplus” and the “GRIL Surplus” so as to clarify that each of the respectively referenced “financial statements” are “U.S. GAAP financial statements.” In addition, the SILP LPA included the following: “The Investment Portfolio of each Partner will not exceed the product of (a) such Partner’s surplus (Greenlight Re Surplus or GRIL Surplus, as the case may be) multiplied by (b) the Investment Cap (50%), and the General Partner will designate any portion of a Partner’s Investment Portfolio as Designated Securities to effectuate such limit”. The SILP LPA also amended the investment guidelines to reflect the amended investment guidelines adopted by the Company’s Board of Directors effective as of January 1, 2021.

The Company has concluded that SILP qualifies as a variable interest entity (“VIE”) under U.S. GAAP. In assessing its interest in SILP, the Company noted the following:

•DME II serves as SILP’s general partner and has the power of appointing the investment manager. The Company does not have the power to appoint, change or replace the investment manager or the general partner except “for cause.” Neither of the GLRE Limited Partners can participate in the investment decisions of SILP as long as SILP adheres to the investment guidelines provided within the SILP LPA. For these reasons, the GLRE Limited Partners are not considered to have substantive participating rights or kick-out rights.

•DME II holds an interest in excess of 10% of SILP’s net assets, which the Company considers to represent an obligation to absorb losses and a right to receive benefits of SILP that are significant to SILP.

Consequently, the Company has concluded that DME II’s interests, not the Company’s, meet both the “power” and “benefits” criteria associated with VIE accounting guidance, and therefore DME II is SILP’s primary beneficiary. The Company presents its investment in SILP in its condensed consolidated balance sheets in the caption “Investment in related party investment fund.”

The Company’s maximum exposure to loss relating to SILP is limited to the net asset value of the GLRE Limited Partners’ investment in SILP. At September 30, 2021, the net asset value of the GLRE Limited Partners’ investment in SILP was $180.2 million (December 31, 2020: $166.7 million), representing 78.0% (December 31, 2020: 75.7%) of SILP’s total net assets. DME II held the remaining 22.0% (December 31, 2020: 24.3%) of SILP’s total net assets. The investment in SILP is recorded at the GLRE Limited Partners’ share of the net asset value of SILP as reported by SILP’s third-party administrator. The GLRE Limited Partners can redeem their assets from SILP for operational purposes by providing three business days’ notice to DME II. At September 30, 2021, the majority of SILP’s long investments were composed of cash and publicly traded equity securities, which could be readily liquidated to meet the GLRE Limited Partners’ redemption requests.

The Company’s share of the change in the net asset value of SILP for the three and nine months ended September 30,
11
2021, was $(6.2) million and $(4.2) million, respectively, (three and nine months ended September 30, 2020: $6.4 million and $(34.1) million, respectively), and shown in the caption “Income (loss) from investment in related party investment fund” in the Company’s condensed consolidated statements of operations.

The summarized financial statements of SILP are presented below.

Summarized Statement of Assets and Liabilities of Solasglas Investments, LP
September 30, 2021December 31, 2020
($ in thousands)
Assets
Investments, at fair value$262,058 $272,398 
Derivative contracts, at fair value9,071 1,450 
Due from brokers77,638 92,053 
Cash and cash equivalents1,076 — 
Interest and dividends receivable14 59 
Total assets349,857 365,960 
Liabilities and partners’ capital
Liabilities
Investments sold short, at fair value(109,044)(131,902)
Derivative contracts, at fair value(7,793)(4,156)
Due to brokers(1,170)(9,179)
Interest and dividends payable(603)(429)
Other liabilities(133)(175)
Total liabilities(118,743)(145,841)
Net Assets$231,114 $220,119 
GLRE Limited Partners’ share of Net Assets$180,239 $166,735 


12
Summarized Statement of Operations of Solasglas Investments, LP
Three months ended September 30Nine months ended September 30
2021202020212020
($ in thousands)
Investment income
Dividend income (net of withholding taxes)$146 $170 $509 $1,204 
Interest income51 36 770 262 
Total Investment income197 206 1,279 1,466 
Expenses
Management fee(883)(703)(2,632)(1,981)
Interest(205)(176)(874)(518)
Dividends(306)(213)(852)(612)
Professional fees and other(227)(432)(786)(764)
Total expenses(1,621)(1,524)(5,144)(3,875)
Net investment income (loss)(1,424)(1,318)(3,865)(2,409)
Realized and change in unrealized gains (losses)
Net realized gain (loss) (1,411)(1,412)(14,809)(44,972)
Net change in unrealized appreciation (depreciation) (5,437)10,832 12,143 5,811 
Net gain (loss) on investment transactions(6,848)9,420 (2,666)(39,161)
Net income (loss)$(8,272)$8,102 $(6,531)$(41,570)
GLRE Limited Partners’ share of net income (loss) (1)
$(6,214)$6,431 $(4,196)$(34,086)

(1) Net income (loss) is net of management fees and performance allocation presented below:

Three months ended September 30Nine months ended September 30
2021202020212020
($ in thousands)
Management fees$883 $703 $2,632 $1,981 
Performance allocation$(224)$— $— $— 
Total$659 $703 $2,632 $1,981 

See Note 11 for further details on management fees and performance allocation.

4. FINANCIAL INSTRUMENTS 
 
Investments
  
Other Investments

The Company’s “Other investments” are composed of the following:

•Private investments and unlisted equities, which consist primarily of Innovations-related investments supporting technology innovators in the (re)insurance market; and
•Derivative financial instruments associated with the Company’s Innovations investments.
13

At September 30, 2021, the Company included the following securities in the caption “Other investments”:
CostUnrealized
gains		Unrealized
losses		Fair value / carrying value
 ($ in thousands)
Private investments and unlisted equities $17,175 $24,017 $(1,800)$39,392 
Derivative financial instruments (not designated as hedging instruments)— 3,088 — 3,088 
Total other investments$17,175 $27,105 $(1,800)$42,480 

At December 31, 2020, the Company included the following securities in the caption “Other investments”: 
CostUnrealized
gains		Unrealized
losses		Fair value / carrying value
 ($ in thousands)
Private investments and unlisted equities$12,414 $10,679 $(1,300)$21,793 
Derivative financial instruments (not designated as hedging instruments)— 1,080 — 1,080 
Other investments$12,414 $11,759 $(1,300)$22,873 
Investment accounted for under the equity method6,545 
Total other investments$29,418 

Private investments and unlisted equities include securities that do not have readily determinable fair values. The carrying values of these holdings are determined based on their original cost minus impairment, if any, plus or minus changes resulting from observable price changes. At September 30, 2021, the carrying value of private investments and unlisted equities was $39.4 million (December 31, 2020: $21.8 million). It incorporated upward adjustments of $7.6 million and $12.9 million during the three and nine months ended September 30, 2021, respectively (three and nine months ended September 30, 2020: $0.0 million and $4.1 million, respectively), excluding any unrealized gains or losses related to changes in foreign currency exchange rates. Since acquiring these private investments, the Company has recognized net upward adjustments of $22.1 million and $9.3 million as of September 30, 2021, and December 31, 2020, respectively.

At December 31, 2020, the investment accounted for under the equity method represented an investment in AccuRisk Holdings LLC (“AccuRisk”), a Chicago, Illinois-based managing general underwriter focused on employee and health insurance benefits. During the nine months ended September 30, 2021, the Company sold its investment in AccuRisk and realized a pre-tax gain of $14.2 million.

The Company’s derivative financial instruments are composed of warrants granting the Company the right, but not the obligation, to purchase shares at a specified price on or before the maturity date. The Company has not designated any of its derivative financial instruments as hedging instruments. The Company’s maximum exposure to loss relating to these warrants is limited to the warrants’ carrying amount.

Fair Value Hierarchy

The fair value of a financial instrument is the amount that would be received in an asset sale or paid to transfer a liability in an orderly transaction between unaffiliated market participants. Assets and liabilities measured at fair value are categorized based on whether the inputs are observable in the market and the degree that the inputs are observable. The categorization of financial instruments within the valuation hierarchy is based on the lowest level of input that is significant to the fair value measurement. The hierarchy is prioritized into three levels (with Level 3 being the lowest) defined as follows:

14
•Level 1: Quoted prices in active markets for identical assets or liabilities that the entity has the ability to access.
•Level 2: Observable inputs other than prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; or other inputs that are observable or can be corroborated with observable market data.
•Level 3: Unobservable inputs supported by little or no market activity and significant to the fair value of the assets and liabilities. The term “unobservable inputs” includes certain pricing models, discounted cash flow methodologies, and similar techniques.

The Company values its derivative instruments using the Black-Scholes option pricing model based on Level 3 inputs. The Company uses the carrying value of the underlying stock as an input in the option pricing model. The underlying stock does not have a readily determinable fair value. Its carrying value is determined based on its original cost minus impairment, if any, plus or minus changes resulting from observable price changes. The other assumptions applied to the option pricing model include a risk-free rate of 0.50% and estimated volatility of 50%. The carrying value of the derivative instruments represents the fair value.

For the derivative instruments valued on the basis of Level 3 inputs, the Company includes any change in unrealized gains or losses in the caption “Net investment income (loss)” in the condensed consolidated statements of operations.

At September 30, 2021, and December 31, 2020, the Company did not carry any other investments at fair value with an assigned Level within the fair value hierarchy. The Company’s investment in the related party investment fund is measured at fair value using the net asset value practical expedient. It is therefore not classified within the fair value hierarchy. (See Note 3 for further details on the related party investment fund.)

Financial Instruments Disclosed, But Not Carried, at Fair Value

The caption “Convertible senior notes payable” represents financial instruments that the Company carries at amortized cost. The fair value of the convertible senior notes payable is estimated based on the bid price observed in an inactive market for the identical instrument (Level 2 input) (see Note 7).

5. LOSS AND LOSS ADJUSTMENT EXPENSE RESERVES

At September 30, 2021, the Company’s loss and loss adjustment expense reserves included estimated amounts for several catastrophe events. For significant catastrophe events, including, but not limited to, hurricanes, typhoons, floods, wildfires, and pandemics, loss reserves are generally established based on loss payments and case reserves reported by clients when, and if, received. To establish IBNR loss estimates, the Company makes use of, among other things, the following:

•estimates communicated by ceding companies;
•information received from clients, brokers, and loss adjusters;
•an understanding of the underlying business written and its exposures to catastrophe event-related losses;
•industry data;
•catastrophe scenario modeling software; and
•management’s judgment.

The COVID-19 pandemic is unprecedented, and the Company does not have previous loss experience on which to base the associated estimate for loss and loss adjustment expenses. The Company based its estimate on the following:

•a review of in-force treaties that may provide coverage and incur losses;
•catastrophe and scenario modeling analyses and results shared by cedents;
•preliminary loss estimates received from clients and their analysts and loss adjusters;
•reviews of industry insured loss estimates and market share analyses; and
•management’s judgment.

Significant assumptions which served as the basis for the Company's estimates of reserves for the COVID-19 pandemic losses and loss adjustment expenses include:

•the scope of coverage provided by the underlying policies, particularly those that provide for business interruption coverage;
15
•the regulatory, legislative, and judicial actions that could influence contract interpretations across the insurance industry;
•the extent of economic contraction caused by the COVID-19 pandemic and associated measures, particularly in the United States; and
•the ability of the cedents and insured to mitigate some or all of their losses.

While the Company believes its estimate of loss and loss adjustment expense reserves for the COVID-19 pandemic is adequate as of September 30, 2021, based on available information, actual losses may ultimately differ materially from the Company's current estimates. The Company will continue to monitor the appropriateness of its assumptions as new information becomes available and will adjust its estimates accordingly. Such adjustments may be material to the Company's results of operations and financial condition.

The Company made no significant changes in the actuarial methodology or reserving process related to its loss and loss adjustment expense reserves for the nine months ended September 30, 2021.

At September 30, 2021 and December 31, 2020, loss and loss adjustment expense reserves were composed of the following:
September 30, 2021December 31, 2020
 ($ in thousands)
Case reserves$191,151 $176,805 
IBNR349,628 317,374 
Total$540,779 $494,179 

A summary of changes in outstanding loss and loss adjustment expense reserves for all lines of business consolidated
for the nine months ended September 30, 2021 and 2020 is as follows: 
Consolidated20212020
 ($ in thousands)
Gross balance at January 1$494,179 $470,588 
Less: Losses recoverable(16,851)(27,531)
Net balance at January 1477,328 443,057 
Incurred losses related to:  
Current year296,333 247,559 
Prior years(1,255)5,385 
Total incurred295,078 252,944 
Paid losses related to:  
Current year(96,442)(72,453)
Prior years(146,545)(161,222)
Total paid(242,987)(233,675)
Foreign currency revaluation(1,722)(505)
Net balance at September 30527,697 461,821 
Add: Losses recoverable13,082 19,949 
Gross balance at September 30$540,779 $481,770 
    
For the nine months ended September 30, 2021, the estimate of net losses incurred relating to prior accident years decreased by $1.3 million, due primarily to favorable development on catastrophe events, a mortgage contract associated with the COVID-19 pandemic, and certain health contracts. The decrease in prior accident years was partially offset by adverse loss development on certain workers’ compensation and multi-line casualty contracts written between 2014 and 2018. The favorable loss development on a mortgage contract was offset by increased profit commissions on the same contract.

For the nine months ended September 30, 2020, the estimate of net losses incurred relating to prior accident years increased by $5.4 million, due primarily to certain general liability, health and multi-line contracts, partially offset by favorable loss development on professional liability contracts.
16
The changes in the outstanding loss and loss adjustment expense reserves for health claims for the nine months ended September 30, 2021 and 2020 are as follows:
Health20212020
 ($ in thousands)
Gross balance at January 1$17,485 $18,063 
Less: Losses recoverable— — 
Net balance at January 117,485 18,063 
Incurred losses related to: 
Current year31,189 25,032 
Prior years(1,898)1,341 
Total incurred29,291 26,373 
Paid losses related to: 
Current year(20,224)(15,115)
Prior years(13,824)(16,327)
Total paid(34,048)(31,442)
Foreign currency revaluation— — 
Net balance at September 3012,728 12,994 
Add: Losses recoverable— — 
Gross balance at September 30$12,728 $12,994 


6. RETROCESSION
 
From time to time, the Company purchases retrocessional coverage for one or more of the following reasons: to manage its overall exposure, reduce its net liability on individual risks, obtain additional underwriting capacity and balance its underwriting portfolio. The Company records loss and loss adjustment expenses recoverable from retrocessionaires as assets.

For the three and nine months ended September 30, 2021, the Company’s earned ceded premiums were insignificant compared to $1.7 million and $3.2 million for the three and nine months ended September 30, 2020, respectively. For the three and nine months ended September 30, 2021, loss and loss expenses recovered were insignificant compared to $2.5 million and $6.2 million for the three and nine months ended September 30, 2020, respectively.

Retrocession contracts do not relieve the Company from its obligations to its cedents. Failure of retrocessionaires to honor their obligations could result in losses to the Company. At September 30, 2021, the Company’s loss reserves recoverable consisted of (i) $9.9 million (December 31, 2020: $12.6 million) from unrated retrocessionaires, of which $9.7 million (December 31, 2020: $11.9 million) were secured by cash, letters of credit and collateral held in trust accounts for the benefit of the Company and (ii) $3.2 million (December 31, 2020: $4.3 million) from retrocessionaires rated A- or above by A.M. Best.

The Company regularly evaluates its net credit exposure to assess the ability of the retrocessionaires to honor their respective obligations. At September 30, 2021, the Company had recorded an allowance for expected credit losses of $47.0 thousand (December 31, 2020: $47.0 thousand).

7. SENIOR CONVERTIBLE NOTES

On August 7, 2018, the Company issued $100.0 million of senior unsecured convertible notes (the “Notes”), which mature on August 1, 2023. The Notes bear interest at 4.0%, payable semi-annually on February 1 and August 1 of each year beginning February 1, 2019.

Note holders have the option, under certain conditions, to redeem the Notes prior to maturity.
If a holder redeems the Notes, the Company shall have the option to settle the conversion obligation in cash, ordinary shares of the Company, or a combination thereof pursuant to the terms of the indenture governing the Notes. The Company has therefore bifurcated the Notes into liability and equity components.
17
At September 30, 2021, the Company’s share price was lower than the conversion price of $17.19 per share.
The Company’s effective borrowing rate for non-convertible debt at the time of issuance of the Notes was estimated to be 6.0%, which equated to an $8.2 million discount. At September 30, 2021, and December 31, 2020, the unamortized debt discount was $3.0 million and $4.2 million, respectively. The debt discount also represents the portion of the Note’s principal amount allocated to the equity component.
The Company incurred issuance costs in connection with the issuance of the Notes. At September 30, 2021, the unamortized portion of these costs attributed to the debt component was $1.2 million (December 31, 2020: $1.6 million), which the Company expects to amortize through the maturity date. The Company netted the portion of these issuance costs attributed to the equity component against the gross proceeds allocated to equity, resulting in the Company including $7.9 million in the caption “Additional paid-in capital” in the Company’s condensed consolidated balance sheets.

The carrying value of the Notes at September 30, 2021, including accrued interest of $0.7 million, was $96.5 million (December 31, 2020: $95.8 million). At September 30, 2021, the Company estimated the fair value of the Notes to be $94.6 million (December 31, 2020: $83.6 million) (see Note 4 Financial Instruments).
For the three and nine months ended September 30, 2021, the Company recognized interest expenses of $1.6 million and $4.7 million, respectively (2020: $1.6 million and $4.7 million, respectively) in connection with the interest coupon, amortization of issuance costs, and amortization of the discount.

The Company was in compliance with all covenants relating to the Notes at September 30, 2021, and December 31, 2020.

8. SHARE CAPITAL

The Company’s share capital is made up of ordinary share capital and additional paid-in capital. Ordinary share capital represents the issued and outstanding Class A and Class B ordinary shares at their par values of $0.10 per share. Additional paid-in capital includes the premium paid per share by the subscribing shareholders for Class A and Class B ordinary shares, as well as the earned portion of the grant-date fair value of share-based awards.

On October 29, 2020, the Company’s shareholders approved an amendment to the stock incentive plan to increase the number of Class A ordinary shares available for issuance by 3.0 million shares from 5.0 million to 8.0 million. At September 30, 2021, 3,128,276 (December 31, 2020: 3,474,888) Class A ordinary shares remained available for future issuance under the Company’s stock incentive plan. The Compensation Committee of the Board of Directors administers the Company’s stock incentive plan. 

The Board has adopted a share repurchase plan. The timing of such repurchases and the actual number of shares repurchased will depend on various factors, including price, market conditions, and applicable regulatory and corporate requirements. On March 26, 2020, the Board of Directors extended the share repurchase plan to June 30, 2021. It increased the number of shares authorized to be repurchased to 5.0 million Class A ordinary shares or securities convertible into Class A ordinary shares in the open market through privately negotiated transactions or Rule 10b5-1 stock trading plans. In addition, the Board of Directors also authorized the Company to repurchase up to $25.0 million aggregate face amount of the Company’s 4.00% Convertible Senior Notes due 2023 (the “Notes”) in privately negotiated transactions, in open market repurchases, or pursuant to one or more tender offers. The Company did not repurchase any Notes under the repurchase plan.

On May 4, 2021, the Board of Directors approved a new share repurchase plan effective from July 1, 2021, until June 30, 2022, authorizing the Company to purchase up to $25 million of Class A ordinary shares or securities convertible into Class A ordinary shares in the open market, through privately negotiated transactions or Rule 10b5-1 stock trading plans. The Company is not required to repurchase any of the Class A ordinary shares or the Notes. The repurchase plans may be modified, suspended, or terminated at the election of our Board of Directors at any time without prior notice.

The Company repurchased 1,079,544 Class A ordinary shares during the nine months ended September 30, 2021. All Class A ordinary shares repurchased are canceled immediately upon repurchase.


18
The following table is a summary of ordinary shares issued and outstanding:
Nine months ended September 30Nine months ended September 30
 20212020
Class AClass BClass AClass B
Balance – beginning of period28,260,075 6,254,715 30,739,395 6,254,715 
Issue of ordinary shares, net of forfeitures409,200 — 248,726 — 
Repurchase of ordinary shares(1,079,544)— (1,874,419)— 
Balance – end of period27,589,731 6,254,715 29,113,702 6,254,715 


9. SHARE-BASED COMPENSATION
 
The Company has a stock incentive plan for directors, employees, and consultants administered by the Compensation Committee of the Board of Directors.
 
Employee and Director Restricted Shares
 
For the nine months ended September 30, 2021, the Company issued 334,312 (2020: 306,264) Class A ordinary shares to employees pursuant to the Company’s stock incentive plan. These shares contain certain restrictions relating to, among other things, vesting, forfeiture in the event of termination of employment, and transferability. The restricted shares cliff vest three years after the date of issuance, subject to the grantee’s continued service with the Company. During the vesting period, the holder of the restricted shares retains voting rights and is entitled to any dividends declared by the Company.

For the nine months ended September 30, 2021, grantees forfeited 20,592 (2020: 210,109) restricted shares. For the nine months ended September 30, 2021, the Company reversed $0.1 million of stock compensation expense (2020: $0.7 million) in relation to the forfeited restricted shares.

The Company recorded $1.8 million of share-based compensation expense, net of forfeiture reversals, relating to restricted shares for the nine months ended September 30, 2021 (2020: $0.6 million). At September 30, 2021, there was $3.3 million (December 31, 2020: $1.9 million) of unrecognized compensation cost relating to non-vested restricted shares (excluding any restricted shares with performance conditions that the Company currently does not expect will be met), which the Company expects to recognize over a weighted-average period of 1.9 years (December 31, 2020: 1.5 years). For the nine months ended September 30, 2021, the total fair value of restricted shares vested was $1.6 million (2020: $2.8 million).

For the nine months ended September 30, 2021, the Company also issued to non-employee directors an aggregate of 74,769 (2020: 0) restricted Class A ordinary shares as part of their remuneration for services to the Company. Each of these restricted shares issued to non-employee directors contains similar restrictions to those issued to employees and will vest on the earlier of the first anniversary of the date of the share issuance or the Company’s next annual general meeting, subject to the grantee’s continued service with the Company.

The following table summarizes the activity for unvested outstanding restricted share awards during the nine months ended September 30, 2021:

 Number of
non-vested
restricted
 shares		Weighted
 average
grant date
fair value
Balance at December 31, 2020697,549 $9.38 
Granted409,081 9.11 
Vested(139,482)11.53 
Forfeited(20,592)8.35 
Balance at September 30, 2021946,556 $8.97 
 
19
Employee and Director Stock Options

For the nine months ended September 30, 2021, and 2020, no Class A ordinary share purchase options were granted or exercised by directors or employees. For the nine months ended September 30, 2021, 100,000 (2020: 40,000) stock options expired and 80,000 (2020: 80,000) stock options vested. When the Company grants stock options, it reduces the corresponding number from the shares authorized for issuance as part of the Company’s stock incentive plan.

The Board of Directors does not currently anticipate that the Company will declare any dividends during the expected term of the options. The Company uses graded vesting for expensing employee stock options. The total compensation cost expensed relating to stock options for the nine months ended September 30, 2021, was $0.3 million (2020: $0.5 million). At September 30, 2021, the total compensation cost related to non-vested options not yet recognized was $0.3 million (December 31, 2020: $0.7 million), which will be recognized over a weighted-average period of 1.4 years (December 31, 2020: 1.8 years) assuming the grantee completes the service period for vesting of the options.

At September 30, 2021, and December 31, 2020, 0.7 million and 0.8 million stock options were outstanding, respectively, with a weighted average exercise price of $22.35 and $22.22 per share, respectively, and a weighted average grant date fair value of $10.23 and $10.25 per share, respectively. The stock options’ weighted-average remaining contractual terms were 4.9 years and 5.1 years, at September 30, 2021, and December 31, 2020, respectively.

 Employee Restricted Stock Units

The Company issues RSUs to certain employees as part of the stock incentive plan.

These RSUs contain restrictions relating to vesting, forfeiture in the event of termination of employment, transferability, and other matters. Each RSU grant cliff vests three years after the date of issuance, subject to the grantee’s continued service with the Company. On the vesting date, the Company converts each RSU into one Class A ordinary share and issues new Class A ordinary shares from the shares authorized for issuance as part of the Company’s stock incentive plan. For the nine months ended September 30, 2021, the Company issued 58,123 (2020: 60,622) RSUs to employees pursuant to the Company’s stock incentive plan. For the nine months ended September 30, 2021, and 2020, no RSUs were forfeited.

The Company recorded $0.3 million of share-based compensation expense relating to RSUs for the nine months ended September 30, 2021 (2020: $0.3 million). At September 30, 2021, the total compensation cost related to non-vested RSUs not yet recognized was $0.6 million (2020: $0.4 million), which the Company expects to recognize over a weighted-average period of 1.9 years (2020: 1.8 years).

Employee RSU activity during the nine months ended September 30, 2021, was as follows:
 Number of
non-vested
RSUs		Weighted
 average
grant date
fair value
Balance at December 31, 2020116,722 $9.60 
Granted58,123 9.18 
Vested(20,711)15.90 
Balance at September 30, 2021154,134 $8.59 

Performance Restricted Shares

Prior to 2021, the Company issued Class A ordinary shares to the Chief Executive Officer (“CEO”) pursuant to the Company’s stock incentive plan. These shares contain performance and service conditions and certain restrictions relating to, among other things, vesting, forfeiture in the event of termination of the CEO’s employment, and transferability. These restricted shares cliff vest five years after the date of issuance, subject to the performance condition being met and the CEO’s continued service with the Company. The weighted average grant date fair value of these restricted shares subject to performance conditions was $6.72 per share. At September 30, 2021, 193,149 unvested performance restricted shares were outstanding (December 31, 2020: 193,149). As the performance conditions associated with these restricted shares have not been met, the Company recognized no compensation cost relating to the unvested shares for the nine months ended September 30, 2021, and 2020.
20

For the nine months ended September 30, 2021 and 2020, the combined stock compensation expense (net of forfeitures) included in the caption “General and administrative expenses” in the Company’s statements of operations was $2.4 million and $1.4 million, respectively.


10. TAXATION

At September 30, 2021, the Company recorded a gross deferred tax asset of $4.0 million (2020: $3.5 million) and a deferred tax asset valuation allowance of $3.5 million (2020: $3.0 million). The net deferred tax asset is included in the caption “Other assets” in the Company’s condensed consolidated balance sheets. The Company has determined that it is more likely than not to fully realize the recorded deferred tax asset (net of the valuation allowance) in the future. The Company based this determination on the expected timing of the reversal of the temporary differences and the likelihood of generating sufficient taxable income to realize the future tax benefit.

The following table sets forth our current and deferred income tax benefit (expense) on a consolidated basis for the nine months ended September 30, 2021 and 2020:
Three months ended September 30Nine months ended September 30
 2021202020212020
 ($ in thousands)($ in thousands)
Current tax (expense) benefit$323 $(33)$(3,240)$272 
Decrease (increase) in deferred tax valuation allowance(323)33 (493)(696)
Income tax (expense) benefit $— $— $(3,733)$(424)

For the nine months ended September 30, 2021, the income tax expense of $3.7 million resulted from Verdant’s gain on the sale of its AccuRisk investment.


11. RELATED PARTY TRANSACTIONS 
 
Investment Advisory Agreement
 
DME, DME II, and DME Advisors are each an affiliate of David Einhorn, Chairman of the Company’s Board of Directors, and therefore, are related parties to the Company.

The Company has entered into the SILP LPA (as described in Note 3 of the condensed consolidated financial statements). DME II receives a performance allocation equal to (with capitalized terms having the meaning provided under the SILP LPA) (a) 10% of the portion of the Positive Performance Change for each limited partner’s capital account that is less than or equal to the positive balance in such limited partner’s Carryforward Account, plus (b) 20% of the portion of the Positive Performance Change for each limited partner’s capital account that exceeds the positive balance in such limited partner’s Carryforward Account. The Carryforward Account for Greenlight Re and GRIL includes the amount of losses that were to be recouped under the Joint Venture as well as any loss generated on the assets invested in SILP, subject to adjustments for redemptions. The loss carry-forward provision contained in the SILP LPA allows DME II to earn a reduced performance allocation of 10% of profits in years subsequent to any year in which SILP has incurred a loss until all losses are recouped, and an additional amount equal to 150% of the loss is earned.

In accordance with the SILP LPA, DME Advisors constructs a levered investment portfolio as agreed by the Company (the “Investment Portfolio” as defined in the SILP LPA). On September 1, 2018, SILP entered into the IAA with DME Advisors, which entitles DME Advisors to a monthly management fee equal to 0.125% (1.5% on an annual basis) of each limited partner’s Investment Portfolio. The IAA has an initial term ending on August 31, 2023, subject to an automatic extension for successive three-year terms.

For a detailed breakdown of management fees and performance compensation for the three and nine months ended September 30, 2021, and 2020, refer to Note 3 of the condensed consolidated financial statements.
 
21
Pursuant to the SILP LPA and the IAA, the Company has agreed to indemnify DME, DME II, and DME Advisors for any expense, loss, liability, or damage arising out of any claim asserted or threatened in connection with DME Advisors serving as the Company’s or SILP’s investment advisor. The Company will reimburse DME, DME II, and DME Advisors for reasonable costs and expenses of investigating and defending such claims, provided such claims were not caused due to gross negligence, breach of contract, or misrepresentation by DME, DME II, or DME Advisors. The Company incurred no indemnification amounts during the periods presented.

Green Brick Partners, Inc.

David Einhorn also serves as the Chairman of the Board of Directors of Green Brick Partners, Inc. (“GRBK”), a publicly-traded company. At September 30, 2021, SILP, along with certain affiliates of DME Advisors, collectively owned 34.3% of the issued and outstanding common shares of GRBK. Under applicable securities laws, DME Advisors may be limited at times in its ability to trade GRBK shares on behalf of SILP.

Service Agreement
 
The Company has entered into a service agreement with DME Advisors, pursuant to which DME Advisors provides certain investor relations services to the Company for compensation of five thousand dollars per month (plus expenses). The agreement is automatically renewed annually until terminated by either the Company or DME Advisors for any reason with 30 days prior written notice to the other party. 

Collateral Assets Investment Management Agreement

Effective January 1, 2019, the Company (and its subsidiaries) entered into a collateral assets investment management agreement (the “CMA”) with DME Advisors, pursuant to which DME Advisors manages certain assets of the Company that are not subject to the SILP LPA and are held by the Company to provide collateral required by the cedents in the form of trust accounts and letters of credit. In accordance with the CMA, DME Advisors receives no fees and is required to comply with the collateral investment guidelines. The CMA can be terminated by any of the parties upon 30 days’ prior written notice to the other parties.


12. COMMITMENTS AND CONTINGENCIES 
 
Letters of Credit and Trusts
 
At September 30, 2021, the Company had one letter of credit facility, which automatically renews each year unless terminated by either party in accordance with the applicable required notice period:
Maximum Facility LimitTermination DateNotice period required for termination
 ($ in thousands)  
Citibank Europe plc$275,000 August 20, 2022
120 days before the termination date

At September 30, 2021, an aggregate amount of $138.4 million (December 31, 2020: $135.3 million) in letters of credit was issued under the credit facility. At September 30, 2021, the Company had pledged total cash and cash equivalents with a fair value in the aggregate of $142.4 million (December 31, 2020: $137.6 million) as collateral against the letters of credit issued and included in the caption “Restricted cash and cash equivalents” in the Company’s condensed consolidated balance sheets. The credit facility contains customary events of default and restrictive covenants, including but not limited to limitations on liens on collateral, transactions with affiliates, mergers, and sales of assets, as well as solvency and maintenance of certain minimum pledged equity requirements and restricts issuance of any debt without the consent of the letter of credit provider. Additionally, if an event of default exists, as defined in the letter of credit facility, Greenlight Re will be prohibited from paying dividends to its parent company. The Company was in compliance with all the credit facility covenants at September 30, 2021 and December 31, 2020.

The Company has also established regulatory trust arrangements for certain cedents. At September 30, 2021, collateral of $550.2 million (December 31, 2020: $607.8 million) was provided to cedents in the form of regulatory trust accounts and included in the caption “Restricted cash and cash equivalents” in the Company’s condensed consolidated balance sheets.

22
Lease Obligations
 
Greenlight Re entered into a new lease agreement for office space in the Cayman Islands commencing July 1, 2021. The lease expires on June 30, 2026, unless Greenlight Re exercises its right to renew the lease for another five-year period. The annual lease obligation ranges from $0.5 million to $0.6 million. The Company determined that this agreement qualifies as an operating lease. At September 30, 2021, the right-of-use asset and a corresponding lease liability relating to the lease agreement were $2.2 million. The operating lease expense for the three and nine months ended September 30, 2021, was $0.1 million and $0.1 million, respectively.

Greenlight Re’s previous lease arrangement qualified as a short-term lease. The short-term lease expense for the three and nine months ended September 30, 2021, was nil and $0.3 million, respectively (three and nine months ended September 30, 2020: $0.1 million and $0.4 million, respectively).
Schedule of Commitments and Contingencies
The following is a schedule of future minimum payments required under the above commitments:  
 20212022202320242025ThereafterTotal
 ($ in thousands)
Operating lease obligations$130 $588 $624 $640 $657 $788 $3,427 
Interest and convertible note payable$— $4,000 $104,000 — — — 108,000 
 $130 $4,588 $104,624 $640 $657 $788 $111,427 

Litigation
 
From time to time, in the normal course of business, the Company may be involved in formal and informal dispute resolution procedures, which may include arbitration or litigation. The outcomes of these procedures determine the rights and obligations under the Company’s reinsurance contracts and other contractual agreements. In some disputes, the Company may seek to enforce its rights under an agreement or collect funds owed. In other matters, the Company may resist attempts by others to collect funds or enforce alleged rights. While the Company cannot predict the outcome of legal disputes with certainty, the Company does not believe that any existing dispute, when finally resolved, will have a material adverse effect on the Company’s business, financial condition, or operating results.


23
13. SEGMENT REPORTING
 
The Company has one operating segment, Property & Casualty Reinsurance.

Substantially all of the Company’s business is sourced through reinsurance brokers. The following table sets forth the premiums generated through our largest brokers and their subsidiaries and affiliates (totals may not sum due to rounding):   

Gross Premiums Written by Line of Business
  Three months ended September 30Nine months ended September 30
2021202020212020
  ($ in thousands)($ in thousands)
Property
Commercial$3,398 2.6 %$3,396 2.5 %$9,700 2.2 %$9,426 2.6 %
Motor6,103 4.7 10,091 7.4 24,537 5.6 25,136 6.9 
Personal3,631 2.8 3,691 2.7 10,318 2.3 10,326 2.9 
Total Property13,132 10.2 17,178 12.6 44,555 10.1 44,888 12.4 
Casualty
General Liability7,376 5.7 3,224 2.4 10,749 2.4 3,920 1.1 
Motor Liability19,823 15.4 41,679 30.7 96,795 22.0 96,729 26.7 
Professional Liability 154 0.1 76 0.1 302 0.1 199 0.1 
Workers' Compensation17,117 13.3 21,979 16.2 55,237 12.5 60,908 16.8 
Multi-line 40,162 31.2 25,820 19.0 137,857 31.3 67,379 18.6 
Total Casualty84,632 65.7 92,778 68.4 300,940 68.4 229,135 63.3 
Other
Accident & Health4,175 3.2 12,418 9.3 26,427 6.0 40,522 11.2 
Financial17,920 13.9 1,817 1.3 40,134 9.1 15,704 4.3 
Marine2,462 1.9 127 0.1 8,412 1.9 749 0.2 
Other Specialty6,414 5.0 11,278 8.3 19,781 4.5 31,074 8.6 
Total Other30,971 24.1 25,640 19.0 94,754 21.5 88,049 24.3 
$128,735 100.0 %$135,596 100.0 %$440,249 100.0 %$362,072 100.0 %

Gross Premiums Written by Geographic Area of Risks Insured
 Three months ended September 30Nine months ended September 30
2021202020212020
 ($ in thousands)($ in thousands)
U.S. and Caribbean$67,087 52.1 %$110,798 81.7 %$258,849 58.8 %$291,511 80.5 %
Worldwide (1)
59,616 46.3 22,738 16.8 174,470 39.6 66,150 18.3 
Europe
1,483 1.2 — — 2,787 0.6 — — 
Asia
549 0.4 2,060 1.5 4,143 0.9 4,411 1.2 
$128,735 100.0 %$135,596 100.0 %$440,249 100.0 %$362,072 100.0 %
(1) “Worldwide” is composed of contracts that reinsure risks in more than one geographic area and may include risks in the U.S. 

24
Item 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
 
References to “we,” “us,” “our,” “our company,”  or “the Company” refer to Greenlight Capital Re, Ltd. (“GLRE”) and our wholly-owned subsidiaries, Greenlight Reinsurance, Ltd, (“Greenlight Re”), Greenlight Reinsurance Ireland, Designated Activity Company (“GRIL”), Greenlight Re Marketing (UK) Limited (“Greenlight Re UK”) and Verdant Holding Company, Ltd. (“Verdant”), unless the context dictates otherwise. References to our “Ordinary Shares” refer collectively to our Class A Ordinary Shares and Class B Ordinary Shares.
 
The following is a discussion and analysis of our results of operations for the three and nine months ended September 30, 2021 and 2020 and financial condition at September 30, 2021 and December 31, 2020. The following discussion should be read in conjunction with the audited consolidated financial statements and accompanying notes, which appear in our annual report on Form 10-K for the fiscal year ended December 31, 2020.
  
Special Note About Forward-Looking Statements
 
Certain statements in Management’s Discussion and Analysis, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives, and expected operating results, and the assumptions upon which those statements are based, are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). These forward-looking statements generally are identified by the words “believe,” “project,” “predict,” “expect,” “anticipate,” “estimate,” “intend,” “plan,” “may,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions. Forward-looking statements are based on current expectations and assumptions that are subject to risks and uncertainties, which may cause actual results to differ materially from the forward-looking statements. We have included a detailed discussion of risks and uncertainties that could cause actual results and events to differ materially from such forward-looking statements in the section entitled “Risk Factors” (refer to Part I, Item 1A) contained in our Form 10-K for the fiscal year ended December 31, 2020, as filed with the Securities and Exchange Commission (the “SEC”) on March 10, 2021. Such risks and uncertainties include, but are not limited to:

•The impact of disruptions to commerce, reduced economic activity, and other consequences of a pandemic, including the novel coronavirus (“COVID-19”), is unknown;
•A.M. Best may downgrade or withdraw either of our ratings;
•Our results of operations will likely fluctuate from period to period and may not be indicative of our long-term prospects;
•Under our investment management structure, we have limited control over Solasglas Investments, LP (“SILP”);
•SILP may be concentrated in a few large positions, which could result in large losses;
•Competitors with greater resources may make it difficult for us to effectively market our products or offer our products at a profit;
•If our losses and loss adjustment expenses greatly exceed our loss reserves, our financial condition may be significantly and negatively affected;
•We may face risks from future strategic transactions such as acquisitions, dispositions, mergers, or joint ventures;
•The effect of emerging claim and coverage issues on our business is uncertain;
•The property and casualty reinsurance market may be affected by cyclical trends;
•The loss of key executives could adversely impact our ability to implement our business strategy; and
•Currency fluctuations could result in exchange rate losses and negatively impact our business.

We undertake no obligation to publicly update or revise any forward-looking statements, whether due to new information, future events, or otherwise. Readers are cautioned not to place undue reliance on the forward-looking statements, which speak only to the dates they were made.
 
We intend to communicate certain events that we believe may have a material adverse impact on our operations or financial position, including property and casualty catastrophic events and material losses in our investment portfolio, in a timely manner through a public announcement. Other than as required by the Exchange Act, we do not intend to make public announcements regarding reinsurance or investment events that we do not believe, based on management’s estimates and current information, will have a material adverse impact on our operations or financial position.

25
General
 
We are a global specialty property and casualty reinsurer headquartered in the Cayman Islands, with a reinsurance and investment strategy that we believe differentiates us from most of our competitors. Our goal is to build long-term shareholder value by providing risk management solutions to the insurance, reinsurance, and other risk marketplaces. We focus on delivering risk solutions to clients and brokers who value our expertise, analytics, and customer service offerings.
 
We aim to complement our underwriting activities with a non-traditional investment approach designed to achieve higher rates of return over the long term than reinsurance companies that exclusively employ more traditional investment strategies. Our investment portfolio is managed according to a value-oriented philosophy, in which our investment advisor takes long positions in perceived undervalued securities and short positions in perceived overvalued securities. In 2018, we launched our Greenlight Re Innovations unit, which supports technology innovators in the (re)insurance market by providing investment, risk capacity, and access to a broad insurance network.

Because we seek to capitalize on favorable market conditions and opportunities, period-to-period comparisons of our underwriting results may not be meaningful. Also, our historical investment results are not necessarily indicative of future performance. Due to the nature of our reinsurance and investment strategies, our operating results will likely fluctuate from period to period.

The Company’s subsidiaries hold an A.M. Best Financial Strength Rating of A- (Excellent) with a stable outlook.

Critical Accounting Policies and Estimates
 
Our condensed consolidated financial statements contain certain amounts that are inherently subjective and have required management to make assumptions and best estimates to determine reported values. If certain factors, including those described in “Part I. Item IA. — Risk Factors” included in our Form 10-K for the fiscal year ended December 31, 2020, as filed with the SEC on March 10, 2021, cause actual events or results to differ materially from our underlying assumptions or estimates, there could be a material adverse effect on our results of operations, financial condition or liquidity. “Part II. Item 7. — Management’s Discussion and Analysis of Financial Condition and Results on Operations” included in our annual report on Form 10-K for the fiscal year ended December 31, 2020, describes our critical accounting policies and estimates. The most significant estimates relate to premium revenues and risk transfer, loss and loss adjustment expense reserves, investment impairments, allowances for credit losses, bonus accruals, and share-based compensation.

Recently issued and adopted accounting standards and their impact on the Company, if any, are presented under “Recent Accounting Pronouncements” in Note 2 to the condensed consolidated financial statements.

Segments
 
We have one operating segment, Property & Casualty reinsurance, and we analyze our business based on the following categories:
 ●Property
●Casualty
●Other

Property business covers automobile physical damage, personal lines, and commercial lines exposures. Property business includes both catastrophe and non-catastrophe coverage. We expect catastrophe business to make up a small proportion of our property business.

Casualty business covers general liability, motor liability, professional liability, and workers’ compensation exposures. The Company’s multi-line business relates predominantly to casualty reinsurance, and as such, the Company includes all multi-line business within the casualty category. Casualty business generally has losses reported and paid over a longer period than property business. We categorize Lloyd’s syndicate contracts, which incorporate incidental catastrophe exposure, as multi-line (and therefore casualty) business.

Other business covers accident and health, financial lines (including transactional liability, mortgage insurance, surety, and trade credit), marine, energy, and to a lesser extent, other specialty business such as aviation, crop, cyber, political, and terrorism exposures.
26

Outlook and Trends

During the first nine months of 2021, we saw improved rates in most of the classes of business we wrote which enabled us to selectively expand our specialty book while taking advantage of improved rates. Our in-force portfolio reflects increased diversification across the classes of business we write and a lower concentration risk to individual counterparties than at any time in our history.

In the third quarter of 2021, the reinsurance industry was challenged by an unusually high incidence of large losses. Our adjusted combined ratio, which excludes the impact of such catastrophes, has reduced steadily over the past few quarters, reflecting improvements in our underwriting quality and the overall rating environment.

Looking forward to 2022, it is not clear to us how the reinsurance market will respond to another year of significant property-catastrophe losses. Our current expectation is that structural problems within the “pure catastrophe” class will limit premium rate increases. However, we do expect that the recent property catastrophe losses will help support and extend the generally favorable market conditions in most other classes. We expect that the continued low interest rate environment will further support overall pricing conditions.

We continue to be encouraged by our Innovations unit, whose central objective is enhancing our underwriting product and quality of return by establishing a range of strategic partnerships. Year to date, Innovations business represents approximately 6% of our total written premium, and we see the potential for significant growth from Innovations-derived underwriting opportunities going forward.


Key Financial Measures and Non-GAAP Measures

Basic Book Value Per Share and Fully Diluted Book Value Per Share

We believe that long-term growth in fully diluted book value per share is the most relevant measure of our financial performance because it provides management and investors a yardstick to monitor the shareholder value generated. Fully diluted book value per share may also help our investors, shareholders, and other interested parties form a basis of comparison with other companies within the property and casualty reinsurance industry.

We calculate basic book value per share based on ending shareholders' equity and aggregate of Class A and Class B Ordinary shares issued and outstanding, as well as all unvested restricted shares. Fully diluted book value per share represents basic book value per share combined with any dilutive impact of in-the-money stock options and RSUs issued and outstanding as of any period end. Fully diluted book value per share also includes the dilutive effect, if any, of ordinary shares to be issued upon conversion of the convertible notes.

Our primary financial goal is to increase fully diluted book value per share over the long term.

27
The following table presents the basis and fully diluted book value per share for the recent periods:
September 30, 2021June 30, 2021March 31, 2021December 31, 2020September 30, 2020
   ($ in thousands, except per share and share amounts)
Numerator for basic and fully diluted book value per share: 
Total equity (U.S. GAAP) (numerator for basic and fully diluted book value per share)$450,514 $466,826 $472,119 $464,857 $426,867 
Denominator for basic and fully diluted book value per share: (1)
Ordinary shares issued and outstanding (denominator for basic book value per share) 33,844,44634,171,06834,850,52834,514,79035,368,417
Add: In-the-money stock options and RSUs issued and outstanding154,134154,134154,134116,722116,722
Denominator for fully diluted book value per share 33,998,58034,325,20235,004,66234,631,51235,485,139
Basic book value per share$13.31 $13.66 $13.55 $13.47 $12.07 
Increase (decrease) in basic book value per share ($)$(0.35)$0.11 $0.08 $1.40 $0.22 
Increase (decrease) in basic book value per share (%)(2.6)%0.8 %0.6 %11.6 %1.9 %
Fully diluted book value per share$13.25 $13.60 $13.49 $13.42 $12.03 
Increase (decrease) in fully diluted book value per share ($)$(0.35)$0.11 $0.07 $1.39 $0.22 
Increase (decrease) in fully diluted book value per share (%)(2.6)%0.8 %0.5 %11.6 %1.9 %

(1) All unvested restricted shares, including those with performance conditions, are included in the “basic” and “fully diluted” denominators. At September 30, 2021, the number of unvested restricted shares with performance conditions was 193,149 (at June 30, 2021: 193,149, March 31, 2021: 193,149, December 31, 2020: 193,149, September 30, 2020: 429,444).

Management also uses certain key financial measures, some of which are not prescribed under U.S. GAAP rules and standards (“non-GAAP financial measures”), to evaluate our financial performance, financial position, and the change in shareholder value. Generally, a non-GAAP financial measure, as defined in SEC Regulation G, is a numerical measure of a company’s historical or future financial performance, financial position, or cash flows that either excludes or includes amounts that are not normally excluded or included in the most directly comparable measure calculated and presented under U.S. GAAP. We believe that these measures, which may be calculated or defined differently by other companies, provide consistent and comparable metrics of our business performance to help shareholders understand performance trends and allow for a more thorough understanding of the Company’s business. Non-GAAP financial measures should not be viewed as a substitute for those determined under U.S. GAAP. The key non-GAAP financial measures used in this report are:

•Adjusted combined ratio; and
•Net underwriting income (loss).

These non-GAAP measures are described below.

Adjusted combined ratio

“Combined ratio” is a commonly used measure in the property and casualty insurance industry and is calculated using U.S. GAAP components. We use the combined ratio, as well as an adjusted combined ratio that excludes the impacts of certain items, to evaluate our underwriting performance. We believe this adjusted non-GAAP measure provides management and financial statement users with a better understanding of the factors influencing our underwriting results.
28
In calculating the adjusted combined ratio, we exclude underwriting income and losses attributable to (i) prior accident-year reserve development, (ii) catastrophe events, and (iii) other significant infrequent adjustments.
Prior accident-year reserve development, which can be favorable or unfavorable, represents changes in our estimates of losses and loss adjustment expenses associated with loss events that occurred in prior years. We believe a discussion of current accident-year performance, which excludes prior accident-year reserve development, is helpful since it provides more insight into current underwriting performance.
By their nature, catastrophe events and other significant infrequent adjustments are not representative of the type of loss activity that we would expect to occur in every period.
We believe an adjusted combined ratio that excludes the effects of these items aids in understanding the underlying trends and variability in our underwriting results that these items may obscure.
The following table reconciles the combined ratio to the adjusted combined ratio:

Three months ended September 30Nine months ended September 30
2021202020212020
Combined ratio109.3 %100.4 %102.4 %100.1 %
Impact on combined ratio of selected items:
Prior-year development(0.1)%(0.2)%0.8 %1.4 %
Catastrophes (current year)19.1 %7.0 %7.9 %2.4 %
Other adjustments — %— %0.7 %1.8 %
Adjusted combined ratio90.3 %93.6 %93.0 %94.5 %
•For the three and nine months ended September 30, 2021, the caption “Prior-year development” includes development on losses relating to the COVID-19 pandemic.
•The caption “Catastrophes (current year)” includes events that occur during a given period, as well as current-period development on catastrophe events occurring earlier in the fiscal year.
•The caption “Other adjustments” represents, for the nine months ended September 30, 2021, interest income and expense on deposit-accounted contracts due to changes in the associated estimated ultimate cash flows and, for the nine months ended September 30, 2020, losses relating to the COVID-19 pandemic.

Net Underwriting Income (Loss)

One way that we evaluate the Company’s underwriting performance is through the measurement of net underwriting income (loss). We do not use premiums written as a measure of performance. Net underwriting income (loss) is a performance measure used by management to evaluate the fundamentals underlying the Company’s underwriting operations. We believe that the use of net underwriting income (loss) enables investors and other users of the Company’s financial information to analyze our performance in a manner similar to how management analyzes performance. Management also believes that this measure follows industry practice and allows the users of financial information to compare the Company’s performance with those of our industry peer group.

Net underwriting income (loss) is considered a non-GAAP financial measure because it excludes items used to calculate net income before taxes under U.S. GAAP. We calculate net underwriting income (loss) as net premiums earned, plus other income (expense) relating to reinsurance and deposit-accounted contracts, less net loss and loss adjustment expenses, acquisition costs, and underwriting expenses. The measure excludes, on a recurring basis: (1) investment income (loss); (2) other income (expense) not related to underwriting, including foreign exchange gains or losses and adjustments to the allowance for expected credit losses; (3) corporate general and administrative expenses; and (4) interest expense. We exclude total investment income or loss, foreign exchange gains or losses, and expected credit losses as we believe these items are influenced by market conditions and other factors not related to underwriting decisions. We exclude corporate and interest expenses because these costs are generally fixed and not incremental to or directly related to our underwriting operations. We believe all of these amounts are largely independent of our underwriting process, and including them could hinder the analysis of trends in our underwriting operations. Net underwriting income (loss) should not be viewed as a substitute for U.S. GAAP net income before income taxes.

29
The reconciliations of net underwriting income (loss) to income (loss) before income taxes (the most directly comparable U.S. GAAP financial measure) on a consolidated basis are shown below:
Three months ended September 30Nine months ended September 30
2021202020212020
($ in thousands)
Income (loss) before income tax$(13,853)$2,183 $(2,993)$(37,726)
Add (subtract):
Total investment (income) loss(4,089)(6,897)(24,803)22,849 
Other non-underwriting (income) expense342 (257)1,076 (6)
Corporate expenses3,444 2,972 12,030 9,711 
Interest expense1,578 1,579 4,684 4,702 
Net underwriting income (loss)$(12,578)$(420)$(10,006)$(470)


30
Results of Operations

The table below summarizes our operating results for the three and nine months ended September 30, 2021 and 2020:
Three months ended September 30Nine months ended September 30
2021202020212020
(in thousands, except percentages)
Underwriting revenue
Gross premiums written$128,735 $135,596 $440,249 $362,072 
Gross premiums ceded(60)(1,464)(6)(2,274)
Net premiums written128,675 134,132 440,243 359,798 
Change in net unearned premium reserves6,849 (18,613)(36,844)(24,844)
Net premiums earned$135,524 $115,519 $403,399 $334,954 
Underwriting related expenses
Net loss and loss adjustment expenses incurred
Current year$111,052 $88,334 $296,333 $247,559 
Prior year *(652)(281)(1,255)5,385 
Net loss and loss adjustment expenses incurred110,400 88,053 295,078 252,944 
Acquisition costs35,048 27,018 106,060 76,660 
Underwriting expenses2,616 2,180 9,310 8,384 
Deposit accounting and other reinsurance expense (income)38 (1,312)2,957 (2,564)
Net underwriting income (loss)$(12,578)$(420)$(10,006)$(470)
Income (loss) from investment in related party investment fund$(6,214)$6,431 $(4,196)$(34,086)
Net investment income (loss)10,303 466 28,999 11,237 
Total investment income (loss)$4,089 $6,897 $24,803 $(22,849)
Net underwriting and investment income (loss)$(8,489)$6,477 $14,797 $(23,319)
Corporate expenses$3,444 $2,972 $12,030 $9,711 
Other (income) expense, net342 (257)1,076 (6)
Interest expense1,578 1,579 4,684 4,702 
Income tax expense (benefit)— — 3,733 424 
Net income (loss)$(13,853)$2,183 $(6,726)$(38,150)
Earnings (loss) per share
Basic$(0.42)$0.06 $(0.20)$(1.07)
Diluted$(0.42)$0.06 $(0.20)$(1.07)
Underwriting ratios
Loss ratio - current year81.9 %76.5 %73.5 %73.9 %
Loss ratio - prior year(0.4)%(0.3)%(0.4)%1.6 %
Loss ratio81.5 %76.2 %73.1 %75.5 %
Acquisition cost ratio25.9 %23.4 %26.3 %22.9 %
Composite ratio107.4 %99.6 %99.4 %98.4 %
Underwriting expense ratio1.9 %0.8 %3.0 %1.7 %
Combined ratio109.3 %100.4 %102.4 %100.1 %

31
* The net financial impacts associated with changes in the estimate of losses incurred in prior years, which incorporate earned reinstatement premiums assumed and ceded, and adjustments to assumed and ceded acquisition costs, were a gain of $0.2 million and $0.2 million for the three months ended September 30, 2021, and 2020, respectively, and a loss of $3.2 million and $4.8 million, for the nine months ended September 30, 2021, and 2020, respectively.


Three months ended September 30, 2021 and 2020

For the three months ended September 30, 2021, the fully diluted book value per share decreased by $0.35 per share, or 2.6%, to $13.25 per share from $13.60 per share at June 30, 2021. For the three months ended September 30, 2021, the basic book value per share decreased by $0.35 per share, or 2.6%, to $13.31 per share from $13.66 per share at June 30, 2021.

For the three months ended September 30, 2021, our net loss was $13.9 million, compared to net income of $2.2 million reported for the equivalent 2020 period.

The developments that most significantly affected our financial performance during the three months ended September 30, 2021, compared to the equivalent 2020 period, are summarized below:

•Underwriting: The underwriting loss for the three months ended September 30, 2021, was $12.6 million. This underwriting loss included catastrophe losses of $25.9 million, principally from Hurricane Ida, the European floods and hailstorms, and South African riots. By comparison, the equivalent period in 2020 reported an underwriting loss of $0.4 million. Natural catastrophe losses from hurricanes Laura, Isaias and Sally, the Midwest derecho storm, and North American wildfires, in aggregate contributed $8.1 million to the underwriting loss during the third quarter of 2020.
Our overall combined ratio was 109.3% for the three months ended September 30, 2021, compared to 100.4% during the equivalent 2020 period. The net impact of catastrophe losses contributed 19.1% to the combined ratio for three months ended September 30, 2021.

•Investments: Our total investment income for the three months ended September 30, 2021, was $4.1 million compared to total investment income of $6.9 million reported for the same period in 2020. Our investment in SILP reported a loss of $6.2 million during the three months ended September 30, 2021, compared to a gain of $6.4 million during the equivalent period in 2020. Other investment income totaled $10.3 million and $0.5 million during the three months ended September 30, 2021, and 2020, respectively. The investment income recognized during the third quarter of 2021 was driven primarily by gains in our Innovations portfolio.

Nine months ended September 30, 2021 and 2020

For the nine months ended September 30, 2021, fully diluted book value per share decreased by $0.17 per share, or 1.3%, to $13.25 per share from $13.42 per share at December 31, 2020. For the nine months ended September 30, 2021, basic book value per share decreased by $0.16 per share, or 1.2%, to $13.31 per share from $13.47 per share at December 31, 2020.

For the nine months ended September 30, 2021, our net loss was $6.7 million, compared to a net loss of $38.2 million reported for the equivalent 2020 period.

The developments that most significantly affected our financial performance during the nine months ended September 30, 2021, compared to the equivalent 2020 period, are summarized below:

•Underwriting: The underwriting loss for the nine months ended September 30, 2021, was $10.0 million, driven primarily by Hurricane Ida, winter storm Uri, the European floods and hailstorms, and the South African riots. Losses from deposit-accounted contracts also contributed to the underwriting loss for the nine months ended September 30, 2021. By comparison, the underwriting loss for the same period in 2020 was $0.5 million.

Our overall combined ratio was 102.4% for the nine months ended September 30, 2021, compared to 100.1% for the same period in 2020. The catastrophe events contributed 7.9% to the combined ratio for the nine months ended September 30, 2021.

•Investments: Our total investment income for the nine months ended September 30, 2021, was $24.8 million compared to a total investment loss of $22.8 million incurred during the equivalent 2020 period. The investment
32
income for the nine months ended September 30, 2021, was due primarily to a gain realized on the sale of our investment in AccuRisk and the third-quarter Innovations gains noted earlier. For the nine months ended September 30, 2021, our investment in SILP reported a loss of $4.2 million. The investment loss during the equivalent 2020 period was driven by $34.1 million of losses from our investment in SILP, partially offset by other investment income of $11.2 million.

Underwriting results

We analyze our business based on three categories: “property,” “casualty,” and “other.”

Gross Premiums Written
 
Details of gross premiums written are provided in the following table: 
 Three months ended September 30Nine months ended September 30
 2021202020212020
($ in thousands)($ in thousands)
Property$13,132 10.2 %$17,178 12.7 %$44,555 10.1 %$44,888 12.4 %
Casualty84,631 65.7 92,778 68.4 300,939 68.4 229,135 63.3 
Other30,972 24.1 25,640 18.9 94,755 21.5 88,049 24.3 
Total$128,735 100.0 %$135,596 100.0 %$440,249 100.0 %$362,072 100.0 %

As a result of our underwriting philosophy, the total premiums we write and the mix of premiums between property, casualty, and other business, may vary significantly from period to period depending on the market opportunities we identify.

For the three months ended September 30, 2021, our gross premiums written decreased by $6.9 million, or 5.1%, compared to the equivalent 2020 period. The primary drivers for this change are the following:

Gross Premiums Written
Three months ended September 30, 2021
Increase (decrease)
($ in millions)		% changeExplanation
Property$(4.0)(23.6)%The decrease in property gross premiums written during the three months ended September 30, 2021, over the comparable 2020 period was primarily related to motor contracts on which we elected to reduce or not renew our participation. As part of our strategy to reduce our exposure to motor business, effective July 1, 2021, we did not renew a quota share motor contract and decreased our share on another motor contract.
Casualty$(8.1)(8.8)%The decrease in casualty gross premiums written during the three months ended September 30, 2021, over the comparable 2020 period was due primarily to motor contracts as described above. To a lesser extent, the decrease is also related to certain workers’ compensation contracts we elected not to renew during 2021. The decrease was partially offset by an increase in multi-line contracts driven primarily by Lloyd’s syndicate business written during 2021.
Other$5.320.8%The increase in “other” gross premiums written during the three months ended September 30, 2021 over the comparable 2020 period was primarily related to financial lines driven by growth in transactional liability business. The increase was partially offset by a decrease in premiums relating to health contracts.



33
For the nine months ended September 30, 2021, our gross premiums written increased by $78.2 million, or 21.6%, compared to the equivalent 2020 period. The primary drivers of this change are the following:
Gross Premiums Written
Nine months ended September 30, 2021
Increase (decrease)
($ in millions)		% changeExplanation
Property$(0.3)(0.7)%The personal and commercial property premiums remained steady during the nine months ended September 30, 2021, over the comparable 2020 period.
Casualty$71.831.3%The increase in casualty gross premiums written during the first nine months of 2021 over the comparable 2020 period was due primarily to an increase in Lloyd’s syndicate multi-line quota share contracts written during 2021. We also experienced an increase in general liability business. These increases were partially offset by decreases in workers’ compensation business resulting from a contract we did not renew in 2021.
Other$6.77.6%The increase in “other” gross premiums written during the first nine months of 2021 over the comparable 2020 period was primarily attributable to new contracts and improved rates relating to financial, marine, energy, and other specialty lines. A decrease in health and crop premiums partially offset these increases as we lowered our participation in these lines during 2021.

Premiums Ceded
 
For the three and nine months ended September 30, 2021, premiums ceded were insignificant compared to $1.5 million and $2.3 million for the three and nine months ended September 30, 2020, respectively. In general, we use retrocessional coverage to manage our net portfolio exposure, leverage areas of expertise, and improve our strategic position in meeting the needs of clients and brokers.

Net Premiums Written

Details of net premiums written are provided in the following table: 
 Three months ended September 30Nine months ended September 30
 2021202020212020
($ in thousands)($ in thousands)
Property$13,132 10.2 %$16,845 12.6 %$44,594 10.1 %$44,465 12.4 %
Casualty84,632 65.8 91,646 68.3 300,971 68.4 227,453 63.2 
Other30,911 24.0 25,641 19.1 94,678 21.5 87,880 24.4 
Total$128,675 100.0 %$134,132 100.0 %$440,243 100.0 %$359,798 100.0 %

For the three and nine months ended September 30, 2021, net premiums written decreased by $5.5 million, or 4.1%, and increased by $80.4 million, or 22.4%, respectively, compared to the three and nine months ended September 30, 2020. The movement in net premiums written resulted from the changes in gross premiums written and ceded during the periods.
34

Net Premiums Earned
 
Details of net premiums earned are provided in the following table: 
 Three months ended September 30Nine months ended September 30
 2021202020212020
($ in thousands)($ in thousands)
Property$14,744 10.9 %$16,045 13.9 %$43,660 10.8 %$45,111 13.5 %
Casualty87,960 64.9 77,731 67.3 260,741 64.6 212,203 63.3 
Other32,820 24.2 21,743 18.8 98,998 24.5 77,640 23.2 
Total$135,524 100.0 %$115,519 100.0 %$403,399 100.0 %$334,954 100.0 %

Net premiums earned are primarily a function of the amount and timing of net premiums written during the current and prior periods.

Loss and Loss Adjustment Expenses Incurred, Net
 
Details of net losses incurred are provided in the following table:

 Three months ended September 30Nine months ended September 30
 2021202020212020
($ in thousands)($ in thousands)
Property$15,031 13.6 %$14,909 16.9 %$33,677 11.4 %$34,704 13.7 %
Casualty70,151 63.5 55,028 62.5 199,636 67.7 151,257 59.8 
Other25,218 22.8 18,116 20.6 61,765 20.9 66,983 26.5 
Total$110,400 100.0 %$88,053 100.0 %$295,078 100.0 %$252,944 100.0 %

The below table summarizes the loss ratios for the three and nine months ended September 30, 2021 and 2020:
 Three months ended September 30Nine months ended September 30
 20212020Increase / (decrease) in loss ratio points20212020Increase / (decrease) in loss ratio points
Property101.9 %92.9 %9.0 77.1 %76.9 %0.2 
Casualty79.8 %70.8 %9.0 76.6 %71.3 %5.3 
Other76.8 %83.3 %(6.5)62.4 %86.3 %(23.9)
Total81.5 %76.2 %5.3 73.1 %75.5 %(2.4)

35
The changes in net losses incurred for the three months ended September 30, 2021, as compared to the equivalent 2020 period, were attributable to the following:
Net Losses Incurred
Three months ended September 30, 2021
Increase (decrease)
($ in millions)		Increase / (decrease) in loss ratio pointsExplanation
Property$0.19.0
The property losses incurred during the three months ended September 30, 2021, included approximately $7.3 million of estimated losses relating to the 2021 European floods and hailstorms and Hurricane Ida. The comparable 2020 period included losses from hurricanes Isaias, Laura, and Sally, the Midwest derecho storm, and the North American wildfires.

Despite the small increase in losses incurred during the three months ended September 30, 2021, the property loss ratio increased 9.0 percentage points due to lower earned premiums on property contracts during the third quarter of 2021.

Casualty$15.19.0
The increase in losses incurred during the three months ended September 30, 2021, over the comparable 2020 period was due primarily to:

•losses relating to Hurricane Ida;
•increased workers' compensation and Lloyd's syndicate losses due to increased exposure in these lines of business; and
•favorable loss development recorded in the comparable 2020 period on professional liability contracts.

The casualty loss ratio increased 9.0 percentage points during the three months ended September 30, 2021 over the comparable 2020 period due to (i) losses from Hurricane Ida and (ii) favorable loss development recognized in the comparable 2020 period.

Other$7.1(6.5)
The increase in “other” losses incurred during the three months ended September 30, 2021, over the comparable 2020 period was due primarily to:

•losses on marine and energy contracts relating to Hurricane Ida; and
•losses on certain terrorism contracts relating to the South African riots.

Despite the increase in losses incurred during the three months ended September 30, 2021, the property loss ratio decreased 6.5 percentage points due to higher earned premiums on other contracts during the third quarter of 2021.
36

The changes in net losses incurred and loss ratios during the nine months ended September 30, 2021, were attributable to the following:
Net Losses Incurred
Nine months ended September 30, 2021
Increase (decrease)
($ in millions)		Increase / (decrease) in loss ratio pointsExplanation
Property$(1.0)0.2
The decrease in property losses incurred during the first nine months of 2021, over the comparable 2020 period, was due primarily to favorable development on prior catastrophe events. The decrease was partially offset by losses relating to the winter storm Uri, Hurricane Ida, and the 2021 European floods and hailstorms.
 
During the first nine months of 2021, the property loss ratio increased 0.2 percentage points due to the decrease in earned premiums, which outweighed the impact of the reduction in property losses incurred.

Casualty$48.45.3
The increase in casualty losses incurred during the first nine months of 2021, over the comparable 2020 period, was due primarily to:

•losses from the winter storm Uri and Hurricane Ida on certain multi-line contracts; and
•increased workers' compensation and Lloyd's syndicate losses due to increased exposure in these lines of business.

During the first nine months of 2021, the casualty loss ratio increased 5.3 percentage points over the comparable 2020 period for reasons consistent with those driving the increase in losses incurred noted above.

Other$(5.2)(23.9)
The decrease in other losses incurred during the first nine months of 2021, over the comparable 2020 period, was due primarily to:

•favorable development on a mortgage contract relating to the COVID-19 pandemic losses; and
•the prior period included losses relating to the COVID-19 pandemic.

The decrease in losses incurred was partially offset by increases related primarily to:
•losses on marine and energy contracts relating to Hurricane Ida;
•losses relating to the South African riots on certain terrorism contracts;
•a satellite loss occurring during 2021; and
•an increase in the volume of marine, energy, and other specialty business.

The reasons for the 23.9 percentage point decrease in the “other” loss ratio are consistent with those driving the reduction in losses incurred.

See Note 5 of the accompanying condensed consolidated financial statements for additional discussion of our reserving techniques and prior period development of net claims and claim expenses.

37
Acquisition Costs, Net
 
Details of acquisition costs are provided in the following table: 
 Three months ended September 30Nine months ended September 30
 2021202020212020
($ in thousands)($ in thousands)
Property$3,178 9.1 %$3,329 12.3 %$9,260 8.7 %$9,191 12.0 %
Casualty22,942 65.5 20,418 75.6 67,499 63.6 58,106 75.8 
Other8,928 25.5 3,271 12.1 29,301 27.6 9,363 12.2 
Total$35,048 100.0 %$27,018 100.0 %$106,060 100.0 %$76,660 100.0 %

The acquisition cost ratios for the nine months ended September 30, 2021 and 2020, were as follows:
 Three months ended September 30Nine months ended September 30
 20212020Increase / (decrease)20212020Increase / (decrease)
Property21.6 %20.7 %0.9 %21.2 %20.4 %0.8 %
Casualty26.1 %26.3 %(0.2)%25.9 %27.4 %(1.5)%
Other27.2 %15.0 %12.2 %29.6 %12.1 %17.5 %
Total25.9 %23.4 %2.5 %26.3 %22.9 %3.4 %

The changes in the acquisition cost ratios for the three months ended September 30, 2021, compared to the equivalent period in 2020, were attributable to the following:
Change in Acquisition Cost Ratios
Three months ended September 30, 2021
 Increase / (decrease) in acquisition cost ratio pointsExplanation
Property0.9There was no significant change in the property acquisition cost ratio during the three months ended September 30, 2021, over the comparable 2020 period.
Casualty(0.2)The decrease in the casualty acquisition cost ratio during the three months ended September 30, 2021, over the comparable 2020 period was due primarily to lower ceding commissions on certain quota share workers’ compensation contracts relative to other casualty contracts.

The decrease in casualty acquisition cost ratio was partially offset by higher commissions relating to multi-line contracts.
Other12.2The increase in the “other” acquisition cost ratio during the three months ended September 30, 2021, over the comparable 2020 period was due to the reversal in 2020 of profit commissions on mortgage contracts as a result of COVID-19 losses.
38


The changes in the acquisition cost ratios during the nine months ended September 30, 2021, compared to the equivalent period in 2020, were attributable to the following:
Change in Acquisition Cost Ratios
Nine months ended September 30, 2021
 Increase / (decrease) in acquisition cost ratio pointsExplanation
Property0.8There was no significant change in the property acquisition cost ratio during the first nine months of 2021 over the comparable 2020 period.
Casualty(1.5)The casualty acquisition cost ratio decreased during the first nine months of 2021 over the comparable 2020 period due primarily to lower ceding commissions on certain quota share workers’ compensation contracts relative to other casualty contracts.
Other17.5
The increase in the “other” acquisition cost ratio during the first nine months of 2021 over the comparable 2020 period is related to profit commission adjustments on mortgage contracts.

The increase was partially offset by a shift in the business mix towards non-proportional specialty business during the first nine months of 2021. This business incorporates relatively lower commission rates as compared to proportional health and financial lines business.

39

Ratio Analysis
 
The following table provides our underwriting ratios by line of business: 


 Three months ended September 30Three months ended September 30
20212020
 PropertyCasualtyOtherTotalPropertyCasualtyOtherTotal
 
Loss ratio101.9 %79.8 %76.8 %81.5 %92.9 %70.8 %83.3 %76.2 %
Acquisition cost ratio21.6 26.1 27.2 25.9 20.7 26.3 15.0 23.4 
Composite ratio123.5 %105.9 %104.0 %107.4 %113.6 %97.1 %98.3 %99.6 %
Underwriting expense ratio1.9 0.8 
Combined ratio109.3 %100.4 %


Nine months ended September 30Nine months ended September 30
20212020
PropertyCasualtyOtherTotalPropertyCasualtyOtherTotal
Loss ratio77.1 %76.6 %62.4 %73.1 %76.9 %71.3 %86.3 %75.5 %
Acquisition cost ratio21.2 25.9 29.6 26.3 20.4 27.4 12.1 22.9 
Composite ratio98.3 %102.5 %92.0 %99.4 %97.3 %98.7 %98.4 %98.4 %
Underwriting expense ratio3.0 1.7 
Combined ratio102.4 %100.1 %

The underwriting expense ratio for the nine months ended September 30, 2021, compared to the equivalent 2020 period, included 0.7 percentage points relating to interest expense on deposit-accounted contracts based on revised expectations of ultimate cash flows.

General and Administrative Expenses

Details of general and administrative expenses are provided in the following table: 
Three months ended September 30Nine months ended September 30
2021202020212020
($ in thousands)($ in thousands)
Underwriting expenses$2,616 $2,180 $9,310 $8,384 
Corporate expenses3,444 2,972 12,030 9,711 
General and administrative expenses$6,060 $5,152 $21,340 $18,095 

For the three months ended September 30, 2021, general and administrative expenses increased by $0.9 million, or 17.6%, compared to the equivalent 2020 period. The increase was due primarily to higher expenses relating to (i) our Innovations unit, (ii) legal and other professional fees, and (iii) information systems and technology, compared to the same period in 2020.

For the nine months ended September 30, 2021, general and administrative expenses increased by $3.2 million, or 17.9%, compared to the equivalent 2020 period. The increase was due primarily to higher expenses relating to (i) our Innovations unit, (ii) directors’ and officers’ insurance premiums, (iii) personnel costs, and (iv) information system and technology. The increase was partially offset by lower legal and other professional fees.
40
For the nine months ended September 30, 2021, and 2020, general and administrative expenses included $2.4 million and $1.4 million, respectively, of expenses related to stock compensation granted to employees and directors.

Total Investment Income (Loss)
 
Total investment income (loss) incorporates (i) changes in the net asset value of our investment in SILP managed by DME Advisors, (ii) interest income earned on the restricted cash and cash equivalents pledged as collateral to our clients, and (iii) gains (or losses) and interest on our portfolio of strategic and Innovations investments, notes receivable and investments accounted for under the equity method. We expect our total investment income, including any change in the net asset value of our investment in SILP, to fluctuate from period to period.

A summary of our total investment income (loss) is as follows:
Three months ended September 30Nine months ended September 30
 2021202020212020
 ($ in thousands)
Realized gains (losses)$— $— $14,210 $(15,000)
Change in unrealized gains and losses9,637 40 14,860 18,884 
Investment-related foreign exchange gains (losses)(15)44 (14)(110)
Interest and dividend income, net of withholding taxes691 1,021 175 7,351 
Interest, dividend and other expenses(10)(719)(232)(757)
Income (loss) from equity method investment— 80 — 869 
Net investment-related income (loss)$10,303 $466 $28,999 $11,237 
Income (loss) from investments in related party investment fund$(6,214)$6,431 $(4,196)$(34,086)
Total investment income (loss)$4,089 $6,897 $24,803 $(22,849)

The caption “Income (loss) from investment in related party investment fund” in the above table is net of management fees paid by SILP to DME Advisors and performance compensation, if any, allocated from the Company’s investment in SILP to DME II. No performance compensation is allocated in periods of loss reported by SILP. For detailed breakdowns of management fees and performance compensation for the three and nine months ended September 30, 2021 and 2020, please refer to Note 3 of the condensed consolidated financial statements.

For the three months ended September 30, 2021, the Investment Portfolio managed by DME Advisors reported a loss of 2.7%, compared to a gain of 1.4% for the three months ended September 30, 2020. SILP’s long portfolio lost 3.5%, while the short portfolio gained 1.1% during the three months ended September 30, 2021. For the three months ended September 30, 2021, the significant contributors to SILP’s investment return were a long position in Atlas Air Worldwide (AAWW) and various short positions. The largest detractors were long positions in The Chemours Company (CC) and Green Brick Partners (GRBK).

For the nine months ended September 30, 2021, the Investment Portfolio managed by DME Advisors reported a loss of 2.2% on the Investment Portfolio managed by DME Advisors, compared to a loss of 6.5% for the nine months ended September 30, 2020. The long portfolio gained 12.3%, while the short portfolio and macro positions lost 7.9% and 5.2%, respectively, during the nine months ended September 30, 2021. For the nine months ended September 30, 2021, the most significant contributors to SILP’s investment return were long positions in Brighthouse Financial (BHF), CONSOL Energy (CEIX), and AAWW. During the nine months ended September 30, 2021, the most significant detractors were GRBK and various short positions.

For the three and nine months ended September 30, 2021, the decrease in interest income compared to the equivalent period in 2020 resulted primarily from lower interest rates offered by financial institutions on the restricted cash and cash equivalents we have pledged as collateral to our clients.

During the nine months ended September 30, 2021, we recorded a realized gain of $14.2 million (pre-tax) relating to the sale of our investment in AccuRisk. Additionally, during the three and nine months ended September 30, 2021, we recorded a net unrealized gain of $9.6 million and $14.9 million, respectively, on our portfolio of Innovations related investments.
41
During the equivalent period in 2020, we wrote off a valuation allowance previously recorded on certain notes receivable. The write-off represented a realized loss, which was fully offset by a reduction in unrealized losses.

For the three months ended September 30, 2021, and 2020, and for the nine months ended September 30, 2021, and 2020, the gross investment return (loss) on our investments managed by DME Advisors (excluding investment advisor performance allocation) was composed of the following:
Three months ended September 30Nine months ended September 30
2021202020212020
Long portfolio gains (losses)(3.5)%3.2 %12.3 %0.9 %
Short portfolio gains (losses)1.1 (1.9)(7.9)(7.7)
Macro gains (losses)— 0.3 (5.2)0.7 
Other income and expenses 1
(0.4)(0.2)(1.4)(0.4)
Gross investment return(2.8)%1.4 %(2.2)%(6.5)%
Net investment return 1
(2.7)%1.4 %(2.2)%(6.5)%

1 “Other income and expenses” excludes performance compensation but includes management fees. “Net investment return” incorporates both of these amounts.

Effective January 1, 2021, the Investment Portfolio is calculated based on 50% of GLRE Surplus, or the shareholders’ equity of the Company, as reported in the then most recent quarterly U.S. GAAP financial statements. It is adjusted monthly for our share of the net profits and net losses reported by SILP during any intervening period. Prior to January 1, 2021, the Investment Portfolio was calculated based on several factors, including our share of SILP’s net asset value and our posted collateral and net reserves.

Each month, we post on our website (www.greenlightre.com) the returns from our investment in SILP.
       
Income Taxes
 
We are not obligated to pay taxes in the Cayman Islands on either income or capital gains. The Governor-In-Cabinet has granted us an exemption from any income taxes that may be imposed in the Cayman Islands for a period of 20 years, expiring on February 1, 2025.

GRIL is incorporated in Ireland and is subject to the Irish corporation tax. We expect GRIL to be taxed at 12.5% on its taxable trading income and 25% on its non-trading income, if any.

Verdant is incorporated in Delaware and is subject to taxes under the U.S. federal rates and regulations prescribed by the Internal Revenue Service. We expect Verdant’s future taxable income to be taxed at 21%. For the nine months ended September 30, 2021, the income tax expense of $3.7 million was due primarily to the gain on the sale of our investment in AccuRisk.

At September 30, 2021, we have included a gross deferred tax asset of $4.0 million (December 31, 2020: $3.5 million) in the caption “Other assets” in the Company’s condensed consolidated balance sheets. At September 30, 2021, a valuation allowance of $3.5 million (December 31, 2020: $3.0 million) partially offset this gross deferred tax asset. We have concluded that it is more likely than not that the Company will fully realize the recorded deferred tax asset (net of the valuation allowance) in the future. We have based this conclusion on the expected timing of the reversal of the temporary differences and the likelihood of generating sufficient taxable income to realize the future tax benefit. We have not taken any other tax positions that we believe are subject to uncertainty or reasonably likely to have a material impact on the Company.
             

42
Financial Condition
 
Total investments
 
The total investments reported in the condensed consolidated balance sheets at September 30, 2021, was $222.7 million, compared to $196.2 million at December 31, 2020, an increase of $26.5 million, or 13.5%. The increase was primarily related to net contributions into SILP from the collateral released by our ceding insurers. New Innovation investments and income from the Innovation investments also contributed to the increase, which was partially offset by losses from our investment in SILP.

At September 30, 2021, 92.5% of SILP’s investments were valued based on quoted prices in actively traded markets (Level 1), 4.3% was composed of instruments valued based on observable inputs other than quoted prices (Level 2), and 0.7% was composed of instruments valued based on non-observable inputs (Level 3). At September 30, 2021, 2.5% of SILP’s investments consisted of private equity funds valued using the funds’ net asset values as a practical expedient.

Restricted cash and cash equivalents

We use our restricted cash and cash equivalents for funding trusts and letters of credit issued to our ceding insurers. Our restricted cash decreased by $52.8 million, or 7.1%, from $745.4 million at December 31, 2020, to $692.5 million, at September 30, 2021, primarily due to collateral released by our ceding insurers.

Reinsurance balances receivable

During the nine months ended September 30, 2021, reinsurance balances receivable increased by $50.2 million, or 15.2%, to $380.4 million from $330.2 million at December 31, 2020. This increase was related primarily to increases in funds withheld on reinsurance contracts with Lloyd’s syndicates. A decrease in premiums receivable partially offset the increase during the nine months ended September 30, 2021.

Loss and Loss Adjustment Expense Reserves; Loss and Loss Adjustment Expenses Recoverable
 
The COVID-19 pandemic is unprecedented, and we do not have previous loss experience on which to base our estimates for the associated loss and loss adjustment expense reserves. See Note 5 of the accompanying condensed consolidated financial statements for assumptions used in our loss estimates relating to the COVID-19 pandemic.

Reserves for loss and loss adjustment expenses were composed of the following: 
 September 30, 2021December 31, 2020
 Case
Reserves		IBNRTotalCase
Reserves		IBNRTotal
 ($ in thousands)
Property$23,058 $46,873 $69,931 $25,833 $45,680 $71,513 
Casualty153,295 222,995 376,290 138,432 206,152 344,584 
Other14,798 79,760 94,558 12,540 65,542 78,082 
Total$191,151 $349,628 $540,779 $176,805 $317,374 $494,179 
 
During the nine months ended September 30, 2021, the total gross loss and loss adjustment expense reserves increased by $46.6 million, or 9.4%, to $540.8 million from $494.2 million at December 31, 2020. See Note 5 of the accompanying condensed consolidated financial statements for a summary of changes in outstanding loss and loss adjustment expense reserves and a description of prior period loss developments.

During the nine months ended September 30, 2021, the total loss and loss adjustment expenses recoverable decreased by $3.8 million, or 22.4%, to $13.1 million from $16.9 million at December 31, 2020. See Note 6 of the accompanying condensed consolidated financial statements for a description of the credit risk associated with our retrocessionaires.

For most of the contracts we write, defined limits of liability limit our risk exposure. Once each contract’s limit of liability has been reached, we have no further exposure to additional losses from that contract. However, certain contracts, particularly quota share contracts covering first-dollar exposure, may not contain aggregate limits.

43
Our property business, and to a lesser extent our casualty and other business, incorporate contracts that contain natural peril loss exposure. We estimate catastrophe loss exposure in terms of our PML. We anticipate that our PML will vary from period to period depending upon the modeled simulated losses and the composition of our in-force book of business. We describe projected severity levels in terms of a 1-in-250 year return period. The 1-in-250 year return period PML means that we believe there is a 0.4% chance in any given year that an occurrence of a natural catastrophe will lead to losses exceeding the stated estimate. In other words, it corresponds to a 99.6% probability that the loss from an event will fall below the indicated PML.

PMLs are estimates. As a result, we cannot provide assurance that any actual event will align with the modeled event or that actual losses from events similar to the modeled events will not vary materially from the modeled event PML. Our PML estimate incorporates all significant exposure from our reinsurance operations, including coverage for property, marine and energy, motor, and catastrophe workers’ compensation.
At October 1, 2021, our estimated PML exposure (net of retrocession and reinstatement premiums) at a 1-in-250 year return period for a single event and in aggregate was $84.5 million and $107.3 million, respectively. The following table provides the PML for single event loss exposure and aggregate loss exposure to natural peril losses for each of the peak zones at October 1, 2021:
October 1, 2021
1-in-250 year return period
ZoneSingle Event LossAggregate Loss
($ in thousands)
United States, Canada and the Caribbean$84,502 $97,574 
Europe45,134 51,491 
Japan45,240 49,105 
Rest of the world53,492 58,751 
Maximum84,502 107,331 

Total shareholders’ equity
 
Total equity reported on the condensed consolidated balance sheet decreased by $14.3 million to $450.5 million at September 30, 2021, compared to $464.9 million at December 31, 2020. The decrease in shareholders’ equity during the nine months ended September 30, 2021, was due to (i) the repurchase of the Class A ordinary shares and (ii) the net loss of $6.7 million reported for the period. For details of other movements in shareholders’ equity, see the “Condensed Consolidated Statements of Shareholders’ Equity.”

Liquidity and Capital Resources
 
General

Greenlight Capital Re is a holding company with no operations of its own. As a holding company, Greenlight Capital Re has minimal continuing cash needs, most of which are related to the payment of corporate and general administrative expenses and interest expenses. We conduct all our underwriting operations through our wholly-owned reinsurance subsidiaries, Greenlight Re and GRIL, which underwrite property and casualty reinsurance. There are restrictions on Greenlight Re’s and GRIL’s ability to pay dividends, described in more detail below. It is our current policy to retain earnings to support the growth of our business. We currently do not expect to pay dividends on our ordinary shares.

At September 30, 2021, Greenlight Re and GRIL were each rated “A- (Excellent)” with a stable outlook by A.M. Best. The ratings reflect A.M. Best’s opinion of our reinsurance subsidiaries’ financial strength, operating performance, and ability to meet obligations. They are not evaluations directed toward the protection of investors or a recommendation to buy, sell or hold our Class A ordinary shares. If A.M. Best downgrades our ratings below “A- (Excellent)” or withdraws our rating, we could be severely limited or prevented from writing any new reinsurance contracts, which would significantly and negatively affect our business. Our A.M. Best ratings may be revised or revoked at the sole discretion of the rating agency. 

44
Sources and Uses of Funds
 
Our sources of funds consist primarily of premium receipts (net of brokerage and ceding commissions), investment income, and other income. We use cash from our operations to pay losses and loss adjustment expenses, profit commissions, interest, and general and administrative expenses. At September 30, 2021, all of our investable assets, excluding strategic and Innovations investments and funds required for business operations and capital risk management, are invested by DME Advisors in SILP, subject to our investment guidelines. We can redeem funds from SILP at any time for operational purposes by providing three days’ notice to the general partner. At September 30, 2021, the majority of SILP’s long investments were composed of cash and cash equivalents and publicly traded equity securities, which can be readily liquidated to meet our redemption requests. We record all investment income (loss), including any changes in the net asset value of SILP, and any unrealized gains and losses, in our condensed consolidated statements of operations for each reporting period.    
   
For the nine months ended September 30, 2021 and 2020, the net cash used in operating activities was $18.8 million and $44.7 million, respectively. The net cash used in operating activities was primarily used for our underwriting activities and for payment of corporate and general administrative expenses for the nine months ended September 30, 2021 and 2020. Generally, if the premiums collected exceed claim payments within a given period, we generate cash from our underwriting activities. Our underwriting activities represented a net use of cash for the nine months ended September 30, 2021 and 2020, as the losses we paid exceeded the premiums we collected. The cash used in, and generated from, underwriting activities may vary significantly from period to period depending on the underwriting opportunities available and claims submitted to us by our cedents.

For the nine months ended September 30, 2021, our investing activities used $17.7 million of cash for contribution into SILP (net of redemptions) and $4.8 million for new Innovations investments. Investing activities also provided $26.9 million of cash from the sale of our AccuRisk investment and the collection of a note receivable from AccuRisk. By comparison, for the same period in 2020 our investing activities provided cash of $20.8 million as a result of net redemptions from SILP.

For the nine months ended September 30, 2021, our financing activities included the repurchase of $10.0 million of our Class A ordinary shares, compared to $12.7 million of repurchases during the equivalent 2020 period.
  
At September 30, 2021, we believe we have sufficient cash flow from operating and investing activities to meet our foreseeable liquidity requirements. We do not expect that the recent catastrophic events, including Hurricane Ida, the European floods and hailstorm, and the COVID-19 pandemic, will materially impact our operational liquidity needs, which will be met by cash, funds generated from underwriting activities, and investment income, including withdrawals from SILP if necessary. At September 30, 2021, we expect to fund our operations for the next twelve months from operating and investing cash flow. However, we may explore various financing options, including capital raising alternatives, to fund our business strategy, improve our capital structure, increase surplus, pay claims or make acquisitions. We can provide no assurances regarding the terms of such transactions or that any such transactions will occur.
 
Although GLRE is not subject to any significant legal prohibitions on the payment of dividends, Greenlight Re and GRIL are each subject to regulatory minimum capital requirements and regulatory constraints that affect their ability to pay dividends to us. In addition, any dividend payment would have to be approved by the relevant regulatory authorities prior to payment. At September 30, 2021, Greenlight Re and GRIL both exceeded the regulatory minimum capital requirements. 

Letters of Credit and Trust Arrangements
 
At September 30, 2021, neither Greenlight Re nor GRIL was licensed or admitted as a reinsurer in any jurisdiction other than the Cayman Islands and the European Economic Area, respectively. Many jurisdictions do not permit domestic insurance companies to take credit on their statutory financial statements for loss recoveries or ceded unearned premiums unless appropriate measures are in place for reinsurance obtained from unlicensed or non-admitted insurers. As a result, we anticipate that all of our U.S. clients and some of our non-U.S. clients will require us to provide collateral through funds withheld, trust arrangements, letters of credit, or a combination thereof.

At September 30, 2021, we had one letter of credit facility available with an aggregate capacity of $275.0 million (December 31, 2020: $275.0 million). See Note 12 of the accompanying condensed consolidated financial statements for details on the letter of credit facility. We provide collateral to cedents in the form of letters of credit and trust arrangements. At September 30, 2021, the aggregate amount of collateral provided to cedents under such arrangements was $688.6 million (December 31, 2020: $743.0 million). At September 30, 2021, the letters of credit and trust accounts were secured by restricted cash and cash equivalents with a total fair value of $692.5 million (December 31, 2020: $745.4 million).
45

The letter of credit facility contains customary events of default and restrictive covenants, including but not limited to limitations on liens on collateral, transactions with affiliates, mergers and sales of assets, as well as solvency and maintenance of certain minimum pledged equity requirements, and restricts issuance of any debt without the consent of the letter of credit provider. Additionally, if an event of default exists, as defined in the letter of credit facility, Greenlight Re would be prohibited from paying dividends to its parent company. The Company was in compliance with all the covenants of this facility at September 30, 2021.

Capital
 
Our capital structure currently consists of senior convertible notes and equity issued in two classes of ordinary shares. We expect that the existing capital base and internally generated funds will be sufficient to implement our business strategy for the foreseeable future. Consequently, we do not presently anticipate that we will incur any additional material indebtedness in the ordinary course of our business. However, to provide us with flexibility and timely access to public capital markets should we require additional capital for working capital, capital expenditures, acquisitions, or other general corporate purposes, we have filed a Form S-3 registration statement, which expires in July 2024. In addition, as noted above, we may explore various financing alternatives, although there can be no assurance that additional financing will be available on acceptable terms when needed or desired. We did not make any significant commitments for capital expenditures during the nine months ended September 30, 2021.

Our Board of Directors had previously extended the share repurchase plan to June 30, 2021, and the authorized repurchase of up to 5.0 million Class A ordinary shares or securities convertible into Class A ordinary shares in the open market, through privately negotiated transactions or Rule 10b5-1 stock trading plans. In addition, the Board of Directors had also authorized the Company to repurchase up to $25.0 million aggregate face amount of the Company’s 4.00% Convertible Senior Notes due 2023 (the “Notes”) in privately negotiated transactions, in open market repurchases, or pursuant to one or more tender offers.

On May 4, 2021, the Board of Directors approved a share repurchase plan effective from July 1, 2021, until June 30, 2022, authorizing the Company to purchase up to $25.0 million of Class A ordinary shares or securities convertible into Class A ordinary shares in the open market, through privately negotiated transactions or Rule 10b5-1 stock trading plans.

The Company is not required to repurchase any of the Class A ordinary shares or the Notes, and the repurchase plans may be modified, suspended, or terminated at the election of our Board of Directors at any time without prior notice. During the nine months ended September 30, 2021, the Company repurchased 1,079,544 Class A ordinary shares.

Under the Company’s stock incentive plan, the number of Class A ordinary shares authorized for issuance is 8.0 million shares. At September 30, 2021, 3,128,276 Class A ordinary shares were available for future issuance under the Company’s stock incentive plan. The Compensation Committee of the Board of Directors administers the stock incentive plan. 
 
Contractual Obligations and Commitments
 
Due to the nature of our reinsurance operations, the amount and timing of the cash flows associated with our reinsurance contractual liabilities will fluctuate, perhaps materially, and, therefore, are highly uncertain. As of September 30, 2021, we estimate that we will pay the loss and loss adjustment expense reserves as follows: 
Less than
 1 year		1-3 years3-5 yearsMore than
 5 years		Total
   ($ in thousands)
Loss and loss adjustment expense reserves (1)
$264,982 $158,448 $58,404 $58,945 $540,779 
(1)      Due to the nature of our reinsurance operations, the amount and timing of the cash flows associated with our reinsurance contractual liabilities will fluctuate, perhaps materially, and, therefore, are highly uncertain.

Greenlight Re has entered into a lease agreement for office space in the Cayman Islands commencing from July 1, 2021. The lease expires on June 30, 2026, unless Greenlight Re exercises its right to renew the lease for another five-year period. The annual lease obligation ranges from $0.5 million to $0.6 million.
 
46
The Company has $100.0 million of senior convertible notes payable, which mature on August 1, 2023. The Company is obligated to make semi-annual interest payments of $2.0 million at an interest rate of 4.0% per annum. The Company has received regulatory approval to declare dividends from Greenlight Re to meet the interest payments obligation.
 
Pursuant to the IAA between SILP and DME Advisors, DME Advisors is entitled to a monthly management fee equal to 0.125% (1.5% on an annual basis) of each limited partner’s Investment Portfolio, as provided in the SILP LPA. The IAA has an initial term ending on August 31, 2023, subject to automatic extension for successive three-year terms. Pursuant to the SILP LPA, DME II is entitled to a performance allocation equal to 20% of the net profit, calculated per annum, of each limited partner’s share of the capital account managed by DME Advisors, subject to a loss carry-forward provision. DME II is not entitled to earn a performance allocation in a year in which SILP incurs a loss. The loss carry-forward provision contained in the SILP LPA allows DME II to earn reduced performance allocation of 10% of net profits in years subsequent to the year in which the capital accounts of the limited partners incur a loss, until all losses are recouped and an additional amount equal to 150% of the loss is earned. At September 30, 2021, we estimate the reduced performance allocation of 10% to continue to be applied until SILP achieves additional investment returns of 197%, at which point the performance allocation will revert to 20%. For detailed breakdowns of management fees and performance compensation for the three and nine months ended September 30, 2021 and 2020, please refer to Note 3 of the condensed consolidated financial statements.

The Company has entered into a service agreement with DME Advisors pursuant to which DME Advisors will provide investor relations services to us for compensation of $5,000 per month plus expenses. The service agreement had an initial term of one year and continues for sequential one-year periods until terminated by us or DME Advisors. Either party may terminate the service agreement for any reason with 30 days prior written notice to the other party.

Our related party transactions are presented in Note 11 to the accompanying condensed consolidated financial statements.

Off-Balance Sheet Financing Arrangements
 
We have no obligations, assets, or liabilities which would be considered off-balance sheet arrangements. Other than our investment in SILP (see Note 3 of the accompanying condensed consolidated financial statements), we have not participated in transactions that created relationships with unconsolidated entities or financial partnerships, including VIEs, established to facilitate off-balance sheet arrangements. 

Effects of Inflation
 
Inflation generally affects the cost of claims and claim expenses, as well as asset values in our investment portfolio. Our pricing and reserving models incorporate considerations of the anticipated effects of inflation on our claim costs. However, we cannot predict or estimate the onset, duration, and severity of an inflationary period with precision. This actual effect of inflation may differ significantly from our estimate.

Item 3.    QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
 
We believe we are exposed to the following types of market risk: 
•equity price risk;
•commodity price risk;
•foreign currency risk;
•interest rate risk;
•credit risk; and
•political risk.
 
47
Equity Price Risk
At September 30, 2021, our investments consisted primarily of an investment in SILP. Among SILP’s holdings are equity securities, the carrying values of which are based primarily on quoted market prices. Generally, market prices of common equity securities are subject to fluctuation, which could cause the amount to be realized upon the closing of a position to differ significantly from its current reported value. This risk is partly mitigated by the presence of both long and short equity securities as part of our investment strategy. At September 30, 2021, a 10% decline in the price of each of the underlying listed equity securities and equity-based derivative instruments would result in a $6.9 million loss to our Investment Portfolio.
 
Computations of the prospective effects of hypothetical equity price changes are based on numerous assumptions, including the maintenance of the current composition of SILP’s portfolio. They should not be relied on as indicative of future results.

Commodity Price Risk
Generally, market prices of commodities are subject to fluctuation. SILP’s investments periodically include long or short investments in commodities or derivatives directly impacted by fluctuations in the prices of commodities. At September 30, 2021, SILP’s investments incorporate unhedged exposure to changes in gold, silver, and crude oil prices.
The following table summarizes the net impact that a 10% increase and decrease in commodity prices would have on the value of our Investment Portfolio at September 30, 2021. The below table excludes the indirect effect that changes in commodity prices might have on equity securities in our Investment Portfolio. 
10% increase in commodity prices10% decrease in commodity prices
CommodityChange in
fair value		Change in
fair value
  ($ in millions)
Gold$2.0 $(2.0)
Silver0.5 (0.5)
Crude oil— (0.1)
Total$2.5 $(2.6)

Foreign Currency Risk
Certain of our reinsurance contracts are denominated in foreign currencies, whereby premiums are receivable and losses are payable in foreign currencies. Foreign currency exchange rate risk exists to the extent that our foreign currency reinsurance balances are more than (or less than) the corresponding foreign currency cash balances and there is an increase (or decrease) in the exchange rate of that foreign currency.  

While we do not seek to precisely match our liabilities under reinsurance policies that are payable in foreign currencies with investments denominated in such currencies, we continually monitor our exposure to potential foreign currency losses and may use foreign currency cash and cash equivalents or forward foreign currency exchange contracts to mitigate against adverse foreign currency movements. At September 30, 2021, our exposure to GBP denominated net reinsurance asset balance was £1.8 million. At September 30, 2021, a 10% decrease in the U.S. dollar against the GBP (all else constant) would result in an estimated $0.2 million foreign exchange gain. Alternatively, a 10% increase in the U.S dollar against the GBP would result in an estimated $0.2 million foreign exchange loss. Similarly, at September 30, 2021, our net exposure to Euro-denominated reinsurance liability balances was €4.8 million. At September 30, 2021, a 10% decrease in the U.S. dollar against the Euro (all else constant) would result in an estimated $0.5 million foreign exchange loss. Alternatively, a 10% increase in the U.S dollar against the Euro would result in an estimated $0.5 million foreign exchange gain.

We may also be exposed to foreign currency risk through SILP’s underlying cash, forwards, options, and investments in securities denominated in foreign currencies. At September 30, 2021, most of our currency exposures resulting from foreign denominated securities (longs and shorts) were reduced by offsetting cash balances denominated in the corresponding foreign currencies.

At September 30, 2021, a 10% increase or decrease in the value of the U.S. dollar against foreign currencies would have no meaningful impact on the value of our Investment Portfolio. 
 
48
Interest Rate Risk
Our investment in SILP includes interest-rate sensitive securities, such as corporate and sovereign debt instruments and interest rate options. The primary market risk exposure for any debt instrument is interest rate risk. As interest rates rise, the fair value of a long fixed-income portfolio generally falls. Similarly, falling interest rates generally lead to increases in the fair value of fixed-income securities. Additionally, some derivative investments may be sensitive to interest rates, and their value may indirectly fluctuate with changes in interest rates. 

As of September 30, 2021, a 100 basis points increase or decrease in interest rates would have no meaningful impact on the value of our Investment Portfolio.

We, along with DME Advisors, monitor the net exposure to interest rate risk and generally do not expect changes in interest rates to have a materially adverse impact on our operations.
 
Credit Risk

Credit risk relates to the uncertainty of a counterparty’s ability to make timely payments in accordance with terms of the instrument or contract. Our maximum exposure to credit risk is the carrying value of our financial assets. We evaluate the financial condition of our business partners and clients relating to balances receivable under our reinsurance contracts, including premiums receivable, losses recoverable, and commission adjustments recoverable. We obtain collateral in the form of funds withheld, trusts, and letters of credit from our counterparties to mitigate this credit risk. We monitor our net exposure to each counterparty relative to the financial strength of our counterparties and assess the collectibility of these balances on a regular basis. See Note 2 of the accompanying condensed consolidated financial statements for further details on allowance for credit loss on reinsurance assets.

In addition, the securities, commodities, and cash in SILP’s investment portfolio are held with several prime brokers and derivative counterparties, subjecting SILP, and indirectly us, to a significant concentration of credit risk. While we have no direct control over SILP, DME Advisors regularly monitors the concentration of credit risk with each counterparty and, if appropriate, transfers cash or securities between counterparties or requests collateral to diversify and mitigate this credit risk. 

Political Risk

Through our assumed reinsurance contracts, we currently provide a limited amount of political risk insurance coverage. We do not expect this exposure to have a materially adverse impact on our underwriting results.

We are exposed to political risk to the extent that we underwrite business from entities located in foreign markets and to the extent that DME Advisors, on behalf of SILP and subject to our investment guidelines, trades securities listed on various U.S. and foreign exchanges and markets. The governments in any of these jurisdictions could impose restrictions, regulations, or other measures, which may have a material adverse impact on our underwriting operations and investment strategy. See “Item 1A. Risk Factors - We could face unanticipated losses from political instability which could have a material adverse effect on our financial condition and results of operations” included in our Form 10-K for the fiscal year ended December 31, 2020.

 
Item 4. CONTROLS AND PROCEDURES
 
Disclosure Controls and Procedures
 
As required by Rules 13a-15 and 15d-15 of the Exchange Act, the Company has evaluated, with the participation of management, including the Chief Executive Officer and the Chief Financial Officer, the effectiveness of its disclosure controls and procedures (as defined in such rules) as of the end of the period covered by this report. Based on such evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures are effective to ensure that information required to be disclosed by the Company in reports prepared in accordance with the rules and regulations of the SEC is recorded, processed, summarized and reported within the time periods specified by the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act is accumulated and communicated to the issuer’s management, including its principal executive officer and principal financial officer, or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure.
 
49
Our management, including our Chief Executive Officer and Chief Financial Officer, does not expect that the Company’s disclosure controls and procedures will prevent all errors and all frauds. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple error or mistake.
 
Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the controls. The design of any system of controls also is based, in part, upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions; over time, controls may become inadequate because of changes in conditions, or the degree of compliance with the policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.  
  
Changes in Internal Control Over Financial Reporting
 
There have been no changes in the Company’s internal control over financial reporting during the fiscal quarter ended September 30, 2021, that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting. The Company continues to review its disclosure controls and procedures, including its internal controls over financial reporting, and may, from time to time, make changes aimed at enhancing their effectiveness and ensuring that the Company’s systems evolve with its business.


50
PART II — OTHER INFORMATION
 
Item 1.    LEGAL PROCEEDINGS
 
From time to time, in the normal course of business, we may be involved in formal and informal dispute resolution procedures, which may include arbitration or litigation, the outcomes of which determine our rights and obligations under our reinsurance contracts and other contractual agreements. In some disputes, we may seek to enforce our rights under an agreement or to collect funds owing to us. In other matters, we may resist attempts by others to collect funds or enforce alleged rights. While the final outcome of legal disputes cannot be predicted with certainty, we do not believe that any of our existing contractual disputes, when finally resolved, will have a material adverse effect on our business, financial condition or operating results.
 
Item 1A. RISK FACTORS
 
Factors that could cause our actual results to differ materially from those in this report are any of the risks described in “Part I. Item 1A. Risk Factors” included in our Form 10-K for the fiscal year ended December 31, 2020, as filed with the "Securities and Exchange Commission ("SEC") on March 10, 2021 (the “Form 10-K”). Any of these factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risk factors not presently known to us or that we currently deem immaterial may also impair our business or results of operations.
As of the date of this report, there have been no other material changes to the risk factors as disclosed in the Form 10-K. We may disclose changes to such factors or disclose additional factors from time to time in our future filings with the SEC.

Item 2.    UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS 
 
The Board has adopted a share and notes repurchase plan. Our Board of Directors had previously extended the share repurchase plan to June 30, 2021, and the authorized repurchase of up to 5.0 million Class A ordinary shares or securities convertible into Class A ordinary shares in the open market, through privately negotiated transactions or Rule 10b5-1 stock trading plans. In addition, the Board of Directors had also authorized the Company to repurchase up to $25.0 million aggregate face amount of the Company’s 4.00% Convertible Senior Notes due 2023 (the “Notes”) in privately negotiated transactions, in open market repurchases, or pursuant to one or more tender offers.

On May 4, 2021, the Board of Directors approved a share repurchase plan effective from July 1, 2021, until June 30, 2022, authorizing the Company to purchase up to $25.0 million of Class A ordinary shares or securities convertible into Class A ordinary shares in the open market, through privately negotiated transactions or Rule 10b5-1 stock trading plans. The Company is not required to repurchase any of the Class A ordinary shares or Notes and the repurchase plans may be modified, suspended or terminated at the election of our Board of Directors at any time without prior notice. There were no repurchases of Notes during the three months ended September 30, 2021.

The table below details the share repurchases that were made under the plan during the three months ended September 30, 2021:
Issuer Purchases of Equity Securities
PeriodTotal Number of Shares Purchased
(1)		Average Price Paid per ShareTotal Number of Shares Purchased as Part of Publicly Announced Plans or Programs
(1)		Maximum Value of Shares that May Yet Be Purchased Under the Plans or Programs
 ($ in thousands)
(2)
July 1 - 31, 2021354,411$9.18 354,411$21,747 
August 1 - 31, 2021— — 0$21,747 
September 1 - 30, 2021— — 0$21,747 
Total354,411 $9.18 354,411 $21,747 
(1) Class A ordinary shares.
(2) The new share repurchase plan took effect on July 1, 2021 as further described above.



51
Item 3.    DEFAULTS UPON SENIOR SECURITIES 
 
None.
 
Item 4.    MINE SAFETY DISCLOSURES

Not applicable
 
Item 5.    OTHER INFORMATION

None
 
Item 6.    EXHIBITS

10.1
10.2
31.1
31.2
32.1
32.2
101The following materials from the Company’s Quarterly Report on Form 10-Q for the three and nine months ended September 30, 2021 formatted in Inline XBRL (Extensible Business Reporting Language): (i) the Condensed Consolidated Balance Sheets; (ii) the Condensed Consolidated Statements of Operations; (iii) the Condensed Consolidated Statements of Changes in Shareholders’ Equity; (iv) the Condensed Consolidated Statements of Cash Flows; and (v) the Notes to Condensed Consolidated Financial Statements.
104Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

 
 
52


SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 GREENLIGHT CAPITAL RE, LTD.
 (Registrant)
 By:/s/ SIMON BURTON                     
 Simon Burton
Director and Chief Executive Officer
(principal executive officer)
 November 3, 2021
 By:/s/ NEIL GREENSPAN                           
 Neil Greenspan
Chief Financial Officer
(principal financial and accounting officer)
 November 3, 2021
53
 EX-10.1 2 ex10-1glreshortxtermincent.htm EX-10.1 Document

Greenlight Capital Re, Ltd.
Short-Term Incentive Plan

1.Purpose. The purpose of this Greenlight Capital Re, Ltd. Short-Term Incentive Plan (as amended, restated or otherwise modified from time to time, the “Plan”) is to foster and promote the success of Greenlight Capital Re, Ltd. (the “Company”) and its subsidiaries (together with the Company, collectively, the “Greenlight Group”) by motivating the eligible employees of the Greenlight Group selected by the Compensation Committee of the Board of Directors of the Company (the “Committee”) to participate in this Plan to maximize the performance of the Greenlight Group and rewarding them with cash bonuses directly related to such performance. The Plan is an annual plan that coincides with the calendar year (each, a “Plan Year”) commencing on January 1 and ending on December 31 of each year beginning with calendar year 2021. This Plan replaces any other annual incentive plans or programs sponsored or maintained by any member of the Greenlight Group in respect of calendar year 2021.

2.Participation. All full-time salaried employees of the Greenlight Group shall be eligible to participate in the Plan (each, an “Eligible Employee”). With respect to each Plan Year, the Chief Executive Officer of the Company (the “CEO”) shall recommend to the Committee those Eligible Employees to be considered for selection as participants in the Plan for such Plan Year. Any such Eligible Employee (i) recommended by the CEO and actually selected by the Committee, in its sole discretion, to participate in the Plan with respect to such Plan Year and (ii) notified in writing by the Company of such selection and of the terms and conditions who acknowledges and agrees to such terms and conditions, shall be referred to herein as a “Participant” with respect to such Plan Year. Participation by a Participant for a particular Plan Year does not guarantee participation for any subsequent Plan Year.

3.Administration. The Plan shall be interpreted and administered by the Committee. The Committee shall have full power and authority to (i) designate Participants in accordance with Section 2 above, (ii) determine the amount of any bonus in accordance with Section 6 below, (iii) interpret and administer the Plan, (iv) make factual determinations with respect to the Plan, (v) waive any terms or conditions under the Plan, (vi) resolve any disputes, correct any defect, reconcile any inconsistency, and supply any omissions under the Plan, (vii) prescribe or amend forms or procedures as it deems necessary or appropriate for the proper administration of the Plan, and (viii) make any other determinations and take such other actions as it deems necessary or advisable under or with respect to the Plan. Any action required of the Company under the Plan need not be uniformly applied to similarly situated individuals. All determinations, interpretations or other actions made or taken (including, but not limited to, any failure to make any determination or interpretation or failure to make or take any other action) by the Committee, including with respect to the resolution of disputes under the Plan, shall be within the sole discretion of the Committee, shall be final, conclusive and binding upon the Company, all Participants and all other interested individuals and/or entities, including, without limitation, all Eligible Employees, and shall be given deference in any proceeding with respect thereto.

4.Awards. With respect to each Plan Year in which a Participant participates in this Plan, each such Participant will have an aggregate target bonus opportunity (each, an “Aggregate Target Bonus”), which will be expressed as a percentage of the Participant’s Base Salary (as defined below) as set forth in such individual’s employment agreement or offer letter, as
1


applicable, with a member of the Greenlight Group or as otherwise communicated to the Participant in writing, and such Aggregate Target Bonus may be broken down into two parts: (x) the Company Performance Target Bonus (as defined below) and (y) the Individual Performance Target Bonus (as defined below). The Aggregate Target Bonus will vary by individual Participant and may vary among Participants in the same Base Salary grade level or same internal reporting relationship. The weighting between the Company Performance Target Bonus and the Individual Performance Target Bonus, to the extent applicable, for each Participant shall be determined with respect to each Plan Year by the Committee based on recommendations by the CEO (other than the weighting for the CEO). Weightings may be changed from Plan Year to Plan Year. For purposes of this Plan, (i) the term “Base Salary” means the base salary of a Participant, excluding all other forms of compensation, such as benefits, insurance, retirement plan contributions and any other additional compensation received in or with respect to a Plan Year, and to the extent a Participant’s base salary is modified during a Plan Year, base salary shall be prorated between the original and modified base salary amount, (ii) the term “Company Performance Target Bonus” means the portion of the bonus that is determined based on the Company Performance Criteria (as defined below) with respect to a particular Plan Year (the “Company Performance Bonus”) that would be payable, if at all, upon the achievement of such Company Performance Criteria at a level of 100% (it being understood that the foregoing shall be applied in a corresponding manner in the event there is more than one Company Performance Criteria), and (iii) the term “Individual Performance Target Bonus” means the portion of the bonus that is determined with respect to a particular Plan Year (the “Individual Performance Bonus”) that would be payable, if at all, upon achievement at a level of 100%. Each of the Company Performance Bonus and the Individual Performance Bonus may be earned independent of one another.

a.Company Performance Bonus. The Committee shall select one or more of the Company Performance Criteria as the Company Performance Criteria for the relevant Plan Year that relate(s) to the Company Performance Bonus and each selected Company Performance Criteria shall be assigned a threshold, target and maximum level of achievement (including the corresponding percentage of the Company Performance Target Bonus that can be earned) as determined by the Committee in its sole discretion. If more than one Company Performance Criteria is selected for a particular Plan Year, the Committee shall determine, in its sole discretion, the weighting between the various Company Performance Criteria (including the corresponding percentage of the Company Performance Target Bonus that can be earned). The Company Performance Criteria and requisite level of performance corresponding to the threshold and maximum levels of performance (including the corresponding percentage of the Company Performance Target Bonus that can be earned) may be changed from Plan Year to Plan Year, but in no event may the maximum level of performance result in a payment in excess of two hundred percent (200%) of the Company Performance Target Bonus (it being understood that the foregoing shall be applied in a corresponding manner in the event that there is more than one Company Performance Criteria). The target level of performance shall equate to 100% of the applicable Company Performance Criteria being attained and the Company Performance Bonus being earned at 100% of the Company Performance Target Bonus, subject to the terms and conditions of this Plan (it being understood that the foregoing shall be applied in a corresponding manner in the event there is more than one Company Performance Criteria). For purposes of this Plan, the term “Company Performance Criteria” means the criteria selected by the Committee to measure performance of one or more members of the Greenlight Group for a Plan Year based
2


on any one of the following: (i) adjusted operating profit; (ii) growth in book value per share; (iii) total shareholder return; (iv) underwriting loss ratio; (v) underwriting combined ratio; (vi) expense ratio; (vii) net income; or (viii) any other performance criteria that the Committee may select in its discretion. The threshold, target and maximum levels of any Company Performance Criteria may be increased or decreased by the Committee, as determined in its sole discretion, to reflect transactions not in the ordinary course which may affect such Company Performance Criteria, including, but not limited to, share issuances or conversions, share repurchases, dividends, distributions or other transactions affecting such Company Performance Criteria. In no event shall any bonus relating to the Company Performance Bonus be payable hereunder if the relevant threshold level of performance with respect to the Company Performance Criteria is not attained (it being understood that the foregoing shall be applied in a corresponding manner in the event there is more than one Company Performance Criteria). Actual performance between two hurdles will be subject to interpolation on a straight line basis.

b.Individual Performance Bonus. The aggregate amount that can be earned with respect to the Individual Performance Bonus will range from zero percent (0%) to one hundred percent (100%) of the Individual Performance Target Bonus. The Committee shall determine, in its sole discretion, the percentage of the Individual Performance Target Bonus, if any, that a Participant who is an executive officer of the Company shall be eligible to earn based on recommendations of the CEO (other than with respect to the CEO, which determination shall be made solely by the Committee). The CEO shall determine, in his or her sole discretion, the percentage of the Individual Performance Target Bonus, if any, that a Participant who is not an executive officer of the Company shall be eligible to earn.

5.Termination of Employment. Except as otherwise determined by the Committee in its sole discretion, or as set forth in a Participant’s employment agreement or offer letter, as applicable, with a member of the Greenlight Group or otherwise, if (x) the Participant’s employment with a member of the Greenlight Group terminates for any reason on or prior to the last day of the applicable Plan Year or (y) the Participant has given notice of termination for any reason or received notice of termination by a member of the Greenlight Group for any reason, in any such case, on or prior to the last day of the applicable Plan Year, the Participant shall cease to be a Participant in the Plan with respect to any and all applicable Plan Years, the Participant’s bonus, if any, under the Plan shall be forfeited, and the Participant shall have no further rights hereunder; provided, however, that in the event of a termination of the Participant’s employment due to death or Disability (as defined below) on or prior to the last day of the applicable Plan Year in which such Participant participates in this Plan, the Participant will be entitled to receive a pro-rata bonus hereunder based on actual performance for the applicable Plan Year in which the termination occurs, subject to compliance with the terms of such Participant’s employment agreement or other agreement for services with a member of the Greenlight Group, as applicable. For purposes of this Plan, the term “Disability” means, if the Participant is a party to any employment agreement or other agreement for services with a member of the Greenlight Group and such agreement provides for a definition of Disability, the definition therein contained, or, if no such agreement or definition exists, it means the failure of any Participant to perform his or her duties due to physical or mental incapacity as determined by the Committee.

6.Bonus Determination/Payments. Performance and bonus achievement will be measured following the end of each applicable Plan Year. Following the approval by the Board
3


of Directors of the Company (the “Board”) of the Company’s audited fiscal year results for the applicable Plan Year, the Committee will determine the level of achievement of the Company Performance Criteria and the Committee or the CEO, as applicable, will determine the level of achievement of each Participant’s individual performance (after review with the CEO of the Participant’s performance for the applicable Plan Year, other than with respect to the CEO, whose performance will be reviewed by the Committee) with respect to each Plan Year (such approval, the “Determination”). Any bonuses that are determined by the Committee or the CEO, as applicable, to be paid in accordance with the terms and conditions of this Plan and have not been forfeited in accordance with the terms and conditions of this Plan shall be paid by the applicable member of the Greenlight Group that employs the Participant in a lump sum cash payment following the date of the Determination, but in no event later than March 15 of the year following the Plan Year to which the bonus relates. Bonuses, if any, hereunder will be calculated based on (i) the Plan Year achievement of the relevant Company Performance Criteria with respect to the relevant Plan Year measured on a percentage basis by reference to the target level of achievement and (ii) the Plan Year achievement of a Participant’s Individual Performance Target Bonus. Linear interpolation shall be used to calibrate payouts between the threshold, target and maximum levels. Subject to the terms of the Plan, a Participant’s bonus, if any, under this Plan in respect of a particular Plan Year will be equal to the sum of the Actual Company Performance Bonus (as defined bellow), if any, and the Actual Individual Performance Bonus (as defined below), if any. For purposes of this Plan, the term “Actual Company Performance Bonus” shall mean the amount of the Company Performance Target Bonus that is determined to be earned, if at all, in accordance with the terms and conditions of this Plan based on the level of achievement of the Company Performance Criteria as determined by the Committee in accordance with, and subject to the terms and conditions of, this Plan and “Actual Individual Performance Bonus” shall mean the amount of the Individual Performance Target Bonus that is determined to be earned, if at all, in accordance with, and subject to the terms and conditions of, this Plan based on the level of achievement as determined by the Committee or the CEO, as applicable, in accordance with the terms and conditions of the Plan. Set forth below is an example of how a bonus could be calculated under the terms and conditions of the Plan.

Example: A Participant has a Base Salary of $200,000 and an Aggregate Target Bonus of 25% of Base Salary. The Participant’s Company Performance Target Bonus is weighted at 75% of the Aggregate Target Bonus and the Individual Performance Target Bonus is weighted at 25% of the Aggregate Target Bonus.

If the Committee determines that the Company Performance Criteria have been attained at the target level of performance with respect to the Plan Year and that 50% of the Individual Performance Target Bonus has been earned, subject to the terms and conditions of the Plan, the bonus, if any, under the Plan would be determined as follows:

Aggregate Target Bonus = $50,000
Company Performance Target Bonus = $37,500
Individual Performance Target Bonus = $12,500

$37,500 (target level of performance for the Company Performance Criteria) + $6,250 (50% of the Individual Performance Target Bonus) = $43,750

4


Notwithstanding anything herein to the contrary, bonuses payable hereunder to individuals who commence participation in the Plan after the first day of the applicable Plan Year shall be pro-rated based on the portion of the Plan Year during which the applicable Participant was employed. All determinations regarding achievement of the Company Performance Criteria and the achievement of the Individual Performance Target Bonus will be made by the Committee or the CEO, as applicable, and all calculations of any bonuses payable hereunder shall be made by the Committee.

7.Amendment/Termination. The Board at any time, and from time to time, and for any reason or no reason, may amend, modify, or terminate the Plan without prior notice to Participants. No waiver by the Company at any time of any breach by any Participant of any condition or provision of this Plan to be performed by such Participant shall be deemed a waiver of similar or dissimilar provisions or conditions at the same or at any prior or subsequent time.

8.Clawback. Notwithstanding anything herein or in any agreement between a Participant and any member of the Greenlight Group to the contrary, any and all payments under this Plan may (or, to the extent required by applicable law, rule, regulation or listing standards of any securities exchange or association on which the Company’s securities are listed, shall) be subject to recoupment, cancellation, reduction or forfeiture (i) in accordance with any clawback, forfeiture or similar policy adopted by the Committee or the Board and as in effect from time to time, (ii) in accordance with any clawback, forfeiture or other similar policy that the Company or any other member of the Greenlight Group is required to adopt pursuant to the listing standards of any securities exchange or association on which the Company’s securities are listed or as is otherwise required by Section 304 of the Sarbanes-Oxley Act of 2002 (as it may be amended and any successor provision thereto), Section 954 of the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 (as it may be amended and any successor provision thereto) or other applicable law, rule or regulation or (iii) in the event of fraud or any financial restatements or irregularities. In addition, unless otherwise determined by the Committee, to the extent that a Participant receives an amount in excess of the amount the Participant should otherwise have received under the terms of this Plan for any reason (including, without limitation, by reason of a financial restatement, mistake of calculations or other administrative error), the Participant will be required to promptly repay such excess amount to the Company. The Committee will make any determination regarding recoupment, cancellation, reduction or forfeiture in its sole discretion and in accordance with any applicable law, government regulation or Company policy, as applicable. For the avoidance of doubt, no recoupment, cancellation, reduction or forfeiture hereunder will be an event giving rise to a right to resign for “good reason” or “constructive termination” (or similar term) under any agreement with any member of the Greenlight Group or otherwise. Any individual who becomes a Participant in the Plan shall be deemed automatically to have consented and agreed to the foregoing terms.

9.Miscellaneous.

a.Governing Law. This Plan shall be governed by and construed in accordance with the laws of the Cayman Islands.

b.Alternative Forms of Payment. Notwithstanding anything herein or in any agreement between a Participant and any member of the Greenlight Group to the contrary, in
5


accordance with the Company’s Share Ownership and Retention Policy for Executives and Non-Employee Directors (effective July 29, 2021) (as it may be amended and restated from time to time (the “Policy”) or any successor thereto, the Committee may elect to pay all or some of a Participant’s bonus hereunder in Class A ordinary shares of the Company if the Participant has not satisfied the Policy or any successor thereto.

c.Taxes. The Company or any other member of the Greenlight Group shall have the right to deduct from any compensation paid to the Participant pursuant to the Plan the amount of taxes required by law in any jurisdiction to be withheld therefrom.

d.Section 409A. Notwithstanding anything herein to the contrary, to the extent applicable, this Plan is intended to comply with or be exempt from and shall be administered in a manner that is intended to comply with or be exempt from Section 409A of the U.S. Internal Revenue Code of 1986, as amended, and the rules and regulations promulgated thereunder (collectively, “Section 409A”) and the Plan shall be limited, construed and interpreted with such intent. Notwithstanding the foregoing, no member of the Greenlight Group guarantees that any payment under the Plan complies with or is exempt from Section 409A, and neither the Company, its subsidiaries or affiliates, nor their respective executives, members, partners, directors, officers, or affiliates shall have any liability with respect to any failure of any payments or benefits under the Plan to comply with or be exempt from Section 409A. If any provision hereunder results in the imposition of an additional income or other tax on any Participant under Section 409A, to the extent permitted by Section 409A, such provision shall be reformed to the extent practicable to avoid any such imposition in such manner as the Company determines is appropriate to comply with Section 409A. Each payment under the Plan to which Section 409A applies shall be treated as a separate identified payment for purposes of Section 409A. In no event may any Participant, directly or indirectly, designate the calendar year of any payment to be made under this Plan which constitutes a “deferral of compensation” within the meaning of Section 409A. To the extent any payment under the Plan is subject to Section 409A, any reference to termination of service or similar terms shall mean a “separation from service” under Section 409A.

e.Successors. This Plan shall be binding upon, and inure to the benefit of, the successors and assigns of the Company, and shall be assignable by the Company to any entity acquiring substantially all of the assets of the Company, whether by merger, consolidation, sale of assets or similar transactions.

f.Non-Transferability. No bonus under this Plan shall be subject to anticipation, alienation, sale, assignment, pledge, encumbrance, garnishment, execution or levy of any kind or charge by the Participant and any attempt to transfer, alienate, sell, assign, pledge, encumber and, to the extent permitted by applicable law, charge, garnish, execute upon or levy upon the same shall be void and shall not be recognized or given effect by the Company. Except as expressly provided by the Committee, the rights and benefits under the Plan shall not be transferrable or assignable by the Participant other than by will or the laws of descent and distribution.

g.No Right to Employment/Limitation of Rights. Nothing in this Plan shall be deemed by implication or otherwise to impose any limitation on any right of any member of the Greenlight Group to terminate any Participant’s employment at any time. Nothing in the Plan or
6


otherwise shall confer upon any person the right to participate or continue to participate in the Plan. There is no obligation for uniformity of treatment of Participants under the Plan. Payments under the Plan are an extraordinary item of compensation that is outside the normal and expected compensation for purposes of calculating any benefits unrelated to the Plan, including, without limitation, any end-of-service. Participation in the Plan does not guarantee participation in other or future incentive plans of any member of the Greenlight Group.

h.Unfunded Status. No Participant in the Plan or any other person or entity claiming a benefit under or through a Participant or otherwise shall have any right, title or interest by reason of his, her or its participation to any particular assets of the Company or any of its subsidiaries or affiliates. Neither the Company nor any of its subsidiaries or affiliates shall be required to establish any fund or make any other segregation of assets to assure satisfaction of the obligations under the Plan. Nothing in the Plan gives any Participant or any other person or entity claiming a benefit under or through a Participant any rights that are greater than those of a general unsecured creditor of the Company or any of its subsidiaries or affiliates.

i.No Constraint on Corporate Action. Nothing in the Plan shall be construed to: (i) limit, impair or otherwise affect the Company’s right or power to make adjustments, reclassifications, reorganizations or changes of its capital or business structure or to merge or consolidate or dissolve, liquidate, sell or transfer all or any part of its business or assets; or (ii) limit the right or power of the Company to take any action which such entity deemed to be necessary or appropriate.

j.Indemnification. Neither the Committee, the Board nor any member thereof shall be liable for any action or determination taken or made in good faith with respect to the Plan. Without limiting any other rights to indemnification, each member of the Board and the Committee shall be indemnified by the Company against any losses incurred in such administration of the Plan to the fullest extent permitted by applicable law.

k.Entire Agreement. This Plan constitutes the entire agreement between a Participant and the Company and its subsidiaries and affiliates regarding the subject matter of this Plan and supersede all prior compensation or incentive plans or any written or verbal representations regarding the subject matter of this Plan.

l.Severability. Every provision of this Plan is intended to be severable and any illegal or invalid term shall not affect the validity or legality of the remaining terms.

m.Headings. The headings of the Sections hereof are provided for convenience only and are not to serve as a basis for interpretation of construction, and shall not constitute a part of this Plan.
7

 EX-31.1 3 glre-20210930exhibit311.htm EX-31.1 Document

EXHIBIT 31.1  

CERTIFICATION OF
CHIEF EXECUTIVE OFFICER OF
GREENLIGHT CAPITAL RE, LTD.

I, Simon Burton, certify that:
1.
I have reviewed this quarterly report on Form 10-Q of Greenlight Capital Re, Ltd.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the periods covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; 

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; 

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and 

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and 
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and 

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.   

Dated:November 3, 2021/s/ SIMON BURTON                     
  Simon Burton
Chief Executive Officer
(principal executive officer)
  

 EX-31.2 4 glre-20210930exhibit312.htm EX-31.2 Document

 EXHIBIT 31.2 

CERTIFICATION OF
CHIEF FINANCIAL OFFICER OF
GREENLIGHT CAPITAL RE, LTD.

I, Neil Greenspan, certify that:
1.
I have reviewed this quarterly report on Form 10-Q of Greenlight Capital Re, Ltd.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the periods covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; 

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; 

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and 

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and 
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and 

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.   


Dated:November 3, 2021/s/ NEIL GREENSPAN  
  Neil Greenspan
  Chief Financial Officer
(principal financial officer)

 EX-32.1 5 glre-20210930exhibit321.htm EX-32.1 Document

EXHIBIT 32.1   
CERTIFICATION OF
CHIEF EXECUTIVE OFFICER OF
GREENLIGHT CAPITAL RE, LTD.  


This certification is provided pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and accompanies the quarterly report on Form 10-Q (the ‘‘Form 10-Q’’) for the period ended September 30, 2021 of Greenlight Capital Re, Ltd. (the ‘‘Issuer’’). 

I, Simon Burton, the Principal Executive Officer of the Issuer, certify that to the best of my knowledge: 

1. The Form 10-Q fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or 78o(d)), as amended; and 

2. The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Issuer. 


Dated:November 3, 2021/s/ SIMON BURTON                     
  Simon Burton
Chief Executive Officer
(principal executive officer)
 


 EX-32.2 6 glre-20210930exhibit322.htm EX-32.2 Document

EXHIBIT 32.2  
CERTIFICATION OF
CHIEF FINANCIAL OFFICER OF
GREENLIGHT CAPITAL RE, LTD.  


This certification is provided pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and accompanies the quarterly report on Form 10-Q (the ‘‘Form 10-Q’’) for the period ended September 30, 2021 of Greenlight Capital Re, Ltd. (the ‘‘Issuer’’). 

I, Neil Greenspan, the Principal Financial Officer of the Issuer, certify that to the best of my knowledge: 

1. The Form 10-Q fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or 78o(d)), as amended; and 

2. The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Issuer.  


Dated:November 3, 2021/s/ NEIL GREENSPAN
  Neil Greenspan
Chief Financial Officer
(principal financial officer)
 


 EX-101.SCH 7 glre-20210930.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001001 - Document - Cover Page link:presentationLink link:calculationLink link:definitionLink 1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 1006007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 2101101 - Disclosure - ORGANIZATION AND BASIS OF PRESENTATION link:presentationLink link:calculationLink link:definitionLink 2102102 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 2203201 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 2304301 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables) link:presentationLink link:calculationLink link:definitionLink 2405401 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents (Details) link:presentationLink link:calculationLink link:definitionLink 2406402 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2407403 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Interest Income and Interest Expense (Details) link:presentationLink link:calculationLink link:definitionLink 2408404 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Weighted Average Number of Shares (Details) link:presentationLink link:calculationLink link:definitionLink 2109103 - Disclosure - INVESTMENT IN RELATED PARTY INVESTMENT FUND link:presentationLink link:calculationLink link:definitionLink 2310302 - Disclosure - INVESTMENT IN RELATED PARTY INVESTMENT FUND (Tables) link:presentationLink link:calculationLink link:definitionLink 2411405 - Disclosure - INVESTMENT IN RELATED PARTY INVESTMENT FUND - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2412406 - Disclosure - INVESTMENT IN RELATED PARTY INVESTMENT FUND - Financial Information of Investment (Details) link:presentationLink link:calculationLink link:definitionLink 2413407 - Disclosure - INVESTMENT IN RELATED PARTY INVESTMENT FUND -Summarized Statement of Operations of Solasglas Investments, LP (Details) link:presentationLink link:calculationLink link:definitionLink 2114104 - Disclosure - FINANCIAL INSTRUMENTS link:presentationLink link:calculationLink link:definitionLink 2315303 - Disclosure - FINANCIAL INSTRUMENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 2416408 - Disclosure - FINANCIAL INSTRUMENTS - Other Investments (Details) link:presentationLink link:calculationLink link:definitionLink 2417409 - Disclosure - FINANCIAL INSTRUMENTS - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2118105 - Disclosure - LOSS AND LOSS ADJUSTMENT EXPENSE RESERVES link:presentationLink link:calculationLink link:definitionLink 2319304 - Disclosure - LOSS AND LOSS ADJUSTMENT EXPENSE RESERVES (Tables) link:presentationLink link:calculationLink link:definitionLink 2420410 - Disclosure - LOSS AND LOSS ADJUSTMENT EXPENSE RESERVES - Liability for Unpaid Claims and Claims Adjustment Expense (Details) link:presentationLink link:calculationLink link:definitionLink 2121106 - Disclosure - RETROCESSION link:presentationLink link:calculationLink link:definitionLink 2422411 - Disclosure - RETROCESSION (Details) link:presentationLink link:calculationLink link:definitionLink 2123107 - Disclosure - SENIOR CONVERTIBLE NOTES link:presentationLink link:calculationLink link:definitionLink 2424412 - Disclosure - SENIOR CONVERTIBLE NOTES (Details) link:presentationLink link:calculationLink link:definitionLink 2125108 - Disclosure - SHARE CAPITAL link:presentationLink link:calculationLink link:definitionLink 2326305 - Disclosure - SHARE CAPITAL (Tables) link:presentationLink link:calculationLink link:definitionLink 2427413 - Disclosure - SHARE CAPITAL - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2428414 - Disclosure - SHARE CAPITAL - Stock by Class (Details) link:presentationLink link:calculationLink link:definitionLink 2129109 - Disclosure - SHARE-BASED COMPENSATION link:presentationLink link:calculationLink link:definitionLink 2330306 - Disclosure - SHARE-BASED COMPENSATION (Tables) link:presentationLink link:calculationLink link:definitionLink 2431415 - Disclosure - SHARE-BASED COMPENSATION - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2432416 - Disclosure - SHARE-BASED COMPENSATION - Share-based Compensation, Restricted Stock Activity (Details) link:presentationLink link:calculationLink link:definitionLink 2433417 - Disclosure - SHARE-BASED COMPENSATION - Restricted Stock Units (Details) link:presentationLink link:calculationLink link:definitionLink 2134110 - Disclosure - TAXATION link:presentationLink link:calculationLink link:definitionLink 2335307 - Disclosure - TAXATION (Tables) link:presentationLink link:calculationLink link:definitionLink 2436418 - Disclosure - TAXATION - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2437419 - Disclosure - TAXATION - Components of Income Tax Expense (Benefit) (Details) link:presentationLink link:calculationLink link:definitionLink 2138111 - Disclosure - RELATED PARTY TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 2439420 - Disclosure - RELATED PARTY TRANSACTIONS (Details) link:presentationLink link:calculationLink link:definitionLink 2140112 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 2341308 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables) link:presentationLink link:calculationLink link:definitionLink 2442421 - Disclosure - COMMITMENTS AND CONTINGENCIES - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2443422 - Disclosure - COMMITMENTS AND CONTINGENCIES - Letters of Credit Facilities (Details) link:presentationLink link:calculationLink link:definitionLink 2444423 - Disclosure - COMMITMENTS AND CONTINGENCIES - Commitments and Contingencies, Fiscal Year Maturity Schedule (Details) link:presentationLink link:calculationLink link:definitionLink 2444423 - Disclosure - COMMITMENTS AND CONTINGENCIES - Commitments and Contingencies, Fiscal Year Maturity Schedule (Details) link:presentationLink link:calculationLink link:definitionLink 2145113 - Disclosure - SEGMENT REPORTING link:presentationLink link:calculationLink link:definitionLink 2346309 - Disclosure - SEGMENT REPORTING (Tables) link:presentationLink link:calculationLink link:definitionLink 2447424 - Disclosure - SEGMENT REPORTING - Gross Premiums Written by Line of Business (Details) link:presentationLink link:calculationLink link:definitionLink 2448425 - Disclosure - SEGMENT REPORTING - Gross Premiums Written by Geographic Area of Risks Insured (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 glre-20210930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 9 glre-20210930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 10 glre-20210930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Supplementary information Supplemental Cash Flow Information [Abstract] Loss and loss adjustment expense reserves Liability for Claims and Claims Adjustment Expense, Property Casualty Liability Earnings (Loss) Per Share Earnings Per Share, Policy [Policy Text Block] Interest and convertible note payable Convertible Debt [Member] Vested (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period Net income (loss) Net income (loss) Net Income (Loss) Attributable to Parent Consolidated Entities [Axis] Consolidated Entities [Axis] Entity Emerging Growth Company Entity Emerging Growth Company Operating lease right of use asset Operating Lease, Right-of-Use Asset AccuRisk Holdings LLC AccuRisk Holdings LLC [Member] AccuRisk Holdings LLC [Member] Income Statement Location [Axis] Income Statement Location [Axis] Statistical Measurement [Domain] Statistical Measurement [Domain] Ceded Credit Risk, Collateralization [Domain] Ceded Credit Risk, Collateralization [Domain] Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two 2023 Contractual Obligation, to be Paid, Year Two Liability for Claims and Claims Adjustment Expense [Line Items] Liability for Claims and Claims Adjustment Expense [Line Items] Derivative contracts, at fair value Derivative Liability Case reserves Liability for Unpaid Claims and Claims Adjustment Expense, Reported Claims, Amount Debt conversion price (in dollars per share) Debt Instrument, Convertible, Conversion Price Equity method investments, fair value Equity Method Investments, Fair Value Disclosure Forfeited (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Entity Filer Category Entity Filer Category Investment management fee rate - monthly Related Party Transaction, Monthly Management Fee Percentage The monthly rate charged by investment advisor calculated as a percentage of assets under management Loss and loss expenses recovered and recoverable Policyholder Benefits and Claims Incurred, Assumed and Ceded 2021 Contractual Obligation, to be Paid, Remainder of Fiscal Year Unrealized losses Other Investments, Accumulated Gross Unrealized Holding Loss Other Investments, Accumulated Gross Unrealized Holding Loss Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Derivative instruments Derivatives, Policy [Policy Text Block] Shares available for future issuance (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant Interest income Interest Income, Operating Net increase (decrease) in cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 2023 Long-Term Debt, Maturity, Year Two Share-based compensation expense APIC, Share-based Payment Arrangement, Increase for Cost Recognition Investor relations monthly fee Related Party Transaction, Expenses from Transactions with Related Party Management fees Equity Method Investment, Summarized Financial Information, Management Fee Expense Equity Method Investment, Summarized Financial Information, Management Fee Expense Dividend income (net of withholding taxes) Dividend Income, Operating 2021 Long-Term Debt, Maturity, Remainder of Fiscal Year Net Assets Net Assets, Fair Value Disclosure Net Assets, Fair Value Disclosure Document Fiscal Year Focus Document Fiscal Year Focus Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Board of Directors Chairman Board of Directors Chairman [Member] Anti-dilutive stock options outstanding (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Service Agreement Service Agreement [Member] Service Agreement [Member] Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block] Granted (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Total fair value of restricted shares vested Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value Revenue from External Customer [Line Items] Revenue from External Customer [Line Items] Title of Individual [Domain] Title of Individual [Domain] Schedule of Operating Leased Assets [Table] Schedule of Operating Leased Assets [Table] Income Tax Examination [Table] Income Tax Examination [Table] Less: Losses recoverable Loss and loss adjustment expenses recoverable Reinsurance Recoverables, Including Reinsurance Premium Paid Credit Rating Source [Axis] Credit Rating, AM Best [Axis] Award Type [Domain] Award Type [Domain] Credit Facility [Domain] Credit Facility [Domain] Assets Assets [Abstract] Related Party Transactions [Abstract] Related Party Transactions [Abstract] 2024 Long-Term Debt, Maturity, Year Three Number of s issued to employees RSUs (in shares) Granted (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period New Accounting Pronouncements or Change in Accounting Principle [Line Items] New Accounting Pronouncements or Change in Accounting Principle [Line Items] Preferred share capital (par value $0.10; authorized, 50,000,000; none issued) Preferred Stock, Value, Issued New Accounting Pronouncements or Change in Accounting Principle [Table] Accounting Standards Update and Change in Accounting Principle [Table] Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward] Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward] Options outstanding (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Entity Address, City or Town Entity Address, City or Town Variable Interest Entity, Not Primary Beneficiary Variable Interest Entity, Not Primary Beneficiary [Member] Investment management fee rate - annual Related Party Transaction, Annual Management Fee Percentage The annual rate charged by investment advisor calculated as a percentage of assets under management Retained earnings (deficit) Retained Earnings [Member] Effect of dilutive employee and director share-based awards (in shares) Incremental Common Shares Attributable To Dilutive Effect Of Share-based Payment Arrangements, Employees And Directors Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements, Employees and Directors Debt Instrument [Axis] Debt Instrument [Axis] Fair value of debt Debt Instrument, Fair Value Disclosure Reinsurance Disclosures [Abstract] Reinsurance Disclosures [Abstract] Expenses Benefits, Losses and Expenses [Abstract] Ceded Credit Risk, Collateralization [Axis] Ceded Credit Risk, Collateralization [Axis] COMMITMENTS AND CONTINGENCIES Commitments and Contingencies Disclosure [Text Block] Stock-based compensation expense Shares Granted, Value, Share-based Payment Arrangement, Forfeited Net investment income (loss) Investment Income The net income earned from investments in securities and other investments including derivatives. It includes dividends from shares in corporations, and interest from bonds, loans, mortgages, derivatives, commercial paper, bank accounts, certificates of deposits, treasuries, and other financial securities. It also includes realized and unrealized gains and losses on all investments. Professional Liability Professional Malpractice Liability Insurance [Member] Related Party [Axis] Related Party [Axis] Performance compensation full rate Related Party Transaction, Performance Compensation Full Rate As Percentage Of Investment Income The full rate of performance compensation as a percent of investment income charged by a related party. Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Prior years Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Entity Interactive Data Current Entity Interactive Data Current Performance allocation Incentive Fee Expense Number of operating segments Number of Operating Segments Worldwide Worldwide [Member] Worldwide Prior years Estimate of net losses Prior Year Claims and Claims Adjustment Expense General Partner General Partner [Member] Basic (in dollars per share) Earnings Per Share, Basic Operating lease expense Operating Lease, Expense 2024 Lessee, Operating Lease, Liability, to be Paid, Year Three Unvested performance restricted shares outstanding (in shares) Beginning balance (in shares) Ending balance (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number Net realized (gains) losses on investments and notes receivable Realized gains losses on sale of investments and derivatives Realized Gains Losses On Sale Of Investments And Derivatives The net realized gains (losses) on investments and derivatives sold during the period. Document Type Document Type 2022 Long-Term Debt, Maturity, Year One Unamortized debt issuance expense Unamortized Debt Issuance Expense Number of non-vested restricted  shares Number of non-vested RSUs Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Interest and dividends receivable Interest And Dividends Receivable, Fair Value Disclosure Interest And Dividends Receivable, Fair Value Disclosure Entity Current Reporting Status Entity Current Reporting Status Cumulative Effect, Period of Adoption, Adjustment Cumulative Effect, Period of Adoption, Adjustment [Member] Secured Ceded Credit Risk, Secured [Member] Shares authorized for the company's stock incentive plan (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized Restricted cash and cash equivalents Restricted Cash and Cash Equivalents 2025 Contractual Obligation, to be Paid, Year Four Unearned premium reserves Increase (Decrease) in Unearned Premiums Loss and loss adjustment expenses recoverable (net of allowance for expected credit losses of $47 and $47) Add: Losses recoverable Reinsurance Recoverable for Unpaid Claims and Claims Adjustments Realized and change in unrealized gains (losses) Equity Method Investment, Summarized Financial Information, Gain (Loss) On Investment [Abstract] Equity Method Investment, Summarized Financial Information, Gain (Loss) On Investment Current expected credit losses recognized on notes receivable and reinsurance assets Accounts Receivable, Credit Loss Expense (Reversal) Due to brokers Payables To Broker-Dealers, Fair Value Disclosure Payables To Broker-Dealers, Fair Value Disclosure Assets Assets, Fair Value Disclosure [Abstract] Total Long-term Debt Total assets Assets, Fair Value Disclosure Proceeds from redemptions from related party investment fund Proceeds from Equity Method Investment, Distribution, Return of Capital Ceded Credit Risk [Line Items] Ceded Credit Risk [Line Items] Investing activities Net Cash Provided by (Used in) Investing Activities [Abstract] Other liabilities Other Liabilities Document Transition Report Document Transition Report Income Tax Disclosure [Abstract] Operating lease obligations Lessee, Operating Lease, Liability, Payment, Due [Abstract] Total liabilities and equity Liabilities and Equity Reinsurance balances receivable (net of allowance for expected credit losses of $89 and $89) Premiums and Other Receivables, Net Scenario [Axis] Scenario [Axis] Additional paid-in capital Additional Paid in Capital Thereafter Long-Term Debt, Maturity, After Year Four Long-Term Debt, Maturity, After Year Four Personal Property and Casualty, Personal Insurance [Member] Liabilities and equity Liabilities and Equity [Abstract] Expenses Operating Expenses [Abstract] Equity method investment, ownership percentage Equity Method Investment, Ownership Percentage Minimum Minimum [Member] ORGANIZATION AND BASIS OF PRESENTATION Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Affiliated Entity Affiliated Entity [Member] General Liability General Liability [Member] 2023 Lessee, Operating Lease, Liability, to be Paid, Year Two Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Workers' Compensation Workers' Compensation Insurance Product Line [Member] Workers' compensation line of business of insurance coverage Balance Sheet Location [Domain] Balance Sheet Location [Domain] Total liabilities Financial and Nonfinancial Liabilities, Fair Value Disclosure Unearned premium reserves Unearned Premiums Schedule of Stock by Class Schedule of Stock by Class [Table Text Block] Estimated volatility Estimated Volatility Estimated Volatility Preferred share capital, authorized (in shares) Preferred Stock, Shares Authorized Gross deferred tax asset Deferred Tax Assets, Gross Cumulative Effect, Period Of Adoption [Axis] Cumulative Effect, Period of Adoption [Axis] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Trading Symbol Trading Symbol Collateral held in trust Collateral Held In Trust Cash and securities posted as collateral by the retrocessionaire in a trust account for the benefit of the ceding reinsurer. Acquisition costs Deferred Policy Acquisition Costs, Amortization Expense Citibank Europe plc Citibank Europe plc [Member] Citibank Europe plc Entity Address, Country Entity Address, Country 2025 Long-Term Debt, Maturity, Year Four Management fee Management fee Management fee Management Fee Expense General and administrative expenses General and Administrative Expense SENIOR CONVERTIBLE NOTES Debt Disclosure [Text Block] Unrated Unrated [Member] No rating assigned by any external rating agencies. Schedule of Components of Income Tax Expense (Benefit) Schedule of Components of Income Tax Expense (Benefit) [Table Text Block] SHARE-BASED COMPENSATION Share-based Payment Arrangement [Text Block] Net change in notes receivable Increase (Decrease) in Notes Receivables Senior Notes Senior Notes [Member] Reinsurance balances receivable Increase (Decrease) in Premiums Receivable Accounting Policies [Abstract] Accounting Policies [Abstract] Other Specialty Insurance, Other [Member] Total Contractual Obligation Weighted average remaining contractual term Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Issue of ordinary shares, net of forfeitures (in shares) Stock Issued During Period, Shares, New Issues Contract termination prior notice period Related Party Transactions, Contract Termination Prior Notice Period Related Party Transactions, Contract Termination Prior Notice Period Operating lease liability Operating Lease, Liability Aggregate amount of letters of credit issued Letters of Credit Outstanding, Amount Foreign exchange (gains) losses on investments Foreign Currency Transaction Gain (Loss), before Tax Schedule of Interest Income and Interest Expense Interest Income and Interest Expense Disclosure [Table Text Block] Ordinary share capital (Class A: par value $0.10; authorized, 100,000,000; issued and outstanding, 27,589,731 (2020: 28,260,075): Class B: par value $0.10; authorized, 25,000,000; issued and outstanding, 6,254,715 (2020: 6,254,715)) Common Stock, Value, Issued Weighted average period for recognition Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Beginning balance (in dollars per share) Ending balance (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value RETROCESSION Reinsurance [Text Block] Derivative financial instruments (not designated as hedging instruments) Derivative Financial Instruments [Member] Derivative Financial Instruments Interest and convertible note payable Long-term Debt, Fiscal Year Maturity [Abstract] 2021 Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year Other investments Other Investments Participating securities excluded from calculation of loss per share  Employee and Director Restricted Shares Restricted Stock [Member] Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Document Period End Date Document Period End Date Foreign currency revaluation Liability for Unpaid Claims and Claims Adjustment Expense, Foreign Currency Translation Gain (Loss) Schedule of Gross Premiums Written by Geographic Area of Risks Insured Revenue from External Customers by Geographic Areas [Table Text Block] Class of Stock [Axis] Class of Stock [Axis] Entity Registrant Name Entity Registrant Name Total future obligations by year Contractual Obligation, Fiscal Year Maturity [Abstract] Deposit interest income/(expense), net Interest Income (Expense), Net Net balance at January 1 Net balance at September 30 Liability for Unpaid Claims and Claims Adjustment Expense, Net Credit Rating Source [Domain] Credit Rating, AM Best [Domain] Deposit contracts, liabilities Deposit Contracts, Liabilities Income (loss) from investment in related party investment fund (net of related party expenses of $659 and $2,632 (three and nine months ended September 30, 2020: $703 and $1,981, respectively)) Loss (income) from investments in related party investment fund Revenue from related parties GLRE limited partners’ share of net income (loss) Revenue from Related Parties Professional fees and other Professional Fees And Other Noninterest Expense Professional Fees And Other Noninterest Expense Number of credit facilities Number Of Credit Facilities Number Of Credit Facilities Allowance for expected credit losses Reinsurance Recoverable, Allowance for Credit Loss Debt instrument, amount authorized for repurchase (up to) Debt Instrument, Amount Authorized For Repurchase Debt Instrument, Amount Authorized For Repurchase Other investments, adjustment Other Investments, Adjustment Other Investments, Adjustment Anti-dilutive stock options outstanding Employee and Director Stock Options Share-based Payment Arrangement, Option [Member] Funds withheld Funds Held under Reinsurance Agreements, Liability Equity [Abstract] Other investments, adjustment, net Other Investments, Adjustment, Net Other Investments, Adjustment, Net Convertible senior notes payable Convertible Notes Payable Gross premiums written (in percent) Premiums Written, Gross As Percentage Of Total Gross Premiums Written Gross written premiums by line of business as a percentage of total gross written premiums Risk free rate Risk Free Rate Risk Free Rate Ordinary share capital Common Stock [Member] SEGMENT REPORTING Segment Reporting Disclosure [Text Block] Sales of investments Proceeds from (Payments for) Trading Securities, Short-term Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Share-based compensation expense Share-based Payment Arrangement, Noncash Expense Additional paid-in capital Additional Paid-in Capital [Member] Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Funds withheld Increase (Decrease) in Funds Held under Reinsurance Agreements Long-term Debt, Type [Domain] Long-term Debt, Type [Domain] LOSS AND LOSS ADJUSTMENT EXPENSE RESERVES Liability for Future Policy Benefits and Unpaid Claims Disclosure [Text Block] Equity Method Investment, Nonconsolidated Investee [Axis] Equity Method Investment, Nonconsolidated Investee [Axis] Loss and loss adjustment expense reserves Increase (Decrease) in Liability for Claims and Claims Adjustment Expense Reserve Other Assets Other Assets [Member] Notes receivable Financing Receivable, after Allowance for Credit Loss Other liabilities Increase (Decrease) in Other Operating Liabilities Repurchase of ordinary shares (in shares) Repurchase of ordinary shares (in shares) Stock Repurchased and Retired During Period, Shares Maximum Maximum [Member] Share-based Payment Arrangement [Abstract] Share-based Payment Arrangement [Abstract] Non Employee Director Member Non Employee Director Member [Member] Non Employee Director Member Total liabilities Liabilities Legal Entity [Axis] Legal Entity [Axis] Total Other Total Specialty [Domain] Total of all Specialty lines insurance products types [Domain] Deposit interest income Deposit Contract Liabilities Net Investment Income Allocation Accrued Deposit Contract Liabilities Net Investment Income Allocation Accrued Award Type [Axis] Award Type [Axis] Amortization and interest expense, net of change in accruals Amortization And Interest Expense Net Amortization And Interest Expense Net Financing activities Net Cash Provided by (Used in) Financing Activities [Abstract] Expired (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period Total shareholders' equity Beginning balance Ending balance Stockholders' Equity Attributable to Parent Current year Current Year Claims and Claims Adjustment Expense Ordinary share capital, issued (in shares) Common Stock, Shares, Issued Preferred share capital, issued (in shares) Preferred Stock, Shares Issued Commercial Property and Casualty, Commercial Insurance [Member] Ceded premiums earned Ceded Premiums Earned Operating lease renewal term Operating Lease, Renewal Term Operating Lease, Renewal Term Incurred losses related to: Incurred Losses Related To [Abstract] Incurred Losses Related To [Abstract] Investment accounted for under the equity method Equity Method Investments [Member] INVESTMENT IN RELATED PARTY INVESTMENT FUND Equity Method Investments and Joint Ventures Disclosure [Text Block] Collateral Assets Investment Management Agreement Collateral Assets Investement Management Agreement [Member] Collateral Assets Investement Management Agreement [Member] Repurchase of Class A ordinary shares Payments for Repurchase of Common Stock Unsecured Ceded Credit Risk, Unsecured [Member] Deposit contracts, assets Deposit Contracts, Assets Shareholders' equity Stockholders' Equity Attributable to Parent [Abstract] Balance Sheet Location [Axis] Balance Sheet Location [Axis] Adjustments for New Accounting Pronouncements [Axis] Accounting Standards Update [Axis] SILP Limited Partnership Agreement [Member] Limited Partnership Agreement between SILP and its partners Total Casualty Liability and Casualty Insurance Product Line [Member] Total casualty line of business for insurance operations Current tax (expense) benefit Current Income Tax Expense (Benefit) Convertible debt, amount Debt Instrument, Face Amount Interest expense Interest Interest Expense Total Investment income Interest and Dividend Income, Operating Effective interest rate (in percent) Debt Instrument, Interest Rate, Effective Percentage Schedule of Other Investments Investment Holdings, Other than Securities [Table Text Block] City Area Code City Area Code Retained earnings (deficit) Retained Earnings (Accumulated Deficit) Share-based Payment Arrangement Share-based Payment Arrangement [Member] Income Tax Examination [Line Items] Income Tax Examination [Line Items] RSUs Restricted Stock Units (RSUs) [Member] Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Schedule of Financial Information of Investment Equity Method Investments [Table Text Block] Net gain (loss) on investment transactions Gain (Loss) on Investments Schedule of Restrictions on Cash and Cash Equivalents Restrictions on Cash and Cash Equivalents [Table Text Block] Income Statement [Abstract] Income Statement [Abstract] Amendment Flag Amendment Flag AM Best, A- Rating AM Best, A- Rating [Member] Net change in unrealized gains and losses on investments and notes receivable Change In Unrealized Gains Losses On Investments And Derivatives The net increase (decrease) in fair value of unsold investments and derivatives not held for hedging whose gains and losses are included in net income. Related Party Transaction [Axis] Related Party Transaction [Axis] Restricted shares issued pursuant to stock incentive plan (in shares) Stock Issued During Period, Shares, Restricted Stock Award, Gross Shareholders' equity Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Income tax (expense) benefit Income tax (expense) benefit  Income Tax Expense (Benefit) Equity Components [Axis] Equity Components [Axis] Greenlight Capital Re Limited Partners Greenlight Capital Re Limited Partners [Member] Greenlight Capital Re Limited Partners [Member] Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Investment Type [Axis] Investment Type [Axis] Antidilutive Securities [Axis] Antidilutive Securities [Axis] Total Property Property Insurance [Member] Total Lessee, Operating Lease, Liability, to be Paid Shares forfeited (in shares) Forfeited (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period Loss and loss adjustment expenses recoverable Increase (Decrease) in Reinsurance Recoverable Schedule of Gross Premiums Written by Line of Business Schedule of Segment Reporting Information, by Segment [Table Text Block] Schedule of Stock by Class [Table] Schedule of Stock by Class [Table] Entity File Number Entity File Number Equity Method Investment, Nonconsolidated Investee [Domain] Equity Method Investment, Nonconsolidated Investee [Domain] Repurchase of Class A ordinary shares Stock Repurchased During Period, Value Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Equity Method Investments and Joint Ventures [Abstract] Equity Method Investments and Joint Ventures [Abstract] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Decrease (increase) in deferred tax valuation allowance Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount Performance compensation reduced rate Related Party Transaction, Performance Compensation Reduced Rate As Percentage of Investment Income The reduced rate charged by related party for performance compensation as a percent of investment income due to loss carry forward provision. Total compensation cost related to non-vested options not yet recognized Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Product and Service [Axis] Insurance Product Line [Axis] Product and Service [Axis] Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Schedule of Weighted Average Number of Shares Schedule of Weighted Average Number of Shares [Table Text Block] Schedule of Cash and Cash Equivalents Schedule of Cash and Cash Equivalents [Table Text Block] Entity Small Business Entity Small Business Preferred share capital, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share Unrecognized compensation costs related to non-vested restricted shares Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount Chief Executive Officer Chief Executive Officer [Member] SILP SILP [Member] SILP [Member] Solasglas Investments, LP Weighted average grant date fair value, granted (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Equity Component [Domain] Equity Component [Domain] Short term lease cost Short-term Lease, Cost Funds held by cedents Funds Held By Cedents Funds Held By Cedents 2022 Lessee, Operating Lease, Liability, to be Paid, Year One Schedule of Equity Method Investments [Table] Schedule of Equity Method Investments [Table] Investments Investments [Abstract] Total equity securities, restricted cash, and cash and cash equivalents fair value pledged as security against the letters of credit Pledged Financial Instruments, Not Separately Reported, Securities for Letter of Credit Facilities Statement [Line Items] Statement [Line Items] Restricted shares forfeited by employees who left the company prior to the vesting period (in shares) Stock Issued During Period, Shares, Restricted Stock Award, Forfeited Other Liabilities Other Liabilities [Policy Text Block] Description of items aggregated and included under Other Liabilities on the balance sheet. Unearned premiums ceded Increase (Decrease) in Prepaid Reinsurance Premiums Total investments Investments Issue of Class A ordinary shares, net of forfeitures Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture Liabilities Liabilities [Abstract] Counterparty Name [Domain] Counterparty Name [Domain] Deferred acquisition costs Increase (Decrease) in Deferred Policy Acquisition Costs 2025 Lessee, Operating Lease, Liability, to be Paid, Year Four Debt Disclosure [Abstract] Debt Disclosure [Abstract] 2022 Contractual Obligation, to be Paid, Year One Thereafter Lessee, Operating Lease, Liability, To Be Paid, After Year Four Lessee, Operating Lease, Liability, To Be Paid, After Year Four Total expenses Benefits, Losses and Expenses Type of Adoption [Domain] Accounting Standards Update [Domain] Document Information [Table] Document Information [Table] Notice period required for termination Line Of Credit Facility, Termination Notice Period Termination notice period for LOC facilities Deferred tax asset valuation allowance Deferred Tax Assets, Valuation Allowance Segment Reporting [Abstract] Segment Reporting [Abstract] Entity [Domain] Entity [Domain] Gross Premiums Written by Geographic Area of Risks Insured [Table] Revenue from External Customers by Products and Services [Table] Reinsurance balances payable Increase (Decrease) in Reinsurance Payables Use of Estimates Use of Estimates, Policy [Policy Text Block] Granted (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Entity Shell Company Entity Shell Company Local Phone Number Local Phone Number Forecast Forecast [Member] Total assets Assets Net realized gain (loss) Realized Investment Gains (Losses) Ordinary share capital, authorized (in shares) Common Stock, Shares Authorized Interest paid in cash Interest Paid, Excluding Capitalized Interest, Operating Activities Geographical [Domain] Geographical [Domain] Title of Individual [Axis] Title of Individual [Axis] Insurance Product Line [Domain] Product and Service [Domain] Schedule of Liability for Unpaid Claims and Claims Adjustment Expense Schedule of Liability for Unpaid Claims and Claims Adjustment Expense [Table Text Block] Multi-line Multi-line [Member] Multi-line [Member] Debt interest rate (in percent) Debt Instrument, Interest Rate, Stated Percentage Net premiums earned Premiums Earned, Net Unearned premiums ceded Prepaid Reinsurance Premiums Schedule of Letters of Credit Facilities Schedule of Line of Credit Facilities [Table Text Block] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] SIGNIFICANT ACCOUNTING POLICIES Significant Accounting Policies [Text Block] Cumulative Effect, Period Of Adoption [Domain] Cumulative Effect, Period of Adoption [Domain] Equity Method Investment, Nonconsolidated Investee or Group of Investees Equity Method Investment, Nonconsolidated Investee or Group of Investees [Member] Net cash provided by (used in) operating activities Net Cash Provided by (Used in) Operating Activities Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items] Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items] 2024 Contractual Obligation, to be Paid, Year Three Schedule of Long-term Debt Instruments [Table] Schedule of Long-term Debt Instruments [Table] Net loss and loss adjustment expenses incurred Policyholder Benefits and Claims Incurred, Net Geographical [Axis] Geographical [Axis] Other investments Other Investments [Member] Basic (in shares) Weighted average shares outstanding - basic (in shares) Weighted Average Number of Shares Outstanding, Basic Diluted (in dollars per share) Earnings Per Share, Diluted Cost Other Investments, Cost Other Investments, Cost Schedule of Commitments and Contingencies, Fiscal Year Maturity Schedule Contractual Obligation, Fiscal Year Maturity [Table Text Block] Income tax paid in cash Income Taxes Paid, Net Investment in related party investment fund GLRE Limited Partners’ share of Net Assets Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures Private investments and unlisted equities Private and unlisted equity securities [Member] Private equities and unlisted equity securities Accounting Standards Update [Extensible List] Accounting Standards Update [Extensible Enumeration] Purchases of investments Payments to Acquire Trading Securities Held-for-investment Shares authorized for issuance in relation to share purchase options granted to service provider (in shares) Deferred Compensation Arrangement with Individual, Shares Authorized for Issuance Net change in unrealized appreciation (depreciation) Unrealized Gain (Loss) on Investments Due from brokers Due From Brokers, Fair Value Disclosure Due From Brokers, Fair Value Disclosure Net cash provided by (used in) financing activities Net Cash Provided by (Used in) Financing Activities Weighted average number of ordinary shares used in the determination of earnings and loss per share Weighted Average Number of Shares Outstanding, Diluted [Abstract] Related Party Transaction [Line Items] Related Party Transaction [Line Items] Cliff vesting period after date of issuance Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period Gross premiums ceded Ceded Premiums Written Loss (income) from investment accounted for under the equity method Income (Loss) from Equity Method Investments Change in net unearned premium reserves (Increase) Decrease in Unearned Premiums, Net Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block] Deposit Assets and Liabilities Deposit Contracts, Policy [Policy Text Block] Income (loss) before income tax Income (Loss) Attributable to Parent, before Tax Other Assets Other Assets [Policy Text Block] Description of immaterial items aggregated and included under the Other Assets line item on the balance sheet. Fair value / carrying value Other Investments, Fair Value Disclosure Other Investments, Fair Value Disclosure Solasglas Investment LP (silp) Solasglas Investment LP (SILP) [Member] Solasglas Investment LP (SILP) [Member] Other assets Other Assets Ordinary share capital, outstanding (in shares) Balance – beginning of period (in shares) Balance – end of period (in shares) Common Stock, Shares, Outstanding Other income (expense), net Other Operating Income (Expense), Net Depreciation expense Depreciation, Nonproduction Automatic agreement extension, term Related Party Transactions, Automatic Agreement Extension, Term Related Party Transactions, Automatic Agreement Extension, Term Revenues Revenues [Abstract] Investment income Interest and Dividend Income, Operating [Abstract] Conversion ratio (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Conversion Ratio Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Conversion Ratio Liabilities and partners’ capital Equity Method Investment, Summarized Financial Information, Liabilities And Partners' Capital [Abstract] Equity Method Investment, Summarized Financial Information, Liabilities And Partners' Capital [Abstract] Common Class B Common Class B [Member] Line of Credit Facility, Lender [Domain] Line of Credit Facility, Lender [Domain] Consolidated Entities [Domain] Consolidated Entities [Domain] Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table] Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table] Income Statement Location [Domain] Income Statement Location [Domain] Investments, at fair value Investments, Fair Value Disclosure Net investment income (loss) Net Investment Income Insurance Loss Reserves [Abstract] Insurance Loss Reserves [Abstract] Lender Name [Axis] Lender Name [Axis] Debt Instrument [Line Items] Debt Instrument [Line Items] Health Accident & Health Health Insurance Product Line [Member] Earnings (loss) per share Earnings Per Share [Abstract] Reinsurance balances payable Reinsurance Payable Derivative contracts, at fair value Derivative Asset Interest and dividends payable Interest And Dividends Payable, Fair Value Disclosure Interest And Dividends Payable, Fair Value Disclosure Loss and loss adjustment expenses recoverable, allowance Accounts Receivable, Allowance for Credit Loss Related Party Transaction [Domain] Related Party Transaction [Domain] Document Quarterly Report Document Quarterly Report Other assets, excluding depreciation Increase (Decrease) in Other Operating Assets Total revenues Revenues Paid losses related to: Paid Losses Related To [Abstract] Paid Losses Related To [Abstract] Line of Credit Facility [Table] Line of Credit Facility [Table] Other liabilities Other Liabilities, Fair Value Disclosure Exercise price (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Investment Advisory Agreement Investment Advisory Agreement [Member] Investment Advisory Agreement [Member] Liabilities Liabilities, Fair Value Disclosure [Abstract] Schedule of Related Party Transactions, by Related Party [Table] Schedule of Related Party Transactions, by Related Party [Table] Facility Financial Standby Letter of Credit [Member] Stock based compensation expense, net of forfeiture reversals Share-based Payment Arrangement, Expense Debt Securities, Trading, and Equity Securities, FV-NI [Table] Debt Securities, Trading, and Equity Securities, FV-NI [Table] Schedule of Equity Method Investments [Line Items] Schedule of Equity Method Investments [Line Items] Europe Europe [Member] Net premiums written Premiums Written, Net Weighted  average grant date fair value Weighted  average grant date fair value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Document Fiscal Period Focus Document Fiscal Period Focus IBNR Liability for Unpaid Claims and Claims Adjustment Expense, Incurred but Not Reported (IBNR) Claims, Amount Ownership percentage Related Party Transaction, Investment Owned, Percentage Related Party Transaction, Investment Owned, Percentage Funds Held by Cedents Funds Held by Cedents [Policy Text Block] Funds Held by Cedents Investments [Domain] Investments [Domain] Recognized interest expense Amortization of Debt Issuance Costs Total expenses Interest And Noninterest Expenses Interest And Noninterest Expenses Counterparty Name [Axis] Counterparty Name [Axis] Liability for Claims and Claims Adjustment Expense [Table] Liability for Claims and Claims Adjustment Expense [Table] Common Class A Common Class A [Member] Cash, cash equivalents and restricted cash at beginning of the period Cash, cash equivalents and restricted cash at end of the period Total cash, cash equivalents and restricted cash presented in the condensed consolidated statements of cash flows Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Performance compensation reduced rate as a percentage of investment income Related Party Transaction, Performance Compensation Reduced Rate as a Percentage of Investment Income The reduced rate charged by related party for performance compensation as a percent of investment income due to loss carry forward provision. Dividends Dividends Ordinary share capital, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Loss carry forward recoupment required Related Party Transaction, Loss Carry Forward Recoupment Required As Percentage Of Aggregate Investment Loss Earned The additional amount of investment income required after a period of investment loss, in order for the performance compensation rate to return from reduced rate to full rate. Entity Central Index Key Entity Central Index Key Taxation Income Tax, Policy [Policy Text Block] Security Exchange Name Security Exchange Name Thereafter Contractual Obligation, To Be Paid, After Year Four Contractual Obligation, To Be Paid, After Year Four Total Gross balance at January 1 Gross balance at September 30 Liability for Claims and Claims Adjustment Expense Cash and cash equivalents Cash and Cash Equivalents, Fair Value Disclosure Motor Liability Motor Vehicle Liability Casualty Product Line [Member] Motor liability line of business for insurance operations Asset redemption notice to general partner Related Party Transaction, Asset Redemption Notice To General Partner Related Party Transaction, Asset Redemption Notice To General Partner Diluted (in shares) Weighted average shares outstanding - diluted (in shares) Weighted average shares outstanding - diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted TAXATION Income Tax Disclosure [Text Block] Accrued interest Interest Payable, Current Senior Unsecured Convertible Notes Senior Unsecured Convertible Notes [Member] Senior Unsecured Convertible Notes [Member] Motor Motor Vehicle Physical Damage Product Line [Member] Motor physical damage line of business for insurance operations Long-term Debt, Type [Axis] Long-term Debt, Type [Axis] Related Party [Domain] Related Party [Domain] Current Fiscal Year End Date Current Fiscal Year End Date SHARE CAPITAL Stockholders' Equity Note Disclosure [Text Block] Total incurred Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims Ceded Credit Risk [Table] Ceded Credit Risk [Table] Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Contributions to related party investment fund Payments to Acquire Equity Method Investments Class of Stock [Line Items] Class of Stock [Line Items] Credit Facility [Axis] Credit Facility [Axis] Net cash provided by (used in) investing activities Net Cash Provided by (Used in) Investing Activities Net change in Increase (Decrease) in Operating Capital [Abstract] Cash provided by (used in) operating activities Net Cash Provided by (Used in) Operating Activities [Abstract] Vested (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value General and Administrative Expense General and Administrative Expense [Member] Deferred acquisition costs Deferred Policy Acquisition Cost Class of Stock [Domain] Class of Stock [Domain] Deposit interest expense Deposit Contract Liabilities Net Investment Expense Allocation Accrued Deposit Contract Liabilities Net Investment Expense Allocation Accrued Gross premiums written Gross premiums written Assumed Premiums Written Maximum Facility Limit Line of Credit Facility, Maximum Borrowing Capacity Debt and Equity Securities, FV-NI [Line Items] Debt and Equity Securities, FV-NI [Line Items] Asia Asia [Member] Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Entity Address, Postal Zip Code Entity Address, Postal Zip Code FINANCIAL INSTRUMENTS Financial Instruments Disclosure [Text Block] Marine Marine Casualty Insurance [Member] Marine Casualty Insurance [Member] Line of Credit Facility [Line Items] Line of Credit Facility [Line Items] Document Information [Line Items] Document Information [Line Items] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Unrealized gains Other Investments, Accumulated Gross Unrealized Holding Gain Other Investments, Accumulated Gross Unrealized Holding Gain Title of 12(b) Security Title of 12(b) Security Operating Leased Assets [Line Items] Operating Leased Assets [Line Items] Statement [Table] Statement [Table] Total paid Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid Recent Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Restricted shares Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Statistical Measurement [Axis] Statistical Measurement [Axis] Green Bricks Partners Inc (GRBK) Green Bricks Partners Inc (GRBK) [Member] Green Bricks Partners Inc (GRBK) [Member] U.S. and Caribbean North America [Member] Cover [Abstract] Cover [Abstract] Vested number of shares (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares Accounting Standards Update 2020-06 Accounting Standards Update 2020-06 [Member] Scenario [Domain] Scenario [Domain] Adjustments to reconcile net income or loss to net cash provided by (used in) operating activities Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Reinsurance Assets Reinsurance Accounting Policy [Policy Text Block] Operating lease cost Operating Lease, Cost Financial Financial Guarantee Insurance and Surety Product Line [Member] Specialized insurance coverage relating to financial risks such as surety (surety bonds) and trade credit. Investments sold short, at fair value Investment Sold Note Yet Purchased, Fair Value Disclosure Investment Sold Note Yet Purchased, Fair Value Disclosure RELATED PARTY TRANSACTIONS Related Party Transactions Disclosure [Text Block] Unamortized discount Debt Instrument, Unamortized Discount Current year Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year Accounting Standards Update 2016-13 [Member] EX-101.PRE 11 glre-20210930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 12 glre-20210930_htm.xml IDEA: XBRL DOCUMENT 0001385613 2021-01-01 2021-09-30 0001385613 us-gaap:CommonClassAMember 2021-10-29 0001385613 us-gaap:CommonClassBMember 2021-10-29 0001385613 2021-09-30 0001385613 2020-12-31 0001385613 us-gaap:CommonClassAMember 2021-09-30 0001385613 us-gaap:CommonClassAMember 2020-12-31 0001385613 us-gaap:CommonClassBMember 2021-09-30 0001385613 us-gaap:CommonClassBMember 2020-12-31 0001385613 2021-07-01 2021-09-30 0001385613 2020-07-01 2020-09-30 0001385613 2020-01-01 2020-09-30 0001385613 us-gaap:CommonStockMember 2021-06-30 0001385613 us-gaap:CommonStockMember 2020-06-30 0001385613 us-gaap:CommonStockMember 2020-12-31 0001385613 us-gaap:CommonStockMember 2019-12-31 0001385613 us-gaap:CommonStockMember 2021-07-01 2021-09-30 0001385613 us-gaap:CommonStockMember 2020-07-01 2020-09-30 0001385613 us-gaap:CommonStockMember 2021-01-01 2021-09-30 0001385613 us-gaap:CommonStockMember 2020-01-01 2020-09-30 0001385613 us-gaap:CommonStockMember 2021-09-30 0001385613 us-gaap:CommonStockMember 2020-09-30 0001385613 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001385613 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0001385613 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001385613 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001385613 us-gaap:AdditionalPaidInCapitalMember 2021-07-01 2021-09-30 0001385613 us-gaap:AdditionalPaidInCapitalMember 2020-07-01 2020-09-30 0001385613 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-09-30 0001385613 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-09-30 0001385613 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0001385613 us-gaap:AdditionalPaidInCapitalMember 2020-09-30 0001385613 us-gaap:RetainedEarningsMember 2021-06-30 0001385613 us-gaap:RetainedEarningsMember 2020-06-30 0001385613 us-gaap:RetainedEarningsMember 2020-12-31 0001385613 us-gaap:RetainedEarningsMember 2019-12-31 0001385613 2019-01-01 2019-12-31 0001385613 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:RetainedEarningsMember 2019-12-31 0001385613 us-gaap:RetainedEarningsMember 2021-07-01 2021-09-30 0001385613 us-gaap:RetainedEarningsMember 2020-07-01 2020-09-30 0001385613 us-gaap:RetainedEarningsMember 2021-01-01 2021-09-30 0001385613 us-gaap:RetainedEarningsMember 2020-01-01 2020-09-30 0001385613 us-gaap:RetainedEarningsMember 2021-09-30 0001385613 us-gaap:RetainedEarningsMember 2020-09-30 0001385613 2020-09-30 0001385613 2019-12-31 0001385613 us-gaap:EmployeeStockOptionMember 2021-07-01 2021-09-30 0001385613 us-gaap:EmployeeStockOptionMember 2020-07-01 2020-09-30 0001385613 us-gaap:EmployeeStockOptionMember 2021-01-01 2021-09-30 0001385613 us-gaap:EmployeeStockOptionMember 2020-01-01 2020-09-30 0001385613 us-gaap:RestrictedStockMember 2021-07-01 2021-09-30 0001385613 us-gaap:RestrictedStockMember 2020-07-01 2020-09-30 0001385613 us-gaap:RestrictedStockMember 2021-01-01 2021-09-30 0001385613 us-gaap:RestrictedStockMember 2020-01-01 2020-09-30 0001385613 srt:ScenarioForecastMember us-gaap:AccountingStandardsUpdate202006Member 2021-12-31 0001385613 srt:ScenarioForecastMember us-gaap:AccountingStandardsUpdate202006Member 2021-01-01 2021-12-31 0001385613 glre:SILPMember glre:GreenlightCapitalReLimitedPartnersMember 2021-09-30 0001385613 glre:SILPMember glre:GreenlightCapitalReLimitedPartnersMember 2020-12-31 0001385613 us-gaap:GeneralPartnerMember 2021-09-30 0001385613 us-gaap:GeneralPartnerMember 2020-12-31 0001385613 glre:LimitedPartnershipAgreementMember 2021-01-01 2021-09-30 0001385613 us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember glre:SolasglasInvestmentLPSILPMember 2021-09-30 0001385613 us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember glre:SolasglasInvestmentLPSILPMember 2020-12-31 0001385613 glre:SolasglasInvestmentLPSILPMember 2021-07-01 2021-09-30 0001385613 glre:SolasglasInvestmentLPSILPMember 2020-07-01 2020-09-30 0001385613 glre:SolasglasInvestmentLPSILPMember 2021-01-01 2021-09-30 0001385613 glre:SolasglasInvestmentLPSILPMember 2020-01-01 2020-09-30 0001385613 glre:PrivateAndUnlistedEquitySecuritiesMember 2021-09-30 0001385613 glre:DerivativeFinancialInstrumentsMember 2021-09-30 0001385613 glre:PrivateAndUnlistedEquitySecuritiesMember 2020-12-31 0001385613 glre:DerivativeFinancialInstrumentsMember 2020-12-31 0001385613 us-gaap:OtherInvestmentsMember 2020-12-31 0001385613 us-gaap:EquityMethodInvestmentsMember 2020-12-31 0001385613 glre:PrivateAndUnlistedEquitySecuritiesMember 2021-07-01 2021-09-30 0001385613 glre:PrivateAndUnlistedEquitySecuritiesMember 2021-01-01 2021-09-30 0001385613 glre:PrivateAndUnlistedEquitySecuritiesMember 2020-07-01 2020-09-30 0001385613 glre:PrivateAndUnlistedEquitySecuritiesMember 2020-01-01 2020-09-30 0001385613 us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember glre:AccuRiskHoldingsLLCMember 2021-01-01 2021-09-30 0001385613 us-gaap:HealthInsuranceProductLineMember 2020-12-31 0001385613 us-gaap:HealthInsuranceProductLineMember 2019-12-31 0001385613 us-gaap:HealthInsuranceProductLineMember 2021-01-01 2021-09-30 0001385613 us-gaap:HealthInsuranceProductLineMember 2020-01-01 2020-09-30 0001385613 us-gaap:HealthInsuranceProductLineMember 2021-09-30 0001385613 us-gaap:HealthInsuranceProductLineMember 2020-09-30 0001385613 glre:UnratedMember us-gaap:CededCreditRiskUnsecuredMember 2021-09-30 0001385613 glre:UnratedMember us-gaap:CededCreditRiskUnsecuredMember 2020-12-31 0001385613 glre:UnratedMember us-gaap:CededCreditRiskSecuredMember 2021-09-30 0001385613 glre:UnratedMember us-gaap:CededCreditRiskSecuredMember 2020-12-31 0001385613 srt:AMBestAMinusRatingMember 2021-09-30 0001385613 srt:AMBestAMinusRatingMember 2020-12-31 0001385613 glre:SeniorUnsecuredConvertibleNotesMember us-gaap:SeniorNotesMember 2018-08-07 0001385613 glre:SeniorUnsecuredConvertibleNotesMember us-gaap:SeniorNotesMember 2021-09-30 0001385613 glre:SeniorUnsecuredConvertibleNotesMember us-gaap:SeniorNotesMember 2020-12-31 0001385613 glre:SeniorUnsecuredConvertibleNotesMember us-gaap:SeniorNotesMember us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0001385613 glre:SeniorUnsecuredConvertibleNotesMember us-gaap:SeniorNotesMember 2021-07-01 2021-09-30 0001385613 glre:SeniorUnsecuredConvertibleNotesMember us-gaap:SeniorNotesMember 2021-01-01 2021-09-30 0001385613 glre:SeniorUnsecuredConvertibleNotesMember us-gaap:SeniorNotesMember 2020-07-01 2020-09-30 0001385613 glre:SeniorUnsecuredConvertibleNotesMember us-gaap:SeniorNotesMember 2020-01-01 2020-09-30 0001385613 us-gaap:StockCompensationPlanMember us-gaap:CommonClassAMember 2020-10-29 0001385613 srt:MinimumMember us-gaap:StockCompensationPlanMember us-gaap:CommonClassAMember 2020-10-29 0001385613 srt:MaximumMember us-gaap:StockCompensationPlanMember us-gaap:CommonClassAMember 2020-10-29 0001385613 us-gaap:CommonClassAMember 2020-03-26 0001385613 glre:SeniorUnsecuredConvertibleNotesMember us-gaap:SeniorNotesMember 2020-03-26 0001385613 glre:SeniorUnsecuredConvertibleNotesMember us-gaap:SeniorNotesMember 2021-05-04 0001385613 us-gaap:CommonClassAMember 2021-01-01 2021-09-30 0001385613 us-gaap:CommonClassAMember 2019-12-31 0001385613 us-gaap:CommonClassBMember 2019-12-31 0001385613 us-gaap:CommonClassBMember 2021-01-01 2021-09-30 0001385613 us-gaap:CommonClassAMember 2020-01-01 2020-09-30 0001385613 us-gaap:CommonClassBMember 2020-01-01 2020-09-30 0001385613 us-gaap:CommonClassAMember 2020-09-30 0001385613 us-gaap:CommonClassBMember 2020-09-30 0001385613 us-gaap:RestrictedStockMember us-gaap:CommonClassAMember 2021-01-01 2021-09-30 0001385613 us-gaap:RestrictedStockMember us-gaap:CommonClassAMember 2020-01-01 2020-09-30 0001385613 us-gaap:RestrictedStockMember 2021-01-01 2021-09-30 0001385613 us-gaap:RestrictedStockMember 2020-01-01 2020-09-30 0001385613 us-gaap:RestrictedStockMember 2021-09-30 0001385613 us-gaap:RestrictedStockMember 2020-12-31 0001385613 us-gaap:RestrictedStockMember 2021-09-30 2021-09-30 0001385613 us-gaap:RestrictedStockMember 2020-12-31 2020-12-31 0001385613 glre:NonEmployeeDirectorMemberMember us-gaap:RestrictedStockUnitsRSUMember us-gaap:CommonClassAMember 2021-01-01 2021-09-30 0001385613 glre:NonEmployeeDirectorMemberMember us-gaap:RestrictedStockUnitsRSUMember us-gaap:CommonClassAMember 2020-01-01 2020-09-30 0001385613 srt:ChiefExecutiveOfficerMember us-gaap:EmployeeStockOptionMember us-gaap:CommonClassAMember 2020-01-01 2020-09-30 0001385613 srt:ChiefExecutiveOfficerMember us-gaap:EmployeeStockOptionMember us-gaap:CommonClassAMember 2021-01-01 2021-09-30 0001385613 us-gaap:EmployeeStockOptionMember 2021-01-01 2021-09-30 0001385613 us-gaap:EmployeeStockOptionMember 2020-01-01 2020-09-30 0001385613 us-gaap:EmployeeStockOptionMember 2021-09-30 0001385613 us-gaap:EmployeeStockOptionMember 2020-12-31 0001385613 us-gaap:EmployeeStockOptionMember 2020-01-01 2020-12-31 0001385613 us-gaap:RestrictedStockUnitsRSUMember 2021-01-01 2021-09-30 0001385613 us-gaap:RestrictedStockUnitsRSUMember us-gaap:CommonClassAMember 2021-01-01 2021-09-30 0001385613 us-gaap:RestrictedStockUnitsRSUMember 2020-01-01 2020-09-30 0001385613 us-gaap:RestrictedStockUnitsRSUMember 2021-09-30 0001385613 us-gaap:RestrictedStockUnitsRSUMember 2020-09-30 0001385613 us-gaap:RestrictedStockUnitsRSUMember 2020-12-31 0001385613 srt:ChiefExecutiveOfficerMember us-gaap:RestrictedStockMember 2021-01-01 2021-09-30 0001385613 srt:ChiefExecutiveOfficerMember us-gaap:RestrictedStockMember 2021-09-30 0001385613 srt:ChiefExecutiveOfficerMember us-gaap:RestrictedStockMember 2020-12-31 0001385613 us-gaap:GeneralAndAdministrativeExpenseMember 2021-01-01 2021-09-30 0001385613 us-gaap:GeneralAndAdministrativeExpenseMember 2020-01-01 2020-09-30 0001385613 us-gaap:OtherAssetsMember 2021-09-30 0001385613 us-gaap:OtherAssetsMember 2020-09-30 0001385613 glre:LimitedPartnershipAgreementMember srt:BoardOfDirectorsChairmanMember 2018-09-01 2018-09-01 0001385613 glre:LimitedPartnershipAgreementMember srt:BoardOfDirectorsChairmanMember 2021-01-01 2021-09-30 0001385613 glre:InvestmentAdvisoryAgreementMember srt:BoardOfDirectorsChairmanMember 2018-09-01 2018-09-01 0001385613 glre:GreenBricksPartnersIncGRBKMember srt:AffiliatedEntityMember 2021-09-30 0001385613 glre:ServiceAgreementMember srt:BoardOfDirectorsChairmanMember 2021-01-01 2021-09-30 0001385613 glre:CollateralAssetsInvestementManagementAgreementMember srt:BoardOfDirectorsChairmanMember 2019-01-01 2019-01-01 0001385613 us-gaap:FinancialStandbyLetterOfCreditMember glre:CitibankEuropePlcMember 2021-09-30 0001385613 us-gaap:FinancialStandbyLetterOfCreditMember glre:CitibankEuropePlcMember 2021-01-01 2021-09-30 0001385613 srt:MinimumMember 2021-01-01 2021-09-30 0001385613 srt:MaximumMember 2021-01-01 2021-09-30 0001385613 us-gaap:ConvertibleDebtMember 2021-09-30 0001385613 us-gaap:PropertyAndCasualtyCommercialInsuranceProductLineMember 2021-07-01 2021-09-30 0001385613 us-gaap:PropertyAndCasualtyCommercialInsuranceProductLineMember 2020-07-01 2020-09-30 0001385613 us-gaap:PropertyAndCasualtyCommercialInsuranceProductLineMember 2021-01-01 2021-09-30 0001385613 us-gaap:PropertyAndCasualtyCommercialInsuranceProductLineMember 2020-01-01 2020-09-30 0001385613 glre:MotorVehiclePhysicalDamageProductLineMember 2021-07-01 2021-09-30 0001385613 glre:MotorVehiclePhysicalDamageProductLineMember 2020-07-01 2020-09-30 0001385613 glre:MotorVehiclePhysicalDamageProductLineMember 2021-01-01 2021-09-30 0001385613 glre:MotorVehiclePhysicalDamageProductLineMember 2020-01-01 2020-09-30 0001385613 us-gaap:PropertyAndCasualtyPersonalInsuranceProductLineMember 2021-07-01 2021-09-30 0001385613 us-gaap:PropertyAndCasualtyPersonalInsuranceProductLineMember 2020-07-01 2020-09-30 0001385613 us-gaap:PropertyAndCasualtyPersonalInsuranceProductLineMember 2021-01-01 2021-09-30 0001385613 us-gaap:PropertyAndCasualtyPersonalInsuranceProductLineMember 2020-01-01 2020-09-30 0001385613 us-gaap:PropertyInsuranceProductLineMember 2021-07-01 2021-09-30 0001385613 us-gaap:PropertyInsuranceProductLineMember 2020-07-01 2020-09-30 0001385613 us-gaap:PropertyInsuranceProductLineMember 2021-01-01 2021-09-30 0001385613 us-gaap:PropertyInsuranceProductLineMember 2020-01-01 2020-09-30 0001385613 us-gaap:GeneralLiabilityMember 2021-07-01 2021-09-30 0001385613 us-gaap:GeneralLiabilityMember 2020-07-01 2020-09-30 0001385613 us-gaap:GeneralLiabilityMember 2021-01-01 2021-09-30 0001385613 us-gaap:GeneralLiabilityMember 2020-01-01 2020-09-30 0001385613 glre:MotorVehicleLiabilityCasualtyProductLineMember 2021-07-01 2021-09-30 0001385613 glre:MotorVehicleLiabilityCasualtyProductLineMember 2020-07-01 2020-09-30 0001385613 glre:MotorVehicleLiabilityCasualtyProductLineMember 2021-01-01 2021-09-30 0001385613 glre:MotorVehicleLiabilityCasualtyProductLineMember 2020-01-01 2020-09-30 0001385613 us-gaap:ProfessionalMalpracticeLiabilityMember 2021-07-01 2021-09-30 0001385613 us-gaap:ProfessionalMalpracticeLiabilityMember 2020-07-01 2020-09-30 0001385613 us-gaap:ProfessionalMalpracticeLiabilityMember 2021-01-01 2021-09-30 0001385613 us-gaap:ProfessionalMalpracticeLiabilityMember 2020-01-01 2020-09-30 0001385613 glre:WorkersCompensationInsuranceProductLineMember 2021-07-01 2021-09-30 0001385613 glre:WorkersCompensationInsuranceProductLineMember 2020-07-01 2020-09-30 0001385613 glre:WorkersCompensationInsuranceProductLineMember 2021-01-01 2021-09-30 0001385613 glre:WorkersCompensationInsuranceProductLineMember 2020-01-01 2020-09-30 0001385613 glre:MultilineMember 2021-07-01 2021-09-30 0001385613 glre:MultilineMember 2020-07-01 2020-09-30 0001385613 glre:MultilineMember 2021-01-01 2021-09-30 0001385613 glre:MultilineMember 2020-01-01 2020-09-30 0001385613 glre:LiabilityandCasualtyInsuranceProductLineMember 2021-07-01 2021-09-30 0001385613 glre:LiabilityandCasualtyInsuranceProductLineMember 2020-07-01 2020-09-30 0001385613 glre:LiabilityandCasualtyInsuranceProductLineMember 2021-01-01 2021-09-30 0001385613 glre:LiabilityandCasualtyInsuranceProductLineMember 2020-01-01 2020-09-30 0001385613 us-gaap:HealthInsuranceProductLineMember 2021-07-01 2021-09-30 0001385613 us-gaap:HealthInsuranceProductLineMember 2020-07-01 2020-09-30 0001385613 glre:FinancialGuaranteeInsuranceandSuretyProductLineMember 2021-07-01 2021-09-30 0001385613 glre:FinancialGuaranteeInsuranceandSuretyProductLineMember 2020-07-01 2020-09-30 0001385613 glre:FinancialGuaranteeInsuranceandSuretyProductLineMember 2021-01-01 2021-09-30 0001385613 glre:FinancialGuaranteeInsuranceandSuretyProductLineMember 2020-01-01 2020-09-30 0001385613 glre:MarineCasualtyInsuranceMember 2021-07-01 2021-09-30 0001385613 glre:MarineCasualtyInsuranceMember 2020-07-01 2020-09-30 0001385613 glre:MarineCasualtyInsuranceMember 2021-01-01 2021-09-30 0001385613 glre:MarineCasualtyInsuranceMember 2020-01-01 2020-09-30 0001385613 us-gaap:OtherInsuranceProductLineMember 2021-07-01 2021-09-30 0001385613 us-gaap:OtherInsuranceProductLineMember 2020-07-01 2020-09-30 0001385613 us-gaap:OtherInsuranceProductLineMember 2021-01-01 2021-09-30 0001385613 us-gaap:OtherInsuranceProductLineMember 2020-01-01 2020-09-30 0001385613 glre:TotalSpecialtyDomain 2021-07-01 2021-09-30 0001385613 glre:TotalSpecialtyDomain 2020-07-01 2020-09-30 0001385613 glre:TotalSpecialtyDomain 2021-01-01 2021-09-30 0001385613 glre:TotalSpecialtyDomain 2020-01-01 2020-09-30 0001385613 srt:NorthAmericaMember 2021-07-01 2021-09-30 0001385613 srt:NorthAmericaMember 2020-07-01 2020-09-30 0001385613 srt:NorthAmericaMember 2021-01-01 2021-09-30 0001385613 srt:NorthAmericaMember 2020-01-01 2020-09-30 0001385613 glre:WorldwideMember 2021-07-01 2021-09-30 0001385613 glre:WorldwideMember 2020-07-01 2020-09-30 0001385613 glre:WorldwideMember 2021-01-01 2021-09-30 0001385613 glre:WorldwideMember 2020-01-01 2020-09-30 0001385613 srt:EuropeMember 2021-07-01 2021-09-30 0001385613 srt:EuropeMember 2020-07-01 2020-09-30 0001385613 srt:EuropeMember 2021-01-01 2021-09-30 0001385613 srt:EuropeMember 2020-01-01 2020-09-30 0001385613 srt:AsiaMember 2021-07-01 2021-09-30 0001385613 srt:AsiaMember 2020-07-01 2020-09-30 0001385613 srt:AsiaMember 2021-01-01 2021-09-30 0001385613 srt:AsiaMember 2020-01-01 2020-09-30 shares iso4217:USD iso4217:USD shares pure glre:facility glre:segment 0001385613 --12-31 2021 Q3 false http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate201613Member P3D 10-Q true 2021-09-30 false 001-33493 GREENLIGHT CAPITAL RE, LTD. E9 65 Market Street Suite 1207, Jasmine Court Camana Bay KY KY1-1205 345 943-4573 Class A Ordinary Shares GLRE NASDAQ Yes Yes Accelerated Filer false false false 27589731 6254715 180239000 166735000 42480000 29418000 222719000 196153000 37380000 8935000 692542000 745371000 89000 89000 380417000 330232000 47000 47000 13082000 16851000 60634000 51014000 26000 0 0 6101000 6737000 2993000 1413537000 1357650000 540779000 494179000 237926000 201089000 77525000 92247000 5087000 4475000 5228000 5009000 96478000 95794000 963023000 892793000 0.10 0.10 50000000 50000000 0 0 0 0 0.10 0.10 100000000 100000000 27589731 27589731 28260075 28260075 0.10 0.10 25000000 25000000 6254715 6254715 6254715 6254715 3384000 3452000 480939000 488488000 -33809000 -27083000 450514000 464857000 1413537000 1357650000 128735000 135596000 440249000 362072000 60000 1464000 6000 2274000 128675000 134132000 440243000 359798000 6849000 -18613000 -36844000 -24844000 135524000 115519000 403399000 334954000 659000 2632000 703000 1981000 -6214000 6431000 -4196000 -34086000 10303000 466000 28999000 11237000 -380000 1569000 -4033000 2570000 139233000 123985000 424169000 314675000 110400000 88053000 295078000 252944000 35048000 27018000 106060000 76660000 6060000 5152000 21340000 18095000 1578000 1579000 4684000 4702000 153086000 121802000 427162000 352401000 -13853000 2183000 -2993000 -37726000 0 0 3733000 424000 -13853000 2183000 -6726000 -38150000 -0.42 0.06 -0.20 -1.07 -0.42 0.06 -0.20 -1.07 32929097 35677554 33507060 35569292 32929097 35779703 33507060 35569292 3417000 3627000 3452000 3699000 3000 -19000 41000 25000 36000 71000 109000 187000 3384000 3537000 3384000 3537000 483365000 497559000 488488000 503547000 3216000 4828000 9891000 12484000 790000 -302000 2342000 1366000 480939000 492429000 480939000 492429000 -19956000 -71282000 -27083000 -30063000 -886000 -13853000 2183000 -6726000 -38150000 -33809000 -69099000 -33809000 -69099000 450514000 426867000 450514000 426867000 -6726000 -38150000 -4196000 -34086000 0 870000 14860000 19153000 14210000 -15000000 -14000 -232000 0 250000 2383000 1391000 -684000 -702000 16000 21000 50185000 33932000 -3769000 -7535000 9620000 2031000 26000 -901000 3760000 1121000 46600000 11182000 36837000 24395000 -14722000 -42301000 -612000 -274000 219000 -3069000 -18779000 -44658000 51904000 69108000 69604000 48094000 4761000 944000 20755000 0 -6101000 -741000 4395000 20811000 10000000 12671000 -10000000 -12671000 0 -122000 -24384000 -36640000 754306000 767906000 729922000 731266000 4000000 4000000 3700000 0 ORGANIZATION AND BASIS OF PRESENTATION <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Greenlight Capital Re, Ltd. (“GLRE”) was incorporated as an exempted company under the Companies Law of the Cayman Islands on July 13, 2004. GLRE’s wholly-owned subsidiary, Greenlight Reinsurance, Ltd. (“Greenlight Re”), provides global specialty property and casualty reinsurance. Greenlight Re has a Class D insurer license issued in accordance with the terms of The Insurance Act, 2010 (as amended) and underlying regulations thereto (the “Act”) and is subject to regulation by the Cayman Islands Monetary Authority, in terms of the Act. Greenlight Re commenced underwriting in April 2006. Verdant Holding Company, Ltd. (“Verdant”), a wholly-owned subsidiary of GLRE, was incorporated in 2008 in the state of Delaware. During 2010, GLRE established Greenlight Reinsurance Ireland, Designated Activity Company (“GRIL”), a wholly-owned reinsurance subsidiary based in Dublin, Ireland. GRIL is authorized as a non-life reinsurance undertaking in accordance with the provisions of the European Union (Insurance and Reinsurance) Regulations 2015. GRIL provides multi-line property and casualty reinsurance capacity to the European broker market and provides GLRE with an additional platform to serve clients located in Europe and North America.  In 2020, GLRE established Greenlight Re Marketing (UK) Limited (“Greenlight Re UK”) as a wholly-owned subsidiary to increase the Company’s presence in the London market. As used herein, the “Company” refers collectively to GLRE and its consolidated subsidiaries. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Class A ordinary shares of GLRE are listed on Nasdaq Global Select Market under the symbol “GLRE.”</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information, and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all the information and footnotes required by U.S. GAAP for complete financial statements. In addition, the year-end balance sheet data was derived from audited financial statements but does not include all disclosures required by U.S. GAAP. These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020, as filed with the U.S. Securities and Exchange Commission on March 10, 2021. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the opinion of management, these unaudited condensed consolidated financial statements reflect all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation of the Company’s financial position and results of operations as at the end of and for the periods presented. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant estimates used in the preparation of the Company’s condensed consolidated financial statements, including those associated with premiums and the estimations of loss and loss adjustment expense reserves, including losses arising from the novel coronavirus (the “COVID-19 pandemic”), may be subject to significant adjustments in future periods. (See Note 5 for the significant assumptions that served as the basis for the Company's estimates of reserves for the COVID-19 pandemic). All significant intercompany accounts and transactions have been eliminated.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of operations and cash flows for any interim period will not necessarily be indicative of the results of operations and cash flows for the full fiscal year or subsequent periods.</span></div> SIGNIFICANT ACCOUNTING POLICIES <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes to the Company’s significant accounting policies as described in its Annual Report on Form 10-K for the year ended December 31, 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the period. Actual results could differ from these estimates. The significant estimates reflected in the Company’s condensed consolidated financial statements include, but are not limited to, loss and loss adjustment expense reserves, </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">premiums written, earned and receivable, variability underlying risk transfer assessments, allowances for credit losses, bonus accruals, share-based compensation, valuation allowances associated with deferred tax assets and investment impairments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains cash and cash equivalent balances to collateralize regulatory trusts and letters of credit issued to cedents (see Note 12). The following table reconciles the cash, cash equivalents, and restricted cash reported within the condensed consolidated balance sheets to the total presented in the condensed consolidated statements of cash flows:</span></div><div style="text-indent:27pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.029%"><tr><td style="width:1.0%"/><td style="width:60.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.438%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.569%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.593%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,380 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,935 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">692,542 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">745,371 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash presented in the condensed consolidated statements of cash flows</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">729,922 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">754,306 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Funds Held by Cedents</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The caption “Reinsurance balances receivable” in the Company’s condensed consolidated balance sheets includes amounts held by cedents. Such amounts include premiums and funds held at Lloyd’s, which is held in trust at Lloyd's as security for members’ underwriting activities. At September 30, 2021, funds held by cedents were $201.3 million (December 31, 2020: $127.6 million). </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reinsurance Assets</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company calculates an allowance for expected credit losses for its reinsurance balances receivable and loss and loss adjustment expenses recoverable by applying a Probability of Default (“PD”) / Loss Given Default (“LGD”) model. The PD / LGD approach considers the Company’s collectibility history on its reinsurance assets and representative external loss history. In calculating the probability of default, the Company also considers the estimated duration of its reinsurance assets. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates each counterparty’s creditworthiness based on credit ratings that independent agencies assign to the counterparty. The Company manages its credit risk in its reinsurance assets by transacting only with insurers and reinsurers that it considers financially sound. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For its retrocessional counterparties that are unrated, the Company may hold collateral in the form of funds withheld, trust accounts, or irrevocable letters of credit. In evaluating credit risk associated with reinsurance balances receivable, the Company considers its right to offset loss obligations against premiums receivable. The Company regularly evaluates its net credit exposure to assess the ability of cedents and retrocessionaires to honor their respective obligations.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2021, the Company has recorded an allowance for expected credit loss on its Reinsurance Assets of $0.1 million (December 31, 2020: $0.1 million).</span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Deposit Assets and Liabilities</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company applies deposit accounting to reinsurance contracts that do not transfer sufficient insurance risk to merit reinsurance accounting. Under deposit accounting, the Company recognizes an asset or liability based on its paid or received consideration. The deposit asset or liability balance is subsequently adjusted using the interest method with the corresponding income or expense recorded in the Company’s condensed consolidated statements of operations under the caption “Other income (expense).” The Company records deposit assets and liabilities in its condensed consolidated balance sheets in the caption “Reinsurance balances receivable” and “Reinsurance balances payable,” respectively. At September 30, 2021, deposit assets and deposit liabilities were $4.9 million and $14.0 million, respectively (December 31, 2020: $4.6 million and $31.0 million, respectively). For the three and nine months ended September 30, 2021, and 2020, the interest income and (expense) on deposit accounted contracts were as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.888%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.110%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended September 30</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deposit interest income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">560 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,812 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deposit interest expense</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,957)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deposit interest income/(expense), net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">560 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,957)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,812 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Derivative instruments</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes derivative financial instruments in the condensed consolidated balance sheets at their fair values. It includes any realized gains and losses and changes in unrealized gains and losses in the caption “Net investment income (loss)” in the condensed consolidated statements of operations.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s derivatives do not qualify as hedges for financial reporting purposes. The Company records the associated assets and liabilities in its condensed consolidated balance sheets on a gross basis. The Company does not offset these balances against collateral pledged or received.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Assets</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The caption “Other assets” in the Company’s condensed consolidated balance sheets consists primarily of prepaid expenses, fixed assets, right-of-use lease assets, other receivables, and deferred tax assets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Liabilities</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The caption “Other liabilities” in the Company’s condensed consolidated balance sheets consists primarily of accruals for legal and other professional fees, employee bonuses, taxes payable, and lease liabilities. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Earnings (Loss) Per Share</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s unvested restricted stock awards, which contain non-forfeitable rights to dividends or dividend equivalents, whether paid or unpaid, are considered “participating securities” for the purposes of calculating earnings (loss) per share. Basic earnings per share is calculated on the basis of the weighted average number of common shares and participating securities outstanding during the period. Diluted earnings (or loss) per share includes the dilutive effect of the following:</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:21.4pt">Restricted Stock Units (“RSUs”) issued that would convert to common shares upon vesting; </span></div><div style="margin-bottom:6pt;padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:400;line-height:80%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%;padding-left:21.4pt">additional potential common shares issuable when in-the-money stock options are exercised, determined using the treasury stock method; and </span></div><div style="margin-bottom:3pt;padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:400;line-height:80%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%;padding-left:21.4pt">those common shares with the potential to be issued in connection with convertible debt and other such convertible instruments, determined using the treasury stock method. </span></div><div style="padding-left:63pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted earnings (or loss) per share contemplates a conversion to common shares of all convertible instruments only if they are dilutive with regards to earnings per share. In the event of a net loss, all RSUs, stock options, convertible debt, and participating securities are excluded from the calculation of both basic and diluted loss per share as their inclusion would be anti-dilutive.</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the shares outstanding for the calculation of earnings (loss) per share for the three and nine months ended September 30, 2021 and 2020:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"/><td style="width:45.201%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.769%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.769%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.769%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.775%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended September 30</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding - basic</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,929,097 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,677,554 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,507,060 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,569,292 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive employee and director share-based awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,149 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding - diluted</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,929,097 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,779,703 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,507,060 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,569,292 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Anti-dilutive stock options outstanding</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">735,627 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">835,627 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">735,627 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">835,627 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Participating securities excluded from calculation of loss per share </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">946,556 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">946,556 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">878,498 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center;text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Taxation</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under current Cayman Islands law, no corporate entity, including GLRE and Greenlight Re, is obligated to pay taxes in the Cayman Islands on either income or capital gains. The Company has an undertaking from the Governor-in-Cabinet of the Cayman Islands, pursuant to the provisions of the Tax Concessions Law, as amended, that, in the event that the Cayman Islands enacts any legislation that imposes tax on profits, income, gains or appreciations, or any tax in the nature of estate duty or inheritance tax, such tax will not be applicable to GLRE, Greenlight Re nor their respective operations, or to the Class A or Class B ordinary shares or related obligations, before February 1, 2025.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Verdant is incorporated in Delaware and therefore is subject to taxes in accordance with the U.S. federal rates and regulations prescribed by the U.S. Internal Revenue Service (“IRS”). Verdant’s taxable income is generally expected to be taxed at a marginal rate of 21% (2020: 21%). Verdant’s tax years 2017 and beyond remain open and subject to examination by the IRS.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GRIL is incorporated in Ireland and therefore is subject to the Irish corporation tax rate of 12.5% on its trading income and 25% on its non-trading income.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records a valuation allowance to the extent that the Company considers it more likely than not that all or a portion of the deferred tax asset will not be realized in the future. Other than this valuation allowance, the Company has not taken any income tax positions subject to significant uncertainty that is reasonably likely to have a material impact on the Company. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Standards Adopted</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In January 2020, the FASB issued ASU No. 2020-01, Investments - Equity Securities (Topic 321), Investments - Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815) - Clarifying the Interactions between Topic 321, Topic 323, and Topic 815 (a consensus of the Emerging Issues Task Force) (“ASU 2020-01”). ASU 2020-01 clarifies interactions between the accounting guidance for (i) certain equity securities under Topic 321, (ii) investments under the equity method of accounting in Topic 323, and (iii) certain derivative instruments in Topic 815. ASU 2020-01 is effective for public business entities for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years. The adoption of ASU 2020-01 during the first quarter of 2021 had no material impact on the Company’s consolidated financial statements.</span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Recently Issued Accounting Standards Not Yet Adopted</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU No. 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity's Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity's Own Equity (“ASU 2020-06”). ASU 2020-06 is designed to simplify the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments. The amendments remove the separation models in Subtopic 470-20 for certain contracts. As a result, entities will no longer present embedded conversion features separately in equity; rather, the convertible debt instrument will be accounted for as a single liability measured at its amortized cost. ASU 2020-06 also addresses the computation of earnings per share for convertible debt instruments, requiring </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the application of the if-converted method when calculating diluted earnings per share. The Company intends to adopt ASU 2020-06 during the first quarter of 2022, using the “modified retrospective” transition method. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company expects that its adoption of ASU 2020-06 will impact the accounting for its senior convertible notes (see Note 7) and will lead to a decrease in its opening shareholders’ equity of approximately $2.5 million, with a corresponding increase in the carrying value of the senior convertible notes. The Company expects that in the periods in which the Company reports a net income, the number of shares outstanding for the diluted earnings per share calculation will be approximately 5.8 million higher under the if-converted method. The Company does not expect the adoption of ASU 2020-06 to have a material impact on net income, cash flows, or any other balances.</span></div> <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the period. Actual results could differ from these estimates. The significant estimates reflected in the Company’s condensed consolidated financial statements include, but are not limited to, loss and loss adjustment expense reserves, </span></div>premiums written, earned and receivable, variability underlying risk transfer assessments, allowances for credit losses, bonus accruals, share-based compensation, valuation allowances associated with deferred tax assets and investment impairments. <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div>The Company maintains cash and cash equivalent balances to collateralize regulatory trusts and letters of credit issued to cedents (see Note 12). The following table reconciles the cash, cash equivalents, and restricted cash reported within the condensed consolidated balance sheets to the total presented in the condensed consolidated statements of cash flows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.029%"><tr><td style="width:1.0%"/><td style="width:60.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.438%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.569%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.593%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,380 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,935 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">692,542 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">745,371 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash presented in the condensed consolidated statements of cash flows</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">729,922 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">754,306 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> The following table reconciles the cash, cash equivalents, and restricted cash reported within the condensed consolidated balance sheets to the total presented in the condensed consolidated statements of cash flows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.029%"><tr><td style="width:1.0%"/><td style="width:60.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.438%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.569%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.593%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,380 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,935 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">692,542 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">745,371 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash presented in the condensed consolidated statements of cash flows</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">729,922 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">754,306 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 37380000 8935000 692542000 745371000 729922000 754306000 Funds Held by CedentsThe caption “Reinsurance balances receivable” in the Company’s condensed consolidated balance sheets includes amounts held by cedents. Such amounts include premiums and funds held at Lloyd’s, which is held in trust at Lloyd's as security for members’ underwriting activities. At September 30, 2021, funds held by cedents were $201.3 million (December 31, 2020: $127.6 million). 201300000 127600000 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reinsurance Assets</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company calculates an allowance for expected credit losses for its reinsurance balances receivable and loss and loss adjustment expenses recoverable by applying a Probability of Default (“PD”) / Loss Given Default (“LGD”) model. The PD / LGD approach considers the Company’s collectibility history on its reinsurance assets and representative external loss history. In calculating the probability of default, the Company also considers the estimated duration of its reinsurance assets. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates each counterparty’s creditworthiness based on credit ratings that independent agencies assign to the counterparty. The Company manages its credit risk in its reinsurance assets by transacting only with insurers and reinsurers that it considers financially sound. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For its retrocessional counterparties that are unrated, the Company may hold collateral in the form of funds withheld, trust accounts, or irrevocable letters of credit. In evaluating credit risk associated with reinsurance balances receivable, the Company considers its right to offset loss obligations against premiums receivable. The Company regularly evaluates its net credit exposure to assess the ability of cedents and retrocessionaires to honor their respective obligations.</span></div> 100000 100000 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Deposit Assets and Liabilities</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div>The Company applies deposit accounting to reinsurance contracts that do not transfer sufficient insurance risk to merit reinsurance accounting. Under deposit accounting, the Company recognizes an asset or liability based on its paid or received consideration. The deposit asset or liability balance is subsequently adjusted using the interest method with the corresponding income or expense recorded in the Company’s condensed consolidated statements of operations under the caption “Other income (expense).” The Company records deposit assets and liabilities in its condensed consolidated balance sheets in the caption “Reinsurance balances receivable” and “Reinsurance balances payable,” respectively. 4900000 14000000 4600000 31000000 For the three and nine months ended September 30, 2021, and 2020, the interest income and (expense) on deposit accounted contracts were as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.888%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.110%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended September 30</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deposit interest income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">560 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,812 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deposit interest expense</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,957)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deposit interest income/(expense), net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">560 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,957)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,812 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 0 560000 0 1812000 38000 0 2957000 0 -38000 560000 -2957000 1812000 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Derivative instruments</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes derivative financial instruments in the condensed consolidated balance sheets at their fair values. It includes any realized gains and losses and changes in unrealized gains and losses in the caption “Net investment income (loss)” in the condensed consolidated statements of operations.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s derivatives do not qualify as hedges for financial reporting purposes. The Company records the associated assets and liabilities in its condensed consolidated balance sheets on a gross basis. The Company does not offset these balances against collateral pledged or received.</span></div> <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Assets</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The caption “Other assets” in the Company’s condensed consolidated balance sheets consists primarily of prepaid expenses, fixed assets, right-of-use lease assets, other receivables, and deferred tax assets.</span></div> Other LiabilitiesThe caption “Other liabilities” in the Company’s condensed consolidated balance sheets consists primarily of accruals for legal and other professional fees, employee bonuses, taxes payable, and lease liabilities. <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Earnings (Loss) Per Share</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s unvested restricted stock awards, which contain non-forfeitable rights to dividends or dividend equivalents, whether paid or unpaid, are considered “participating securities” for the purposes of calculating earnings (loss) per share. Basic earnings per share is calculated on the basis of the weighted average number of common shares and participating securities outstanding during the period. Diluted earnings (or loss) per share includes the dilutive effect of the following:</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:21.4pt">Restricted Stock Units (“RSUs”) issued that would convert to common shares upon vesting; </span></div><div style="margin-bottom:6pt;padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:400;line-height:80%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%;padding-left:21.4pt">additional potential common shares issuable when in-the-money stock options are exercised, determined using the treasury stock method; and </span></div><div style="margin-bottom:3pt;padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:400;line-height:80%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%;padding-left:21.4pt">those common shares with the potential to be issued in connection with convertible debt and other such convertible instruments, determined using the treasury stock method. </span></div><div style="padding-left:63pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted earnings (or loss) per share contemplates a conversion to common shares of all convertible instruments only if they are dilutive with regards to earnings per share. In the event of a net loss, all RSUs, stock options, convertible debt, and participating securities are excluded from the calculation of both basic and diluted loss per share as their inclusion would be anti-dilutive.</span></div> <div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the shares outstanding for the calculation of earnings (loss) per share for the three and nine months ended September 30, 2021 and 2020:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"/><td style="width:45.201%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.769%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.769%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.769%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.775%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended September 30</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding - basic</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,929,097 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,677,554 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,507,060 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,569,292 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive employee and director share-based awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,149 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding - diluted</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,929,097 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,779,703 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,507,060 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,569,292 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Anti-dilutive stock options outstanding</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">735,627 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">835,627 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">735,627 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">835,627 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Participating securities excluded from calculation of loss per share </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">946,556 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">946,556 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">878,498 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 32929097 35677554 33507060 35569292 0 102149 0 0 32929097 35779703 33507060 35569292 735627 835627 735627 835627 946556 0 946556 878498 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Taxation</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under current Cayman Islands law, no corporate entity, including GLRE and Greenlight Re, is obligated to pay taxes in the Cayman Islands on either income or capital gains. The Company has an undertaking from the Governor-in-Cabinet of the Cayman Islands, pursuant to the provisions of the Tax Concessions Law, as amended, that, in the event that the Cayman Islands enacts any legislation that imposes tax on profits, income, gains or appreciations, or any tax in the nature of estate duty or inheritance tax, such tax will not be applicable to GLRE, Greenlight Re nor their respective operations, or to the Class A or Class B ordinary shares or related obligations, before February 1, 2025.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Verdant is incorporated in Delaware and therefore is subject to taxes in accordance with the U.S. federal rates and regulations prescribed by the U.S. Internal Revenue Service (“IRS”). Verdant’s taxable income is generally expected to be taxed at a marginal rate of 21% (2020: 21%). Verdant’s tax years 2017 and beyond remain open and subject to examination by the IRS.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GRIL is incorporated in Ireland and therefore is subject to the Irish corporation tax rate of 12.5% on its trading income and 25% on its non-trading income.</span></div>The Company records a valuation allowance to the extent that the Company considers it more likely than not that all or a portion of the deferred tax asset will not be realized in the future. Other than this valuation allowance, the Company has not taken any income tax positions subject to significant uncertainty that is reasonably likely to have a material impact on the Company. <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Standards Adopted</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In January 2020, the FASB issued ASU No. 2020-01, Investments - Equity Securities (Topic 321), Investments - Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815) - Clarifying the Interactions between Topic 321, Topic 323, and Topic 815 (a consensus of the Emerging Issues Task Force) (“ASU 2020-01”). ASU 2020-01 clarifies interactions between the accounting guidance for (i) certain equity securities under Topic 321, (ii) investments under the equity method of accounting in Topic 323, and (iii) certain derivative instruments in Topic 815. ASU 2020-01 is effective for public business entities for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years. The adoption of ASU 2020-01 during the first quarter of 2021 had no material impact on the Company’s consolidated financial statements.</span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Recently Issued Accounting Standards Not Yet Adopted</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU No. 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity's Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity's Own Equity (“ASU 2020-06”). ASU 2020-06 is designed to simplify the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments. The amendments remove the separation models in Subtopic 470-20 for certain contracts. As a result, entities will no longer present embedded conversion features separately in equity; rather, the convertible debt instrument will be accounted for as a single liability measured at its amortized cost. ASU 2020-06 also addresses the computation of earnings per share for convertible debt instruments, requiring </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the application of the if-converted method when calculating diluted earnings per share. The Company intends to adopt ASU 2020-06 during the first quarter of 2022, using the “modified retrospective” transition method. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company expects that its adoption of ASU 2020-06 will impact the accounting for its senior convertible notes (see Note 7) and will lead to a decrease in its opening shareholders’ equity of approximately $2.5 million, with a corresponding increase in the carrying value of the senior convertible notes. The Company expects that in the periods in which the Company reports a net income, the number of shares outstanding for the diluted earnings per share calculation will be approximately 5.8 million higher under the if-converted method. The Company does not expect the adoption of ASU 2020-06 to have a material impact on net income, cash flows, or any other balances.</span></div> -2500000 5800000 INVESTMENT IN RELATED PARTY INVESTMENT FUND <div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 1, 2018, the Company entered into an amended and restated exempted limited partnership agreement (as amended by the letter agreement dated as of August 5, 2020, (the “Previous SILP LPA”) of Solasglas Investments, LP (“SILP”), with DME Advisors II, LLC (“DME II”), as General Partner, Greenlight Re, and GRIL, (together the “GLRE Limited Partners”), and the initial limited partner (each, a “Partner”). On September 1, 2018, SILP also entered into a SILP investment advisory agreement (“IAA”) with DME Advisors. LP (“DME Advisors”) pursuant to which DME Advisors is the investment manager for SILP. DME II and DME Advisors are related to the Company, and each is an affiliate of David Einhorn, Chairman of the Company’s Board of Directors. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 7, 2021, the Company and DME II entered into the Second Amended and Restated Exempted Limited Partnership Agreement, effective as of January 1, 2021 (the “SILP LPA”). The SILP LPA amends, restates, supersedes, and incorporates all material terms of the Previous SILP LPA, as amended as of February 26, 2019, and the letter agreements dated June 18, 2019, December 27, 2019, and August 5, 2020 (collectively, the “Amendments”). The SILP LPA agreement also amended the definition of “Additional Investment Ratio” and each of the defined terms “Greenlight Re Surplus” and the “GRIL Surplus” so as to clarify that each of the respectively referenced “financial statements” are “U.S. GAAP financial statements.” In addition, the SILP LPA included the following: “The Investment Portfolio of each Partner will not exceed the product of (a) such Partner’s surplus (Greenlight Re Surplus or GRIL Surplus, as the case may be) multiplied by (b) the Investment Cap (50%), and the General Partner will designate any portion of a Partner’s Investment Portfolio as Designated Securities to effectuate such limit”. The SILP LPA also amended the investment guidelines to reflect the amended investment guidelines adopted by the Company’s Board of Directors effective as of January 1, 2021.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has concluded that SILP qualifies as a variable interest entity (“VIE”) under U.S. GAAP. In assessing its interest in SILP, the Company noted the following:</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">DME II serves as SILP’s general partner and has the power of appointing the investment manager. The Company does not have the power to appoint, change or replace the investment manager or the general partner except “for cause.” Neither of the GLRE Limited Partners can participate in the investment decisions of SILP as long as SILP adheres to the investment guidelines provided within the SILP LPA. For these reasons, the GLRE Limited Partners are not considered to have substantive participating rights or kick-out rights.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">DME II holds an interest in excess of 10% of SILP’s net assets, which the Company considers to represent an obligation to absorb losses and a right to receive benefits of SILP that are significant to SILP. </span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consequently, the Company has concluded that DME II’s interests, not the Company’s, meet both the “power” and “benefits” criteria associated with VIE accounting guidance, and therefore DME II is SILP’s primary beneficiary. The Company presents its investment in SILP in its condensed consolidated balance sheets in the caption “Investment in related party investment fund.” </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company’s maximum exposure to loss relating to SILP is limited to the net asset value of the GLRE Limited Partners’ investment in SILP. At September 30, 2021, the net asset value of the GLRE Limited Partners’ investment in SILP was $180.2 million (December 31, 2020: $166.7 million), representing 78.0% (December 31, 2020: 75.7%) of SILP’s total net assets. DME II held the remaining 22.0% (December 31, 2020: 24.3%) of SILP’s total net assets. The investment in SILP is recorded at the GLRE Limited Partners’ share of the net asset value of SILP as reported by SILP’s third-party administrator. The GLRE Limited Partners can redeem their assets from SILP for operational purposes by providing <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjczN2NkZTVjZWU5NzQ0MDJiNDhkNjFiZWJlNzRmMmY2L3NlYzo3MzdjZGU1Y2VlOTc0NDAyYjQ4ZDYxYmViZTc0ZjJmNl80MC9mcmFnOmUwZDU3ODU5YzRiNDRmYzRhMjBhZTQyZGJmYjlhYzNiL3RleHRyZWdpb246ZTBkNTc4NTljNGI0NGZjNGEyMGFlNDJkYmZiOWFjM2JfMzk0Mw_05f14731-9f69-405f-bf02-111679f3e86e">three</span> business days’ notice to DME II. At September 30, 2021, the majority of SILP’s long investments were composed of cash and publicly traded equity securities, which could be readily liquidated to meet the GLRE Limited Partners’ redemption requests. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s share of the change in the net asset value of SILP for the three and nine months ended September 30, </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021, was $(6.2) million and $(4.2) million, respectively, (three and nine months ended September 30, 2020: $6.4 million and $(34.1) million, respectively), and shown in the caption “Income (loss) from investment in related party investment fund” in the Company’s condensed consolidated statements of operations. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The summarized financial statements of SILP are presented below. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summarized Statement of Assets and Liabilities of Solasglas Investments, LP</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:62.026%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.599%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.601%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments, at fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262,058 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272,398 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative contracts, at fair value</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,071 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,450 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due from brokers</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,638 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,053 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,076 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and dividends receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349,857 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365,960 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities and partners’ capital</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments sold short, at fair value</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(109,044)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(131,902)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative contracts, at fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,793)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,156)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due to brokers</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,170)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,179)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and dividends payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(603)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(429)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(133)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(175)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(118,743)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(145,841)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">231,114</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">220,119</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GLRE Limited Partners’ share of Net Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">180,239</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">166,735</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summarized Statement of Operations of Solasglas Investments, LP</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:36.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended September 30</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">($ in thousands)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investment income</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend income (net of withholding taxes)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">509 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,204 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">770 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Investment income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,279 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,466 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Management fee</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(883)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(703)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,632)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,981)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(205)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(176)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(874)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(518)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(306)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(213)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(852)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(612)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional fees and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(227)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(432)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(786)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(764)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,621)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,524)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,144)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,875)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,424)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,318)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,865)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,409)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Realized and change in unrealized gains (losses) </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized gain (loss) </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,411)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,412)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,809)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44,972)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in unrealized appreciation (depreciation) </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,437)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,832 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,143 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,811 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain (loss) on investment transactions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,848)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,420 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,666)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,161)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(8,272)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,102</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(6,531)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(41,570)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GLRE Limited Partners’ share of net income (loss)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(6,214)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,431</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(4,196)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(34,086)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income (loss) is net of management fees and performance allocation presented below:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:36.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.964%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended September 30</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Management fees</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">883 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">703 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,632 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,981 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance allocation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(224)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">659 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">703 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,632 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,981 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 11 for further details on management fees and performance allocation.</span></div> 180200000 166700000 0.780 0.757 0.220 0.243 -6200000 -4200000 6400000 -34100000 <div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The summarized financial statements of SILP are presented below. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summarized Statement of Assets and Liabilities of Solasglas Investments, LP</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:62.026%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.599%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.601%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments, at fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262,058 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272,398 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative contracts, at fair value</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,071 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,450 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due from brokers</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,638 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,053 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,076 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and dividends receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349,857 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365,960 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities and partners’ capital</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments sold short, at fair value</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(109,044)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(131,902)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative contracts, at fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,793)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,156)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due to brokers</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,170)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,179)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and dividends payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(603)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(429)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(133)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(175)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(118,743)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(145,841)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">231,114</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">220,119</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GLRE Limited Partners’ share of Net Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">180,239</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">166,735</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summarized Statement of Operations of Solasglas Investments, LP</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:36.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended September 30</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">($ in thousands)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investment income</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend income (net of withholding taxes)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">509 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,204 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">770 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Investment income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,279 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,466 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Management fee</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(883)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(703)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,632)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,981)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(205)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(176)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(874)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(518)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(306)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(213)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(852)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(612)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional fees and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(227)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(432)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(786)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(764)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,621)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,524)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,144)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,875)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,424)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,318)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,865)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,409)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Realized and change in unrealized gains (losses) </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized gain (loss) </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,411)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,412)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,809)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44,972)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in unrealized appreciation (depreciation) </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,437)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,832 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,143 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,811 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain (loss) on investment transactions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,848)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,420 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,666)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,161)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(8,272)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,102</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(6,531)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(41,570)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GLRE Limited Partners’ share of net income (loss)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(6,214)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,431</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(4,196)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(34,086)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income (loss) is net of management fees and performance allocation presented below:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:36.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.964%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended September 30</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Management fees</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">883 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">703 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,632 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,981 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance allocation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(224)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">659 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">703 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,632 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,981 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 262058000 272398000 9071000 1450000 77638000 92053000 1076000 0 14000 59000 349857000 365960000 109044000 131902000 7793000 4156000 1170000 9179000 603000 429000 133000 175000 118743000 145841000 231114000 220119000 180239000 166735000 146000 170000 509000 1204000 51000 36000 770000 262000 197000 206000 1279000 1466000 883000 703000 2632000 1981000 205000 176000 874000 518000 306000 213000 852000 612000 227000 432000 786000 764000 1621000 1524000 5144000 3875000 -1424000 -1318000 -3865000 -2409000 -1411000 -1412000 -14809000 -44972000 -5437000 10832000 12143000 5811000 -6848000 9420000 -2666000 -39161000 -8272000 8102000 -6531000 -41570000 -6214000 6431000 -4196000 -34086000 883000 703000 2632000 1981000 -224000 0 0 0 659000 703000 2632000 1981000 FINANCIAL INSTRUMENTS <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Investments</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> I</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">nvestments</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s “Other investments” are composed of the following:</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="padding-left:54pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:23.5pt">Private investments and unlisted equities, which consist primarily of Innovations-related investments supporting technology innovators in the (re)insurance market; and</span></div><div style="padding-left:54pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:23.5pt">Derivative financial instruments associated with the Company’s Innovations investments.</span></div><div style="padding-left:18pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">At September 30, 2021, the Company included the following securities in the caption “Other investments”:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:39.749%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.955%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.955%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.955%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.958%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized<br/>gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized<br/>losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair value / carrying value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private investments and unlisted equities </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,175 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,017 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,800)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,392 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative financial instruments (not designated as hedging instruments)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,088 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,088 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,175 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,105 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,800)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,480 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2020, the Company included the following securities in the caption “Other investments”: </span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:39.515%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.125%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized<br/>gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized<br/>losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair value / carrying value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private investments and unlisted equities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,414 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,679 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,300)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,793 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative financial instruments (not designated as hedging instruments)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,080 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,080 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,414 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,759 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,300)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,873 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment accounted for under the equity method</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,545 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,418 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Private investments and unlisted equities include securities that do not have readily determinable fair values. The carrying values of these holdings are determined based on their original cost minus impairment, if any, plus or minus changes resulting from observable price changes. At September 30, 2021, the carrying value of private investments and unlisted equities was $39.4 million (December 31, 2020: $21.8 million). It incorporated upward adjustments of $7.6 million and $12.9 million during the three and nine months ended September 30, 2021, respectively (three and nine months ended September 30, 2020: $0.0 million and $4.1 million, respectively), excluding any unrealized gains or losses related to changes in foreign currency exchange rates. Since acquiring these private investments, the Company has recognized net upward adjustments of $22.1 million and $9.3 million as of September 30, 2021, and December 31, 2020, respectively.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2020, the investment accounted for under the equity method represented an investment in AccuRisk Holdings LLC (“AccuRisk”), a Chicago, Illinois-based managing general underwriter focused on employee and health insurance benefits. During the nine months ended September 30, 2021, the Company sold its investment in AccuRisk and realized a pre-tax gain of $14.2 million. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company’s derivative financial instruments are composed of warrants granting the Company the right, but not the obligation, to purchase shares at a specified price on or before the maturity date. The Company has not designated any of its derivative financial instruments as hedging instruments. The Company’s maximum exposure to loss relating to these warrants is limited to the warrants’ carrying amount. </span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Hierarchy</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of a financial instrument is the amount that would be received in an asset sale or paid to transfer a liability in an orderly transaction between unaffiliated market participants. Assets and liabilities measured at fair value are categorized based on whether the inputs are observable in the market and the degree that the inputs are observable. The categorization of financial instruments within the valuation hierarchy is based on the lowest level of input that is significant to the fair value measurement. The hierarchy is prioritized into three levels (with Level 3 being the lowest) defined as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.859%"><tr><td style="width:1.0%"/><td style="width:2.482%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.318%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">•</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1: Quoted prices in active markets for identical assets or liabilities that the entity has the ability to access.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">•</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2: Observable inputs other than prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; or other inputs that are observable or can be corroborated with observable market data.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">•</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 3: Unobservable inputs supported by little or no market activity and significant to the fair value of the assets and liabilities. The term “unobservable inputs” includes certain pricing models, discounted cash flow methodologies, and similar techniques.</span></td></tr></table></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company values its derivative instruments using the Black-Scholes option pricing model based on Level 3 inputs. The Company uses the carrying value of the underlying stock as an input in the option pricing model. The underlying stock does not have a readily determinable fair value. Its carrying value is determined based on its original cost minus impairment, if any, plus or minus changes resulting from observable price changes. The other assumptions applied to the option pricing model include a risk-free rate of 0.50% and estimated volatility of 50%. The carrying value of the derivative instruments represents the fair value.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For the derivative instruments valued on the basis of Level 3 inputs, the Company includes any change in unrealized gains or losses in the caption “Net investment income (loss)” in the condensed consolidated statements of operations.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2021, and December 31, 2020, the Company did not carry any other investments at fair value with an assigned Level within the fair value hierarchy. The Company’s investment in the related party investment fund is measured at fair value using the net asset value practical expedient. It is therefore not classified within the fair value hierarchy. (See Note 3 for further details on the related party investment fund.)</span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Instruments Disclosed, But Not Carried, at Fair Value</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The caption “Convertible senior notes payable” represents financial instruments that the Company carries at amortized cost. The fair value of the convertible senior notes payable is estimated based on the bid price observed in an inactive market for the identical instrument (Level 2 input) (see Note 7).</span></div> <div style="padding-left:18pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">At September 30, 2021, the Company included the following securities in the caption “Other investments”:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:39.749%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.955%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.955%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.955%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.958%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized<br/>gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized<br/>losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair value / carrying value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private investments and unlisted equities </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,175 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,017 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,800)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,392 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative financial instruments (not designated as hedging instruments)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,088 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,088 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,175 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,105 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,800)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,480 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2020, the Company included the following securities in the caption “Other investments”: </span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:39.515%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.125%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized<br/>gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized<br/>losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair value / carrying value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private investments and unlisted equities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,414 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,679 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,300)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,793 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative financial instruments (not designated as hedging instruments)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,080 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,080 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,414 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,759 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,300)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,873 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment accounted for under the equity method</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,545 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,418 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 17175000 24017000 1800000 39392000 0 3088000 0 3088000 17175000 27105000 1800000 42480000 12414000 10679000 1300000 21793000 0 1080000 0 1080000 12414000 11759000 1300000 22873000 6545000 29418000 39400000 21800000 7600000 12900000 0 4100000 22100000 9300000 14200000 0.0050 0.50 LOSS AND LOSS ADJUSTMENT EXPENSE RESERVES <div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2021, the Company’s loss and loss adjustment expense reserves included estimated amounts for several catastrophe events. For significant catastrophe events, including, but not limited to, hurricanes, typhoons, floods, wildfires, and pandemics, loss reserves are generally established based on loss payments and case reserves reported by clients when, and if, received. To establish IBNR loss estimates, the Company makes use of, among other things, the following:</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">estimates communicated by ceding companies;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">information received from clients, brokers, and loss adjusters;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">an understanding of the underlying business written and its exposures to catastrophe event-related losses; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">industry data;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">catastrophe scenario modeling software; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">management’s judgment.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The COVID-19 pandemic is unprecedented, and the Company does not have previous loss experience on which to base the associated estimate for loss and loss adjustment expenses. The Company based its estimate on the following:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">a review of in-force treaties that may provide coverage and incur losses;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">catastrophe and scenario modeling analyses and results shared by cedents;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">preliminary loss estimates received from clients and their analysts and loss adjusters; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">reviews of industry insured loss estimates and market share analyses; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">management’s judgment.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Significant assumptions which served as the basis for the Company's estimates of reserves for the COVID-19 pandemic losses and loss adjustment expenses include:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">the scope of coverage provided by the underlying policies, particularly those that provide for business interruption coverage;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">the regulatory, legislative, and judicial actions that could influence contract interpretations across the insurance industry;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">the extent of economic contraction caused by the COVID-19 pandemic and associated measures, particularly in the United States; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">the ability of the cedents and insured to mitigate some or all of their losses.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">While the Company believes its estimate of loss and loss adjustment expense reserves for the COVID-19 pandemic is adequate as of September 30, 2021, based on available information, actual losses may ultimately differ materially from the Company's current estimates. The Company will continue to monitor the appropriateness of its assumptions as new information becomes available and will adjust its estimates accordingly. Such adjustments may be material to the Company's results of operations and financial condition. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company made no significant changes in the actuarial methodology or reserving process related to its loss and loss adjustment expense reserves for the nine months ended September 30, 2021. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2021 and December 31, 2020, loss and loss adjustment expense reserves were composed of the following:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:61.070%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.108%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.056%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Case reserves</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191,151 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176,805 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IBNR</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349,628 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317,374 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">540,779 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494,179 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of changes in outstanding loss and loss adjustment expense reserves for all lines of business consolidated </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for the nine months ended September 30, 2021 and 2020 is as follows:  </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:68.108%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.562%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.564%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross balance at January 1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494,179 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470,588 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Losses recoverable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,851)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,531)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net balance at January 1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">477,328 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">443,057 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incurred losses related to:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296,333 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247,559 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,255)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,385 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total incurred</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295,078 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252,944 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Paid losses related to:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96,442)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72,453)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(146,545)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(161,222)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total paid</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(242,987)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(233,675)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency revaluation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,722)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(505)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net balance at September 30</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">527,697 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">461,821 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Losses recoverable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,082 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,949 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross balance at September 30</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">540,779 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">481,770 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">    </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For the nine months ended September 30, 2021, the estimate of net losses incurred relating to prior accident years decreased by $1.3 million, due primarily to favorable development on catastrophe events, a mortgage contract associated with the COVID-19 pandemic, and certain health contracts. The decrease in prior accident years was partially offset by adverse loss development on certain workers’ compensation and multi-line casualty contracts written between 2014 and 2018. The favorable loss development on a mortgage contract was offset by increased profit commissions on the same contract. </span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended September 30, 2020, the estimate of net losses incurred relating to prior accident years increased by $5.4 million, due primarily to certain general liability, health and multi-line contracts, partially offset by favorable loss development on professional liability contracts. </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the outstanding loss and loss adjustment expense reserves for health claims for the nine months ended September 30, 2021 and 2020 are as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:68.108%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.562%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.564%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Health</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross balance at January 1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,485 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,063 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Losses recoverable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net balance at January 1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,485 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,063 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incurred losses related to:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,189 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,032 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,898)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,341 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total incurred</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,291 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,373 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Paid losses related to:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,224)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,115)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,824)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,327)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total paid</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,048)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,442)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency revaluation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net balance at September 30</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,728 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,994 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Losses recoverable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross balance at September 30</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,728 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,994 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2021 and December 31, 2020, loss and loss adjustment expense reserves were composed of the following:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:61.070%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.108%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.056%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Case reserves</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191,151 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176,805 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IBNR</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349,628 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317,374 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">540,779 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494,179 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of changes in outstanding loss and loss adjustment expense reserves for all lines of business consolidated </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for the nine months ended September 30, 2021 and 2020 is as follows:  </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:68.108%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.562%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.564%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross balance at January 1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494,179 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470,588 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Losses recoverable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,851)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,531)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net balance at January 1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">477,328 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">443,057 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incurred losses related to:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296,333 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247,559 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,255)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,385 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total incurred</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295,078 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252,944 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Paid losses related to:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96,442)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72,453)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(146,545)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(161,222)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total paid</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(242,987)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(233,675)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency revaluation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,722)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(505)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net balance at September 30</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">527,697 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">461,821 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Losses recoverable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,082 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,949 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross balance at September 30</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">540,779 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">481,770 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the outstanding loss and loss adjustment expense reserves for health claims for the nine months ended September 30, 2021 and 2020 are as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:68.108%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.562%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.564%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Health</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross balance at January 1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,485 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,063 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Losses recoverable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net balance at January 1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,485 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,063 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incurred losses related to:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,189 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,032 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,898)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,341 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total incurred</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,291 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,373 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Paid losses related to:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,224)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,115)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,824)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,327)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total paid</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,048)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,442)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency revaluation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net balance at September 30</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,728 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,994 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Losses recoverable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross balance at September 30</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,728 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,994 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 191151000 176805000 349628000 317374000 540779000 494179000 494179000 470588000 16851000 27531000 477328000 443057000 296333000 247559000 -1255000 5385000 295078000 252944000 96442000 72453000 146545000 161222000 242987000 233675000 -1722000 -505000 527697000 461821000 13082000 19949000 540779000 481770000 -1300000 5400000 17485000 18063000 0 0 17485000 18063000 31189000 25032000 -1898000 1341000 29291000 26373000 20224000 15115000 13824000 16327000 34048000 31442000 0 0 12728000 12994000 0 0 12728000 12994000 RETROCESSION <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company purchases retrocessional coverage for one or more of the following reasons: to manage its overall exposure, reduce its net liability on individual risks, obtain additional underwriting capacity and balance its underwriting portfolio. The Company records loss and loss adjustment expenses recoverable from retrocessionaires as assets. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and nine months ended September 30, 2021, the Company’s earned ceded premiums were insignificant compared to $1.7 million and $3.2 million for the three and nine months ended September 30, 2020, respectively. For the three and nine months ended September 30, 2021, loss and loss expenses recovered were insignificant compared to $2.5 million and $6.2 million for the three and nine months ended September 30, 2020, respectively.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Retrocession contracts do not relieve the Company from its obligations to its cedents. Failure of retrocessionaires to honor their obligations could result in losses to the Company. At September 30, 2021, the Company’s loss reserves recoverable consisted of (i) $9.9 million (December 31, 2020: $12.6 million) from unrated retrocessionaires, of which $9.7 million (December 31, 2020: $11.9 million) were secured by cash, letters of credit and collateral held in trust accounts for the benefit of the Company and (ii) $3.2 million (December 31, 2020: $4.3 million) from retrocessionaires rated A- or above by A.M. Best. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company regularly evaluates its net credit exposure to assess the ability of the retrocessionaires to honor their respective obligations. At September 30, 2021, the Company had recorded an allowance for expected credit losses of $47.0 thousand (December 31, 2020: $47.0 thousand).</span></div> 1700000 3200000 2500000 6200000 9900000 12600000 9700000 11900000 3200000 4300000 47000 47000 SENIOR CONVERTIBLE NOTES <div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 7, 2018, the Company issued $100.0 million of senior unsecured convertible notes (the “Notes”), which mature on August 1, 2023. The Notes bear interest at 4.0%, payable semi-annually on February 1 and August 1 of each year beginning February 1, 2019. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note holders have the option, under certain conditions, to redeem the Notes prior to maturity. </span></div><div style="margin-bottom:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a holder redeems the Notes, the Company shall have the option to settle the conversion obligation in cash, ordinary shares of the Company, or a combination thereof pursuant to the terms of the indenture governing the Notes. The Company has therefore bifurcated the Notes into liability and equity components.</span></div><div style="margin-bottom:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2021, the Company’s share price was lower than the conversion price of $17.19 per share. </span></div><div style="margin-bottom:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s effective borrowing rate for non-convertible debt at the time of issuance of the Notes was estimated to be 6.0%, which equated to an $8.2 million discount. At September 30, 2021, and December 31, 2020, the unamortized debt discount was $3.0 million and $4.2 million, respectively. The debt discount also represents the portion of the Note’s principal amount allocated to the equity component. </span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company incurred issuance costs in connection with the issuance of the Notes. At September 30, 2021, the unamortized portion of these costs attributed to the debt component was $1.2 million (December 31, 2020: $1.6 million), which the Company expects to amortize through the maturity date. The Company netted the portion of these issuance costs attributed to the equity component against the gross proceeds allocated to equity, resulting in the Company including $7.9 million in the caption “Additional paid-in capital” in the Company’s condensed consolidated balance sheets.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="margin-bottom:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value of the Notes at September 30, 2021, including accrued interest of $0.7 million, was $96.5 million (December 31, 2020: $95.8 million). At September 30, 2021, the Company estimated the fair value of the Notes to be $94.6 million (December 31, 2020: $83.6 million) (see Note 4 Financial Instruments).</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and nine months ended September 30, 2021, the Company recognized interest expenses of $1.6 million and $4.7 million, respectively (2020: $1.6 million and $4.7 million, respectively) in connection with the interest coupon, amortization of issuance costs, and amortization of the discount. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company was in compliance with all covenants relating to the Notes at September 30, 2021, and December 31, 2020.</span></div> 100000000 0.040 17.19 0.060 8200000 3000000 4200000 1200000 1600000 7900000 700000 96500000 95800000 94600000 83600000 1600000 4700000 1600000 4700000 SHARE CAPITAL<div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s share capital is made up of ordinary share capital and additional paid-in capital. Ordinary share capital represents the issued and outstanding Class A and Class B ordinary shares at their par values of $0.10 per share. Additional paid-in capital includes the premium paid per share by the subscribing shareholders for Class A and Class B ordinary shares, as well as the earned portion of the grant-date fair value of share-based awards.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 29, 2020, the Company’s shareholders approved an amendment to the stock incentive plan to increase the number of Class A ordinary shares available for issuance by 3.0 million shares from 5.0 million to 8.0 million. At September 30, 2021, 3,128,276 (December 31, 2020: 3,474,888) Class A ordinary shares remained available for future issuance under the Company’s stock incentive plan. The Compensation Committee of the Board of Directors administers the Company’s stock incentive plan. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Board has adopted a share repurchase plan. The timing of such repurchases and the actual number of shares repurchased will depend on various factors, including price, market conditions, and applicable regulatory and corporate requirements. On March 26, 2020, the Board of Directors extended the share repurchase plan to June 30, 2021. It increased the number of shares authorized to be repurchased to 5.0 million Class A ordinary shares or securities convertible into Class A ordinary shares in the open market through privately negotiated transactions or Rule 10b5-1 stock trading plans. In addition, the Board of Directors also authorized the Company to repurchase up to $25.0 million aggregate face amount of the Company’s 4.00% Convertible Senior Notes due 2023 (the “Notes”) in privately negotiated transactions, in open market repurchases, or pursuant to one or more tender offers. The Company did not repurchase any Notes under the repurchase plan.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 4, 2021, the Board of Directors approved a new share repurchase plan effective from July 1, 2021, until June 30, 2022, authorizing the Company to purchase up to $25 million of Class A ordinary shares or securities convertible into Class A ordinary shares in the open market, through privately negotiated transactions or Rule 10b5-1 stock trading plans. The Company is not required to repurchase any of the Class A ordinary shares or the Notes. The repurchase plans may be modified, suspended, or terminated at the election of our Board of Directors at any time without prior notice. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company repurchased 1,079,544 Class A ordinary shares during the nine months ended September 30, 2021. All Class A ordinary shares repurchased are canceled immediately upon repurchase.</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of ordinary shares issued and outstanding:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"><tr><td style="width:1.0%"/><td style="width:37.418%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.540%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.677%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.540%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.455%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.540%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.677%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.540%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.313%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Class B</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Class B</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance – beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,260,075 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,254,715 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,739,395 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,254,715 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issue of ordinary shares, net of forfeitures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">409,200 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248,726 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchase of ordinary shares</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,079,544)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,874,419)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance – end of period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,589,731 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,254,715 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,113,702 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,254,715 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 0.10 0.10 3000000 5000000 8000000 3128276 3474888 5000000 25000000 0.0400 25000000 1079544 <div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of ordinary shares issued and outstanding:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"><tr><td style="width:1.0%"/><td style="width:37.418%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.540%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.677%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.540%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.455%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.540%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.677%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.540%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.313%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Class B</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Class B</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance – beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,260,075 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,254,715 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,739,395 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,254,715 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issue of ordinary shares, net of forfeitures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">409,200 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248,726 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchase of ordinary shares</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,079,544)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,874,419)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance – end of period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,589,731 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,254,715 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,113,702 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,254,715 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 28260075 6254715 30739395 6254715 409200 0 248726 0 1079544 0 1874419 0 27589731 6254715 29113702 6254715 SHARE-BASED COMPENSATION <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a stock incentive plan for directors, employees, and consultants administered by the Compensation Committee of the Board of Directors. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Employee and Director Restricted Shares</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended September 30, 2021, the Company issued 334,312 (2020: 306,264) Class A ordinary shares to employees pursuant to the Company’s stock incentive plan. These shares contain certain restrictions relating to, among other things, vesting, forfeiture in the event of termination of employment, and transferability. The restricted shares cliff vest three years after the date of issuance, subject to the grantee’s continued service with the Company. During the vesting period, the holder of the restricted shares retains voting rights and is entitled to any dividends declared by the Company.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended September 30, 2021, grantees forfeited 20,592 (2020: 210,109) restricted shares. For the nine months ended September 30, 2021, the Company reversed $0.1 million of stock compensation expense (2020: $0.7 million) in relation to the forfeited restricted shares. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded $1.8 million of share-based compensation expense, net of forfeiture reversals, relating to restricted shares for the nine months ended September 30, 2021 (2020: $0.6 million). At September 30, 2021, there was $3.3 million (December 31, 2020: $1.9 million) of unrecognized compensation cost relating to non-vested restricted shares (excluding any restricted shares with performance conditions that the Company currently does not expect will be met), which the Company expects to recognize over a weighted-average period of 1.9 years (December 31, 2020: 1.5 years). For the nine months ended September 30, 2021, the total fair value of restricted shares vested was $1.6 million (2020: $2.8 million).</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended September 30, 2021, the Company also issued to non-employee directors an aggregate of 74,769 (2020: 0) restricted Class A ordinary shares as part of their remuneration for services to the Company. Each of these restricted shares issued to non-employee directors contains similar restrictions to those issued to employees and will vest on the earlier of the first anniversary of the date of the share issuance or the Company’s next annual general meeting, subject to the grantee’s continued service with the Company. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity for unvested outstanding restricted share awards during the nine months ended September 30, 2021: </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-align:center;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.131%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of<br/>non-vested<br/>restricted<br/> shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/> average<br/>grant date<br/>fair value</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">697,549 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.38 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">409,081 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.11 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(139,482)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.53 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,592)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.35 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">946,556 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.97 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Employee and Director Stock Options</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended September 30, 2021, and 2020, no Class A ordinary share purchase options were granted or exercised by directors or employees. For the nine months ended September 30, 2021, 100,000 (2020: 40,000) stock options expired and 80,000 (2020: 80,000) stock options vested. When the Company grants stock options, it reduces the corresponding number from the shares authorized for issuance as part of the Company’s stock incentive plan.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board of Directors does not currently anticipate that the Company will declare any dividends during the expected term of the options. The Company uses graded vesting for expensing employee stock options. The total compensation cost expensed relating to stock options for the nine months ended September 30, 2021, was $0.3 million (2020: $0.5 million). At September 30, 2021, the total compensation cost related to non-vested options not yet recognized was $0.3 million (December 31, 2020: $0.7 million), which will be recognized over a weighted-average period of 1.4 years (December 31, 2020: 1.8 years) assuming the grantee completes the service period for vesting of the options.</span></div><div style="text-align:center;text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2021, and December 31, 2020, 0.7 million and 0.8 million stock options were outstanding, respectively, with a weighted average exercise price of $22.35 and $22.22 per share, respectively, and a weighted average grant date fair value of $10.23 and $10.25 per share, respectively. The stock options’ weighted-average remaining contractual terms were 4.9 years and 5.1 years, at September 30, 2021, and December 31, 2020, respectively. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Employee Restricted Stock Units</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company issues RSUs to certain employees as part of the stock incentive plan. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These RSUs contain restrictions relating to vesting, forfeiture in the event of termination of employment, transferability, and other matters. Each RSU grant cliff vests three years after the date of issuance, subject to the grantee’s continued service with the Company. On the vesting date, the Company converts each RSU into one Class A ordinary share and issues new Class A ordinary shares from the shares authorized for issuance as part of the Company’s stock incentive plan. For the nine months ended September 30, 2021, the Company issued 58,123 (2020: 60,622) RSUs to employees pursuant to the Company’s stock incentive plan. For the nine months ended September 30, 2021, and 2020, no RSUs were forfeited.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded $0.3 million of share-based compensation expense relating to RSUs for the nine months ended September 30, 2021 (2020: $0.3 million). At September 30, 2021, the total compensation cost related to non-vested RSUs not yet recognized was $0.6 million (2020: $0.4 million), which the Company expects to recognize over a weighted-average period of 1.9 years (2020: 1.8 years).</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Employee RSU activity during the nine months ended September 30, 2021, was as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.131%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of<br/>non-vested<br/>RSUs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/> average<br/>grant date<br/>fair value</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,722 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.60 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,123 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.18 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,711)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.90 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154,134 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.59 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Performance Restricted Shares</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to 2021, the Company issued Class A ordinary shares to the Chief Executive Officer (“CEO”) pursuant to the Company’s stock incentive plan. These shares contain performance and service conditions and certain restrictions relating to, among other things, vesting, forfeiture in the event of termination of the CEO’s employment, and transferability. These restricted shares cliff vest five years after the date of issuance, subject to the performance condition being met and the CEO’s continued service with the Company. The weighted average grant date fair value of these restricted shares subject to performance conditions was $6.72 per share. At September 30, 2021, 193,149 unvested performance restricted shares were outstanding (December 31, 2020: 193,149). As the performance conditions associated with these restricted shares have not been met, the Company recognized no compensation cost relating to the unvested shares for the nine months ended September 30, 2021, and 2020.</span></div>For the nine months ended September 30, 2021 and 2020, the combined stock compensation expense (net of forfeitures) included in the caption “General and administrative expenses” in the Company’s statements of operations was $2.4 million and $1.4 million, respectively. 334312 306264 P3Y 20592 210109 100000 700000 1800000 600000 3300000 1900000 P1Y10M24D P1Y6M 1600000 2800000 74769 0 <div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity for unvested outstanding restricted share awards during the nine months ended September 30, 2021: </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-align:center;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.131%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of<br/>non-vested<br/>restricted<br/> shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/> average<br/>grant date<br/>fair value</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">697,549 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.38 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">409,081 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.11 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(139,482)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.53 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,592)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.35 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">946,556 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.97 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Employee RSU activity during the nine months ended September 30, 2021, was as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.131%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of<br/>non-vested<br/>RSUs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/> average<br/>grant date<br/>fair value</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,722 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.60 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,123 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.18 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,711)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.90 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154,134 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.59 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 697549 9.38 409081 9.11 139482 11.53 20592 8.35 946556 8.97 0 0 100000 40000 80000 80000 300000 500000 300000 700000 P1Y4M24D P1Y9M18D 700000 800000 22.35 22.22 10.23 10.25 P4Y10M24D P5Y1M6D P3Y 1 58123 60622 0 0 300000 300000 600000 400000 P1Y10M24D P1Y9M18D 116722 9.60 58123 9.18 20711 15.90 154134 8.59 P5Y 6.72 193149 193149 0 0 2400000 1400000 TAXATION<div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2021, the Company recorded a gross deferred tax asset of $4.0 million (2020: $3.5 million) and a deferred tax asset valuation allowance of $3.5 million (2020: $3.0 million). The net deferred tax asset is included in the caption “Other assets” in the Company’s condensed consolidated balance sheets. The Company has determined that it is more likely than not to fully realize the recorded deferred tax asset (net of the valuation allowance) in the future. The Company based this determination on the expected timing of the reversal of the temporary differences and the likelihood of generating sufficient taxable income to realize the future tax benefit.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth our current and deferred income tax benefit (expense) on a consolidated basis for the nine months ended September 30, 2021 and 2020:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:38.285%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.687%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.687%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.102%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.105%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended September 30</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">($ in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current tax (expense) benefit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">323 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,240)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease (increase) in deferred tax valuation allowance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(323)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(493)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(696)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax (expense) benefit </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,733)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(424)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div>For the nine months ended September 30, 2021, the income tax expense of $3.7 million resulted from Verdant’s gain on the sale of its AccuRisk investment. 4000000 3500000 3500000 3000000 <div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth our current and deferred income tax benefit (expense) on a consolidated basis for the nine months ended September 30, 2021 and 2020:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:38.285%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.687%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.687%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.102%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.105%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended September 30</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">($ in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current tax (expense) benefit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">323 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,240)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease (increase) in deferred tax valuation allowance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(323)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(493)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(696)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax (expense) benefit </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,733)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(424)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> -323000 33000 3240000 -272000 -323000 33000 -493000 -696000 0 0 3733000 424000 3700000 RELATED PARTY TRANSACTIONS <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Investment Advisory Agreement</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DME, DME II, and DME Advisors are each an affiliate of David Einhorn, Chairman of the Company’s Board of Directors, and therefore, are related parties to the Company.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has entered into the SILP LPA (as described in Note 3 of the condensed consolidated financial statements). DME II receives a performance allocation equal to (with capitalized terms having the meaning provided under the SILP LPA) (a) 10% of the portion of the Positive Performance Change for each limited partner’s capital account that is less than or equal to the positive balance in such limited partner’s Carryforward Account, plus (b) 20% of the portion of the Positive Performance Change for each limited partner’s capital account that exceeds the positive balance in such limited partner’s Carryforward Account. The Carryforward Account for Greenlight Re and GRIL includes the amount of losses that were to be recouped under the Joint Venture as well as any loss generated on the assets invested in SILP, subject to adjustments for redemptions. The loss carry-forward provision contained in the SILP LPA allows DME II to earn a reduced performance allocation of 10% of profits in years subsequent to any year in which SILP has incurred a loss until all losses are recouped, and an additional amount equal to 150% of the loss is earned. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with the SILP LPA, DME Advisors constructs a levered investment portfolio as agreed by the Company (the “Investment Portfolio” as defined in the SILP LPA). On September 1, 2018, SILP entered into the IAA with DME Advisors, which entitles DME Advisors to a monthly management fee equal to 0.125% (1.5% on an annual basis) of each limited partner’s Investment Portfolio. The IAA has an initial term ending on August 31, 2023, subject to an automatic extension for successive three-year terms. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a detailed breakdown of management fees and performance compensation for the three and nine months ended September 30, 2021, and 2020, refer to Note 3 of the condensed consolidated financial statements.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the SILP LPA and the IAA, the Company has agreed to indemnify DME, DME II, and DME Advisors for any expense, loss, liability, or damage arising out of any claim asserted or threatened in connection with DME Advisors serving as the Company’s or SILP’s investment advisor. The Company will reimburse DME, DME II, and DME Advisors for reasonable costs and expenses of investigating and defending such claims, provided such claims were not caused due to gross negligence, breach of contract, or misrepresentation by DME, DME II, or DME Advisors. The Company incurred no indemnification amounts during the periods presented.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Green Brick Partners, Inc.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">David Einhorn also serves as the Chairman of the Board of Directors of Green Brick Partners, Inc. (“GRBK”), a publicly-traded company. At September 30, 2021, SILP, along with certain affiliates of DME Advisors, collectively owned 34.3% of the issued and outstanding common shares of GRBK. Under applicable securities laws, DME Advisors may be limited at times in its ability to trade GRBK shares on behalf of SILP. </span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Service Agreement</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has entered into a service agreement with DME Advisors, pursuant to which DME Advisors provides certain investor relations services to the Company for compensation of five thousand dollars per month (plus expenses). The agreement is automatically renewed annually until terminated by either the Company or DME Advisors for any reason with 30 days prior written notice to the other party. </span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Collateral Assets Investment Management Agreement</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective January 1, 2019, the Company (and its subsidiaries) entered into a collateral assets investment management agreement (the “CMA”) with DME Advisors, pursuant to which DME Advisors manages certain assets of the Company that are not subject to the SILP LPA and are held by the Company to provide collateral required by the cedents in the form of trust accounts and letters of credit. In accordance with the CMA, DME Advisors receives no fees and is required to comply with the collateral investment guidelines. The CMA can be terminated by any of the parties upon 30 days’ prior written notice to the other parties.</span></div> 0.10 0.20 0.10 1.50 0.00125 0.015 P3Y 0.00343 5000 P30D P30D COMMITMENTS AND CONTINGENCIES <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Letters of Credit and Trusts</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2021, the Company had one letter of credit facility, which automatically renews each year unless terminated by either party in accordance with the applicable required notice period:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.642%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:30.045%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Maximum Facility Limit</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Termination Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notice period required for termination</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Citibank Europe plc</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275,000 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 20, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120 days before the termination date</span></div></td></tr></table></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2021, an aggregate amount of $138.4 million (December 31, 2020: $135.3 million) in letters of credit was issued under the credit facility. At September 30, 2021, the Company had pledged total cash and cash equivalents with a fair value in the aggregate of $142.4 million (December 31, 2020: $137.6 million) as collateral against the letters of credit issued and included in the caption “Restricted cash and cash equivalents” in the Company’s condensed consolidated balance sheets. The credit facility contains customary events of default and restrictive covenants, including but not limited to limitations on liens on collateral, transactions with affiliates, mergers, and sales of assets, as well as solvency and maintenance of certain minimum pledged equity requirements and restricts issuance of any debt without the consent of the letter of credit provider. Additionally, if an event of default exists, as defined in the letter of credit facility, Greenlight Re will be prohibited from paying dividends to its parent company. The Company was in compliance with all the credit facility covenants at September 30, 2021 and December 31, 2020.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has also established regulatory trust arrangements for certain cedents. At September 30, 2021, collateral of $550.2 million (December 31, 2020: $607.8 million) was provided to cedents in the form of regulatory trust accounts and included in the caption “Restricted cash and cash equivalents” in the Company’s condensed consolidated balance sheets. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Lease Obligations</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Greenlight Re entered into a new lease agreement for office space in the Cayman Islands commencing July 1, 2021. The lease expires on June 30, 2026, unless Greenlight Re exercises its right to renew the lease for another five-year period. The annual lease obligation ranges from $0.5 million to $0.6 million. The Company determined that this agreement qualifies as an operating lease. At September 30, 2021, the right-of-use asset and a corresponding lease liability relating to the lease agreement were $2.2 million. The operating lease expense for the three and nine months ended September 30, 2021, was $0.1 million and $0.1 million, respectively. </span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Greenlight Re’s previous lease arrangement qualified as a short-term lease. The short-term lease expense for the three and nine months ended September 30, 2021, was nil and $0.3 million, respectively (three and nine months ended September 30, 2020: $0.1 million and $0.4 million, respectively).</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Schedule of Commitments and Contingencies</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a schedule of future minimum payments required under the above commitments:  </span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.794%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.718%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.502%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.266%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="39" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease obligations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">588 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">624 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">640 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">657 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">788 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,427 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and convertible note payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,588 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,624 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">640 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">657 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">788 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111,427 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Litigation</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div>From time to time, in the normal course of business, the Company may be involved in formal and informal dispute resolution procedures, which may include arbitration or litigation. The outcomes of these procedures determine the rights and obligations under the Company’s reinsurance contracts and other contractual agreements. In some disputes, the Company may seek to enforce its rights under an agreement or collect funds owed. In other matters, the Company may resist attempts by others to collect funds or enforce alleged rights. While the Company cannot predict the outcome of legal disputes with certainty, the Company does not believe that any existing dispute, when finally resolved, will have a material adverse effect on the Company’s business, financial condition, or operating results. <div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2021, the Company had one letter of credit facility, which automatically renews each year unless terminated by either party in accordance with the applicable required notice period:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.642%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:30.045%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Maximum Facility Limit</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Termination Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notice period required for termination</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Citibank Europe plc</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275,000 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 20, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120 days before the termination date</span></div></td></tr></table></div> 1 275000000 P120D 138400000 135300000 142400000 137600000 550200000 607800000 P5Y 500000 600000 2200000 2200000 100000 100000 0 300000 100000 400000 <div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a schedule of future minimum payments required under the above commitments:  </span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.794%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.718%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.502%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.266%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="39" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease obligations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">588 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">624 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">640 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">657 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">788 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,427 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and convertible note payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,588 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,624 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">640 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">657 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">788 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111,427 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 130000 588000 624000 640000 657000 788000 3427000 0 4000000 104000000 0 0 0 108000000 130000 4588000 104624000 640000 657000 788000 111427000 SEGMENT REPORTING <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has one operating segment, Property &amp; Casualty Reinsurance. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all of the Company’s business is sourced through reinsurance brokers. The following table sets forth the premiums generated through our largest brokers and their subsidiaries and affiliates (totals may not sum due to rounding):   </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="padding-left:36pt;padding-right:36pt;text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Gross Premiums Written by Line of Business</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.874%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.019%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.159%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.304%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.159%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.447%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.447%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.452%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended September 30</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="21" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,398 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,396 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,700 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,426 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Motor</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,103 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,091 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,537 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,136 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Personal</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,631 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,691 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,318 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,326 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Property</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,132 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,178 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.6 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,555 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,888 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.4 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Casualty</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General Liability</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,376 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,224 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,749 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,920 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Motor Liability</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,823 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,679 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,795 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,729 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional Liability </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Workers' Compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,117 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,979 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,237 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,908 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Multi-line </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,162 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,820 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137,857 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,379 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Casualty</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,632 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.7 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,778 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.4 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300,940 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.4 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229,135 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.3 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accident &amp; Health</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,175 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,418 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,427 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,522 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,920 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,817 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,134 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,704 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marine</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,462 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,412 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">749 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Specialty</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,414 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,278 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,781 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,074 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,971 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,640 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,754 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,049 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #99ccff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,735 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,596 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">440,249 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">362,072 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Gross Premiums Written by Geographic Area of Risks Insured</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:21.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.013%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.307%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.013%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.307%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.013%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.164%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.013%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended September 30</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. and Caribbean</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,087 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,798 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258,849 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291,511 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Worldwide </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,616 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,738 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174,470 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,150 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,483 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,787 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">549 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,060 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,143 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,411 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,735 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,596 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">440,249 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">362,072 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div>(1) “Worldwide” is composed of contracts that reinsure risks in more than one geographic area and may include risks in the U.S. 1 The following table sets forth the premiums generated through our largest brokers and their subsidiaries and affiliates (totals may not sum due to rounding):   <div style="padding-left:36pt;padding-right:36pt;text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Gross Premiums Written by Line of Business</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.874%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.019%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.159%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.304%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.159%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.447%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.447%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.452%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended September 30</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="21" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,398 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,396 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,700 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,426 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Motor</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,103 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,091 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,537 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,136 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Personal</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,631 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,691 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,318 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,326 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Property</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,132 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,178 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.6 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,555 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,888 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.4 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Casualty</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General Liability</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,376 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,224 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,749 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,920 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Motor Liability</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,823 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,679 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,795 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,729 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional Liability </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Workers' Compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,117 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,979 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,237 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,908 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Multi-line </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,162 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,820 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137,857 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,379 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Casualty</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,632 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.7 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,778 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.4 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300,940 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.4 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229,135 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.3 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accident &amp; Health</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,175 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,418 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,427 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,522 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,920 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,817 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,134 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,704 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marine</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,462 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,412 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">749 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Specialty</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,414 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,278 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,781 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,074 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,971 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,640 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,754 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,049 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #99ccff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,735 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,596 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">440,249 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">362,072 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div> 3398000 0.026 3396000 0.025 9700000 0.022 9426000 0.026 6103000 0.047 10091000 0.074 24537000 0.056 25136000 0.069 3631000 0.028 3691000 0.027 10318000 0.023 10326000 0.029 13132000 0.102 17178000 0.126 44555000 0.101 44888000 0.124 7376000 0.057 3224000 0.024 10749000 0.024 3920000 0.011 19823000 0.154 41679000 0.307 96795000 0.220 96729000 0.267 154000 0.001 76000 0.001 302000 0.001 199000 0.001 17117000 0.133 21979000 0.162 55237000 0.125 60908000 0.168 40162000 0.312 25820000 0.190 137857000 0.313 67379000 0.186 84632000 0.657 92778000 0.684 300940000 0.684 229135000 0.633 4175000 0.032 12418000 0.093 26427000 0.060 40522000 0.112 17920000 0.139 1817000 0.013 40134000 0.091 15704000 0.043 2462000 0.019 127000 0.001 8412000 0.019 749000 0.002 6414000 0.050 11278000 0.083 19781000 0.045 31074000 0.086 30971000 0.241 25640000 0.190 94754000 0.215 88049000 0.243 128735000 1.000 135596000 1.000 440249000 1.000 362072000 1.000 Gross Premiums Written by Geographic Area of Risks Insured<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:21.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.013%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.307%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.013%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.307%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.013%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.164%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.013%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended September 30</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. and Caribbean</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,087 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,798 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258,849 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291,511 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Worldwide </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,616 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,738 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174,470 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,150 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,483 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,787 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">549 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,060 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,143 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,411 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,735 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,596 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">440,249 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">362,072 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table>(1) “Worldwide” is composed of contracts that reinsure risks in more than one geographic area and may include risks in the U.S. 67087000 0.521 110798000 0.817 258849000 0.588 291511000 0.805 59616000 0.463 22738000 0.168 174470000 0.396 66150000 0.183 1483000 0.012 0 0 2787000 0.006 0 0 549000 0.004 2060000 0.015 4143000 0.009 4411000 0.012 128735000 1.000 135596000 1.000 440249000 1.000 362072000 1.000 XML 13 R1.htm IDEA: XBRL DOCUMENT v3.21.2
Cover Page - shares
 9 Months Ended
Sep. 30, 2021
Oct. 29, 2021
Document Information [Line Items]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Sep. 30, 2021  
Document Transition Report false  
Entity File Number 001-33493  
Entity Registrant Name GREENLIGHT CAPITAL RE, LTD.  
Entity Incorporation, State or Country Code E9  
Entity Address, Address Line One 65 Market Street  
Entity Address, Address Line Two Suite 1207, Jasmine Court  
Entity Address, City or Town Camana Bay  
Entity Address, Country KY  
Entity Address, Postal Zip Code KY1-1205  
City Area Code 345  
Local Phone Number 943-4573  
Title of 12(b) Security Class A Ordinary Shares  
Trading Symbol GLRE  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Central Index Key 0001385613  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2021  
Document Fiscal Period Focus Q3  
Amendment Flag false  
Common Class A    
Document Information [Line Items]    
Entity Common Stock, Shares Outstanding   27,589,731
Common Class B    
Document Information [Line Items]    
Entity Common Stock, Shares Outstanding   6,254,715
XML 14 R2.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($)
$ in Thousands
Sep. 30, 2021
Dec. 31, 2020
Investments    
Investment in related party investment fund $ 180,239 $ 166,735
Other investments 42,480 29,418
Total investments 222,719 196,153
Cash and cash equivalents 37,380 8,935
Restricted cash and cash equivalents 692,542 745,371
Reinsurance balances receivable (net of allowance for expected credit losses of $89 and $89) 380,417 330,232
Loss and loss adjustment expenses recoverable (net of allowance for expected credit losses of $47 and $47) 13,082 16,851
Deferred acquisition costs 60,634 51,014
Unearned premiums ceded 26 0
Notes receivable 0 6,101
Other assets 6,737 2,993
Total assets 1,413,537 1,357,650
Liabilities    
Loss and loss adjustment expense reserves 540,779 494,179
Unearned premium reserves 237,926 201,089
Reinsurance balances payable 77,525 92,247
Funds withheld 5,087 4,475
Other liabilities 5,228 5,009
Convertible senior notes payable 96,478 95,794
Total liabilities 963,023 892,793
Shareholders' equity    
Preferred share capital (par value $0.10; authorized, 50,000,000; none issued) 0 0
Ordinary share capital (Class A: par value $0.10; authorized, 100,000,000; issued and outstanding, 27,589,731 (2020: 28,260,075): Class B: par value $0.10; authorized, 25,000,000; issued and outstanding, 6,254,715 (2020: 6,254,715)) 3,384 3,452
Additional paid-in capital 480,939 488,488
Retained earnings (deficit) (33,809) (27,083)
Total shareholders' equity 450,514 464,857
Total liabilities and equity $ 1,413,537 $ 1,357,650
XML 15 R3.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) - USD ($)
Sep. 30, 2021
Dec. 31, 2020
Allowance for expected credit losses $ 89,000 $ 89,000
Loss and loss adjustment expenses recoverable, allowance $ 47,000 $ 47,000
Preferred share capital, par value (in dollars per share) $ 0.10 $ 0.10
Preferred share capital, authorized (in shares) 50,000,000 50,000,000
Preferred share capital, issued (in shares) 0 0
Common Class A    
Ordinary share capital, par value (in dollars per share) $ 0.10 $ 0.10
Ordinary share capital, authorized (in shares) 100,000,000 100,000,000
Ordinary share capital, issued (in shares) 27,589,731 28,260,075
Ordinary share capital, outstanding (in shares) 27,589,731 28,260,075
Common Class B    
Ordinary share capital, par value (in dollars per share) $ 0.10 $ 0.10
Ordinary share capital, authorized (in shares) 25,000,000 25,000,000
Ordinary share capital, issued (in shares) 6,254,715 6,254,715
Ordinary share capital, outstanding (in shares) 6,254,715 6,254,715
XML 16 R4.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Revenues        
Gross premiums written $ 128,735 $ 135,596 $ 440,249 $ 362,072
Gross premiums ceded (60) (1,464) (6) (2,274)
Net premiums written 128,675 134,132 440,243 359,798
Change in net unearned premium reserves 6,849 (18,613) (36,844) (24,844)
Net premiums earned 135,524 115,519 403,399 334,954
Income (loss) from investment in related party investment fund (net of related party expenses of $659 and $2,632 (three and nine months ended September 30, 2020: $703 and $1,981, respectively)) (6,214) 6,431 (4,196) (34,086)
Net investment income (loss) 10,303 466 28,999 11,237
Other income (expense), net (380) 1,569 (4,033) 2,570
Total revenues 139,233 123,985 424,169 314,675
Expenses        
Net loss and loss adjustment expenses incurred 110,400 88,053 295,078 252,944
Acquisition costs 35,048 27,018 106,060 76,660
General and administrative expenses 6,060 5,152 21,340 18,095
Interest expense 1,578 1,579 4,684 4,702
Total expenses 153,086 121,802 427,162 352,401
Income (loss) before income tax (13,853) 2,183 (2,993) (37,726)
Income tax (expense) benefit 0 0 (3,733) (424)
Net income (loss) $ (13,853) $ 2,183 $ (6,726) $ (38,150)
Earnings (loss) per share        
Basic (in dollars per share) $ (0.42) $ 0.06 $ (0.20) $ (1.07)
Diluted (in dollars per share) $ (0.42) $ 0.06 $ (0.20) $ (1.07)
Weighted average number of ordinary shares used in the determination of earnings and loss per share        
Basic (in shares) 32,929,097 35,677,554 33,507,060 35,569,292
Diluted (in shares) 32,929,097 35,779,703 33,507,060 35,569,292
XML 17 R5.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Income Statement [Abstract]        
Management fee $ 659 $ 703 $ 2,632 $ 1,981
XML 18 R6.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY (UNAUDITED) - USD ($)
$ in Thousands
Total
Ordinary share capital
Additional paid-in capital
Retained earnings (deficit)
Retained earnings (deficit)
Cumulative Effect, Period of Adoption, Adjustment
Beginning balance at Dec. 31, 2019   $ 3,699 $ 503,547 $ (30,063) $ (886)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issue of Class A ordinary shares, net of forfeitures   25      
Repurchase of Class A ordinary shares   (187) (12,484)    
Share-based compensation expense     1,366    
Net income (loss) $ (38,150)     (38,150)  
Ending balance at Sep. 30, 2020 426,867 3,537 492,429 (69,099)  
Beginning balance at Jun. 30, 2020   3,627 497,559 (71,282)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issue of Class A ordinary shares, net of forfeitures   (19)      
Repurchase of Class A ordinary shares   (71) (4,828)    
Share-based compensation expense     (302)    
Net income (loss) 2,183     2,183  
Ending balance at Sep. 30, 2020 426,867 3,537 492,429 (69,099)  
Beginning balance at Dec. 31, 2020 464,857 3,452 488,488 (27,083)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issue of Class A ordinary shares, net of forfeitures   41      
Repurchase of Class A ordinary shares   (109) (9,891)    
Share-based compensation expense     2,342    
Net income (loss) (6,726)     (6,726)  
Ending balance at Sep. 30, 2021 450,514 3,384 480,939 (33,809)  
Beginning balance at Jun. 30, 2021   3,417 483,365 (19,956)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issue of Class A ordinary shares, net of forfeitures   3      
Repurchase of Class A ordinary shares   (36) (3,216)    
Share-based compensation expense     790    
Net income (loss) (13,853)     (13,853)  
Ending balance at Sep. 30, 2021 $ 450,514 $ 3,384 $ 480,939 $ (33,809)  
XML 19 R7.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Cash provided by (used in) operating activities    
Net income (loss) $ (6,726) $ (38,150)
Adjustments to reconcile net income or loss to net cash provided by (used in) operating activities    
Loss (income) from investments in related party investment fund 4,196 34,086
Loss (income) from investment accounted for under the equity method 0 (870)
Net change in unrealized gains and losses on investments and notes receivable (14,860) (19,153)
Net realized (gains) losses on investments and notes receivable (14,210) 15,000
Foreign exchange (gains) losses on investments 14 232
Current expected credit losses recognized on notes receivable and reinsurance assets 0 250
Share-based compensation expense 2,383 1,391
Amortization and interest expense, net of change in accruals 684 702
Depreciation expense 16 21
Net change in    
Reinsurance balances receivable (50,185) (33,932)
Loss and loss adjustment expenses recoverable 3,769 7,535
Deferred acquisition costs (9,620) (2,031)
Unearned premiums ceded (26) 901
Other assets, excluding depreciation (3,760) (1,121)
Loss and loss adjustment expense reserves 46,600 11,182
Unearned premium reserves 36,837 24,395
Reinsurance balances payable (14,722) (42,301)
Funds withheld 612 274
Other liabilities 219 (3,069)
Net cash provided by (used in) operating activities (18,779) (44,658)
Investing activities    
Proceeds from redemptions from related party investment fund 51,904 69,108
Contributions to related party investment fund (69,604) (48,094)
Purchases of investments (4,761) (944)
Sales of investments 20,755 0
Net change in notes receivable 6,101 741
Net cash provided by (used in) investing activities 4,395 20,811
Financing activities    
Repurchase of Class A ordinary shares (10,000) (12,671)
Net cash provided by (used in) financing activities (10,000) (12,671)
Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash 0 (122)
Net increase (decrease) in cash, cash equivalents and restricted cash (24,384) (36,640)
Cash, cash equivalents and restricted cash at beginning of the period 754,306 767,906
Cash, cash equivalents and restricted cash at end of the period 729,922 731,266
Supplementary information    
Interest paid in cash 4,000 4,000
Income tax paid in cash $ 3,700 $ 0
XML 20 R8.htm IDEA: XBRL DOCUMENT v3.21.2
ORGANIZATION AND BASIS OF PRESENTATION
 9 Months Ended
Sep. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
ORGANIZATION AND BASIS OF PRESENTATION ORGANIZATION AND BASIS OF PRESENTATION
 
Greenlight Capital Re, Ltd. (“GLRE”) was incorporated as an exempted company under the Companies Law of the Cayman Islands on July 13, 2004. GLRE’s wholly-owned subsidiary, Greenlight Reinsurance, Ltd. (“Greenlight Re”), provides global specialty property and casualty reinsurance. Greenlight Re has a Class D insurer license issued in accordance with the terms of The Insurance Act, 2010 (as amended) and underlying regulations thereto (the “Act”) and is subject to regulation by the Cayman Islands Monetary Authority, in terms of the Act. Greenlight Re commenced underwriting in April 2006. Verdant Holding Company, Ltd. (“Verdant”), a wholly-owned subsidiary of GLRE, was incorporated in 2008 in the state of Delaware. During 2010, GLRE established Greenlight Reinsurance Ireland, Designated Activity Company (“GRIL”), a wholly-owned reinsurance subsidiary based in Dublin, Ireland. GRIL is authorized as a non-life reinsurance undertaking in accordance with the provisions of the European Union (Insurance and Reinsurance) Regulations 2015. GRIL provides multi-line property and casualty reinsurance capacity to the European broker market and provides GLRE with an additional platform to serve clients located in Europe and North America.  In 2020, GLRE established Greenlight Re Marketing (UK) Limited (“Greenlight Re UK”) as a wholly-owned subsidiary to increase the Company’s presence in the London market. As used herein, the “Company” refers collectively to GLRE and its consolidated subsidiaries.

The Class A ordinary shares of GLRE are listed on Nasdaq Global Select Market under the symbol “GLRE.”

These unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information, and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all the information and footnotes required by U.S. GAAP for complete financial statements. In addition, the year-end balance sheet data was derived from audited financial statements but does not include all disclosures required by U.S. GAAP. These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020, as filed with the U.S. Securities and Exchange Commission on March 10, 2021.

In the opinion of management, these unaudited condensed consolidated financial statements reflect all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation of the Company’s financial position and results of operations as at the end of and for the periods presented.

Significant estimates used in the preparation of the Company’s condensed consolidated financial statements, including those associated with premiums and the estimations of loss and loss adjustment expense reserves, including losses arising from the novel coronavirus (the “COVID-19 pandemic”), may be subject to significant adjustments in future periods. (See Note 5 for the significant assumptions that served as the basis for the Company's estimates of reserves for the COVID-19 pandemic). All significant intercompany accounts and transactions have been eliminated.

The results of operations and cash flows for any interim period will not necessarily be indicative of the results of operations and cash flows for the full fiscal year or subsequent periods.
XML 21 R9.htm IDEA: XBRL DOCUMENT v3.21.2
SIGNIFICANT ACCOUNTING POLICIES
 9 Months Ended
Sep. 30, 2021
Accounting Policies [Abstract]  
SIGNIFICANT ACCOUNTING POLICIES SIGNIFICANT ACCOUNTING POLICIES
 
There have been no material changes to the Company’s significant accounting policies as described in its Annual Report on Form 10-K for the year ended December 31, 2020.

Use of Estimates
 
The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the period. Actual results could differ from these estimates. The significant estimates reflected in the Company’s condensed consolidated financial statements include, but are not limited to, loss and loss adjustment expense reserves,
premiums written, earned and receivable, variability underlying risk transfer assessments, allowances for credit losses, bonus accruals, share-based compensation, valuation allowances associated with deferred tax assets and investment impairments.

Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
 
The Company maintains cash and cash equivalent balances to collateralize regulatory trusts and letters of credit issued to cedents (see Note 12). The following table reconciles the cash, cash equivalents, and restricted cash reported within the condensed consolidated balance sheets to the total presented in the condensed consolidated statements of cash flows:

 September 30, 2021December 31, 2020
 ($ in thousands)
Cash and cash equivalents$37,380 $8,935 
Restricted cash and cash equivalents692,542 745,371 
Total cash, cash equivalents and restricted cash presented in the condensed consolidated statements of cash flows$729,922 $754,306 

Funds Held by Cedents

The caption “Reinsurance balances receivable” in the Company’s condensed consolidated balance sheets includes amounts held by cedents. Such amounts include premiums and funds held at Lloyd’s, which is held in trust at Lloyd's as security for members’ underwriting activities. At September 30, 2021, funds held by cedents were $201.3 million (December 31, 2020: $127.6 million).
 
Reinsurance Assets

The Company calculates an allowance for expected credit losses for its reinsurance balances receivable and loss and loss adjustment expenses recoverable by applying a Probability of Default (“PD”) / Loss Given Default (“LGD”) model. The PD / LGD approach considers the Company’s collectibility history on its reinsurance assets and representative external loss history. In calculating the probability of default, the Company also considers the estimated duration of its reinsurance assets.

The Company evaluates each counterparty’s creditworthiness based on credit ratings that independent agencies assign to the counterparty. The Company manages its credit risk in its reinsurance assets by transacting only with insurers and reinsurers that it considers financially sound.

For its retrocessional counterparties that are unrated, the Company may hold collateral in the form of funds withheld, trust accounts, or irrevocable letters of credit. In evaluating credit risk associated with reinsurance balances receivable, the Company considers its right to offset loss obligations against premiums receivable. The Company regularly evaluates its net credit exposure to assess the ability of cedents and retrocessionaires to honor their respective obligations.

At September 30, 2021, the Company has recorded an allowance for expected credit loss on its Reinsurance Assets of $0.1 million (December 31, 2020: $0.1 million).

Deposit Assets and Liabilities
 
The Company applies deposit accounting to reinsurance contracts that do not transfer sufficient insurance risk to merit reinsurance accounting. Under deposit accounting, the Company recognizes an asset or liability based on its paid or received consideration. The deposit asset or liability balance is subsequently adjusted using the interest method with the corresponding income or expense recorded in the Company’s condensed consolidated statements of operations under the caption “Other income (expense).” The Company records deposit assets and liabilities in its condensed consolidated balance sheets in the caption “Reinsurance balances receivable” and “Reinsurance balances payable,” respectively. At September 30, 2021, deposit assets and deposit liabilities were $4.9 million and $14.0 million, respectively (December 31, 2020: $4.6 million and $31.0 million, respectively). For the three and nine months ended September 30, 2021, and 2020, the interest income and (expense) on deposit accounted contracts were as follows:
 Three months ended September 30Nine months ended September 30
 2021202020212020
($ in thousands)($ in thousands)
Deposit interest income$— $560 $— $1,812 
Deposit interest expense$(38)$— $(2,957)$— 
Deposit interest income/(expense), net$(38)$560 $(2,957)$1,812 

Derivative instruments

The Company recognizes derivative financial instruments in the condensed consolidated balance sheets at their fair values. It includes any realized gains and losses and changes in unrealized gains and losses in the caption “Net investment income (loss)” in the condensed consolidated statements of operations.

The Company’s derivatives do not qualify as hedges for financial reporting purposes. The Company records the associated assets and liabilities in its condensed consolidated balance sheets on a gross basis. The Company does not offset these balances against collateral pledged or received.

Other Assets

The caption “Other assets” in the Company’s condensed consolidated balance sheets consists primarily of prepaid expenses, fixed assets, right-of-use lease assets, other receivables, and deferred tax assets.

Other Liabilities

The caption “Other liabilities” in the Company’s condensed consolidated balance sheets consists primarily of accruals for legal and other professional fees, employee bonuses, taxes payable, and lease liabilities.

Earnings (Loss) Per Share
 
The Company’s unvested restricted stock awards, which contain non-forfeitable rights to dividends or dividend equivalents, whether paid or unpaid, are considered “participating securities” for the purposes of calculating earnings (loss) per share. Basic earnings per share is calculated on the basis of the weighted average number of common shares and participating securities outstanding during the period. Diluted earnings (or loss) per share includes the dilutive effect of the following:

•Restricted Stock Units (“RSUs”) issued that would convert to common shares upon vesting;
•additional potential common shares issuable when in-the-money stock options are exercised, determined using the treasury stock method; and
•those common shares with the potential to be issued in connection with convertible debt and other such convertible instruments, determined using the treasury stock method.

Diluted earnings (or loss) per share contemplates a conversion to common shares of all convertible instruments only if they are dilutive with regards to earnings per share. In the event of a net loss, all RSUs, stock options, convertible debt, and participating securities are excluded from the calculation of both basic and diluted loss per share as their inclusion would be anti-dilutive.
The table below presents the shares outstanding for the calculation of earnings (loss) per share for the three and nine months ended September 30, 2021 and 2020:
 Three months ended September 30Nine months ended September 30
 2021202020212020
Weighted average shares outstanding - basic32,929,097 35,677,554 33,507,060 35,569,292 
Effect of dilutive employee and director share-based awards— 102,149 — — 
Weighted average shares outstanding - diluted32,929,097 35,779,703 33,507,060 35,569,292 
Anti-dilutive stock options outstanding735,627 835,627 735,627 835,627 
Participating securities excluded from calculation of loss per share 946,556 — 946,556 878,498 

Taxation
 
Under current Cayman Islands law, no corporate entity, including GLRE and Greenlight Re, is obligated to pay taxes in the Cayman Islands on either income or capital gains. The Company has an undertaking from the Governor-in-Cabinet of the Cayman Islands, pursuant to the provisions of the Tax Concessions Law, as amended, that, in the event that the Cayman Islands enacts any legislation that imposes tax on profits, income, gains or appreciations, or any tax in the nature of estate duty or inheritance tax, such tax will not be applicable to GLRE, Greenlight Re nor their respective operations, or to the Class A or Class B ordinary shares or related obligations, before February 1, 2025.
 
Verdant is incorporated in Delaware and therefore is subject to taxes in accordance with the U.S. federal rates and regulations prescribed by the U.S. Internal Revenue Service (“IRS”). Verdant’s taxable income is generally expected to be taxed at a marginal rate of 21% (2020: 21%). Verdant’s tax years 2017 and beyond remain open and subject to examination by the IRS.

GRIL is incorporated in Ireland and therefore is subject to the Irish corporation tax rate of 12.5% on its trading income and 25% on its non-trading income.

The Company records a valuation allowance to the extent that the Company considers it more likely than not that all or a portion of the deferred tax asset will not be realized in the future. Other than this valuation allowance, the Company has not taken any income tax positions subject to significant uncertainty that is reasonably likely to have a material impact on the Company. 

Recent Accounting Pronouncements

Recently Issued Accounting Standards Adopted

In January 2020, the FASB issued ASU No. 2020-01, Investments - Equity Securities (Topic 321), Investments - Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815) - Clarifying the Interactions between Topic 321, Topic 323, and Topic 815 (a consensus of the Emerging Issues Task Force) (“ASU 2020-01”). ASU 2020-01 clarifies interactions between the accounting guidance for (i) certain equity securities under Topic 321, (ii) investments under the equity method of accounting in Topic 323, and (iii) certain derivative instruments in Topic 815. ASU 2020-01 is effective for public business entities for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years. The adoption of ASU 2020-01 during the first quarter of 2021 had no material impact on the Company’s consolidated financial statements.

Recently Issued Accounting Standards Not Yet Adopted

In August 2020, the FASB issued ASU No. 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity's Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity's Own Equity (“ASU 2020-06”). ASU 2020-06 is designed to simplify the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments. The amendments remove the separation models in Subtopic 470-20 for certain contracts. As a result, entities will no longer present embedded conversion features separately in equity; rather, the convertible debt instrument will be accounted for as a single liability measured at its amortized cost. ASU 2020-06 also addresses the computation of earnings per share for convertible debt instruments, requiring
the application of the if-converted method when calculating diluted earnings per share. The Company intends to adopt ASU 2020-06 during the first quarter of 2022, using the “modified retrospective” transition method.

The Company expects that its adoption of ASU 2020-06 will impact the accounting for its senior convertible notes (see Note 7) and will lead to a decrease in its opening shareholders’ equity of approximately $2.5 million, with a corresponding increase in the carrying value of the senior convertible notes. The Company expects that in the periods in which the Company reports a net income, the number of shares outstanding for the diluted earnings per share calculation will be approximately 5.8 million higher under the if-converted method. The Company does not expect the adoption of ASU 2020-06 to have a material impact on net income, cash flows, or any other balances.
XML 22 R10.htm IDEA: XBRL DOCUMENT v3.21.2
INVESTMENT IN RELATED PARTY INVESTMENT FUND
 9 Months Ended
Sep. 30, 2021
Equity Method Investments and Joint Ventures [Abstract]  
INVESTMENT IN RELATED PARTY INVESTMENT FUND INVESTMENT IN RELATED PARTY INVESTMENT FUND
On September 1, 2018, the Company entered into an amended and restated exempted limited partnership agreement (as amended by the letter agreement dated as of August 5, 2020, (the “Previous SILP LPA”) of Solasglas Investments, LP (“SILP”), with DME Advisors II, LLC (“DME II”), as General Partner, Greenlight Re, and GRIL, (together the “GLRE Limited Partners”), and the initial limited partner (each, a “Partner”). On September 1, 2018, SILP also entered into a SILP investment advisory agreement (“IAA”) with DME Advisors. LP (“DME Advisors”) pursuant to which DME Advisors is the investment manager for SILP. DME II and DME Advisors are related to the Company, and each is an affiliate of David Einhorn, Chairman of the Company’s Board of Directors.

On January 7, 2021, the Company and DME II entered into the Second Amended and Restated Exempted Limited Partnership Agreement, effective as of January 1, 2021 (the “SILP LPA”). The SILP LPA amends, restates, supersedes, and incorporates all material terms of the Previous SILP LPA, as amended as of February 26, 2019, and the letter agreements dated June 18, 2019, December 27, 2019, and August 5, 2020 (collectively, the “Amendments”). The SILP LPA agreement also amended the definition of “Additional Investment Ratio” and each of the defined terms “Greenlight Re Surplus” and the “GRIL Surplus” so as to clarify that each of the respectively referenced “financial statements” are “U.S. GAAP financial statements.” In addition, the SILP LPA included the following: “The Investment Portfolio of each Partner will not exceed the product of (a) such Partner’s surplus (Greenlight Re Surplus or GRIL Surplus, as the case may be) multiplied by (b) the Investment Cap (50%), and the General Partner will designate any portion of a Partner’s Investment Portfolio as Designated Securities to effectuate such limit”. The SILP LPA also amended the investment guidelines to reflect the amended investment guidelines adopted by the Company’s Board of Directors effective as of January 1, 2021.

The Company has concluded that SILP qualifies as a variable interest entity (“VIE”) under U.S. GAAP. In assessing its interest in SILP, the Company noted the following:

•DME II serves as SILP’s general partner and has the power of appointing the investment manager. The Company does not have the power to appoint, change or replace the investment manager or the general partner except “for cause.” Neither of the GLRE Limited Partners can participate in the investment decisions of SILP as long as SILP adheres to the investment guidelines provided within the SILP LPA. For these reasons, the GLRE Limited Partners are not considered to have substantive participating rights or kick-out rights.

•DME II holds an interest in excess of 10% of SILP’s net assets, which the Company considers to represent an obligation to absorb losses and a right to receive benefits of SILP that are significant to SILP.

Consequently, the Company has concluded that DME II’s interests, not the Company’s, meet both the “power” and “benefits” criteria associated with VIE accounting guidance, and therefore DME II is SILP’s primary beneficiary. The Company presents its investment in SILP in its condensed consolidated balance sheets in the caption “Investment in related party investment fund.”

The Company’s maximum exposure to loss relating to SILP is limited to the net asset value of the GLRE Limited Partners’ investment in SILP. At September 30, 2021, the net asset value of the GLRE Limited Partners’ investment in SILP was $180.2 million (December 31, 2020: $166.7 million), representing 78.0% (December 31, 2020: 75.7%) of SILP’s total net assets. DME II held the remaining 22.0% (December 31, 2020: 24.3%) of SILP’s total net assets. The investment in SILP is recorded at the GLRE Limited Partners’ share of the net asset value of SILP as reported by SILP’s third-party administrator. The GLRE Limited Partners can redeem their assets from SILP for operational purposes by providing three business days’ notice to DME II. At September 30, 2021, the majority of SILP’s long investments were composed of cash and publicly traded equity securities, which could be readily liquidated to meet the GLRE Limited Partners’ redemption requests.

The Company’s share of the change in the net asset value of SILP for the three and nine months ended September 30,
2021, was $(6.2) million and $(4.2) million, respectively, (three and nine months ended September 30, 2020: $6.4 million and $(34.1) million, respectively), and shown in the caption “Income (loss) from investment in related party investment fund” in the Company’s condensed consolidated statements of operations.

The summarized financial statements of SILP are presented below.

Summarized Statement of Assets and Liabilities of Solasglas Investments, LP
September 30, 2021December 31, 2020
($ in thousands)
Assets
Investments, at fair value$262,058 $272,398 
Derivative contracts, at fair value9,071 1,450 
Due from brokers77,638 92,053 
Cash and cash equivalents1,076 — 
Interest and dividends receivable14 59 
Total assets349,857 365,960 
Liabilities and partners’ capital
Liabilities
Investments sold short, at fair value(109,044)(131,902)
Derivative contracts, at fair value(7,793)(4,156)
Due to brokers(1,170)(9,179)
Interest and dividends payable(603)(429)
Other liabilities(133)(175)
Total liabilities(118,743)(145,841)
Net Assets$231,114 $220,119 
GLRE Limited Partners’ share of Net Assets$180,239 $166,735 
Summarized Statement of Operations of Solasglas Investments, LP
Three months ended September 30Nine months ended September 30
2021202020212020
($ in thousands)
Investment income
Dividend income (net of withholding taxes)$146 $170 $509 $1,204 
Interest income51 36 770 262 
Total Investment income197 206 1,279 1,466 
Expenses
Management fee(883)(703)(2,632)(1,981)
Interest(205)(176)(874)(518)
Dividends(306)(213)(852)(612)
Professional fees and other(227)(432)(786)(764)
Total expenses(1,621)(1,524)(5,144)(3,875)
Net investment income (loss)(1,424)(1,318)(3,865)(2,409)
Realized and change in unrealized gains (losses)
Net realized gain (loss) (1,411)(1,412)(14,809)(44,972)
Net change in unrealized appreciation (depreciation) (5,437)10,832 12,143 5,811 
Net gain (loss) on investment transactions(6,848)9,420 (2,666)(39,161)
Net income (loss)$(8,272)$8,102 $(6,531)$(41,570)
GLRE Limited Partners’ share of net income (loss) (1)
$(6,214)$6,431 $(4,196)$(34,086)

(1) Net income (loss) is net of management fees and performance allocation presented below:

Three months ended September 30Nine months ended September 30
2021202020212020
($ in thousands)
Management fees$883 $703 $2,632 $1,981 
Performance allocation$(224)$— $— $— 
Total$659 $703 $2,632 $1,981 

See Note 11 for further details on management fees and performance allocation.
XML 23 R11.htm IDEA: XBRL DOCUMENT v3.21.2
FINANCIAL INSTRUMENTS
 9 Months Ended
Sep. 30, 2021
Fair Value Disclosures [Abstract]  
FINANCIAL INSTRUMENTS FINANCIAL INSTRUMENTS 
 
Investments
  
Other Investments

The Company’s “Other investments” are composed of the following:

•Private investments and unlisted equities, which consist primarily of Innovations-related investments supporting technology innovators in the (re)insurance market; and
•Derivative financial instruments associated with the Company’s Innovations investments.
At September 30, 2021, the Company included the following securities in the caption “Other investments”:
CostUnrealized
gains		Unrealized
losses		Fair value / carrying value
 ($ in thousands)
Private investments and unlisted equities $17,175 $24,017 $(1,800)$39,392 
Derivative financial instruments (not designated as hedging instruments)— 3,088 — 3,088 
Total other investments$17,175 $27,105 $(1,800)$42,480 

At December 31, 2020, the Company included the following securities in the caption “Other investments”: 
CostUnrealized
gains		Unrealized
losses		Fair value / carrying value
 ($ in thousands)
Private investments and unlisted equities$12,414 $10,679 $(1,300)$21,793 
Derivative financial instruments (not designated as hedging instruments)— 1,080 — 1,080 
Other investments$12,414 $11,759 $(1,300)$22,873 
Investment accounted for under the equity method6,545 
Total other investments$29,418 

Private investments and unlisted equities include securities that do not have readily determinable fair values. The carrying values of these holdings are determined based on their original cost minus impairment, if any, plus or minus changes resulting from observable price changes. At September 30, 2021, the carrying value of private investments and unlisted equities was $39.4 million (December 31, 2020: $21.8 million). It incorporated upward adjustments of $7.6 million and $12.9 million during the three and nine months ended September 30, 2021, respectively (three and nine months ended September 30, 2020: $0.0 million and $4.1 million, respectively), excluding any unrealized gains or losses related to changes in foreign currency exchange rates. Since acquiring these private investments, the Company has recognized net upward adjustments of $22.1 million and $9.3 million as of September 30, 2021, and December 31, 2020, respectively.

At December 31, 2020, the investment accounted for under the equity method represented an investment in AccuRisk Holdings LLC (“AccuRisk”), a Chicago, Illinois-based managing general underwriter focused on employee and health insurance benefits. During the nine months ended September 30, 2021, the Company sold its investment in AccuRisk and realized a pre-tax gain of $14.2 million.

The Company’s derivative financial instruments are composed of warrants granting the Company the right, but not the obligation, to purchase shares at a specified price on or before the maturity date. The Company has not designated any of its derivative financial instruments as hedging instruments. The Company’s maximum exposure to loss relating to these warrants is limited to the warrants’ carrying amount.

Fair Value Hierarchy

The fair value of a financial instrument is the amount that would be received in an asset sale or paid to transfer a liability in an orderly transaction between unaffiliated market participants. Assets and liabilities measured at fair value are categorized based on whether the inputs are observable in the market and the degree that the inputs are observable. The categorization of financial instruments within the valuation hierarchy is based on the lowest level of input that is significant to the fair value measurement. The hierarchy is prioritized into three levels (with Level 3 being the lowest) defined as follows:
•Level 1: Quoted prices in active markets for identical assets or liabilities that the entity has the ability to access.
•Level 2: Observable inputs other than prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; or other inputs that are observable or can be corroborated with observable market data.
•Level 3: Unobservable inputs supported by little or no market activity and significant to the fair value of the assets and liabilities. The term “unobservable inputs” includes certain pricing models, discounted cash flow methodologies, and similar techniques.

The Company values its derivative instruments using the Black-Scholes option pricing model based on Level 3 inputs. The Company uses the carrying value of the underlying stock as an input in the option pricing model. The underlying stock does not have a readily determinable fair value. Its carrying value is determined based on its original cost minus impairment, if any, plus or minus changes resulting from observable price changes. The other assumptions applied to the option pricing model include a risk-free rate of 0.50% and estimated volatility of 50%. The carrying value of the derivative instruments represents the fair value.

For the derivative instruments valued on the basis of Level 3 inputs, the Company includes any change in unrealized gains or losses in the caption “Net investment income (loss)” in the condensed consolidated statements of operations.

At September 30, 2021, and December 31, 2020, the Company did not carry any other investments at fair value with an assigned Level within the fair value hierarchy. The Company’s investment in the related party investment fund is measured at fair value using the net asset value practical expedient. It is therefore not classified within the fair value hierarchy. (See Note 3 for further details on the related party investment fund.)

Financial Instruments Disclosed, But Not Carried, at Fair Value

The caption “Convertible senior notes payable” represents financial instruments that the Company carries at amortized cost. The fair value of the convertible senior notes payable is estimated based on the bid price observed in an inactive market for the identical instrument (Level 2 input) (see Note 7).
XML 24 R12.htm IDEA: XBRL DOCUMENT v3.21.2
LOSS AND LOSS ADJUSTMENT EXPENSE RESERVES
 9 Months Ended
Sep. 30, 2021
Insurance Loss Reserves [Abstract]  
LOSS AND LOSS ADJUSTMENT EXPENSE RESERVES LOSS AND LOSS ADJUSTMENT EXPENSE RESERVES
At September 30, 2021, the Company’s loss and loss adjustment expense reserves included estimated amounts for several catastrophe events. For significant catastrophe events, including, but not limited to, hurricanes, typhoons, floods, wildfires, and pandemics, loss reserves are generally established based on loss payments and case reserves reported by clients when, and if, received. To establish IBNR loss estimates, the Company makes use of, among other things, the following:

•estimates communicated by ceding companies;
•information received from clients, brokers, and loss adjusters;
•an understanding of the underlying business written and its exposures to catastrophe event-related losses;
•industry data;
•catastrophe scenario modeling software; and
•management’s judgment.

The COVID-19 pandemic is unprecedented, and the Company does not have previous loss experience on which to base the associated estimate for loss and loss adjustment expenses. The Company based its estimate on the following:

•a review of in-force treaties that may provide coverage and incur losses;
•catastrophe and scenario modeling analyses and results shared by cedents;
•preliminary loss estimates received from clients and their analysts and loss adjusters;
•reviews of industry insured loss estimates and market share analyses; and
•management’s judgment.

Significant assumptions which served as the basis for the Company's estimates of reserves for the COVID-19 pandemic losses and loss adjustment expenses include:

•the scope of coverage provided by the underlying policies, particularly those that provide for business interruption coverage;
•the regulatory, legislative, and judicial actions that could influence contract interpretations across the insurance industry;
•the extent of economic contraction caused by the COVID-19 pandemic and associated measures, particularly in the United States; and
•the ability of the cedents and insured to mitigate some or all of their losses.

While the Company believes its estimate of loss and loss adjustment expense reserves for the COVID-19 pandemic is adequate as of September 30, 2021, based on available information, actual losses may ultimately differ materially from the Company's current estimates. The Company will continue to monitor the appropriateness of its assumptions as new information becomes available and will adjust its estimates accordingly. Such adjustments may be material to the Company's results of operations and financial condition.

The Company made no significant changes in the actuarial methodology or reserving process related to its loss and loss adjustment expense reserves for the nine months ended September 30, 2021.

At September 30, 2021 and December 31, 2020, loss and loss adjustment expense reserves were composed of the following:
September 30, 2021December 31, 2020
 ($ in thousands)
Case reserves$191,151 $176,805 
IBNR349,628 317,374 
Total$540,779 $494,179 

A summary of changes in outstanding loss and loss adjustment expense reserves for all lines of business consolidated
for the nine months ended September 30, 2021 and 2020 is as follows: 
Consolidated20212020
 ($ in thousands)
Gross balance at January 1$494,179 $470,588 
Less: Losses recoverable(16,851)(27,531)
Net balance at January 1477,328 443,057 
Incurred losses related to:  
Current year296,333 247,559 
Prior years(1,255)5,385 
Total incurred295,078 252,944 
Paid losses related to:  
Current year(96,442)(72,453)
Prior years(146,545)(161,222)
Total paid(242,987)(233,675)
Foreign currency revaluation(1,722)(505)
Net balance at September 30527,697 461,821 
Add: Losses recoverable13,082 19,949 
Gross balance at September 30$540,779 $481,770 
    
For the nine months ended September 30, 2021, the estimate of net losses incurred relating to prior accident years decreased by $1.3 million, due primarily to favorable development on catastrophe events, a mortgage contract associated with the COVID-19 pandemic, and certain health contracts. The decrease in prior accident years was partially offset by adverse loss development on certain workers’ compensation and multi-line casualty contracts written between 2014 and 2018. The favorable loss development on a mortgage contract was offset by increased profit commissions on the same contract.

For the nine months ended September 30, 2020, the estimate of net losses incurred relating to prior accident years increased by $5.4 million, due primarily to certain general liability, health and multi-line contracts, partially offset by favorable loss development on professional liability contracts.
The changes in the outstanding loss and loss adjustment expense reserves for health claims for the nine months ended September 30, 2021 and 2020 are as follows:
Health20212020
 ($ in thousands)
Gross balance at January 1$17,485 $18,063 
Less: Losses recoverable— — 
Net balance at January 117,485 18,063 
Incurred losses related to: 
Current year31,189 25,032 
Prior years(1,898)1,341 
Total incurred29,291 26,373 
Paid losses related to: 
Current year(20,224)(15,115)
Prior years(13,824)(16,327)
Total paid(34,048)(31,442)
Foreign currency revaluation— — 
Net balance at September 3012,728 12,994 
Add: Losses recoverable— — 
Gross balance at September 30$12,728 $12,994 
XML 25 R13.htm IDEA: XBRL DOCUMENT v3.21.2
RETROCESSION
 9 Months Ended
Sep. 30, 2021
Reinsurance Disclosures [Abstract]  
RETROCESSION RETROCESSION
 
From time to time, the Company purchases retrocessional coverage for one or more of the following reasons: to manage its overall exposure, reduce its net liability on individual risks, obtain additional underwriting capacity and balance its underwriting portfolio. The Company records loss and loss adjustment expenses recoverable from retrocessionaires as assets.

For the three and nine months ended September 30, 2021, the Company’s earned ceded premiums were insignificant compared to $1.7 million and $3.2 million for the three and nine months ended September 30, 2020, respectively. For the three and nine months ended September 30, 2021, loss and loss expenses recovered were insignificant compared to $2.5 million and $6.2 million for the three and nine months ended September 30, 2020, respectively.

Retrocession contracts do not relieve the Company from its obligations to its cedents. Failure of retrocessionaires to honor their obligations could result in losses to the Company. At September 30, 2021, the Company’s loss reserves recoverable consisted of (i) $9.9 million (December 31, 2020: $12.6 million) from unrated retrocessionaires, of which $9.7 million (December 31, 2020: $11.9 million) were secured by cash, letters of credit and collateral held in trust accounts for the benefit of the Company and (ii) $3.2 million (December 31, 2020: $4.3 million) from retrocessionaires rated A- or above by A.M. Best.

The Company regularly evaluates its net credit exposure to assess the ability of the retrocessionaires to honor their respective obligations. At September 30, 2021, the Company had recorded an allowance for expected credit losses of $47.0 thousand (December 31, 2020: $47.0 thousand).
XML 26 R14.htm IDEA: XBRL DOCUMENT v3.21.2
SENIOR CONVERTIBLE NOTES
 9 Months Ended
Sep. 30, 2021
Debt Disclosure [Abstract]  
SENIOR CONVERTIBLE NOTES SENIOR CONVERTIBLE NOTES
On August 7, 2018, the Company issued $100.0 million of senior unsecured convertible notes (the “Notes”), which mature on August 1, 2023. The Notes bear interest at 4.0%, payable semi-annually on February 1 and August 1 of each year beginning February 1, 2019.

Note holders have the option, under certain conditions, to redeem the Notes prior to maturity.
If a holder redeems the Notes, the Company shall have the option to settle the conversion obligation in cash, ordinary shares of the Company, or a combination thereof pursuant to the terms of the indenture governing the Notes. The Company has therefore bifurcated the Notes into liability and equity components.
At September 30, 2021, the Company’s share price was lower than the conversion price of $17.19 per share.
The Company’s effective borrowing rate for non-convertible debt at the time of issuance of the Notes was estimated to be 6.0%, which equated to an $8.2 million discount. At September 30, 2021, and December 31, 2020, the unamortized debt discount was $3.0 million and $4.2 million, respectively. The debt discount also represents the portion of the Note’s principal amount allocated to the equity component.
The Company incurred issuance costs in connection with the issuance of the Notes. At September 30, 2021, the unamortized portion of these costs attributed to the debt component was $1.2 million (December 31, 2020: $1.6 million), which the Company expects to amortize through the maturity date. The Company netted the portion of these issuance costs attributed to the equity component against the gross proceeds allocated to equity, resulting in the Company including $7.9 million in the caption “Additional paid-in capital” in the Company’s condensed consolidated balance sheets.

The carrying value of the Notes at September 30, 2021, including accrued interest of $0.7 million, was $96.5 million (December 31, 2020: $95.8 million). At September 30, 2021, the Company estimated the fair value of the Notes to be $94.6 million (December 31, 2020: $83.6 million) (see Note 4 Financial Instruments).
For the three and nine months ended September 30, 2021, the Company recognized interest expenses of $1.6 million and $4.7 million, respectively (2020: $1.6 million and $4.7 million, respectively) in connection with the interest coupon, amortization of issuance costs, and amortization of the discount.

The Company was in compliance with all covenants relating to the Notes at September 30, 2021, and December 31, 2020.
XML 27 R15.htm IDEA: XBRL DOCUMENT v3.21.2
SHARE CAPITAL
 9 Months Ended
Sep. 30, 2021
Equity [Abstract]  
SHARE CAPITAL SHARE CAPITAL
The Company’s share capital is made up of ordinary share capital and additional paid-in capital. Ordinary share capital represents the issued and outstanding Class A and Class B ordinary shares at their par values of $0.10 per share. Additional paid-in capital includes the premium paid per share by the subscribing shareholders for Class A and Class B ordinary shares, as well as the earned portion of the grant-date fair value of share-based awards.

On October 29, 2020, the Company’s shareholders approved an amendment to the stock incentive plan to increase the number of Class A ordinary shares available for issuance by 3.0 million shares from 5.0 million to 8.0 million. At September 30, 2021, 3,128,276 (December 31, 2020: 3,474,888) Class A ordinary shares remained available for future issuance under the Company’s stock incentive plan. The Compensation Committee of the Board of Directors administers the Company’s stock incentive plan. 

The Board has adopted a share repurchase plan. The timing of such repurchases and the actual number of shares repurchased will depend on various factors, including price, market conditions, and applicable regulatory and corporate requirements. On March 26, 2020, the Board of Directors extended the share repurchase plan to June 30, 2021. It increased the number of shares authorized to be repurchased to 5.0 million Class A ordinary shares or securities convertible into Class A ordinary shares in the open market through privately negotiated transactions or Rule 10b5-1 stock trading plans. In addition, the Board of Directors also authorized the Company to repurchase up to $25.0 million aggregate face amount of the Company’s 4.00% Convertible Senior Notes due 2023 (the “Notes”) in privately negotiated transactions, in open market repurchases, or pursuant to one or more tender offers. The Company did not repurchase any Notes under the repurchase plan.

On May 4, 2021, the Board of Directors approved a new share repurchase plan effective from July 1, 2021, until June 30, 2022, authorizing the Company to purchase up to $25 million of Class A ordinary shares or securities convertible into Class A ordinary shares in the open market, through privately negotiated transactions or Rule 10b5-1 stock trading plans. The Company is not required to repurchase any of the Class A ordinary shares or the Notes. The repurchase plans may be modified, suspended, or terminated at the election of our Board of Directors at any time without prior notice.

The Company repurchased 1,079,544 Class A ordinary shares during the nine months ended September 30, 2021. All Class A ordinary shares repurchased are canceled immediately upon repurchase.
The following table is a summary of ordinary shares issued and outstanding:
Nine months ended September 30Nine months ended September 30
 20212020
Class AClass BClass AClass B
Balance – beginning of period28,260,075 6,254,715 30,739,395 6,254,715 
Issue of ordinary shares, net of forfeitures409,200 — 248,726 — 
Repurchase of ordinary shares(1,079,544)— (1,874,419)— 
Balance – end of period27,589,731 6,254,715 29,113,702 6,254,715 
XML 28 R16.htm IDEA: XBRL DOCUMENT v3.21.2
SHARE-BASED COMPENSATION
 9 Months Ended
Sep. 30, 2021
Share-based Payment Arrangement [Abstract]  
SHARE-BASED COMPENSATION SHARE-BASED COMPENSATION
 
The Company has a stock incentive plan for directors, employees, and consultants administered by the Compensation Committee of the Board of Directors.
 
Employee and Director Restricted Shares
 
For the nine months ended September 30, 2021, the Company issued 334,312 (2020: 306,264) Class A ordinary shares to employees pursuant to the Company’s stock incentive plan. These shares contain certain restrictions relating to, among other things, vesting, forfeiture in the event of termination of employment, and transferability. The restricted shares cliff vest three years after the date of issuance, subject to the grantee’s continued service with the Company. During the vesting period, the holder of the restricted shares retains voting rights and is entitled to any dividends declared by the Company.

For the nine months ended September 30, 2021, grantees forfeited 20,592 (2020: 210,109) restricted shares. For the nine months ended September 30, 2021, the Company reversed $0.1 million of stock compensation expense (2020: $0.7 million) in relation to the forfeited restricted shares.

The Company recorded $1.8 million of share-based compensation expense, net of forfeiture reversals, relating to restricted shares for the nine months ended September 30, 2021 (2020: $0.6 million). At September 30, 2021, there was $3.3 million (December 31, 2020: $1.9 million) of unrecognized compensation cost relating to non-vested restricted shares (excluding any restricted shares with performance conditions that the Company currently does not expect will be met), which the Company expects to recognize over a weighted-average period of 1.9 years (December 31, 2020: 1.5 years). For the nine months ended September 30, 2021, the total fair value of restricted shares vested was $1.6 million (2020: $2.8 million).

For the nine months ended September 30, 2021, the Company also issued to non-employee directors an aggregate of 74,769 (2020: 0) restricted Class A ordinary shares as part of their remuneration for services to the Company. Each of these restricted shares issued to non-employee directors contains similar restrictions to those issued to employees and will vest on the earlier of the first anniversary of the date of the share issuance or the Company’s next annual general meeting, subject to the grantee’s continued service with the Company.

The following table summarizes the activity for unvested outstanding restricted share awards during the nine months ended September 30, 2021:

 Number of
non-vested
restricted
 shares		Weighted
 average
grant date
fair value
Balance at December 31, 2020697,549 $9.38 
Granted409,081 9.11 
Vested(139,482)11.53 
Forfeited(20,592)8.35 
Balance at September 30, 2021946,556 $8.97 
 
Employee and Director Stock Options

For the nine months ended September 30, 2021, and 2020, no Class A ordinary share purchase options were granted or exercised by directors or employees. For the nine months ended September 30, 2021, 100,000 (2020: 40,000) stock options expired and 80,000 (2020: 80,000) stock options vested. When the Company grants stock options, it reduces the corresponding number from the shares authorized for issuance as part of the Company’s stock incentive plan.

The Board of Directors does not currently anticipate that the Company will declare any dividends during the expected term of the options. The Company uses graded vesting for expensing employee stock options. The total compensation cost expensed relating to stock options for the nine months ended September 30, 2021, was $0.3 million (2020: $0.5 million). At September 30, 2021, the total compensation cost related to non-vested options not yet recognized was $0.3 million (December 31, 2020: $0.7 million), which will be recognized over a weighted-average period of 1.4 years (December 31, 2020: 1.8 years) assuming the grantee completes the service period for vesting of the options.

At September 30, 2021, and December 31, 2020, 0.7 million and 0.8 million stock options were outstanding, respectively, with a weighted average exercise price of $22.35 and $22.22 per share, respectively, and a weighted average grant date fair value of $10.23 and $10.25 per share, respectively. The stock options’ weighted-average remaining contractual terms were 4.9 years and 5.1 years, at September 30, 2021, and December 31, 2020, respectively.

 Employee Restricted Stock Units

The Company issues RSUs to certain employees as part of the stock incentive plan.

These RSUs contain restrictions relating to vesting, forfeiture in the event of termination of employment, transferability, and other matters. Each RSU grant cliff vests three years after the date of issuance, subject to the grantee’s continued service with the Company. On the vesting date, the Company converts each RSU into one Class A ordinary share and issues new Class A ordinary shares from the shares authorized for issuance as part of the Company’s stock incentive plan. For the nine months ended September 30, 2021, the Company issued 58,123 (2020: 60,622) RSUs to employees pursuant to the Company’s stock incentive plan. For the nine months ended September 30, 2021, and 2020, no RSUs were forfeited.

The Company recorded $0.3 million of share-based compensation expense relating to RSUs for the nine months ended September 30, 2021 (2020: $0.3 million). At September 30, 2021, the total compensation cost related to non-vested RSUs not yet recognized was $0.6 million (2020: $0.4 million), which the Company expects to recognize over a weighted-average period of 1.9 years (2020: 1.8 years).

Employee RSU activity during the nine months ended September 30, 2021, was as follows:
 Number of
non-vested
RSUs		Weighted
 average
grant date
fair value
Balance at December 31, 2020116,722 $9.60 
Granted58,123 9.18 
Vested(20,711)15.90 
Balance at September 30, 2021154,134 $8.59 

Performance Restricted Shares

Prior to 2021, the Company issued Class A ordinary shares to the Chief Executive Officer (“CEO”) pursuant to the Company’s stock incentive plan. These shares contain performance and service conditions and certain restrictions relating to, among other things, vesting, forfeiture in the event of termination of the CEO’s employment, and transferability. These restricted shares cliff vest five years after the date of issuance, subject to the performance condition being met and the CEO’s continued service with the Company. The weighted average grant date fair value of these restricted shares subject to performance conditions was $6.72 per share. At September 30, 2021, 193,149 unvested performance restricted shares were outstanding (December 31, 2020: 193,149). As the performance conditions associated with these restricted shares have not been met, the Company recognized no compensation cost relating to the unvested shares for the nine months ended September 30, 2021, and 2020.
For the nine months ended September 30, 2021 and 2020, the combined stock compensation expense (net of forfeitures) included in the caption “General and administrative expenses” in the Company’s statements of operations was $2.4 million and $1.4 million, respectively.
XML 29 R17.htm IDEA: XBRL DOCUMENT v3.21.2
TAXATION
 9 Months Ended
Sep. 30, 2021
Income Tax Disclosure [Abstract]  
TAXATION TAXATION
At September 30, 2021, the Company recorded a gross deferred tax asset of $4.0 million (2020: $3.5 million) and a deferred tax asset valuation allowance of $3.5 million (2020: $3.0 million). The net deferred tax asset is included in the caption “Other assets” in the Company’s condensed consolidated balance sheets. The Company has determined that it is more likely than not to fully realize the recorded deferred tax asset (net of the valuation allowance) in the future. The Company based this determination on the expected timing of the reversal of the temporary differences and the likelihood of generating sufficient taxable income to realize the future tax benefit.

The following table sets forth our current and deferred income tax benefit (expense) on a consolidated basis for the nine months ended September 30, 2021 and 2020:
Three months ended September 30Nine months ended September 30
 2021202020212020
 ($ in thousands)($ in thousands)
Current tax (expense) benefit$323 $(33)$(3,240)$272 
Decrease (increase) in deferred tax valuation allowance(323)33 (493)(696)
Income tax (expense) benefit $— $— $(3,733)$(424)
For the nine months ended September 30, 2021, the income tax expense of $3.7 million resulted from Verdant’s gain on the sale of its AccuRisk investment.
XML 30 R18.htm IDEA: XBRL DOCUMENT v3.21.2
RELATED PARTY TRANSACTIONS
 9 Months Ended
Sep. 30, 2021
Related Party Transactions [Abstract]  
RELATED PARTY TRANSACTIONS RELATED PARTY TRANSACTIONS 
 
Investment Advisory Agreement
 
DME, DME II, and DME Advisors are each an affiliate of David Einhorn, Chairman of the Company’s Board of Directors, and therefore, are related parties to the Company.

The Company has entered into the SILP LPA (as described in Note 3 of the condensed consolidated financial statements). DME II receives a performance allocation equal to (with capitalized terms having the meaning provided under the SILP LPA) (a) 10% of the portion of the Positive Performance Change for each limited partner’s capital account that is less than or equal to the positive balance in such limited partner’s Carryforward Account, plus (b) 20% of the portion of the Positive Performance Change for each limited partner’s capital account that exceeds the positive balance in such limited partner’s Carryforward Account. The Carryforward Account for Greenlight Re and GRIL includes the amount of losses that were to be recouped under the Joint Venture as well as any loss generated on the assets invested in SILP, subject to adjustments for redemptions. The loss carry-forward provision contained in the SILP LPA allows DME II to earn a reduced performance allocation of 10% of profits in years subsequent to any year in which SILP has incurred a loss until all losses are recouped, and an additional amount equal to 150% of the loss is earned.

In accordance with the SILP LPA, DME Advisors constructs a levered investment portfolio as agreed by the Company (the “Investment Portfolio” as defined in the SILP LPA). On September 1, 2018, SILP entered into the IAA with DME Advisors, which entitles DME Advisors to a monthly management fee equal to 0.125% (1.5% on an annual basis) of each limited partner’s Investment Portfolio. The IAA has an initial term ending on August 31, 2023, subject to an automatic extension for successive three-year terms.

For a detailed breakdown of management fees and performance compensation for the three and nine months ended September 30, 2021, and 2020, refer to Note 3 of the condensed consolidated financial statements.
 
Pursuant to the SILP LPA and the IAA, the Company has agreed to indemnify DME, DME II, and DME Advisors for any expense, loss, liability, or damage arising out of any claim asserted or threatened in connection with DME Advisors serving as the Company’s or SILP’s investment advisor. The Company will reimburse DME, DME II, and DME Advisors for reasonable costs and expenses of investigating and defending such claims, provided such claims were not caused due to gross negligence, breach of contract, or misrepresentation by DME, DME II, or DME Advisors. The Company incurred no indemnification amounts during the periods presented.

Green Brick Partners, Inc.

David Einhorn also serves as the Chairman of the Board of Directors of Green Brick Partners, Inc. (“GRBK”), a publicly-traded company. At September 30, 2021, SILP, along with certain affiliates of DME Advisors, collectively owned 34.3% of the issued and outstanding common shares of GRBK. Under applicable securities laws, DME Advisors may be limited at times in its ability to trade GRBK shares on behalf of SILP.

Service Agreement
 
The Company has entered into a service agreement with DME Advisors, pursuant to which DME Advisors provides certain investor relations services to the Company for compensation of five thousand dollars per month (plus expenses). The agreement is automatically renewed annually until terminated by either the Company or DME Advisors for any reason with 30 days prior written notice to the other party. 

Collateral Assets Investment Management Agreement

Effective January 1, 2019, the Company (and its subsidiaries) entered into a collateral assets investment management agreement (the “CMA”) with DME Advisors, pursuant to which DME Advisors manages certain assets of the Company that are not subject to the SILP LPA and are held by the Company to provide collateral required by the cedents in the form of trust accounts and letters of credit. In accordance with the CMA, DME Advisors receives no fees and is required to comply with the collateral investment guidelines. The CMA can be terminated by any of the parties upon 30 days’ prior written notice to the other parties.
XML 31 R19.htm IDEA: XBRL DOCUMENT v3.21.2
COMMITMENTS AND CONTINGENCIES
 9 Months Ended
Sep. 30, 2021
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES COMMITMENTS AND CONTINGENCIES 
 
Letters of Credit and Trusts
 
At September 30, 2021, the Company had one letter of credit facility, which automatically renews each year unless terminated by either party in accordance with the applicable required notice period:
Maximum Facility LimitTermination DateNotice period required for termination
 ($ in thousands)  
Citibank Europe plc$275,000 August 20, 2022
120 days before the termination date

At September 30, 2021, an aggregate amount of $138.4 million (December 31, 2020: $135.3 million) in letters of credit was issued under the credit facility. At September 30, 2021, the Company had pledged total cash and cash equivalents with a fair value in the aggregate of $142.4 million (December 31, 2020: $137.6 million) as collateral against the letters of credit issued and included in the caption “Restricted cash and cash equivalents” in the Company’s condensed consolidated balance sheets. The credit facility contains customary events of default and restrictive covenants, including but not limited to limitations on liens on collateral, transactions with affiliates, mergers, and sales of assets, as well as solvency and maintenance of certain minimum pledged equity requirements and restricts issuance of any debt without the consent of the letter of credit provider. Additionally, if an event of default exists, as defined in the letter of credit facility, Greenlight Re will be prohibited from paying dividends to its parent company. The Company was in compliance with all the credit facility covenants at September 30, 2021 and December 31, 2020.

The Company has also established regulatory trust arrangements for certain cedents. At September 30, 2021, collateral of $550.2 million (December 31, 2020: $607.8 million) was provided to cedents in the form of regulatory trust accounts and included in the caption “Restricted cash and cash equivalents” in the Company’s condensed consolidated balance sheets.
Lease Obligations
 
Greenlight Re entered into a new lease agreement for office space in the Cayman Islands commencing July 1, 2021. The lease expires on June 30, 2026, unless Greenlight Re exercises its right to renew the lease for another five-year period. The annual lease obligation ranges from $0.5 million to $0.6 million. The Company determined that this agreement qualifies as an operating lease. At September 30, 2021, the right-of-use asset and a corresponding lease liability relating to the lease agreement were $2.2 million. The operating lease expense for the three and nine months ended September 30, 2021, was $0.1 million and $0.1 million, respectively.

Greenlight Re’s previous lease arrangement qualified as a short-term lease. The short-term lease expense for the three and nine months ended September 30, 2021, was nil and $0.3 million, respectively (three and nine months ended September 30, 2020: $0.1 million and $0.4 million, respectively).
Schedule of Commitments and Contingencies
The following is a schedule of future minimum payments required under the above commitments:  
 20212022202320242025ThereafterTotal
 ($ in thousands)
Operating lease obligations$130 $588 $624 $640 $657 $788 $3,427 
Interest and convertible note payable$— $4,000 $104,000 — — — 108,000 
 $130 $4,588 $104,624 $640 $657 $788 $111,427 

Litigation
 
From time to time, in the normal course of business, the Company may be involved in formal and informal dispute resolution procedures, which may include arbitration or litigation. The outcomes of these procedures determine the rights and obligations under the Company’s reinsurance contracts and other contractual agreements. In some disputes, the Company may seek to enforce its rights under an agreement or collect funds owed. In other matters, the Company may resist attempts by others to collect funds or enforce alleged rights. While the Company cannot predict the outcome of legal disputes with certainty, the Company does not believe that any existing dispute, when finally resolved, will have a material adverse effect on the Company’s business, financial condition, or operating results.
XML 32 R20.htm IDEA: XBRL DOCUMENT v3.21.2
SEGMENT REPORTING
 9 Months Ended
Sep. 30, 2021
Segment Reporting [Abstract]  
SEGMENT REPORTING SEGMENT REPORTING
 
The Company has one operating segment, Property & Casualty Reinsurance.

Substantially all of the Company’s business is sourced through reinsurance brokers. The following table sets forth the premiums generated through our largest brokers and their subsidiaries and affiliates (totals may not sum due to rounding):   

Gross Premiums Written by Line of Business
  Three months ended September 30Nine months ended September 30
2021202020212020
  ($ in thousands)($ in thousands)
Property
Commercial$3,398 2.6 %$3,396 2.5 %$9,700 2.2 %$9,426 2.6 %
Motor6,103 4.7 10,091 7.4 24,537 5.6 25,136 6.9 
Personal3,631 2.8 3,691 2.7 10,318 2.3 10,326 2.9 
Total Property13,132 10.2 17,178 12.6 44,555 10.1 44,888 12.4 
Casualty
General Liability7,376 5.7 3,224 2.4 10,749 2.4 3,920 1.1 
Motor Liability19,823 15.4 41,679 30.7 96,795 22.0 96,729 26.7 
Professional Liability 154 0.1 76 0.1 302 0.1 199 0.1 
Workers' Compensation17,117 13.3 21,979 16.2 55,237 12.5 60,908 16.8 
Multi-line 40,162 31.2 25,820 19.0 137,857 31.3 67,379 18.6 
Total Casualty84,632 65.7 92,778 68.4 300,940 68.4 229,135 63.3 
Other
Accident & Health4,175 3.2 12,418 9.3 26,427 6.0 40,522 11.2 
Financial17,920 13.9 1,817 1.3 40,134 9.1 15,704 4.3 
Marine2,462 1.9 127 0.1 8,412 1.9 749 0.2 
Other Specialty6,414 5.0 11,278 8.3 19,781 4.5 31,074 8.6 
Total Other30,971 24.1 25,640 19.0 94,754 21.5 88,049 24.3 
$128,735 100.0 %$135,596 100.0 %$440,249 100.0 %$362,072 100.0 %

Gross Premiums Written by Geographic Area of Risks Insured
 Three months ended September 30Nine months ended September 30
2021202020212020
 ($ in thousands)($ in thousands)
U.S. and Caribbean$67,087 52.1 %$110,798 81.7 %$258,849 58.8 %$291,511 80.5 %
Worldwide (1)
59,616 46.3 22,738 16.8 174,470 39.6 66,150 18.3 
Europe
1,483 1.2 — — 2,787 0.6 — — 
Asia
549 0.4 2,060 1.5 4,143 0.9 4,411 1.2 
$128,735 100.0 %$135,596 100.0 %$440,249 100.0 %$362,072 100.0 %
(1) “Worldwide” is composed of contracts that reinsure risks in more than one geographic area and may include risks in the U.S.
XML 33 R21.htm IDEA: XBRL DOCUMENT v3.21.2
SIGNIFICANT ACCOUNTING POLICIES (Policies)
 9 Months Ended
Sep. 30, 2021
Accounting Policies [Abstract]  
Use of Estimates
Use of Estimates
 
The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the period. Actual results could differ from these estimates. The significant estimates reflected in the Company’s condensed consolidated financial statements include, but are not limited to, loss and loss adjustment expense reserves,
premiums written, earned and receivable, variability underlying risk transfer assessments, allowances for credit losses, bonus accruals, share-based compensation, valuation allowances associated with deferred tax assets and investment impairments.
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
 
The Company maintains cash and cash equivalent balances to collateralize regulatory trusts and letters of credit issued to cedents (see Note 12).
Funds Held by Cedents Funds Held by CedentsThe caption “Reinsurance balances receivable” in the Company’s condensed consolidated balance sheets includes amounts held by cedents. Such amounts include premiums and funds held at Lloyd’s, which is held in trust at Lloyd's as security for members’ underwriting activities. At September 30, 2021, funds held by cedents were $201.3 million (December 31, 2020: $127.6 million).
Reinsurance Assets
Reinsurance Assets

The Company calculates an allowance for expected credit losses for its reinsurance balances receivable and loss and loss adjustment expenses recoverable by applying a Probability of Default (“PD”) / Loss Given Default (“LGD”) model. The PD / LGD approach considers the Company’s collectibility history on its reinsurance assets and representative external loss history. In calculating the probability of default, the Company also considers the estimated duration of its reinsurance assets.

The Company evaluates each counterparty’s creditworthiness based on credit ratings that independent agencies assign to the counterparty. The Company manages its credit risk in its reinsurance assets by transacting only with insurers and reinsurers that it considers financially sound.

For its retrocessional counterparties that are unrated, the Company may hold collateral in the form of funds withheld, trust accounts, or irrevocable letters of credit. In evaluating credit risk associated with reinsurance balances receivable, the Company considers its right to offset loss obligations against premiums receivable. The Company regularly evaluates its net credit exposure to assess the ability of cedents and retrocessionaires to honor their respective obligations.
Deposit Assets and Liabilities
Deposit Assets and Liabilities
 
The Company applies deposit accounting to reinsurance contracts that do not transfer sufficient insurance risk to merit reinsurance accounting. Under deposit accounting, the Company recognizes an asset or liability based on its paid or received consideration. The deposit asset or liability balance is subsequently adjusted using the interest method with the corresponding income or expense recorded in the Company’s condensed consolidated statements of operations under the caption “Other income (expense).” The Company records deposit assets and liabilities in its condensed consolidated balance sheets in the caption “Reinsurance balances receivable” and “Reinsurance balances payable,” respectively.
Derivative instruments
Derivative instruments

The Company recognizes derivative financial instruments in the condensed consolidated balance sheets at their fair values. It includes any realized gains and losses and changes in unrealized gains and losses in the caption “Net investment income (loss)” in the condensed consolidated statements of operations.

The Company’s derivatives do not qualify as hedges for financial reporting purposes. The Company records the associated assets and liabilities in its condensed consolidated balance sheets on a gross basis. The Company does not offset these balances against collateral pledged or received.
Other Assets
Other Assets

The caption “Other assets” in the Company’s condensed consolidated balance sheets consists primarily of prepaid expenses, fixed assets, right-of-use lease assets, other receivables, and deferred tax assets.
Other Liabilities Other LiabilitiesThe caption “Other liabilities” in the Company’s condensed consolidated balance sheets consists primarily of accruals for legal and other professional fees, employee bonuses, taxes payable, and lease liabilities.
Earnings (Loss) Per Share
Earnings (Loss) Per Share
 
The Company’s unvested restricted stock awards, which contain non-forfeitable rights to dividends or dividend equivalents, whether paid or unpaid, are considered “participating securities” for the purposes of calculating earnings (loss) per share. Basic earnings per share is calculated on the basis of the weighted average number of common shares and participating securities outstanding during the period. Diluted earnings (or loss) per share includes the dilutive effect of the following:

•Restricted Stock Units (“RSUs”) issued that would convert to common shares upon vesting;
•additional potential common shares issuable when in-the-money stock options are exercised, determined using the treasury stock method; and
•those common shares with the potential to be issued in connection with convertible debt and other such convertible instruments, determined using the treasury stock method.

Diluted earnings (or loss) per share contemplates a conversion to common shares of all convertible instruments only if they are dilutive with regards to earnings per share. In the event of a net loss, all RSUs, stock options, convertible debt, and participating securities are excluded from the calculation of both basic and diluted loss per share as their inclusion would be anti-dilutive.
Taxation
Taxation
 
Under current Cayman Islands law, no corporate entity, including GLRE and Greenlight Re, is obligated to pay taxes in the Cayman Islands on either income or capital gains. The Company has an undertaking from the Governor-in-Cabinet of the Cayman Islands, pursuant to the provisions of the Tax Concessions Law, as amended, that, in the event that the Cayman Islands enacts any legislation that imposes tax on profits, income, gains or appreciations, or any tax in the nature of estate duty or inheritance tax, such tax will not be applicable to GLRE, Greenlight Re nor their respective operations, or to the Class A or Class B ordinary shares or related obligations, before February 1, 2025.
 
Verdant is incorporated in Delaware and therefore is subject to taxes in accordance with the U.S. federal rates and regulations prescribed by the U.S. Internal Revenue Service (“IRS”). Verdant’s taxable income is generally expected to be taxed at a marginal rate of 21% (2020: 21%). Verdant’s tax years 2017 and beyond remain open and subject to examination by the IRS.

GRIL is incorporated in Ireland and therefore is subject to the Irish corporation tax rate of 12.5% on its trading income and 25% on its non-trading income.
The Company records a valuation allowance to the extent that the Company considers it more likely than not that all or a portion of the deferred tax asset will not be realized in the future. Other than this valuation allowance, the Company has not taken any income tax positions subject to significant uncertainty that is reasonably likely to have a material impact on the Company.
Recent Accounting Pronouncements
Recent Accounting Pronouncements

Recently Issued Accounting Standards Adopted

In January 2020, the FASB issued ASU No. 2020-01, Investments - Equity Securities (Topic 321), Investments - Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815) - Clarifying the Interactions between Topic 321, Topic 323, and Topic 815 (a consensus of the Emerging Issues Task Force) (“ASU 2020-01”). ASU 2020-01 clarifies interactions between the accounting guidance for (i) certain equity securities under Topic 321, (ii) investments under the equity method of accounting in Topic 323, and (iii) certain derivative instruments in Topic 815. ASU 2020-01 is effective for public business entities for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years. The adoption of ASU 2020-01 during the first quarter of 2021 had no material impact on the Company’s consolidated financial statements.

Recently Issued Accounting Standards Not Yet Adopted

In August 2020, the FASB issued ASU No. 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity's Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity's Own Equity (“ASU 2020-06”). ASU 2020-06 is designed to simplify the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments. The amendments remove the separation models in Subtopic 470-20 for certain contracts. As a result, entities will no longer present embedded conversion features separately in equity; rather, the convertible debt instrument will be accounted for as a single liability measured at its amortized cost. ASU 2020-06 also addresses the computation of earnings per share for convertible debt instruments, requiring
the application of the if-converted method when calculating diluted earnings per share. The Company intends to adopt ASU 2020-06 during the first quarter of 2022, using the “modified retrospective” transition method.

The Company expects that its adoption of ASU 2020-06 will impact the accounting for its senior convertible notes (see Note 7) and will lead to a decrease in its opening shareholders’ equity of approximately $2.5 million, with a corresponding increase in the carrying value of the senior convertible notes. The Company expects that in the periods in which the Company reports a net income, the number of shares outstanding for the diluted earnings per share calculation will be approximately 5.8 million higher under the if-converted method. The Company does not expect the adoption of ASU 2020-06 to have a material impact on net income, cash flows, or any other balances.
XML 34 R22.htm IDEA: XBRL DOCUMENT v3.21.2
SIGNIFICANT ACCOUNTING POLICIES (Tables)
 9 Months Ended
Sep. 30, 2021
Accounting Policies [Abstract]  
Schedule of Cash and Cash Equivalents The following table reconciles the cash, cash equivalents, and restricted cash reported within the condensed consolidated balance sheets to the total presented in the condensed consolidated statements of cash flows:
 September 30, 2021December 31, 2020
 ($ in thousands)
Cash and cash equivalents$37,380 $8,935 
Restricted cash and cash equivalents692,542 745,371 
Total cash, cash equivalents and restricted cash presented in the condensed consolidated statements of cash flows$729,922 $754,306 
Schedule of Restrictions on Cash and Cash Equivalents The following table reconciles the cash, cash equivalents, and restricted cash reported within the condensed consolidated balance sheets to the total presented in the condensed consolidated statements of cash flows:
 September 30, 2021December 31, 2020
 ($ in thousands)
Cash and cash equivalents$37,380 $8,935 
Restricted cash and cash equivalents692,542 745,371 
Total cash, cash equivalents and restricted cash presented in the condensed consolidated statements of cash flows$729,922 $754,306 
Schedule of Interest Income and Interest Expense For the three and nine months ended September 30, 2021, and 2020, the interest income and (expense) on deposit accounted contracts were as follows:
 Three months ended September 30Nine months ended September 30
 2021202020212020
($ in thousands)($ in thousands)
Deposit interest income$— $560 $— $1,812 
Deposit interest expense$(38)$— $(2,957)$— 
Deposit interest income/(expense), net$(38)$560 $(2,957)$1,812 
Schedule of Weighted Average Number of Shares
The table below presents the shares outstanding for the calculation of earnings (loss) per share for the three and nine months ended September 30, 2021 and 2020:
 Three months ended September 30Nine months ended September 30
 2021202020212020
Weighted average shares outstanding - basic32,929,097 35,677,554 33,507,060 35,569,292 
Effect of dilutive employee and director share-based awards— 102,149 — — 
Weighted average shares outstanding - diluted32,929,097 35,779,703 33,507,060 35,569,292 
Anti-dilutive stock options outstanding735,627 835,627 735,627 835,627 
Participating securities excluded from calculation of loss per share 946,556 — 946,556 878,498 
XML 35 R23.htm IDEA: XBRL DOCUMENT v3.21.2
INVESTMENT IN RELATED PARTY INVESTMENT FUND (Tables)
 9 Months Ended
Sep. 30, 2021
Equity Method Investments and Joint Ventures [Abstract]  
Schedule of Financial Information of Investment
The summarized financial statements of SILP are presented below.

Summarized Statement of Assets and Liabilities of Solasglas Investments, LP
September 30, 2021December 31, 2020
($ in thousands)
Assets
Investments, at fair value$262,058 $272,398 
Derivative contracts, at fair value9,071 1,450 
Due from brokers77,638 92,053 
Cash and cash equivalents1,076 — 
Interest and dividends receivable14 59 
Total assets349,857 365,960 
Liabilities and partners’ capital
Liabilities
Investments sold short, at fair value(109,044)(131,902)
Derivative contracts, at fair value(7,793)(4,156)
Due to brokers(1,170)(9,179)
Interest and dividends payable(603)(429)
Other liabilities(133)(175)
Total liabilities(118,743)(145,841)
Net Assets$231,114 $220,119 
GLRE Limited Partners’ share of Net Assets$180,239 $166,735 
Summarized Statement of Operations of Solasglas Investments, LP
Three months ended September 30Nine months ended September 30
2021202020212020
($ in thousands)
Investment income
Dividend income (net of withholding taxes)$146 $170 $509 $1,204 
Interest income51 36 770 262 
Total Investment income197 206 1,279 1,466 
Expenses
Management fee(883)(703)(2,632)(1,981)
Interest(205)(176)(874)(518)
Dividends(306)(213)(852)(612)
Professional fees and other(227)(432)(786)(764)
Total expenses(1,621)(1,524)(5,144)(3,875)
Net investment income (loss)(1,424)(1,318)(3,865)(2,409)
Realized and change in unrealized gains (losses)
Net realized gain (loss) (1,411)(1,412)(14,809)(44,972)
Net change in unrealized appreciation (depreciation) (5,437)10,832 12,143 5,811 
Net gain (loss) on investment transactions(6,848)9,420 (2,666)(39,161)
Net income (loss)$(8,272)$8,102 $(6,531)$(41,570)
GLRE Limited Partners’ share of net income (loss) (1)
$(6,214)$6,431 $(4,196)$(34,086)

(1) Net income (loss) is net of management fees and performance allocation presented below:

Three months ended September 30Nine months ended September 30
2021202020212020
($ in thousands)
Management fees$883 $703 $2,632 $1,981 
Performance allocation$(224)$— $— $— 
Total$659 $703 $2,632 $1,981 
XML 36 R24.htm IDEA: XBRL DOCUMENT v3.21.2
FINANCIAL INSTRUMENTS (Tables)
 9 Months Ended
Sep. 30, 2021
Fair Value Disclosures [Abstract]  
Schedule of Other Investments
At September 30, 2021, the Company included the following securities in the caption “Other investments”:
CostUnrealized
gains		Unrealized
losses		Fair value / carrying value
 ($ in thousands)
Private investments and unlisted equities $17,175 $24,017 $(1,800)$39,392 
Derivative financial instruments (not designated as hedging instruments)— 3,088 — 3,088 
Total other investments$17,175 $27,105 $(1,800)$42,480 

At December 31, 2020, the Company included the following securities in the caption “Other investments”: 
CostUnrealized
gains		Unrealized
losses		Fair value / carrying value
 ($ in thousands)
Private investments and unlisted equities$12,414 $10,679 $(1,300)$21,793 
Derivative financial instruments (not designated as hedging instruments)— 1,080 — 1,080 
Other investments$12,414 $11,759 $(1,300)$22,873 
Investment accounted for under the equity method6,545 
Total other investments$29,418 
XML 37 R25.htm IDEA: XBRL DOCUMENT v3.21.2
LOSS AND LOSS ADJUSTMENT EXPENSE RESERVES (Tables)
 9 Months Ended
Sep. 30, 2021
Insurance Loss Reserves [Abstract]  
Schedule of Liability for Unpaid Claims and Claims Adjustment Expense
At September 30, 2021 and December 31, 2020, loss and loss adjustment expense reserves were composed of the following:
September 30, 2021December 31, 2020
 ($ in thousands)
Case reserves$191,151 $176,805 
IBNR349,628 317,374 
Total$540,779 $494,179 

A summary of changes in outstanding loss and loss adjustment expense reserves for all lines of business consolidated
for the nine months ended September 30, 2021 and 2020 is as follows: 
Consolidated20212020
 ($ in thousands)
Gross balance at January 1$494,179 $470,588 
Less: Losses recoverable(16,851)(27,531)
Net balance at January 1477,328 443,057 
Incurred losses related to:  
Current year296,333 247,559 
Prior years(1,255)5,385 
Total incurred295,078 252,944 
Paid losses related to:  
Current year(96,442)(72,453)
Prior years(146,545)(161,222)
Total paid(242,987)(233,675)
Foreign currency revaluation(1,722)(505)
Net balance at September 30527,697 461,821 
Add: Losses recoverable13,082 19,949 
Gross balance at September 30$540,779 $481,770 
The changes in the outstanding loss and loss adjustment expense reserves for health claims for the nine months ended September 30, 2021 and 2020 are as follows:
Health20212020
 ($ in thousands)
Gross balance at January 1$17,485 $18,063 
Less: Losses recoverable— — 
Net balance at January 117,485 18,063 
Incurred losses related to: 
Current year31,189 25,032 
Prior years(1,898)1,341 
Total incurred29,291 26,373 
Paid losses related to: 
Current year(20,224)(15,115)
Prior years(13,824)(16,327)
Total paid(34,048)(31,442)
Foreign currency revaluation— — 
Net balance at September 3012,728 12,994 
Add: Losses recoverable— — 
Gross balance at September 30$12,728 $12,994 
XML 38 R26.htm IDEA: XBRL DOCUMENT v3.21.2
SHARE CAPITAL (Tables)
 9 Months Ended
Sep. 30, 2021
Equity [Abstract]  
Schedule of Stock by Class
The following table is a summary of ordinary shares issued and outstanding:
Nine months ended September 30Nine months ended September 30
 20212020
Class AClass BClass AClass B
Balance – beginning of period28,260,075 6,254,715 30,739,395 6,254,715 
Issue of ordinary shares, net of forfeitures409,200 — 248,726 — 
Repurchase of ordinary shares(1,079,544)— (1,874,419)— 
Balance – end of period27,589,731 6,254,715 29,113,702 6,254,715 
XML 39 R27.htm IDEA: XBRL DOCUMENT v3.21.2
SHARE-BASED COMPENSATION (Tables)
 9 Months Ended
Sep. 30, 2021
Share-based Payment Arrangement [Abstract]  
Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity
The following table summarizes the activity for unvested outstanding restricted share awards during the nine months ended September 30, 2021:

 Number of
non-vested
restricted
 shares		Weighted
 average
grant date
fair value
Balance at December 31, 2020697,549 $9.38 
Granted409,081 9.11 
Vested(139,482)11.53 
Forfeited(20,592)8.35 
Balance at September 30, 2021946,556 $8.97 
Employee RSU activity during the nine months ended September 30, 2021, was as follows:
 Number of
non-vested
RSUs		Weighted
 average
grant date
fair value
Balance at December 31, 2020116,722 $9.60 
Granted58,123 9.18 
Vested(20,711)15.90 
Balance at September 30, 2021154,134 $8.59 
XML 40 R28.htm IDEA: XBRL DOCUMENT v3.21.2
TAXATION (Tables)
 9 Months Ended
Sep. 30, 2021
Income Tax Disclosure [Abstract]  
Schedule of Components of Income Tax Expense (Benefit)
The following table sets forth our current and deferred income tax benefit (expense) on a consolidated basis for the nine months ended September 30, 2021 and 2020:
Three months ended September 30Nine months ended September 30
 2021202020212020
 ($ in thousands)($ in thousands)
Current tax (expense) benefit$323 $(33)$(3,240)$272 
Decrease (increase) in deferred tax valuation allowance(323)33 (493)(696)
Income tax (expense) benefit $— $— $(3,733)$(424)
XML 41 R29.htm IDEA: XBRL DOCUMENT v3.21.2
COMMITMENTS AND CONTINGENCIES (Tables)
 9 Months Ended
Sep. 30, 2021
Commitments and Contingencies Disclosure [Abstract]  
Schedule of Letters of Credit Facilities
At September 30, 2021, the Company had one letter of credit facility, which automatically renews each year unless terminated by either party in accordance with the applicable required notice period:
Maximum Facility LimitTermination DateNotice period required for termination
 ($ in thousands)  
Citibank Europe plc$275,000 August 20, 2022
120 days before the termination date
Schedule of Commitments and Contingencies, Fiscal Year Maturity Schedule
The following is a schedule of future minimum payments required under the above commitments:  
 20212022202320242025ThereafterTotal
 ($ in thousands)
Operating lease obligations$130 $588 $624 $640 $657 $788 $3,427 
Interest and convertible note payable$— $4,000 $104,000 — — — 108,000 
 $130 $4,588 $104,624 $640 $657 $788 $111,427 
XML 42 R30.htm IDEA: XBRL DOCUMENT v3.21.2
SEGMENT REPORTING (Tables)
 9 Months Ended
Sep. 30, 2021
Segment Reporting [Abstract]  
Schedule of Gross Premiums Written by Line of Business The following table sets forth the premiums generated through our largest brokers and their subsidiaries and affiliates (totals may not sum due to rounding):   
Gross Premiums Written by Line of Business
  Three months ended September 30Nine months ended September 30
2021202020212020
  ($ in thousands)($ in thousands)
Property
Commercial$3,398 2.6 %$3,396 2.5 %$9,700 2.2 %$9,426 2.6 %
Motor6,103 4.7 10,091 7.4 24,537 5.6 25,136 6.9 
Personal3,631 2.8 3,691 2.7 10,318 2.3 10,326 2.9 
Total Property13,132 10.2 17,178 12.6 44,555 10.1 44,888 12.4 
Casualty
General Liability7,376 5.7 3,224 2.4 10,749 2.4 3,920 1.1 
Motor Liability19,823 15.4 41,679 30.7 96,795 22.0 96,729 26.7 
Professional Liability 154 0.1 76 0.1 302 0.1 199 0.1 
Workers' Compensation17,117 13.3 21,979 16.2 55,237 12.5 60,908 16.8 
Multi-line 40,162 31.2 25,820 19.0 137,857 31.3 67,379 18.6 
Total Casualty84,632 65.7 92,778 68.4 300,940 68.4 229,135 63.3 
Other
Accident & Health4,175 3.2 12,418 9.3 26,427 6.0 40,522 11.2 
Financial17,920 13.9 1,817 1.3 40,134 9.1 15,704 4.3 
Marine2,462 1.9 127 0.1 8,412 1.9 749 0.2 
Other Specialty6,414 5.0 11,278 8.3 19,781 4.5 31,074 8.6 
Total Other30,971 24.1 25,640 19.0 94,754 21.5 88,049 24.3 
$128,735 100.0 %$135,596 100.0 %$440,249 100.0 %$362,072 100.0 %
Schedule of Gross Premiums Written by Geographic Area of Risks Insured Gross Premiums Written by Geographic Area of Risks Insured
 Three months ended September 30Nine months ended September 30
2021202020212020
 ($ in thousands)($ in thousands)
U.S. and Caribbean$67,087 52.1 %$110,798 81.7 %$258,849 58.8 %$291,511 80.5 %
Worldwide (1)
59,616 46.3 22,738 16.8 174,470 39.6 66,150 18.3 
Europe
1,483 1.2 — — 2,787 0.6 — — 
Asia
549 0.4 2,060 1.5 4,143 0.9 4,411 1.2 
$128,735 100.0 %$135,596 100.0 %$440,249 100.0 %$362,072 100.0 %
(1) “Worldwide” is composed of contracts that reinsure risks in more than one geographic area and may include risks in the U.S.
XML 43 R31.htm IDEA: XBRL DOCUMENT v3.21.2
SIGNIFICANT ACCOUNTING POLICIES - Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents (Details) - USD ($)
$ in Thousands
Sep. 30, 2021
Dec. 31, 2020
Sep. 30, 2020
Dec. 31, 2019
Accounting Policies [Abstract]        
Cash and cash equivalents $ 37,380 $ 8,935    
Restricted cash and cash equivalents 692,542 745,371    
Total cash, cash equivalents and restricted cash presented in the condensed consolidated statements of cash flows $ 729,922 $ 754,306 $ 731,266 $ 767,906
XML 44 R32.htm IDEA: XBRL DOCUMENT v3.21.2
SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2021
Dec. 31, 2020
New Accounting Pronouncements or Change in Accounting Principle [Line Items]            
Funds held by cedents $ 201,300   $ 201,300     $ 127,600
Allowance for expected credit losses 89   89     89
Deposit contracts, assets 4,900   4,900     4,600
Deposit contracts, liabilities $ 14,000   $ 14,000     $ 31,000
Weighted average shares outstanding - diluted (in shares) 32,929,097 35,779,703 33,507,060 35,569,292    
Accounting Standards Update 2020-06 | Forecast            
New Accounting Pronouncements or Change in Accounting Principle [Line Items]            
Shareholders' equity         $ (2,500)  
Weighted average shares outstanding - diluted (in shares)         5,800,000  
XML 45 R33.htm IDEA: XBRL DOCUMENT v3.21.2
SIGNIFICANT ACCOUNTING POLICIES - Interest Income and Interest Expense (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Accounting Policies [Abstract]        
Deposit interest income $ 0 $ 560 $ 0 $ 1,812
Deposit interest expense (38) 0 (2,957) 0
Deposit interest income/(expense), net $ (38) $ 560 $ (2,957) $ 1,812
XML 46 R34.htm IDEA: XBRL DOCUMENT v3.21.2
SIGNIFICANT ACCOUNTING POLICIES - Weighted Average Number of Shares (Details) - shares
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]        
Weighted average shares outstanding - basic (in shares) 32,929,097 35,677,554 33,507,060 35,569,292
Effect of dilutive employee and director share-based awards (in shares) 0 102,149 0 0
Weighted average shares outstanding - diluted (in shares) 32,929,097 35,779,703 33,507,060 35,569,292
Anti-dilutive stock options outstanding        
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]        
Anti-dilutive stock options outstanding (in shares) 735,627 835,627 735,627 835,627
Participating securities excluded from calculation of loss per share         
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]        
Anti-dilutive stock options outstanding (in shares) 946,556 0 946,556 878,498
XML 47 R35.htm IDEA: XBRL DOCUMENT v3.21.2
INVESTMENT IN RELATED PARTY INVESTMENT FUND - Narrative (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Schedule of Equity Method Investments [Line Items]          
Revenue from related parties $ (6,214) $ 6,431 $ (4,196) $ (34,086)  
General Partner          
Schedule of Equity Method Investments [Line Items]          
Equity method investment, ownership percentage 22.00%   22.00%   24.30%
SILP          
Schedule of Equity Method Investments [Line Items]          
Asset redemption notice to general partner     3 days    
SILP | Greenlight Capital Re Limited Partners          
Schedule of Equity Method Investments [Line Items]          
Equity method investments, fair value $ 180,200   $ 180,200   $ 166,700
Equity method investment, ownership percentage 78.00%   78.00%   75.70%
XML 48 R36.htm IDEA: XBRL DOCUMENT v3.21.2
INVESTMENT IN RELATED PARTY INVESTMENT FUND - Financial Information of Investment (Details) - USD ($)
$ in Thousands
Sep. 30, 2021
Dec. 31, 2020
Liabilities    
GLRE Limited Partners’ share of Net Assets $ 180,239 $ 166,735
Solasglas Investment LP (silp) | Equity Method Investment, Nonconsolidated Investee or Group of Investees    
Assets    
Investments, at fair value 262,058 272,398
Derivative contracts, at fair value 9,071 1,450
Due from brokers 77,638 92,053
Cash and cash equivalents 1,076 0
Interest and dividends receivable 14 59
Total assets 349,857 365,960
Liabilities    
Investments sold short, at fair value (109,044) (131,902)
Derivative contracts, at fair value (7,793) (4,156)
Due to brokers (1,170) (9,179)
Interest and dividends payable (603) (429)
Other liabilities (133) (175)
Total liabilities (118,743) (145,841)
Net Assets 231,114 220,119
GLRE Limited Partners’ share of Net Assets $ 180,239 $ 166,735
XML 49 R37.htm IDEA: XBRL DOCUMENT v3.21.2
INVESTMENT IN RELATED PARTY INVESTMENT FUND -Summarized Statement of Operations of Solasglas Investments, LP (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Expenses        
Management fee $ (659) $ (703) $ (2,632) $ (1,981)
Interest (1,578) (1,579) (4,684) (4,702)
Realized and change in unrealized gains (losses)        
Net income (loss) (13,853) 2,183 (6,726) (38,150)
GLRE limited partners’ share of net income (loss) (6,214) 6,431 (4,196) (34,086)
Management fees 883 703 2,632 1,981
Performance allocation (224) 0 0 0
Management fee 659 703 2,632 1,981
Solasglas Investment LP (silp)        
Investment income        
Dividend income (net of withholding taxes) 146 170 509 1,204
Interest income 51 36 770 262
Total Investment income 197 206 1,279 1,466
Expenses        
Management fee (883) (703) (2,632) (1,981)
Interest (205) (176) (874) (518)
Dividends (306) (213) (852) (612)
Professional fees and other (227) (432) (786) (764)
Total expenses (1,621) (1,524) (5,144) (3,875)
Net investment income (loss) (1,424) (1,318) (3,865) (2,409)
Realized and change in unrealized gains (losses)        
Net realized gain (loss) (1,411) (1,412) (14,809) (44,972)
Net change in unrealized appreciation (depreciation) (5,437) 10,832 12,143 5,811
Net gain (loss) on investment transactions (6,848) 9,420 (2,666) (39,161)
Net income (loss) (8,272) 8,102 (6,531) (41,570)
GLRE limited partners’ share of net income (loss) (6,214) 6,431 (4,196) (34,086)
Management fee $ 883 $ 703 $ 2,632 $ 1,981
XML 50 R38.htm IDEA: XBRL DOCUMENT v3.21.2
FINANCIAL INSTRUMENTS - Other Investments (Details) - USD ($)
$ in Thousands
Sep. 30, 2021
Dec. 31, 2020
Debt and Equity Securities, FV-NI [Line Items]    
Cost $ 17,175  
Unrealized gains 27,105  
Unrealized losses (1,800)  
Fair value / carrying value 42,480 $ 29,418
Private investments and unlisted equities    
Debt and Equity Securities, FV-NI [Line Items]    
Cost 17,175 12,414
Unrealized gains 24,017 10,679
Unrealized losses (1,800) (1,300)
Fair value / carrying value 39,392 21,793
Derivative financial instruments (not designated as hedging instruments)    
Debt and Equity Securities, FV-NI [Line Items]    
Cost 0 0
Unrealized gains 3,088 1,080
Unrealized losses 0 0
Fair value / carrying value $ 3,088 1,080
Other investments    
Debt and Equity Securities, FV-NI [Line Items]    
Cost   12,414
Unrealized gains   11,759
Unrealized losses   (1,300)
Fair value / carrying value   22,873
Investment accounted for under the equity method    
Debt and Equity Securities, FV-NI [Line Items]    
Fair value / carrying value   $ 6,545
XML 51 R39.htm IDEA: XBRL DOCUMENT v3.21.2
FINANCIAL INSTRUMENTS - Narrative (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]          
Fair value / carrying value $ 42,480   $ 42,480   $ 29,418
Realized gains losses on sale of investments and derivatives     $ 14,210 $ (15,000)  
Risk free rate 0.50%   0.50%    
Estimated volatility 50.00%   50.00%    
Variable Interest Entity, Not Primary Beneficiary | AccuRisk Holdings LLC          
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]          
Realized gains losses on sale of investments and derivatives     $ 14,200    
Private investments and unlisted equities          
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]          
Fair value / carrying value $ 39,392   39,392   21,793
Other investments, adjustment 7,600 $ 0 12,900 $ 4,100  
Other investments, adjustment, net $ 22,100   $ 22,100   $ 9,300
XML 52 R40.htm IDEA: XBRL DOCUMENT v3.21.2
LOSS AND LOSS ADJUSTMENT EXPENSE RESERVES - Liability for Unpaid Claims and Claims Adjustment Expense (Details) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Dec. 31, 2019
Liability for Claims and Claims Adjustment Expense [Line Items]        
Case reserves $ 191,151   $ 176,805  
IBNR 349,628   317,374  
Total 540,779 $ 481,770 494,179 $ 470,588
Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]        
Gross balance at January 1 494,179 470,588    
Less: Losses recoverable     (16,851) (27,531)
Net balance at January 1 477,328 443,057    
Incurred losses related to:        
Current year 296,333 247,559    
Prior years (1,255) 5,385    
Total incurred 295,078 252,944    
Paid losses related to:        
Current year (96,442) (72,453)    
Prior years (146,545) (161,222)    
Total paid (242,987) (233,675)    
Foreign currency revaluation (1,722) (505)    
Net balance at September 30 527,697 461,821    
Add: Losses recoverable 13,082 19,949 16,851  
Gross balance at September 30 540,779 481,770    
Estimate of net losses (1,255) 5,385    
Health        
Liability for Claims and Claims Adjustment Expense [Line Items]        
Total 12,728 12,994 17,485 18,063
Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]        
Gross balance at January 1 17,485 18,063    
Less: Losses recoverable     $ 0 $ 0
Net balance at January 1 17,485 18,063    
Incurred losses related to:        
Current year 31,189 25,032    
Prior years (1,898) 1,341    
Total incurred 29,291 26,373    
Paid losses related to:        
Current year (20,224) (15,115)    
Prior years (13,824) (16,327)    
Total paid (34,048) (31,442)    
Foreign currency revaluation 0 0    
Net balance at September 30 12,728 12,994    
Add: Losses recoverable 0 0    
Gross balance at September 30 12,728 12,994    
Estimate of net losses $ (1,898) $ 1,341    
XML 53 R41.htm IDEA: XBRL DOCUMENT v3.21.2
RETROCESSION (Details) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2020
Sep. 30, 2021
Dec. 31, 2020
Dec. 31, 2019
Ceded Credit Risk [Line Items]          
Ceded premiums earned $ 1,700,000 $ 3,200,000      
Loss and loss expenses recovered and recoverable $ 2,500,000 $ 6,200,000      
Loss and loss adjustment expenses recoverable       $ 16,851,000 $ 27,531,000
Loss and loss adjustment expenses recoverable, allowance     $ 47,000 47,000  
AM Best, A- Rating          
Ceded Credit Risk [Line Items]          
Loss and loss adjustment expenses recoverable     3,200,000 4,300,000  
Unsecured | Unrated          
Ceded Credit Risk [Line Items]          
Loss and loss adjustment expenses recoverable     9,900,000 12,600,000  
Secured | Unrated          
Ceded Credit Risk [Line Items]          
Loss and loss adjustment expenses recoverable     $ 9,700,000 $ 11,900,000  
XML 54 R42.htm IDEA: XBRL DOCUMENT v3.21.2
SENIOR CONVERTIBLE NOTES (Details) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Aug. 07, 2018
Debt Instrument [Line Items]            
Convertible senior notes payable $ 96,478,000   $ 96,478,000   $ 95,794,000  
Senior Notes | Senior Unsecured Convertible Notes            
Debt Instrument [Line Items]            
Convertible debt, amount           $ 100,000,000
Debt interest rate (in percent)           4.00%
Debt conversion price (in dollars per share) $ 17.19   $ 17.19      
Effective interest rate (in percent)           6.00%
Unamortized discount $ 3,000,000   $ 3,000,000   4,200,000 $ 8,200,000
Unamortized debt issuance expense 1,200,000   1,200,000   1,600,000  
Accrued interest 700,000   700,000      
Convertible senior notes payable 96,500,000   96,500,000   95,800,000  
Fair value of debt 94,600,000   94,600,000   $ 83,600,000  
Recognized interest expense 1,600,000 $ 1,600,000 4,700,000 $ 4,700,000    
Senior Notes | Senior Unsecured Convertible Notes | Additional paid-in capital            
Debt Instrument [Line Items]            
Unamortized debt issuance expense $ 7,900,000   $ 7,900,000      
XML 55 R43.htm IDEA: XBRL DOCUMENT v3.21.2
SHARE CAPITAL - Narrative (Details) - USD ($)
 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
May 04, 2021
Dec. 31, 2020
Oct. 29, 2020
Mar. 26, 2020
Aug. 07, 2018
Senior Unsecured Convertible Notes | Senior Notes              
Class of Stock [Line Items]              
Debt instrument, amount authorized for repurchase (up to)     $ 25,000,000     $ 25,000,000  
Debt interest rate (in percent)             4.00%
Common Class A              
Class of Stock [Line Items]              
Ordinary share capital, par value (in dollars per share) $ 0.10     $ 0.10      
Shares authorized for the company's stock incentive plan (in shares)           5,000,000  
Shares available for future issuance (in shares) 3,128,276     3,474,888      
Repurchase of ordinary shares (in shares) 1,079,544 1,874,419          
Common Class A | Share-based Payment Arrangement              
Class of Stock [Line Items]              
Shares authorized for issuance in relation to share purchase options granted to service provider (in shares)         3,000,000    
Common Class A | Share-based Payment Arrangement | Minimum              
Class of Stock [Line Items]              
Shares authorized for the company's stock incentive plan (in shares)         5,000,000    
Common Class A | Share-based Payment Arrangement | Maximum              
Class of Stock [Line Items]              
Shares authorized for the company's stock incentive plan (in shares)         8,000,000    
Common Class B              
Class of Stock [Line Items]              
Ordinary share capital, par value (in dollars per share) $ 0.10     $ 0.10      
Repurchase of ordinary shares (in shares) 0 0          
XML 56 R44.htm IDEA: XBRL DOCUMENT v3.21.2
SHARE CAPITAL - Stock by Class (Details) - shares
 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Common Class A    
Increase (Decrease) in Stockholders' Equity [Roll Forward]    
Balance – beginning of period (in shares) 28,260,075 30,739,395
Issue of ordinary shares, net of forfeitures (in shares) 409,200 248,726
Repurchase of ordinary shares (in shares) (1,079,544) (1,874,419)
Balance – end of period (in shares) 27,589,731 29,113,702
Common Class B    
Increase (Decrease) in Stockholders' Equity [Roll Forward]    
Balance – beginning of period (in shares) 6,254,715 6,254,715
Issue of ordinary shares, net of forfeitures (in shares) 0 0
Repurchase of ordinary shares (in shares) 0 0
Balance – end of period (in shares) 6,254,715 6,254,715
XML 57 R45.htm IDEA: XBRL DOCUMENT v3.21.2
SHARE-BASED COMPENSATION - Narrative (Details) - USD ($)
 9 Months Ended 12 Months Ended
Sep. 30, 2021
Dec. 31, 2020
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Restricted shares $ 0   $ 0 $ 0  
General and Administrative Expense          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Stock based compensation expense, net of forfeiture reversals     $ 2,400,000 1,400,000  
Employee and Director Restricted Shares          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Cliff vesting period after date of issuance     3 years    
Stock-based compensation expense     $ 100,000 700,000  
Stock based compensation expense, net of forfeiture reversals     1,800,000 600,000  
Unrecognized compensation costs related to non-vested restricted shares $ 3,300,000 $ 1,900,000 3,300,000   $ 1,900,000
Weighted average period for recognition 1 year 10 months 24 days 1 year 6 months      
Total fair value of restricted shares vested     $ 1,600,000 $ 2,800,000  
Number of s issued to employees RSUs (in shares)     409,081    
Shares forfeited (in shares)     20,592    
Granted (in dollars per share)     $ 9.11    
Unvested performance restricted shares outstanding (in shares) 946,556 697,549 946,556   697,549
Employee and Director Restricted Shares | Chief Executive Officer          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Cliff vesting period after date of issuance     5 years    
Granted (in dollars per share)     $ 6.72    
Unvested performance restricted shares outstanding (in shares) 193,149 193,149 193,149   193,149
Employee and Director Restricted Shares | Common Class A          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Restricted shares issued pursuant to stock incentive plan (in shares)     334,312 306,264  
Restricted shares forfeited by employees who left the company prior to the vesting period (in shares)     20,592 210,109  
Employee and Director Stock Options          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Stock based compensation expense, net of forfeiture reversals     $ 300,000 $ 500,000  
Weighted average period for recognition     1 year 4 months 24 days   1 year 9 months 18 days
Expired (in shares)     100,000 40,000  
Vested number of shares (in shares)     80,000 80,000  
Total compensation cost related to non-vested options not yet recognized $ 300,000 $ 700,000 $ 300,000   $ 700,000
Options outstanding (in shares) 700,000 800,000 700,000   800,000
Exercise price (in dollars per share) $ 22.35 $ 22.22 $ 22.35   $ 22.22
Weighted average grant date fair value, granted (in dollars per share)     $ 10.23 $ 10.25  
Weighted average remaining contractual term     4 years 10 months 24 days   5 years 1 month 6 days
Employee and Director Stock Options | Common Class A | Chief Executive Officer          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Granted (in shares)     0 0  
RSUs          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Cliff vesting period after date of issuance     3 years    
Stock based compensation expense, net of forfeiture reversals     $ 300,000 $ 300,000  
Weighted average period for recognition     1 year 10 months 24 days 1 year 9 months 18 days  
Total compensation cost related to non-vested options not yet recognized $ 600,000   $ 600,000 $ 400,000  
Number of s issued to employees RSUs (in shares)     58,123 60,622  
Shares forfeited (in shares)     0 0  
Granted (in dollars per share)     $ 9.18    
Unvested performance restricted shares outstanding (in shares) 154,134 116,722 154,134   116,722
RSUs | Common Class A          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Conversion ratio (in shares)     1    
RSUs | Common Class A | Non Employee Director Member          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Restricted shares issued pursuant to stock incentive plan (in shares)     74,769 0  
XML 58 R46.htm IDEA: XBRL DOCUMENT v3.21.2
SHARE-BASED COMPENSATION - Share-based Compensation, Restricted Stock Activity (Details) - Employee and Director Restricted Shares
 9 Months Ended
Sep. 30, 2021
$ / shares
shares
Number of non-vested restricted  shares  
Beginning balance (in shares) | shares 697,549
Granted (in shares) | shares 409,081
Vested (in shares) | shares (139,482)
Forfeited (in shares) | shares (20,592)
Ending balance (in shares) | shares 946,556
Weighted  average grant date fair value  
Beginning balance (in dollars per share) | $ / shares $ 9.38
Granted (in dollars per share) | $ / shares 9.11
Vested (in dollars per share) | $ / shares 11.53
Forfeited (in dollars per share) | $ / shares 8.35
Ending balance (in dollars per share) | $ / shares $ 8.97
XML 59 R47.htm IDEA: XBRL DOCUMENT v3.21.2
SHARE-BASED COMPENSATION - Restricted Stock Units (Details) - RSUs - $ / shares
 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Number of non-vested RSUs    
Beginning balance (in shares) 116,722  
Granted (in shares) 58,123 60,622
Vested (in shares) (20,711)  
Forfeited (in shares) 0 0
Ending balance (in shares) 154,134  
Weighted  average grant date fair value    
Beginning balance (in dollars per share) $ 9.60  
Granted (in dollars per share) 9.18  
Vested (in dollars per share) 15.90  
Ending balance (in dollars per share) $ 8.59  
XML 60 R48.htm IDEA: XBRL DOCUMENT v3.21.2
TAXATION - Narrative (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Income Tax Examination [Line Items]        
Deferred tax asset valuation allowance $ 3,500 $ 3,000 $ 3,500 $ 3,000
Income tax (expense) benefit 0 0 (3,733) (424)
Other Assets        
Income Tax Examination [Line Items]        
Gross deferred tax asset $ 4,000 $ 3,500 $ 4,000 $ 3,500
XML 61 R49.htm IDEA: XBRL DOCUMENT v3.21.2
TAXATION - Components of Income Tax Expense (Benefit) (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Income Tax Disclosure [Abstract]        
Current tax (expense) benefit $ 323 $ (33) $ (3,240) $ 272
Decrease (increase) in deferred tax valuation allowance (323) 33 (493) (696)
Income tax (expense) benefit  $ 0 $ 0 $ (3,733) $ (424)
XML 62 R50.htm IDEA: XBRL DOCUMENT v3.21.2
RELATED PARTY TRANSACTIONS (Details) - USD ($)
 9 Months Ended
Jan. 01, 2019
Sep. 01, 2018
Sep. 30, 2021
Affiliated Entity | Green Bricks Partners Inc (GRBK)      
Related Party Transaction [Line Items]      
Ownership percentage     0.343%
Board of Directors Chairman | SILP      
Related Party Transaction [Line Items]      
Performance compensation reduced rate as a percentage of investment income   10.00%  
Performance compensation full rate   20.00%  
Performance compensation reduced rate     10.00%
Loss carry forward recoupment required     150.00%
Board of Directors Chairman | Investment Advisory Agreement      
Related Party Transaction [Line Items]      
Investment management fee rate - monthly   0.125%  
Investment management fee rate - annual   1.50%  
Automatic agreement extension, term   3 years  
Board of Directors Chairman | Service Agreement      
Related Party Transaction [Line Items]      
Investor relations monthly fee     $ 5,000
Contract termination prior notice period     30 days
Board of Directors Chairman | Collateral Assets Investment Management Agreement      
Related Party Transaction [Line Items]      
Contract termination prior notice period 30 days    
XML 63 R51.htm IDEA: XBRL DOCUMENT v3.21.2
COMMITMENTS AND CONTINGENCIES - Narrative (Details)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2021
USD ($)
facility
Sep. 30, 2020
USD ($)
Sep. 30, 2021
USD ($)
facility
Sep. 30, 2020
USD ($)
Dec. 31, 2020
USD ($)
Line of Credit Facility [Line Items]          
Number of credit facilities | facility 1   1    
Aggregate amount of letters of credit issued $ 138.4   $ 138.4   $ 135.3
Total equity securities, restricted cash, and cash and cash equivalents fair value pledged as security against the letters of credit 142.4   142.4   137.6
Collateral held in trust $ 550.2   $ 550.2   $ 607.8
Operating lease renewal term 5 years   5 years    
Operating lease right of use asset $ 2.2   $ 2.2    
Operating lease liability 2.2   2.2    
Operating lease expense 0.1   0.1    
Short term lease cost $ 0.0 $ 0.1 0.3 $ 0.4  
Minimum          
Line of Credit Facility [Line Items]          
Operating lease cost     0.5    
Maximum          
Line of Credit Facility [Line Items]          
Operating lease cost     $ 0.6    
XML 64 R52.htm IDEA: XBRL DOCUMENT v3.21.2
COMMITMENTS AND CONTINGENCIES - Letters of Credit Facilities (Details) - Citibank Europe plc - Facility
 9 Months Ended
Sep. 30, 2021
USD ($)
Line of Credit Facility [Line Items]  
Maximum Facility Limit $ 275,000,000
Notice period required for termination 120 days
XML 65 R53.htm IDEA: XBRL DOCUMENT v3.21.2
COMMITMENTS AND CONTINGENCIES - Commitments and Contingencies, Fiscal Year Maturity Schedule (Details)
$ in Thousands
Sep. 30, 2021
USD ($)
Operating lease obligations  
2021 $ 130
2022 588
2023 624
2024 640
2025 657
Thereafter 788
Total 3,427
Total future obligations by year  
2021 130
2022 4,588
2023 104,624
2024 640
2025 657
Thereafter 788
Total 111,427
Interest and convertible note payable  
Interest and convertible note payable  
2021 0
2022 4,000
2023 104,000
2024 0
2025 0
Thereafter 0
Total $ 108,000
XML 66 R54.htm IDEA: XBRL DOCUMENT v3.21.2
SEGMENT REPORTING - Gross Premiums Written by Line of Business (Details)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2021
USD ($)
Sep. 30, 2020
USD ($)
Sep. 30, 2021
USD ($)
segment
Sep. 30, 2020
USD ($)
Segment Reporting Information [Line Items]        
Number of operating segments | segment     1  
Gross premiums written $ 128,735 $ 135,596 $ 440,249 $ 362,072
Gross premiums written (in percent) 100.00% 100.00% 100.00% 100.00%
Total Property        
Segment Reporting Information [Line Items]        
Gross premiums written $ 13,132 $ 17,178 $ 44,555 $ 44,888
Gross premiums written (in percent) 10.20% 12.60% 10.10% 12.40%
Commercial        
Segment Reporting Information [Line Items]        
Gross premiums written $ 3,398 $ 3,396 $ 9,700 $ 9,426
Gross premiums written (in percent) 2.60% 2.50% 2.20% 2.60%
Motor        
Segment Reporting Information [Line Items]        
Gross premiums written $ 6,103 $ 10,091 $ 24,537 $ 25,136
Gross premiums written (in percent) 4.70% 7.40% 5.60% 6.90%
Personal        
Segment Reporting Information [Line Items]        
Gross premiums written $ 3,631 $ 3,691 $ 10,318 $ 10,326
Gross premiums written (in percent) 2.80% 2.70% 2.30% 2.90%
Total Casualty        
Segment Reporting Information [Line Items]        
Gross premiums written $ 84,632 $ 92,778 $ 300,940 $ 229,135
Gross premiums written (in percent) 65.70% 68.40% 68.40% 63.30%
General Liability        
Segment Reporting Information [Line Items]        
Gross premiums written $ 7,376 $ 3,224 $ 10,749 $ 3,920
Gross premiums written (in percent) 5.70% 2.40% 2.40% 1.10%
Motor Liability        
Segment Reporting Information [Line Items]        
Gross premiums written $ 19,823 $ 41,679 $ 96,795 $ 96,729
Gross premiums written (in percent) 15.40% 30.70% 22.00% 26.70%
Professional Liability        
Segment Reporting Information [Line Items]        
Gross premiums written $ 154 $ 76 $ 302 $ 199
Gross premiums written (in percent) 0.10% 0.10% 0.10% 0.10%
Workers' Compensation        
Segment Reporting Information [Line Items]        
Gross premiums written $ 17,117 $ 21,979 $ 55,237 $ 60,908
Gross premiums written (in percent) 13.30% 16.20% 12.50% 16.80%
Multi-line        
Segment Reporting Information [Line Items]        
Gross premiums written $ 40,162 $ 25,820 $ 137,857 $ 67,379
Gross premiums written (in percent) 31.20% 19.00% 31.30% 18.60%
Total Other        
Segment Reporting Information [Line Items]        
Gross premiums written $ 30,971 $ 25,640 $ 94,754 $ 88,049
Gross premiums written (in percent) 24.10% 19.00% 21.50% 24.30%
Accident & Health        
Segment Reporting Information [Line Items]        
Gross premiums written $ 4,175 $ 12,418 $ 26,427 $ 40,522
Gross premiums written (in percent) 3.20% 9.30% 6.00% 11.20%
Financial        
Segment Reporting Information [Line Items]        
Gross premiums written $ 17,920 $ 1,817 $ 40,134 $ 15,704
Gross premiums written (in percent) 13.90% 1.30% 9.10% 4.30%
Marine        
Segment Reporting Information [Line Items]        
Gross premiums written $ 2,462 $ 127 $ 8,412 $ 749
Gross premiums written (in percent) 1.90% 0.10% 1.90% 0.20%
Other Specialty        
Segment Reporting Information [Line Items]        
Gross premiums written $ 6,414 $ 11,278 $ 19,781 $ 31,074
Gross premiums written (in percent) 5.00% 8.30% 4.50% 8.60%
XML 67 R55.htm IDEA: XBRL DOCUMENT v3.21.2
SEGMENT REPORTING - Gross Premiums Written by Geographic Area of Risks Insured (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Revenue from External Customer [Line Items]        
Gross premiums written $ 128,735 $ 135,596 $ 440,249 $ 362,072
Gross premiums written (in percent) 100.00% 100.00% 100.00% 100.00%
U.S. and Caribbean        
Revenue from External Customer [Line Items]        
Gross premiums written $ 67,087 $ 110,798 $ 258,849 $ 291,511
Gross premiums written (in percent) 52.10% 81.70% 58.80% 80.50%
Worldwide        
Revenue from External Customer [Line Items]        
Gross premiums written $ 59,616 $ 22,738 $ 174,470 $ 66,150
Gross premiums written (in percent) 46.30% 16.80% 39.60% 18.30%
Europe        
Revenue from External Customer [Line Items]        
Gross premiums written $ 1,483 $ 0 $ 2,787 $ 0
Gross premiums written (in percent) 1.20% 0.00% 0.60% 0.00%
Asia        
Revenue from External Customer [Line Items]        
Gross premiums written $ 549 $ 2,060 $ 4,143 $ 4,411
Gross premiums written (in percent) 0.40% 1.50% 0.90% 1.20%
XML 68 R9999.htm IDEA: XBRL DOCUMENT v3.21.2
Label Element Value
Accounting Standards Update [Extensible Enumeration] us-gaap_AccountingStandardsUpdateExtensibleList Accounting Standards Update 2016-13 [Member]
EXCEL 69 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 71 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 72 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.2 html 227 375 1 false 67 0 false 6 false false R1.htm 0001001 - Document - Cover Page Sheet http://www.greenlightre.ky/role/CoverPage Cover Page Cover 1 false false R2.htm 1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) Sheet http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) Statements 2 false false R3.htm 1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) Sheet http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) Statements 3 false false R4.htm 1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) Sheet http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) Statements 4 false false R5.htm 1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical) Sheet http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSParenthetical CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical) Statements 5 false false R6.htm 1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS??? EQUITY (UNAUDITED) Sheet http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS??? EQUITY (UNAUDITED) Statements 6 false false R7.htm 1006007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) Sheet http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) Statements 7 false false R8.htm 2101101 - Disclosure - ORGANIZATION AND BASIS OF PRESENTATION Sheet http://www.greenlightre.ky/role/ORGANIZATIONANDBASISOFPRESENTATION ORGANIZATION AND BASIS OF PRESENTATION Notes 8 false false R9.htm 2102102 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES Sheet http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIES SIGNIFICANT ACCOUNTING POLICIES Notes 9 false false R10.htm 2109103 - Disclosure - INVESTMENT IN RELATED PARTY INVESTMENT FUND Sheet http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUND INVESTMENT IN RELATED PARTY INVESTMENT FUND Notes 10 false false R11.htm 2114104 - Disclosure - FINANCIAL INSTRUMENTS Sheet http://www.greenlightre.ky/role/FINANCIALINSTRUMENTS FINANCIAL INSTRUMENTS Notes 11 false false R12.htm 2118105 - Disclosure - LOSS AND LOSS ADJUSTMENT EXPENSE RESERVES Sheet http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVES LOSS AND LOSS ADJUSTMENT EXPENSE RESERVES Notes 12 false false R13.htm 2121106 - Disclosure - RETROCESSION Sheet http://www.greenlightre.ky/role/RETROCESSION RETROCESSION Notes 13 false false R14.htm 2123107 - Disclosure - SENIOR CONVERTIBLE NOTES Notes http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTES SENIOR CONVERTIBLE NOTES Notes 14 false false R15.htm 2125108 - Disclosure - SHARE CAPITAL Sheet http://www.greenlightre.ky/role/SHARECAPITAL SHARE CAPITAL Notes 15 false false R16.htm 2129109 - Disclosure - SHARE-BASED COMPENSATION Sheet http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATION SHARE-BASED COMPENSATION Notes 16 false false R17.htm 2134110 - Disclosure - TAXATION Sheet http://www.greenlightre.ky/role/TAXATION TAXATION Notes 17 false false R18.htm 2138111 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONS RELATED PARTY TRANSACTIONS Notes 18 false false R19.htm 2140112 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIES COMMITMENTS AND CONTINGENCIES Notes 19 false false R20.htm 2145113 - Disclosure - SEGMENT REPORTING Sheet http://www.greenlightre.ky/role/SEGMENTREPORTING SEGMENT REPORTING Notes 20 false false R21.htm 2203201 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 21 false false R22.htm 2304301 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESTables SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIES 22 false false R23.htm 2310302 - Disclosure - INVESTMENT IN RELATED PARTY INVESTMENT FUND (Tables) Sheet http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDTables INVESTMENT IN RELATED PARTY INVESTMENT FUND (Tables) Tables http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUND 23 false false R24.htm 2315303 - Disclosure - FINANCIAL INSTRUMENTS (Tables) Sheet http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSTables FINANCIAL INSTRUMENTS (Tables) Tables http://www.greenlightre.ky/role/FINANCIALINSTRUMENTS 24 false false R25.htm 2319304 - Disclosure - LOSS AND LOSS ADJUSTMENT EXPENSE RESERVES (Tables) Sheet http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESTables LOSS AND LOSS ADJUSTMENT EXPENSE RESERVES (Tables) Tables http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVES 25 false false R26.htm 2326305 - Disclosure - SHARE CAPITAL (Tables) Sheet http://www.greenlightre.ky/role/SHARECAPITALTables SHARE CAPITAL (Tables) Tables http://www.greenlightre.ky/role/SHARECAPITAL 26 false false R27.htm 2330306 - Disclosure - SHARE-BASED COMPENSATION (Tables) Sheet http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONTables SHARE-BASED COMPENSATION (Tables) Tables http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATION 27 false false R28.htm 2335307 - Disclosure - TAXATION (Tables) Sheet http://www.greenlightre.ky/role/TAXATIONTables TAXATION (Tables) Tables http://www.greenlightre.ky/role/TAXATION 28 false false R29.htm 2341308 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables) Sheet http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESTables COMMITMENTS AND CONTINGENCIES (Tables) Tables http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIES 29 false false R30.htm 2346309 - Disclosure - SEGMENT REPORTING (Tables) Sheet http://www.greenlightre.ky/role/SEGMENTREPORTINGTables SEGMENT REPORTING (Tables) Tables http://www.greenlightre.ky/role/SEGMENTREPORTING 30 false false R31.htm 2405401 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents (Details) Sheet http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESCashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsDetails SIGNIFICANT ACCOUNTING POLICIES - Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents (Details) Details 31 false false R32.htm 2406402 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details) Sheet http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details) Details 32 false false R33.htm 2407403 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Interest Income and Interest Expense (Details) Sheet http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESInterestIncomeandInterestExpenseDetails SIGNIFICANT ACCOUNTING POLICIES - Interest Income and Interest Expense (Details) Details 33 false false R34.htm 2408404 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Weighted Average Number of Shares (Details) Sheet http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESWeightedAverageNumberofSharesDetails SIGNIFICANT ACCOUNTING POLICIES - Weighted Average Number of Shares (Details) Details 34 false false R35.htm 2411405 - Disclosure - INVESTMENT IN RELATED PARTY INVESTMENT FUND - Narrative (Details) Sheet http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDNarrativeDetails INVESTMENT IN RELATED PARTY INVESTMENT FUND - Narrative (Details) Details 35 false false R36.htm 2412406 - Disclosure - INVESTMENT IN RELATED PARTY INVESTMENT FUND - Financial Information of Investment (Details) Sheet http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDFinancialInformationofInvestmentDetails INVESTMENT IN RELATED PARTY INVESTMENT FUND - Financial Information of Investment (Details) Details 36 false false R37.htm 2413407 - Disclosure - INVESTMENT IN RELATED PARTY INVESTMENT FUND -Summarized Statement of Operations of Solasglas Investments, LP (Details) Sheet http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementofOperationsofSolasglasInvestmentsLPDetails INVESTMENT IN RELATED PARTY INVESTMENT FUND -Summarized Statement of Operations of Solasglas Investments, LP (Details) Details 37 false false R38.htm 2416408 - Disclosure - FINANCIAL INSTRUMENTS - Other Investments (Details) Sheet http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSOtherInvestmentsDetails FINANCIAL INSTRUMENTS - Other Investments (Details) Details 38 false false R39.htm 2417409 - Disclosure - FINANCIAL INSTRUMENTS - Narrative (Details) Sheet http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSNarrativeDetails FINANCIAL INSTRUMENTS - Narrative (Details) Details 39 false false R40.htm 2420410 - Disclosure - LOSS AND LOSS ADJUSTMENT EXPENSE RESERVES - Liability for Unpaid Claims and Claims Adjustment Expense (Details) Sheet http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails LOSS AND LOSS ADJUSTMENT EXPENSE RESERVES - Liability for Unpaid Claims and Claims Adjustment Expense (Details) Details 40 false false R41.htm 2422411 - Disclosure - RETROCESSION (Details) Sheet http://www.greenlightre.ky/role/RETROCESSIONDetails RETROCESSION (Details) Details http://www.greenlightre.ky/role/RETROCESSION 41 false false R42.htm 2424412 - Disclosure - SENIOR CONVERTIBLE NOTES (Details) Notes http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTESDetails SENIOR CONVERTIBLE NOTES (Details) Details http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTES 42 false false R43.htm 2427413 - Disclosure - SHARE CAPITAL - Narrative (Details) Sheet http://www.greenlightre.ky/role/SHARECAPITALNarrativeDetails SHARE CAPITAL - Narrative (Details) Details 43 false false R44.htm 2428414 - Disclosure - SHARE CAPITAL - Stock by Class (Details) Sheet http://www.greenlightre.ky/role/SHARECAPITALStockbyClassDetails SHARE CAPITAL - Stock by Class (Details) Details 44 false false R45.htm 2431415 - Disclosure - SHARE-BASED COMPENSATION - Narrative (Details) Sheet http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails SHARE-BASED COMPENSATION - Narrative (Details) Details 45 false false R46.htm 2432416 - Disclosure - SHARE-BASED COMPENSATION - Share-based Compensation, Restricted Stock Activity (Details) Sheet http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONSharebasedCompensationRestrictedStockActivityDetails SHARE-BASED COMPENSATION - Share-based Compensation, Restricted Stock Activity (Details) Details 46 false false R47.htm 2433417 - Disclosure - SHARE-BASED COMPENSATION - Restricted Stock Units (Details) Sheet http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedStockUnitsDetails SHARE-BASED COMPENSATION - Restricted Stock Units (Details) Details 47 false false R48.htm 2436418 - Disclosure - TAXATION - Narrative (Details) Sheet http://www.greenlightre.ky/role/TAXATIONNarrativeDetails TAXATION - Narrative (Details) Details 48 false false R49.htm 2437419 - Disclosure - TAXATION - Components of Income Tax Expense (Benefit) (Details) Sheet http://www.greenlightre.ky/role/TAXATIONComponentsofIncomeTaxExpenseBenefitDetails TAXATION - Components of Income Tax Expense (Benefit) (Details) Details 49 false false R50.htm 2439420 - Disclosure - RELATED PARTY TRANSACTIONS (Details) Sheet http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails RELATED PARTY TRANSACTIONS (Details) Details http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONS 50 false false R51.htm 2442421 - Disclosure - COMMITMENTS AND CONTINGENCIES - Narrative (Details) Sheet http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails COMMITMENTS AND CONTINGENCIES - Narrative (Details) Details 51 false false R52.htm 2443422 - Disclosure - COMMITMENTS AND CONTINGENCIES - Letters of Credit Facilities (Details) Sheet http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESLettersofCreditFacilitiesDetails COMMITMENTS AND CONTINGENCIES - Letters of Credit Facilities (Details) Details 52 false false R53.htm 2444423 - Disclosure - COMMITMENTS AND CONTINGENCIES - Commitments and Contingencies, Fiscal Year Maturity Schedule (Details) Sheet http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESCommitmentsandContingenciesFiscalYearMaturityScheduleDetails COMMITMENTS AND CONTINGENCIES - Commitments and Contingencies, Fiscal Year Maturity Schedule (Details) Details 53 false false R54.htm 2447424 - Disclosure - SEGMENT REPORTING - Gross Premiums Written by Line of Business (Details) Sheet http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyLineofBusinessDetails SEGMENT REPORTING - Gross Premiums Written by Line of Business (Details) Details 54 false false R55.htm 2448425 - Disclosure - SEGMENT REPORTING - Gross Premiums Written by Geographic Area of Risks Insured (Details) Sheet http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyGeographicAreaofRisksInsuredDetails SEGMENT REPORTING - Gross Premiums Written by Geographic Area of Risks Insured (Details) Details 55 false false R9999.htm Uncategorized Items - glre-20210930.htm Sheet http://xbrl.sec.gov/role/uncategorizedFacts Uncategorized Items - glre-20210930.htm Cover 56 false false All Reports Book All Reports glre-20210930.htm ex10-1glreshortxtermincent.htm glre-20210930.xsd glre-20210930_cal.xml glre-20210930_def.xml glre-20210930_lab.xml glre-20210930_pre.xml glre-20210930exhibit311.htm glre-20210930exhibit312.htm glre-20210930exhibit321.htm glre-20210930exhibit322.htm http://fasb.org/us-gaap/2021-01-31 http://fasb.org/srt/2021-01-31 http://xbrl.sec.gov/dei/2021 true true JSON 75 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "glre-20210930.htm": { "axisCustom": 0, "axisStandard": 26, "contextCount": 227, "dts": { "calculationLink": { "local": [ "glre-20210930_cal.xml" ] }, "definitionLink": { "local": [ "glre-20210930_def.xml" ] }, "inline": { "local": [ "glre-20210930.htm" ] }, "labelLink": { "local": [ "glre-20210930_lab.xml" ] }, "presentationLink": { "local": [ "glre-20210930_pre.xml" ] }, "schema": { "local": [ "glre-20210930.xsd" ], "remote": [ "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd" ] } }, "elementCount": 508, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2021-01-31": 1, "http://www.greenlightre.ky/20210930": 1, "http://xbrl.sec.gov/dei/2021": 5, "total": 7 }, "keyCustom": 48, "keyStandard": 327, "memberCustom": 24, "memberStandard": 40, "nsprefix": "glre", "nsuri": "http://www.greenlightre.ky/20210930", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i2f42c5a49a574425923dd34855ba613c_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001001 - Document - Cover Page", "role": "http://www.greenlightre.ky/role/CoverPage", "shortName": "Cover Page", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i2f42c5a49a574425923dd34855ba613c_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i2f42c5a49a574425923dd34855ba613c_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2109103 - Disclosure - INVESTMENT IN RELATED PARTY INVESTMENT FUND", "role": "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUND", "shortName": "INVESTMENT IN RELATED PARTY INVESTMENT FUND", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i2f42c5a49a574425923dd34855ba613c_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i2f42c5a49a574425923dd34855ba613c_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2114104 - Disclosure - FINANCIAL INSTRUMENTS", "role": "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTS", "shortName": "FINANCIAL INSTRUMENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i2f42c5a49a574425923dd34855ba613c_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i2f42c5a49a574425923dd34855ba613c_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2118105 - Disclosure - LOSS AND LOSS ADJUSTMENT EXPENSE RESERVES", "role": "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVES", "shortName": "LOSS AND LOSS ADJUSTMENT EXPENSE RESERVES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i2f42c5a49a574425923dd34855ba613c_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i2f42c5a49a574425923dd34855ba613c_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ReinsuranceTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2121106 - Disclosure - RETROCESSION", "role": "http://www.greenlightre.ky/role/RETROCESSION", "shortName": "RETROCESSION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i2f42c5a49a574425923dd34855ba613c_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ReinsuranceTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i2f42c5a49a574425923dd34855ba613c_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2123107 - Disclosure - SENIOR CONVERTIBLE NOTES", "role": "http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTES", "shortName": "SENIOR CONVERTIBLE NOTES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i2f42c5a49a574425923dd34855ba613c_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i2f42c5a49a574425923dd34855ba613c_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2125108 - Disclosure - SHARE CAPITAL", "role": "http://www.greenlightre.ky/role/SHARECAPITAL", "shortName": "SHARE CAPITAL", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i2f42c5a49a574425923dd34855ba613c_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i2f42c5a49a574425923dd34855ba613c_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2129109 - Disclosure - SHARE-BASED COMPENSATION", "role": "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATION", "shortName": "SHARE-BASED COMPENSATION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i2f42c5a49a574425923dd34855ba613c_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i2f42c5a49a574425923dd34855ba613c_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2134110 - Disclosure - TAXATION", "role": "http://www.greenlightre.ky/role/TAXATION", "shortName": "TAXATION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i2f42c5a49a574425923dd34855ba613c_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i2f42c5a49a574425923dd34855ba613c_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2138111 - Disclosure - RELATED PARTY TRANSACTIONS", "role": "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONS", "shortName": "RELATED PARTY TRANSACTIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i2f42c5a49a574425923dd34855ba613c_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i2f42c5a49a574425923dd34855ba613c_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2140112 - Disclosure - COMMITMENTS AND CONTINGENCIES", "role": "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIES", "shortName": "COMMITMENTS AND CONTINGENCIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i2f42c5a49a574425923dd34855ba613c_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "id0695da7ea5a4c2d995e5630acda739f_I20210930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)", "role": "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED", "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "id0695da7ea5a4c2d995e5630acda739f_I20210930", "decimals": "-3", "lang": "en-US", "name": "us-gaap:OtherInvestments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i2f42c5a49a574425923dd34855ba613c_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2145113 - Disclosure - SEGMENT REPORTING", "role": "http://www.greenlightre.ky/role/SEGMENTREPORTING", "shortName": "SEGMENT REPORTING", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i2f42c5a49a574425923dd34855ba613c_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i2f42c5a49a574425923dd34855ba613c_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:UseOfEstimates", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2203201 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)", "role": "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies", "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i2f42c5a49a574425923dd34855ba613c_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:UseOfEstimates", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i2f42c5a49a574425923dd34855ba613c_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2304301 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)", "role": "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESTables", "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i2f42c5a49a574425923dd34855ba613c_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i2f42c5a49a574425923dd34855ba613c_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestmentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2310302 - Disclosure - INVESTMENT IN RELATED PARTY INVESTMENT FUND (Tables)", "role": "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDTables", "shortName": "INVESTMENT IN RELATED PARTY INVESTMENT FUND (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i2f42c5a49a574425923dd34855ba613c_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestmentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i2f42c5a49a574425923dd34855ba613c_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentHoldingsOtherThanSecuritiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2315303 - Disclosure - FINANCIAL INSTRUMENTS (Tables)", "role": "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSTables", "shortName": "FINANCIAL INSTRUMENTS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i2f42c5a49a574425923dd34855ba613c_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentHoldingsOtherThanSecuritiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i2f42c5a49a574425923dd34855ba613c_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2319304 - Disclosure - LOSS AND LOSS ADJUSTMENT EXPENSE RESERVES (Tables)", "role": "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESTables", "shortName": "LOSS AND LOSS ADJUSTMENT EXPENSE RESERVES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i2f42c5a49a574425923dd34855ba613c_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i2f42c5a49a574425923dd34855ba613c_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfStockByClassTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2326305 - Disclosure - SHARE CAPITAL (Tables)", "role": "http://www.greenlightre.ky/role/SHARECAPITALTables", "shortName": "SHARE CAPITAL (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i2f42c5a49a574425923dd34855ba613c_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfStockByClassTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i2f42c5a49a574425923dd34855ba613c_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2330306 - Disclosure - SHARE-BASED COMPENSATION (Tables)", "role": "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONTables", "shortName": "SHARE-BASED COMPENSATION (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i2f42c5a49a574425923dd34855ba613c_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i2f42c5a49a574425923dd34855ba613c_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2335307 - Disclosure - TAXATION (Tables)", "role": "http://www.greenlightre.ky/role/TAXATIONTables", "shortName": "TAXATION (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i2f42c5a49a574425923dd34855ba613c_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i2f42c5a49a574425923dd34855ba613c_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2341308 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)", "role": "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESTables", "shortName": "COMMITMENTS AND CONTINGENCIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i2f42c5a49a574425923dd34855ba613c_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "id0695da7ea5a4c2d995e5630acda739f_I20210930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ReinsuranceRecoverablesAllowance", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical)", "role": "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical", "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "us-gaap:PreferredStockParOrStatedValuePerShare", "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "id0695da7ea5a4c2d995e5630acda739f_I20210930", "decimals": "INF", "lang": "en-US", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i2f42c5a49a574425923dd34855ba613c_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2346309 - Disclosure - SEGMENT REPORTING (Tables)", "role": "http://www.greenlightre.ky/role/SEGMENTREPORTINGTables", "shortName": "SEGMENT REPORTING (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i2f42c5a49a574425923dd34855ba613c_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "id0695da7ea5a4c2d995e5630acda739f_I20210930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2405401 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents (Details)", "role": "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESCashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsDetails", "shortName": "SIGNIFICANT ACCOUNTING POLICIES - Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R32": { "firstAnchor": { "ancestors": [ "ix:continuation", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "id0695da7ea5a4c2d995e5630acda739f_I20210930", "decimals": "-5", "first": true, "lang": "en-US", "name": "glre:FundsHeldByCedents", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2406402 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details)", "role": "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails", "shortName": "SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "ix:continuation", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i6cd1731919d44aa48cd13cc7af71142c_I20201231", "decimals": "-5", "lang": "en-US", "name": "glre:FundsHeldByCedents", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i261feb4692484cb49c8352137a643350_D20210701-20210930", "decimals": "-3", "first": true, "lang": "en-US", "name": "glre:DepositContractLiabilitiesNetInvestmentIncomeAllocationAccrued", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2407403 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Interest Income and Interest Expense (Details)", "role": "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESInterestIncomeandInterestExpenseDetails", "shortName": "SIGNIFICANT ACCOUNTING POLICIES - Interest Income and Interest Expense (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i261feb4692484cb49c8352137a643350_D20210701-20210930", "decimals": "-3", "first": true, "lang": "en-US", "name": "glre:DepositContractLiabilitiesNetInvestmentIncomeAllocationAccrued", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i261feb4692484cb49c8352137a643350_D20210701-20210930", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2408404 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Weighted Average Number of Shares (Details)", "role": "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESWeightedAverageNumberofSharesDetails", "shortName": "SIGNIFICANT ACCOUNTING POLICIES - Weighted Average Number of Shares (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i261feb4692484cb49c8352137a643350_D20210701-20210930", "decimals": "0", "lang": "en-US", "name": "glre:IncrementalCommonSharesAttributableToDilutiveEffectOfSharebasedPaymentArrangementsEmployeesAndDirectors", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i261feb4692484cb49c8352137a643350_D20210701-20210930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromRelatedParties", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2411405 - Disclosure - INVESTMENT IN RELATED PARTY INVESTMENT FUND - Narrative (Details)", "role": "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDNarrativeDetails", "shortName": "INVESTMENT IN RELATED PARTY INVESTMENT FUND - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i749dcfa46c63477491b09e8388d76f49_I20201231", "decimals": "3", "lang": "en-US", "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "id0695da7ea5a4c2d995e5630acda739f_I20210930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2412406 - Disclosure - INVESTMENT IN RELATED PARTY INVESTMENT FUND - Financial Information of Investment (Details)", "role": "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDFinancialInformationofInvestmentDetails", "shortName": "INVESTMENT IN RELATED PARTY INVESTMENT FUND - Financial Information of Investment (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:EquityMethodInvestmentsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i965bd0a5e08a48789bce03431ec2225b_I20210930", "decimals": "-3", "lang": "en-US", "name": "us-gaap:InvestmentsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i261feb4692484cb49c8352137a643350_D20210701-20210930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ManagementFeeExpense", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2413407 - Disclosure - INVESTMENT IN RELATED PARTY INVESTMENT FUND -Summarized Statement of Operations of Solasglas Investments, LP (Details)", "role": "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementofOperationsofSolasglasInvestmentsLPDetails", "shortName": "INVESTMENT IN RELATED PARTY INVESTMENT FUND -Summarized Statement of Operations of Solasglas Investments, LP (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i261feb4692484cb49c8352137a643350_D20210701-20210930", "decimals": "-3", "lang": "en-US", "name": "glre:EquityMethodInvestmentSummarizedFinancialInformationManagementFeeExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:InvestmentHoldingsOtherThanSecuritiesTextBlock", "ix:continuation", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "id0695da7ea5a4c2d995e5630acda739f_I20210930", "decimals": "-3", "first": true, "lang": "en-US", "name": "glre:OtherInvestmentsCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2416408 - Disclosure - FINANCIAL INSTRUMENTS - Other Investments (Details)", "role": "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSOtherInvestmentsDetails", "shortName": "FINANCIAL INSTRUMENTS - Other Investments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:InvestmentHoldingsOtherThanSecuritiesTextBlock", "ix:continuation", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "id0695da7ea5a4c2d995e5630acda739f_I20210930", "decimals": "-3", "first": true, "lang": "en-US", "name": "glre:OtherInvestmentsCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:InvestmentHoldingsOtherThanSecuritiesTextBlock", "ix:continuation", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "id0695da7ea5a4c2d995e5630acda739f_I20210930", "decimals": "-3", "first": true, "lang": "en-US", "name": "glre:OtherInvestmentsFairValueDisclosure", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2417409 - Disclosure - FINANCIAL INSTRUMENTS - Narrative (Details)", "role": "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSNarrativeDetails", "shortName": "FINANCIAL INSTRUMENTS - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i88a355dcfe5346e683f0ac7ebbd20950_D20210101-20210930", "decimals": "-5", "lang": "en-US", "name": "glre:RealizedGainsLossesOnSaleOfInvestmentsAndDerivatives", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i261feb4692484cb49c8352137a643350_D20210701-20210930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AssumedPremiumsWritten", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)", "role": "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i261feb4692484cb49c8352137a643350_D20210701-20210930", "decimals": "-3", "lang": "en-US", "name": "us-gaap:CededPremiumsWritten", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense", "ix:continuation", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "id0695da7ea5a4c2d995e5630acda739f_I20210930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReportedClaimsAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2420410 - Disclosure - LOSS AND LOSS ADJUSTMENT EXPENSE RESERVES - Liability for Unpaid Claims and Claims Adjustment Expense (Details)", "role": "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails", "shortName": "LOSS AND LOSS ADJUSTMENT EXPENSE RESERVES - Liability for Unpaid Claims and Claims Adjustment Expense (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense", "ix:continuation", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "id0695da7ea5a4c2d995e5630acda739f_I20210930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReportedClaimsAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i69a9dd7af2bf4a25a50334d3548cb65f_D20200701-20200930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:CededPremiumsEarned", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2422411 - Disclosure - RETROCESSION (Details)", "role": "http://www.greenlightre.ky/role/RETROCESSIONDetails", "shortName": "RETROCESSION (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i69a9dd7af2bf4a25a50334d3548cb65f_D20200701-20200930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:CededPremiumsEarned", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "id0695da7ea5a4c2d995e5630acda739f_I20210930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ConvertibleNotesPayable", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2424412 - Disclosure - SENIOR CONVERTIBLE NOTES (Details)", "role": "http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTESDetails", "shortName": "SENIOR CONVERTIBLE NOTES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "ic8453f4d99064075a3bee02c29dc771f_I20180807", "decimals": "INF", "lang": "en-US", "name": "us-gaap:DebtInstrumentFaceAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i5e875e4ca9af42979f93c9c6a803cce7_I20210504", "decimals": "INF", "first": true, "lang": "en-US", "name": "glre:DebtInstrumentAmountAuthorizedForRepurchase", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2427413 - Disclosure - SHARE CAPITAL - Narrative (Details)", "role": "http://www.greenlightre.ky/role/SHARECAPITALNarrativeDetails", "shortName": "SHARE CAPITAL - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i5e875e4ca9af42979f93c9c6a803cce7_I20210504", "decimals": "INF", "first": true, "lang": "en-US", "name": "glre:DebtInstrumentAmountAuthorizedForRepurchase", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i1a3d3e3bfb544107a6d5a25105696506_I20201231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockSharesOutstanding", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2428414 - Disclosure - SHARE CAPITAL - Stock by Class (Details)", "role": "http://www.greenlightre.ky/role/SHARECAPITALStockbyClassDetails", "shortName": "SHARE CAPITAL - Stock by Class (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfStockByClassTextBlock", "ix:continuation", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "ie9122f30b65640c2aa388e00c574ab77_I20191231", "decimals": "INF", "lang": "en-US", "name": "us-gaap:CommonStockSharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "id0695da7ea5a4c2d995e5630acda739f_I20210930", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2431415 - Disclosure - SHARE-BASED COMPENSATION - Narrative (Details)", "role": "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails", "shortName": "SHARE-BASED COMPENSATION - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "ida5431073dcc415397d03e4b1759a986_I20200930", "decimals": "INF", "lang": "en-US", "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i9b4bc9373c714a4aa9b4b27078fc27aa_I20201231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2432416 - Disclosure - SHARE-BASED COMPENSATION - Share-based Compensation, Restricted Stock Activity (Details)", "role": "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONSharebasedCompensationRestrictedStockActivityDetails", "shortName": "SHARE-BASED COMPENSATION - Share-based Compensation, Restricted Stock Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i506ae54a9fcf45d0aceac55c74f5aa3f_D20210101-20210930", "decimals": "INF", "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i3922182b09784654ba52e50f52efeb4a_I20201231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2433417 - Disclosure - SHARE-BASED COMPENSATION - Restricted Stock Units (Details)", "role": "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedStockUnitsDetails", "shortName": "SHARE-BASED COMPENSATION - Restricted Stock Units (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i199782a5c82a4875a96877ae89207ff7_D20210101-20210930", "decimals": "INF", "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "id0695da7ea5a4c2d995e5630acda739f_I20210930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DeferredTaxAssetsValuationAllowance", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2436418 - Disclosure - TAXATION - Narrative (Details)", "role": "http://www.greenlightre.ky/role/TAXATIONNarrativeDetails", "shortName": "TAXATION - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R49": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i261feb4692484cb49c8352137a643350_D20210701-20210930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CurrentIncomeTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2437419 - Disclosure - TAXATION - Components of Income Tax Expense (Benefit) (Details)", "role": "http://www.greenlightre.ky/role/TAXATIONComponentsofIncomeTaxExpenseBenefitDetails", "shortName": "TAXATION - Components of Income Tax Expense (Benefit) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i261feb4692484cb49c8352137a643350_D20210701-20210930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CurrentIncomeTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i261feb4692484cb49c8352137a643350_D20210701-20210930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ManagementFeeExpense", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical)", "role": "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSParenthetical", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": null }, "R50": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i1ed683f567b44e81bc40445a2904051f_I20210930", "decimals": "INF", "first": true, "lang": "en-US", "name": "glre:RelatedPartyTransactionInvestmentOwnedPercentage", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2439420 - Disclosure - RELATED PARTY TRANSACTIONS (Details)", "role": "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails", "shortName": "RELATED PARTY TRANSACTIONS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i1ed683f567b44e81bc40445a2904051f_I20210930", "decimals": "INF", "first": true, "lang": "en-US", "name": "glre:RelatedPartyTransactionInvestmentOwnedPercentage", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "span", "div", "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock", "ix:continuation", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "id0695da7ea5a4c2d995e5630acda739f_I20210930", "decimals": "INF", "first": true, "lang": "en-US", "name": "glre:NumberOfCreditFacilities", "reportCount": 1, "unitRef": "facility", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2442421 - Disclosure - COMMITMENTS AND CONTINGENCIES - Narrative (Details)", "role": "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails", "shortName": "COMMITMENTS AND CONTINGENCIES - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i6cd1731919d44aa48cd13cc7af71142c_I20201231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:LettersOfCreditOutstandingAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock", "ix:continuation", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i5d96f9a22e124b17842c6ed4e8e32289_I20210930", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2443422 - Disclosure - COMMITMENTS AND CONTINGENCIES - Letters of Credit Facilities (Details)", "role": "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESLettersofCreditFacilitiesDetails", "shortName": "COMMITMENTS AND CONTINGENCIES - Letters of Credit Facilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock", "ix:continuation", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i5d96f9a22e124b17842c6ed4e8e32289_I20210930", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "id0695da7ea5a4c2d995e5630acda739f_I20210930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2444423 - Disclosure - COMMITMENTS AND CONTINGENCIES - Commitments and Contingencies, Fiscal Year Maturity Schedule (Details)", "role": "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESCommitmentsandContingenciesFiscalYearMaturityScheduleDetails", "shortName": "COMMITMENTS AND CONTINGENCIES - Commitments and Contingencies, Fiscal Year Maturity Schedule (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "id0695da7ea5a4c2d995e5630acda739f_I20210930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i2f42c5a49a574425923dd34855ba613c_D20210101-20210930", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:NumberOfOperatingSegments", "reportCount": 1, "unique": true, "unitRef": "segment", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2447424 - Disclosure - SEGMENT REPORTING - Gross Premiums Written by Line of Business (Details)", "role": "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyLineofBusinessDetails", "shortName": "SEGMENT REPORTING - Gross Premiums Written by Line of Business (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i2f42c5a49a574425923dd34855ba613c_D20210101-20210930", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:NumberOfOperatingSegments", "reportCount": 1, "unique": true, "unitRef": "segment", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i261feb4692484cb49c8352137a643350_D20210701-20210930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AssumedPremiumsWritten", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2448425 - Disclosure - SEGMENT REPORTING - Gross Premiums Written by Geographic Area of Risks Insured (Details)", "role": "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyGeographicAreaofRisksInsuredDetails", "shortName": "SEGMENT REPORTING - Gross Premiums Written by Geographic Area of Risks Insured (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i4791791a0783490a82914262b56c7202_D20210701-20210930", "decimals": "-3", "lang": "en-US", "name": "us-gaap:AssumedPremiumsWritten", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i75d599b11c604c848b8bf578176083e7_I20191231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS\u2019 EQUITY (UNAUDITED)", "role": "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUNAUDITED", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS\u2019 EQUITY (UNAUDITED)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i75d599b11c604c848b8bf578176083e7_I20191231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i2f42c5a49a574425923dd34855ba613c_D20210101-20210930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1006007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)", "role": "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i2f42c5a49a574425923dd34855ba613c_D20210101-20210930", "decimals": "-3", "lang": "en-US", "name": "us-gaap:IncomeLossFromEquityMethodInvestments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i2f42c5a49a574425923dd34855ba613c_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2101101 - Disclosure - ORGANIZATION AND BASIS OF PRESENTATION", "role": "http://www.greenlightre.ky/role/ORGANIZATIONANDBASISOFPRESENTATION", "shortName": "ORGANIZATION AND BASIS OF PRESENTATION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i2f42c5a49a574425923dd34855ba613c_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i2f42c5a49a574425923dd34855ba613c_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2102102 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES", "role": "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIES", "shortName": "SIGNIFICANT ACCOUNTING POLICIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20210930.htm", "contextRef": "i2f42c5a49a574425923dd34855ba613c_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9999": { "firstAnchor": null, "groupType": "", "isDefault": "false", "longName": "Uncategorized Items - glre-20210930.htm", "role": "http://xbrl.sec.gov/role/uncategorizedFacts", "shortName": "Uncategorized Items - glre-20210930.htm", "subGroupType": "", "uniqueAnchor": null } }, "segmentCount": 67, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.greenlightre.ky/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.greenlightre.ky/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.greenlightre.ky/role/CoverPage" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.greenlightre.ky/role/CoverPage" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.greenlightre.ky/role/CoverPage" ], "xbrltype": "gYearItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Document Information [Line Items]", "terseLabel": "Document Information [Line Items]" } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.greenlightre.ky/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.", "label": "Document Information [Table]", "terseLabel": "Document Information [Table]" } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.greenlightre.ky/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.greenlightre.ky/role/CoverPage" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r596" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report", "terseLabel": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.greenlightre.ky/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r597" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.greenlightre.ky/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.greenlightre.ky/role/CoverPage" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.greenlightre.ky/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.greenlightre.ky/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.greenlightre.ky/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country", "terseLabel": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.greenlightre.ky/role/CoverPage" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.greenlightre.ky/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r598" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.greenlightre.ky/role/CoverPage" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.greenlightre.ky/role/CoverPage" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.greenlightre.ky/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.", "label": "Entity [Domain]", "terseLabel": "Entity [Domain]" } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDFinancialInformationofInvestmentDetails", "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementofOperationsofSolasglasInvestmentsLPDetails" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r598" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.greenlightre.ky/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.greenlightre.ky/role/CoverPage" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r598" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.greenlightre.ky/role/CoverPage" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.greenlightre.ky/role/CoverPage" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r601" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.greenlightre.ky/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r598" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.greenlightre.ky/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r598" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.greenlightre.ky/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r598" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.greenlightre.ky/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]", "terseLabel": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDFinancialInformationofInvestmentDetails", "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementofOperationsofSolasglasInvestmentsLPDetails" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.greenlightre.ky/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r594" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.greenlightre.ky/role/CoverPage" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r595" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.greenlightre.ky/role/CoverPage" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.greenlightre.ky/role/CoverPage" ], "xbrltype": "tradingSymbolItemType" }, "glre_AccuRiskHoldingsLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "AccuRisk Holdings LLC [Member]", "label": "AccuRisk Holdings LLC [Member]", "terseLabel": "AccuRisk Holdings LLC" } } }, "localname": "AccuRiskHoldingsLLCMember", "nsuri": "http://www.greenlightre.ky/20210930", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSNarrativeDetails" ], "xbrltype": "domainItemType" }, "glre_AmortizationAndInterestExpenseNet": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amortization And Interest Expense Net", "label": "Amortization And Interest Expense Net", "negatedTerseLabel": "Amortization and interest expense, net of change in accruals" } } }, "localname": "AmortizationAndInterestExpenseNet", "nsuri": "http://www.greenlightre.ky/20210930", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "glre_ChangeInUnrealizedGainsLossesOnInvestmentsAndDerivatives": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net increase (decrease) in fair value of unsold investments and derivatives not held for hedging whose gains and losses are included in net income.", "label": "Change In Unrealized Gains Losses On Investments And Derivatives", "negatedLabel": "Net change in unrealized gains and losses on investments and notes receivable" } } }, "localname": "ChangeInUnrealizedGainsLossesOnInvestmentsAndDerivatives", "nsuri": "http://www.greenlightre.ky/20210930", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "glre_CitibankEuropePlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Citibank Europe plc", "label": "Citibank Europe plc [Member]", "terseLabel": "Citibank Europe plc" } } }, "localname": "CitibankEuropePlcMember", "nsuri": "http://www.greenlightre.ky/20210930", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESLettersofCreditFacilitiesDetails" ], "xbrltype": "domainItemType" }, "glre_CollateralAssetsInvestementManagementAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Collateral Assets Investement Management Agreement [Member]", "label": "Collateral Assets Investement Management Agreement [Member]", "terseLabel": "Collateral Assets Investment Management Agreement" } } }, "localname": "CollateralAssetsInvestementManagementAgreementMember", "nsuri": "http://www.greenlightre.ky/20210930", "presentation": [ "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "domainItemType" }, "glre_CollateralHeldInTrust": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cash and securities posted as collateral by the retrocessionaire in a trust account for the benefit of the ceding reinsurer.", "label": "Collateral Held In Trust", "terseLabel": "Collateral held in trust" } } }, "localname": "CollateralHeldInTrust", "nsuri": "http://www.greenlightre.ky/20210930", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "glre_ContractualObligationToBePaidAfterYearFour": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESCommitmentsandContingenciesFiscalYearMaturityScheduleDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESCommitmentsandContingenciesFiscalYearMaturityScheduleDetails_1": { "order": 5.0, "parentTag": "us-gaap_ContractualObligation", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Contractual Obligation, To Be Paid, After Year Four", "label": "Contractual Obligation, To Be Paid, After Year Four", "totalLabel": "Thereafter" } } }, "localname": "ContractualObligationToBePaidAfterYearFour", "nsuri": "http://www.greenlightre.ky/20210930", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESCommitmentsandContingenciesFiscalYearMaturityScheduleDetails" ], "xbrltype": "monetaryItemType" }, "glre_DebtInstrumentAmountAuthorizedForRepurchase": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Amount Authorized For Repurchase", "label": "Debt Instrument, Amount Authorized For Repurchase", "terseLabel": "Debt instrument, amount authorized for repurchase (up to)" } } }, "localname": "DebtInstrumentAmountAuthorizedForRepurchase", "nsuri": "http://www.greenlightre.ky/20210930", "presentation": [ "http://www.greenlightre.ky/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "glre_DepositContractLiabilitiesNetInvestmentExpenseAllocationAccrued": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESInterestIncomeandInterestExpenseDetails": { "order": 2.0, "parentTag": "us-gaap_InterestIncomeExpenseNet", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deposit Contract Liabilities Net Investment Expense Allocation Accrued", "label": "Deposit Contract Liabilities Net Investment Expense Allocation Accrued", "negatedLabel": "Deposit interest expense" } } }, "localname": "DepositContractLiabilitiesNetInvestmentExpenseAllocationAccrued", "nsuri": "http://www.greenlightre.ky/20210930", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESInterestIncomeandInterestExpenseDetails" ], "xbrltype": "monetaryItemType" }, "glre_DepositContractLiabilitiesNetInvestmentIncomeAllocationAccrued": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESInterestIncomeandInterestExpenseDetails": { "order": 1.0, "parentTag": "us-gaap_InterestIncomeExpenseNet", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deposit Contract Liabilities Net Investment Income Allocation Accrued", "label": "Deposit Contract Liabilities Net Investment Income Allocation Accrued", "terseLabel": "Deposit interest income" } } }, "localname": "DepositContractLiabilitiesNetInvestmentIncomeAllocationAccrued", "nsuri": "http://www.greenlightre.ky/20210930", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESInterestIncomeandInterestExpenseDetails" ], "xbrltype": "monetaryItemType" }, "glre_DerivativeFinancialInstrumentsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Derivative Financial Instruments", "label": "Derivative Financial Instruments [Member]", "terseLabel": "Derivative financial instruments (not designated as hedging instruments)" } } }, "localname": "DerivativeFinancialInstrumentsMember", "nsuri": "http://www.greenlightre.ky/20210930", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSOtherInvestmentsDetails" ], "xbrltype": "domainItemType" }, "glre_DueFromBrokersFairValueDisclosure": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDFinancialInformationofInvestmentDetails": { "order": 4.0, "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Due From Brokers, Fair Value Disclosure", "label": "Due From Brokers, Fair Value Disclosure", "terseLabel": "Due from brokers" } } }, "localname": "DueFromBrokersFairValueDisclosure", "nsuri": "http://www.greenlightre.ky/20210930", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDFinancialInformationofInvestmentDetails" ], "xbrltype": "monetaryItemType" }, "glre_EquityMethodInvestmentSummarizedFinancialInformationGainLossOnInvestmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equity Method Investment, Summarized Financial Information, Gain (Loss) On Investment", "label": "Equity Method Investment, Summarized Financial Information, Gain (Loss) On Investment [Abstract]", "terseLabel": "Realized and change in unrealized gains (losses)" } } }, "localname": "EquityMethodInvestmentSummarizedFinancialInformationGainLossOnInvestmentAbstract", "nsuri": "http://www.greenlightre.ky/20210930", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementofOperationsofSolasglasInvestmentsLPDetails" ], "xbrltype": "stringItemType" }, "glre_EquityMethodInvestmentSummarizedFinancialInformationLiabilitiesAndPartnersCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equity Method Investment, Summarized Financial Information, Liabilities And Partners' Capital [Abstract]", "label": "Equity Method Investment, Summarized Financial Information, Liabilities And Partners' Capital [Abstract]", "terseLabel": "Liabilities and partners\u2019 capital" } } }, "localname": "EquityMethodInvestmentSummarizedFinancialInformationLiabilitiesAndPartnersCapitalAbstract", "nsuri": "http://www.greenlightre.ky/20210930", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDFinancialInformationofInvestmentDetails" ], "xbrltype": "stringItemType" }, "glre_EquityMethodInvestmentSummarizedFinancialInformationManagementFeeExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity Method Investment, Summarized Financial Information, Management Fee Expense", "label": "Equity Method Investment, Summarized Financial Information, Management Fee Expense", "terseLabel": "Management fees" } } }, "localname": "EquityMethodInvestmentSummarizedFinancialInformationManagementFeeExpense", "nsuri": "http://www.greenlightre.ky/20210930", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementofOperationsofSolasglasInvestmentsLPDetails" ], "xbrltype": "monetaryItemType" }, "glre_EstimatedVolatility": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Estimated Volatility", "label": "Estimated Volatility", "terseLabel": "Estimated volatility" } } }, "localname": "EstimatedVolatility", "nsuri": "http://www.greenlightre.ky/20210930", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSNarrativeDetails" ], "xbrltype": "percentItemType" }, "glre_FinancialGuaranteeInsuranceandSuretyProductLineMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Specialized insurance coverage relating to financial risks such as surety (surety bonds) and trade credit.", "label": "Financial Guarantee Insurance and Surety Product Line [Member]", "terseLabel": "Financial" } } }, "localname": "FinancialGuaranteeInsuranceandSuretyProductLineMember", "nsuri": "http://www.greenlightre.ky/20210930", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyLineofBusinessDetails" ], "xbrltype": "domainItemType" }, "glre_FundsHeldByCedents": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Funds Held By Cedents", "label": "Funds Held By Cedents", "terseLabel": "Funds held by cedents" } } }, "localname": "FundsHeldByCedents", "nsuri": "http://www.greenlightre.ky/20210930", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "glre_FundsHeldByCedentsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Funds Held by Cedents", "label": "Funds Held by Cedents [Policy Text Block]", "terseLabel": "Funds Held by Cedents" } } }, "localname": "FundsHeldByCedentsPolicyTextBlock", "nsuri": "http://www.greenlightre.ky/20210930", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "glre_GreenBricksPartnersIncGRBKMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Green Bricks Partners Inc (GRBK) [Member]", "label": "Green Bricks Partners Inc (GRBK) [Member]", "terseLabel": "Green Bricks Partners Inc (GRBK)" } } }, "localname": "GreenBricksPartnersIncGRBKMember", "nsuri": "http://www.greenlightre.ky/20210930", "presentation": [ "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "domainItemType" }, "glre_GreenlightCapitalReLimitedPartnersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Greenlight Capital Re Limited Partners [Member]", "label": "Greenlight Capital Re Limited Partners [Member]", "terseLabel": "Greenlight Capital Re Limited Partners" } } }, "localname": "GreenlightCapitalReLimitedPartnersMember", "nsuri": "http://www.greenlightre.ky/20210930", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDNarrativeDetails" ], "xbrltype": "domainItemType" }, "glre_IncrementalCommonSharesAttributableToDilutiveEffectOfSharebasedPaymentArrangementsEmployeesAndDirectors": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESWeightedAverageNumberofSharesDetails": { "order": 2.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements, Employees and Directors", "label": "Incremental Common Shares Attributable To Dilutive Effect Of Share-based Payment Arrangements, Employees And Directors", "terseLabel": "Effect of dilutive employee and director share-based awards (in shares)" } } }, "localname": "IncrementalCommonSharesAttributableToDilutiveEffectOfSharebasedPaymentArrangementsEmployeesAndDirectors", "nsuri": "http://www.greenlightre.ky/20210930", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESWeightedAverageNumberofSharesDetails" ], "xbrltype": "sharesItemType" }, "glre_IncurredLossesRelatedToAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Incurred Losses Related To [Abstract]", "label": "Incurred Losses Related To [Abstract]", "terseLabel": "Incurred losses related to:" } } }, "localname": "IncurredLossesRelatedToAbstract", "nsuri": "http://www.greenlightre.ky/20210930", "presentation": [ "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails" ], "xbrltype": "stringItemType" }, "glre_InterestAndDividendsPayableFairValueDisclosure": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDFinancialInformationofInvestmentDetails": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesFairValueDisclosure", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Interest And Dividends Payable, Fair Value Disclosure", "label": "Interest And Dividends Payable, Fair Value Disclosure", "negatedLabel": "Interest and dividends payable" } } }, "localname": "InterestAndDividendsPayableFairValueDisclosure", "nsuri": "http://www.greenlightre.ky/20210930", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDFinancialInformationofInvestmentDetails" ], "xbrltype": "monetaryItemType" }, "glre_InterestAndDividendsReceivableFairValueDisclosure": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDFinancialInformationofInvestmentDetails": { "order": 1.0, "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Interest And Dividends Receivable, Fair Value Disclosure", "label": "Interest And Dividends Receivable, Fair Value Disclosure", "terseLabel": "Interest and dividends receivable" } } }, "localname": "InterestAndDividendsReceivableFairValueDisclosure", "nsuri": "http://www.greenlightre.ky/20210930", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDFinancialInformationofInvestmentDetails" ], "xbrltype": "monetaryItemType" }, "glre_InterestAndNoninterestExpenses": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementofOperationsofSolasglasInvestmentsLPDetails": { "order": 1.0, "parentTag": "us-gaap_NetInvestmentIncome", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Interest And Noninterest Expenses", "label": "Interest And Noninterest Expenses", "negatedTotalLabel": "Total expenses" } } }, "localname": "InterestAndNoninterestExpenses", "nsuri": "http://www.greenlightre.ky/20210930", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementofOperationsofSolasglasInvestmentsLPDetails" ], "xbrltype": "monetaryItemType" }, "glre_InvestmentAdvisoryAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investment Advisory Agreement [Member]", "label": "Investment Advisory Agreement [Member]", "terseLabel": "Investment Advisory Agreement" } } }, "localname": "InvestmentAdvisoryAgreementMember", "nsuri": "http://www.greenlightre.ky/20210930", "presentation": [ "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "domainItemType" }, "glre_InvestmentIncome": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED": { "order": 3.0, "parentTag": "us-gaap_Revenues", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net income earned from investments in securities and other investments including derivatives. It includes dividends from shares in corporations, and interest from bonds, loans, mortgages, derivatives, commercial paper, bank accounts, certificates of deposits, treasuries, and other financial securities. It also includes realized and unrealized gains and losses on all investments.", "label": "Investment Income", "terseLabel": "Net investment income (loss)" } } }, "localname": "InvestmentIncome", "nsuri": "http://www.greenlightre.ky/20210930", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "glre_InvestmentSoldNoteYetPurchasedFairValueDisclosure": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDFinancialInformationofInvestmentDetails": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesFairValueDisclosure", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Investment Sold Note Yet Purchased, Fair Value Disclosure", "label": "Investment Sold Note Yet Purchased, Fair Value Disclosure", "negatedLabel": "Investments sold short, at fair value" } } }, "localname": "InvestmentSoldNoteYetPurchasedFairValueDisclosure", "nsuri": "http://www.greenlightre.ky/20210930", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDFinancialInformationofInvestmentDetails" ], "xbrltype": "monetaryItemType" }, "glre_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESCommitmentsandContingenciesFiscalYearMaturityScheduleDetails": { "order": 2.0, "parentTag": "glre_ContractualObligationToBePaidAfterYearFour", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Lessee, Operating Lease, Liability, To Be Paid, After Year Four", "label": "Lessee, Operating Lease, Liability, To Be Paid, After Year Four", "terseLabel": "Thereafter" } } }, "localname": "LesseeOperatingLeaseLiabilityToBePaidAfterYearFour", "nsuri": "http://www.greenlightre.ky/20210930", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESCommitmentsandContingenciesFiscalYearMaturityScheduleDetails" ], "xbrltype": "monetaryItemType" }, "glre_LiabilityandCasualtyInsuranceProductLineMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Total casualty line of business for insurance operations", "label": "Liability and Casualty Insurance Product Line [Member]", "terseLabel": "Total Casualty" } } }, "localname": "LiabilityandCasualtyInsuranceProductLineMember", "nsuri": "http://www.greenlightre.ky/20210930", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyLineofBusinessDetails" ], "xbrltype": "domainItemType" }, "glre_LimitedPartnershipAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Limited Partnership Agreement between SILP and its partners", "label": "Limited Partnership Agreement [Member]", "terseLabel": "SILP" } } }, "localname": "LimitedPartnershipAgreementMember", "nsuri": "http://www.greenlightre.ky/20210930", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDNarrativeDetails", "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "domainItemType" }, "glre_LineOfCreditFacilityTerminationNoticePeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Termination notice period for LOC facilities", "label": "Line Of Credit Facility, Termination Notice Period", "verboseLabel": "Notice period required for termination" } } }, "localname": "LineOfCreditFacilityTerminationNoticePeriod", "nsuri": "http://www.greenlightre.ky/20210930", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESLettersofCreditFacilitiesDetails" ], "xbrltype": "durationItemType" }, "glre_LongTermDebtMaturityAfterYearFour": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESCommitmentsandContingenciesFiscalYearMaturityScheduleDetails": { "order": 5.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Long-Term Debt, Maturity, After Year Four", "label": "Long-Term Debt, Maturity, After Year Four", "terseLabel": "Thereafter" } } }, "localname": "LongTermDebtMaturityAfterYearFour", "nsuri": "http://www.greenlightre.ky/20210930", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESCommitmentsandContingenciesFiscalYearMaturityScheduleDetails" ], "xbrltype": "monetaryItemType" }, "glre_MarineCasualtyInsuranceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Marine Casualty Insurance [Member]", "label": "Marine Casualty Insurance [Member]", "terseLabel": "Marine" } } }, "localname": "MarineCasualtyInsuranceMember", "nsuri": "http://www.greenlightre.ky/20210930", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyLineofBusinessDetails" ], "xbrltype": "domainItemType" }, "glre_MotorVehicleLiabilityCasualtyProductLineMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Motor liability line of business for insurance operations", "label": "Motor Vehicle Liability Casualty Product Line [Member]", "terseLabel": "Motor Liability" } } }, "localname": "MotorVehicleLiabilityCasualtyProductLineMember", "nsuri": "http://www.greenlightre.ky/20210930", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyLineofBusinessDetails" ], "xbrltype": "domainItemType" }, "glre_MotorVehiclePhysicalDamageProductLineMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Motor physical damage line of business for insurance operations", "label": "Motor Vehicle Physical Damage Product Line [Member]", "terseLabel": "Motor" } } }, "localname": "MotorVehiclePhysicalDamageProductLineMember", "nsuri": "http://www.greenlightre.ky/20210930", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyLineofBusinessDetails" ], "xbrltype": "domainItemType" }, "glre_MultilineMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Multi-line [Member]", "label": "Multi-line [Member]", "terseLabel": "Multi-line" } } }, "localname": "MultilineMember", "nsuri": "http://www.greenlightre.ky/20210930", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyLineofBusinessDetails" ], "xbrltype": "domainItemType" }, "glre_NetAssetsFairValueDisclosure": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDFinancialInformationofInvestmentDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Net Assets, Fair Value Disclosure", "label": "Net Assets, Fair Value Disclosure", "totalLabel": "Net Assets" } } }, "localname": "NetAssetsFairValueDisclosure", "nsuri": "http://www.greenlightre.ky/20210930", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDFinancialInformationofInvestmentDetails" ], "xbrltype": "monetaryItemType" }, "glre_NonEmployeeDirectorMemberMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Non Employee Director Member", "label": "Non Employee Director Member [Member]", "terseLabel": "Non Employee Director Member" } } }, "localname": "NonEmployeeDirectorMemberMember", "nsuri": "http://www.greenlightre.ky/20210930", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "domainItemType" }, "glre_NumberOfCreditFacilities": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number Of Credit Facilities", "label": "Number Of Credit Facilities", "terseLabel": "Number of credit facilities" } } }, "localname": "NumberOfCreditFacilities", "nsuri": "http://www.greenlightre.ky/20210930", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails" ], "xbrltype": "integerItemType" }, "glre_OperatingLeaseRenewalTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Operating Lease, Renewal Term", "label": "Operating Lease, Renewal Term", "terseLabel": "Operating lease renewal term" } } }, "localname": "OperatingLeaseRenewalTerm", "nsuri": "http://www.greenlightre.ky/20210930", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails" ], "xbrltype": "durationItemType" }, "glre_OtherAssetsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of immaterial items aggregated and included under the Other Assets line item on the balance sheet.", "label": "Other Assets [Policy Text Block]", "terseLabel": "Other Assets" } } }, "localname": "OtherAssetsPolicyTextBlock", "nsuri": "http://www.greenlightre.ky/20210930", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "glre_OtherInvestmentsAccumulatedGrossUnrealizedHoldingGain": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSOtherInvestmentsDetails": { "order": 1.0, "parentTag": "glre_OtherInvestmentsCost", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Other Investments, Accumulated Gross Unrealized Holding Gain", "label": "Other Investments, Accumulated Gross Unrealized Holding Gain", "terseLabel": "Unrealized gains" } } }, "localname": "OtherInvestmentsAccumulatedGrossUnrealizedHoldingGain", "nsuri": "http://www.greenlightre.ky/20210930", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSOtherInvestmentsDetails" ], "xbrltype": "monetaryItemType" }, "glre_OtherInvestmentsAccumulatedGrossUnrealizedHoldingLoss": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSOtherInvestmentsDetails": { "order": 2.0, "parentTag": "glre_OtherInvestmentsCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Other Investments, Accumulated Gross Unrealized Holding Loss", "label": "Other Investments, Accumulated Gross Unrealized Holding Loss", "negatedLabel": "Unrealized losses" } } }, "localname": "OtherInvestmentsAccumulatedGrossUnrealizedHoldingLoss", "nsuri": "http://www.greenlightre.ky/20210930", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSOtherInvestmentsDetails" ], "xbrltype": "monetaryItemType" }, "glre_OtherInvestmentsAdjustment": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Other Investments, Adjustment", "label": "Other Investments, Adjustment", "terseLabel": "Other investments, adjustment" } } }, "localname": "OtherInvestmentsAdjustment", "nsuri": "http://www.greenlightre.ky/20210930", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "glre_OtherInvestmentsAdjustmentNet": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Other Investments, Adjustment, Net", "label": "Other Investments, Adjustment, Net", "terseLabel": "Other investments, adjustment, net" } } }, "localname": "OtherInvestmentsAdjustmentNet", "nsuri": "http://www.greenlightre.ky/20210930", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "glre_OtherInvestmentsCost": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSOtherInvestmentsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Other Investments, Cost", "label": "Other Investments, Cost", "totalLabel": "Cost" } } }, "localname": "OtherInvestmentsCost", "nsuri": "http://www.greenlightre.ky/20210930", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSOtherInvestmentsDetails" ], "xbrltype": "monetaryItemType" }, "glre_OtherInvestmentsFairValueDisclosure": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSOtherInvestmentsDetails": { "order": 3.0, "parentTag": "glre_OtherInvestmentsCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Other Investments, Fair Value Disclosure", "label": "Other Investments, Fair Value Disclosure", "terseLabel": "Fair value / carrying value" } } }, "localname": "OtherInvestmentsFairValueDisclosure", "nsuri": "http://www.greenlightre.ky/20210930", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSNarrativeDetails", "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSOtherInvestmentsDetails" ], "xbrltype": "monetaryItemType" }, "glre_OtherLiabilitiesPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of items aggregated and included under Other Liabilities on the balance sheet.", "label": "Other Liabilities [Policy Text Block]", "terseLabel": "Other Liabilities" } } }, "localname": "OtherLiabilitiesPolicyTextBlock", "nsuri": "http://www.greenlightre.ky/20210930", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "glre_PaidLossesRelatedToAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Paid Losses Related To [Abstract]", "label": "Paid Losses Related To [Abstract]", "terseLabel": "Paid losses related to:" } } }, "localname": "PaidLossesRelatedToAbstract", "nsuri": "http://www.greenlightre.ky/20210930", "presentation": [ "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails" ], "xbrltype": "stringItemType" }, "glre_PayablesToBrokerDealersFairValueDisclosure": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDFinancialInformationofInvestmentDetails": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesFairValueDisclosure", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payables To Broker-Dealers, Fair Value Disclosure", "label": "Payables To Broker-Dealers, Fair Value Disclosure", "negatedLabel": "Due to brokers" } } }, "localname": "PayablesToBrokerDealersFairValueDisclosure", "nsuri": "http://www.greenlightre.ky/20210930", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDFinancialInformationofInvestmentDetails" ], "xbrltype": "monetaryItemType" }, "glre_PremiumsWrittenGrossAsPercentageOfTotalGrossPremiumsWritten": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Gross written premiums by line of business as a percentage of total gross written premiums", "label": "Premiums Written, Gross As Percentage Of Total Gross Premiums Written", "terseLabel": "Gross premiums written (in percent)" } } }, "localname": "PremiumsWrittenGrossAsPercentageOfTotalGrossPremiumsWritten", "nsuri": "http://www.greenlightre.ky/20210930", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyGeographicAreaofRisksInsuredDetails", "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyLineofBusinessDetails" ], "xbrltype": "percentItemType" }, "glre_PrivateAndUnlistedEquitySecuritiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Private equities and unlisted equity securities", "label": "Private and unlisted equity securities [Member]", "terseLabel": "Private investments and unlisted equities" } } }, "localname": "PrivateAndUnlistedEquitySecuritiesMember", "nsuri": "http://www.greenlightre.ky/20210930", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSNarrativeDetails", "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSOtherInvestmentsDetails" ], "xbrltype": "domainItemType" }, "glre_ProfessionalFeesAndOtherNoninterestExpense": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementofOperationsofSolasglasInvestmentsLPDetails": { "order": 3.0, "parentTag": "glre_InterestAndNoninterestExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Professional Fees And Other Noninterest Expense", "label": "Professional Fees And Other Noninterest Expense", "negatedLabel": "Professional fees and other" } } }, "localname": "ProfessionalFeesAndOtherNoninterestExpense", "nsuri": "http://www.greenlightre.ky/20210930", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementofOperationsofSolasglasInvestmentsLPDetails" ], "xbrltype": "monetaryItemType" }, "glre_RealizedGainsLossesOnSaleOfInvestmentsAndDerivatives": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net realized gains (losses) on investments and derivatives sold during the period.", "label": "Realized Gains Losses On Sale Of Investments And Derivatives", "negatedLabel": "Net realized (gains)\u00a0losses on investments and notes receivable", "terseLabel": "Realized gains losses on sale of investments and derivatives" } } }, "localname": "RealizedGainsLossesOnSaleOfInvestmentsAndDerivatives", "nsuri": "http://www.greenlightre.ky/20210930", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED", "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "glre_RelatedPartyTransactionAnnualManagementFeePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The annual rate charged by investment advisor calculated as a percentage of assets under management", "label": "Related Party Transaction, Annual Management Fee Percentage", "terseLabel": "Investment management fee rate - annual" } } }, "localname": "RelatedPartyTransactionAnnualManagementFeePercentage", "nsuri": "http://www.greenlightre.ky/20210930", "presentation": [ "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "percentItemType" }, "glre_RelatedPartyTransactionAssetRedemptionNoticeToGeneralPartner": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related Party Transaction, Asset Redemption Notice To General Partner", "label": "Related Party Transaction, Asset Redemption Notice To General Partner", "terseLabel": "Asset redemption notice to general partner" } } }, "localname": "RelatedPartyTransactionAssetRedemptionNoticeToGeneralPartner", "nsuri": "http://www.greenlightre.ky/20210930", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDNarrativeDetails" ], "xbrltype": "durationItemType" }, "glre_RelatedPartyTransactionInvestmentOwnedPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related Party Transaction, Investment Owned, Percentage", "label": "Related Party Transaction, Investment Owned, Percentage", "terseLabel": "Ownership percentage" } } }, "localname": "RelatedPartyTransactionInvestmentOwnedPercentage", "nsuri": "http://www.greenlightre.ky/20210930", "presentation": [ "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "percentItemType" }, "glre_RelatedPartyTransactionLossCarryForwardRecoupmentRequiredAsPercentageOfAggregateInvestmentLossEarned": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The additional amount of investment income required after a period of investment loss, in order for the performance compensation rate to return from reduced rate to full rate.", "label": "Related Party Transaction, Loss Carry Forward Recoupment Required As Percentage Of Aggregate Investment Loss Earned", "terseLabel": "Loss carry forward recoupment required" } } }, "localname": "RelatedPartyTransactionLossCarryForwardRecoupmentRequiredAsPercentageOfAggregateInvestmentLossEarned", "nsuri": "http://www.greenlightre.ky/20210930", "presentation": [ "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "percentItemType" }, "glre_RelatedPartyTransactionMonthlyManagementFeePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The monthly rate charged by investment advisor calculated as a percentage of assets under management", "label": "Related Party Transaction, Monthly Management Fee Percentage", "terseLabel": "Investment management fee rate - monthly" } } }, "localname": "RelatedPartyTransactionMonthlyManagementFeePercentage", "nsuri": "http://www.greenlightre.ky/20210930", "presentation": [ "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "percentItemType" }, "glre_RelatedPartyTransactionPerformanceCompensationFullRateAsPercentageOfInvestmentIncome": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The full rate of performance compensation as a percent of investment income charged by a related party.", "label": "Related Party Transaction, Performance Compensation Full Rate As Percentage Of Investment Income", "terseLabel": "Performance compensation full rate" } } }, "localname": "RelatedPartyTransactionPerformanceCompensationFullRateAsPercentageOfInvestmentIncome", "nsuri": "http://www.greenlightre.ky/20210930", "presentation": [ "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "percentItemType" }, "glre_RelatedPartyTransactionPerformanceCompensationReducedRateAsPercentageofInvestmentIncome": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The reduced rate charged by related party for performance compensation as a percent of investment income due to loss carry forward provision.", "label": "Related Party Transaction, Performance Compensation Reduced Rate As Percentage of Investment Income", "terseLabel": "Performance compensation reduced rate" } } }, "localname": "RelatedPartyTransactionPerformanceCompensationReducedRateAsPercentageofInvestmentIncome", "nsuri": "http://www.greenlightre.ky/20210930", "presentation": [ "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "percentItemType" }, "glre_RelatedPartyTransactionPerformanceCompensationReducedRateasaPercentageofInvestmentIncome": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The reduced rate charged by related party for performance compensation as a percent of investment income due to loss carry forward provision.", "label": "Related Party Transaction, Performance Compensation Reduced Rate as a Percentage of Investment Income", "terseLabel": "Performance compensation reduced rate as a percentage of investment income" } } }, "localname": "RelatedPartyTransactionPerformanceCompensationReducedRateasaPercentageofInvestmentIncome", "nsuri": "http://www.greenlightre.ky/20210930", "presentation": [ "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "percentItemType" }, "glre_RelatedPartyTransactionsAutomaticAgreementExtensionTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related Party Transactions, Automatic Agreement Extension, Term", "label": "Related Party Transactions, Automatic Agreement Extension, Term", "terseLabel": "Automatic agreement extension, term" } } }, "localname": "RelatedPartyTransactionsAutomaticAgreementExtensionTerm", "nsuri": "http://www.greenlightre.ky/20210930", "presentation": [ "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "durationItemType" }, "glre_RelatedPartyTransactionsContractTerminationPriorNoticePeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related Party Transactions, Contract Termination Prior Notice Period", "label": "Related Party Transactions, Contract Termination Prior Notice Period", "terseLabel": "Contract termination prior notice period" } } }, "localname": "RelatedPartyTransactionsContractTerminationPriorNoticePeriod", "nsuri": "http://www.greenlightre.ky/20210930", "presentation": [ "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "durationItemType" }, "glre_RiskFreeRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Risk Free Rate", "label": "Risk Free Rate", "terseLabel": "Risk free rate" } } }, "localname": "RiskFreeRate", "nsuri": "http://www.greenlightre.ky/20210930", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSNarrativeDetails" ], "xbrltype": "percentItemType" }, "glre_SILPMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "SILP [Member] Solasglas Investments, LP", "label": "SILP [Member]", "terseLabel": "SILP" } } }, "localname": "SILPMember", "nsuri": "http://www.greenlightre.ky/20210930", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDNarrativeDetails" ], "xbrltype": "domainItemType" }, "glre_SeniorUnsecuredConvertibleNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Senior Unsecured Convertible Notes [Member]", "label": "Senior Unsecured Convertible Notes [Member]", "terseLabel": "Senior Unsecured Convertible Notes" } } }, "localname": "SeniorUnsecuredConvertibleNotesMember", "nsuri": "http://www.greenlightre.ky/20210930", "presentation": [ "http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTESDetails", "http://www.greenlightre.ky/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "domainItemType" }, "glre_ServiceAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Service Agreement [Member]", "label": "Service Agreement [Member]", "terseLabel": "Service Agreement" } } }, "localname": "ServiceAgreementMember", "nsuri": "http://www.greenlightre.ky/20210930", "presentation": [ "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "domainItemType" }, "glre_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionRatio": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Conversion Ratio", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Conversion Ratio", "terseLabel": "Conversion ratio (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionRatio", "nsuri": "http://www.greenlightre.ky/20210930", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "sharesItemType" }, "glre_SolasglasInvestmentLPSILPMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Solasglas Investment LP (SILP) [Member]", "label": "Solasglas Investment LP (SILP) [Member]", "terseLabel": "Solasglas Investment LP (silp)" } } }, "localname": "SolasglasInvestmentLPSILPMember", "nsuri": "http://www.greenlightre.ky/20210930", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDFinancialInformationofInvestmentDetails", "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementofOperationsofSolasglasInvestmentsLPDetails" ], "xbrltype": "domainItemType" }, "glre_TotalSpecialtyDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Total of all Specialty lines insurance products types [Domain]", "label": "Total Specialty [Domain]", "terseLabel": "Total Other" } } }, "localname": "TotalSpecialtyDomain", "nsuri": "http://www.greenlightre.ky/20210930", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyLineofBusinessDetails" ], "xbrltype": "domainItemType" }, "glre_UnratedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "No rating assigned by any external rating agencies.", "label": "Unrated [Member]", "terseLabel": "Unrated" } } }, "localname": "UnratedMember", "nsuri": "http://www.greenlightre.ky/20210930", "presentation": [ "http://www.greenlightre.ky/role/RETROCESSIONDetails" ], "xbrltype": "domainItemType" }, "glre_WorkersCompensationInsuranceProductLineMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Workers' compensation line of business of insurance coverage", "label": "Workers' Compensation Insurance Product Line [Member]", "terseLabel": "Workers' Compensation" } } }, "localname": "WorkersCompensationInsuranceProductLineMember", "nsuri": "http://www.greenlightre.ky/20210930", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyLineofBusinessDetails" ], "xbrltype": "domainItemType" }, "glre_WorldwideMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Worldwide", "label": "Worldwide [Member]", "terseLabel": "Worldwide" } } }, "localname": "WorldwideMember", "nsuri": "http://www.greenlightre.ky/20210930", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyGeographicAreaofRisksInsuredDetails" ], "xbrltype": "domainItemType" }, "srt_AMBestAMinusRatingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A- credit rating as defined by the external credit rating agency, AM Best.", "label": "AM Best, A- Rating [Member]", "terseLabel": "AM Best, A- Rating" } } }, "localname": "AMBestAMinusRatingMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/RETROCESSIONDetails" ], "xbrltype": "domainItemType" }, "srt_AffiliatedEntityMember": { "auth_ref": [ "r295", "r430", "r431", "r434", "r591", "r604" ], "lang": { "en-us": { "role": { "documentation": "An affiliate is a party that, directly or indirectly through one or more intermediaries, controls, is controlled by, or is under common control with the entity.", "label": "Affiliated Entity [Member]", "terseLabel": "Affiliated Entity" } } }, "localname": "AffiliatedEntityMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "domainItemType" }, "srt_AsiaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Continent of Asia.", "label": "Asia [Member]", "terseLabel": "Asia" } } }, "localname": "AsiaMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyGeographicAreaofRisksInsuredDetails" ], "xbrltype": "domainItemType" }, "srt_BoardOfDirectorsChairmanMember": { "auth_ref": [ "r166" ], "lang": { "en-us": { "role": { "documentation": "Leader of board of directors.", "label": "Board of Directors Chairman [Member]", "terseLabel": "Board of Directors Chairman" } } }, "localname": "BoardOfDirectorsChairmanMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "domainItemType" }, "srt_ChiefExecutiveOfficerMember": { "auth_ref": [ "r166" ], "lang": { "en-us": { "role": { "documentation": "Person with designation of chief executive officer.", "label": "Chief Executive Officer [Member]", "terseLabel": "Chief Executive Officer" } } }, "localname": "ChiefExecutiveOfficerMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_ConsolidatedEntitiesAxis": { "auth_ref": [ "r89", "r212", "r217", "r223", "r364", "r365", "r366", "r367", "r437", "r591", "r604", "r614", "r615", "r616" ], "lang": { "en-us": { "role": { "documentation": "Information by consolidated entity or group of entities.", "label": "Consolidated Entities [Axis]", "terseLabel": "Consolidated Entities [Axis]" } } }, "localname": "ConsolidatedEntitiesAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_ConsolidatedEntitiesDomain": { "auth_ref": [ "r89", "r212", "r217", "r223", "r364", "r365", "r366", "r367", "r437", "r591", "r604", "r614", "r615", "r616" ], "lang": { "en-us": { "role": { "documentation": "Entity or group of entities consolidated into reporting entity.", "label": "Consolidated Entities [Domain]", "terseLabel": "Consolidated Entities [Domain]" } } }, "localname": "ConsolidatedEntitiesDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock": { "auth_ref": [ "r600" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of contractual obligation by timing of payment due. Includes, but is not limited to, long-term debt obligation, lease obligation, and purchase obligation.", "label": "Contractual Obligation, Fiscal Year Maturity [Table Text Block]", "terseLabel": "Schedule of Commitments and Contingencies, Fiscal Year Maturity Schedule" } } }, "localname": "ContractualObligationFiscalYearMaturityScheduleTableTextBlock", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESTables" ], "xbrltype": "textBlockItemType" }, "srt_CounterpartyNameAxis": { "auth_ref": [ "r36", "r38", "r86", "r87", "r230", "r269", "r617" ], "lang": { "en-us": { "role": { "documentation": "Information by name of counterparty. A counterparty is the other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution.", "label": "Counterparty Name [Axis]", "terseLabel": "Counterparty Name [Axis]" } } }, "localname": "CounterpartyNameAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSNarrativeDetails", "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "stringItemType" }, "srt_CreditRatingAMBestAxis": { "auth_ref": [ "r168", "r193", "r194", "r207", "r376" ], "lang": { "en-us": { "role": { "documentation": "Information by AM Best rating.", "label": "Credit Rating, AM Best [Axis]", "terseLabel": "Credit Rating Source [Axis]" } } }, "localname": "CreditRatingAMBestAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/RETROCESSIONDetails" ], "xbrltype": "stringItemType" }, "srt_CreditRatingAMBestDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Credit rating as defined by AM Best.", "label": "Credit Rating, AM Best [Domain]", "terseLabel": "Credit Rating Source [Domain]" } } }, "localname": "CreditRatingAMBestDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/RETROCESSIONDetails" ], "xbrltype": "domainItemType" }, "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": { "auth_ref": [ "r2", "r94", "r102", "r108", "r185", "r327", "r328", "r329", "r351", "r352", "r382", "r385", "r387", "r388", "r620" ], "lang": { "en-us": { "role": { "documentation": "Increase (decrease) to financial statements for cumulative-effect adjustment in period of adoption of amendment to accounting standards.", "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]", "terseLabel": "Cumulative Effect, Period of Adoption, Adjustment" } } }, "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUNAUDITED" ], "xbrltype": "domainItemType" }, "srt_CumulativeEffectPeriodOfAdoptionAxis": { "auth_ref": [ "r2", "r94", "r102", "r108", "r185", "r327", "r328", "r329", "r351", "r352", "r382", "r385", "r387", "r388", "r620" ], "lang": { "en-us": { "role": { "documentation": "Information by cumulative-effect adjustment to financial statements in period of adoption of amendment to accounting standards.", "label": "Cumulative Effect, Period of Adoption [Axis]", "terseLabel": "Cumulative Effect, Period Of Adoption [Axis]" } } }, "localname": "CumulativeEffectPeriodOfAdoptionAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUNAUDITED" ], "xbrltype": "stringItemType" }, "srt_CumulativeEffectPeriodOfAdoptionDomain": { "auth_ref": [ "r2", "r94", "r102", "r108", "r185", "r327", "r328", "r329", "r351", "r352", "r382", "r385", "r387", "r388", "r620" ], "lang": { "en-us": { "role": { "documentation": "Cumulative-effect adjustment to financial statements in period of adoption of amendment to accounting standards.", "label": "Cumulative Effect, Period of Adoption [Domain]", "terseLabel": "Cumulative Effect, Period Of Adoption [Domain]" } } }, "localname": "CumulativeEffectPeriodOfAdoptionDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUNAUDITED" ], "xbrltype": "domainItemType" }, "srt_EuropeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Continent of Europe.", "label": "Europe [Member]", "terseLabel": "Europe" } } }, "localname": "EuropeMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyGeographicAreaofRisksInsuredDetails" ], "xbrltype": "domainItemType" }, "srt_MaximumMember": { "auth_ref": [ "r229", "r268", "r296", "r298", "r442", "r443", "r444", "r445", "r446", "r447", "r449", "r528", "r531", "r592", "r593" ], "lang": { "en-us": { "role": { "documentation": "Upper limit of the provided range.", "label": "Maximum [Member]", "terseLabel": "Maximum" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails", "http://www.greenlightre.ky/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r229", "r268", "r296", "r298", "r442", "r443", "r444", "r445", "r446", "r447", "r449", "r528", "r531", "r592", "r593" ], "lang": { "en-us": { "role": { "documentation": "Lower limit of the provided range.", "label": "Minimum [Member]", "terseLabel": "Minimum" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails", "http://www.greenlightre.ky/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_NorthAmericaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Continent of North America.", "label": "North America [Member]", "terseLabel": "U.S. and Caribbean" } } }, "localname": "NorthAmericaMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyGeographicAreaofRisksInsuredDetails" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r159", "r291", "r292", "r450", "r527", "r529" ], "lang": { "en-us": { "role": { "documentation": "Information by product and service, or group of similar products and similar services.", "label": "Product and Service [Axis]", "terseLabel": "Product and Service [Axis]", "verboseLabel": "Insurance Product Line [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails", "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyLineofBusinessDetails" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r159", "r291", "r292", "r450", "r527", "r529" ], "lang": { "en-us": { "role": { "documentation": "Product or service, or a group of similar products or similar services.", "label": "Product and Service [Domain]", "verboseLabel": "Insurance Product Line [Domain]" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails", "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyLineofBusinessDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r229", "r268", "r294", "r296", "r298", "r442", "r443", "r444", "r445", "r446", "r447", "r449", "r528", "r531", "r592", "r593" ], "lang": { "en-us": { "role": { "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.", "label": "Statistical Measurement [Axis]", "terseLabel": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails", "http://www.greenlightre.ky/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r229", "r268", "r294", "r296", "r298", "r442", "r443", "r444", "r445", "r446", "r447", "r449", "r528", "r531", "r592", "r593" ], "lang": { "en-us": { "role": { "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.", "label": "Statistical Measurement [Domain]", "terseLabel": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails", "http://www.greenlightre.ky/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "auth_ref": [ "r37", "r38", "r86", "r87", "r230", "r269" ], "lang": { "en-us": { "role": { "documentation": "Named other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution.", "label": "Counterparty Name [Domain]", "terseLabel": "Counterparty Name [Domain]" } } }, "localname": "RepurchaseAgreementCounterpartyNameDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSNarrativeDetails", "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioForecastMember": { "auth_ref": [ "r103", "r297", "r602" ], "lang": { "en-us": { "role": { "documentation": "Information reported for future period. Excludes information expected to be reported in future period for effect on historical fact.", "label": "Forecast [Member]", "terseLabel": "Forecast" } } }, "localname": "ScenarioForecastMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioUnspecifiedDomain": { "auth_ref": [ "r103", "r108", "r297" ], "lang": { "en-us": { "role": { "documentation": "Scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts.", "label": "Scenario [Domain]", "terseLabel": "Scenario [Domain]" } } }, "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [ "r160", "r161", "r291", "r293", "r530", "r582", "r583", "r584", "r585", "r586", "r587", "r588", "r589", "r590", "r603", "r606", "r607", "r608", "r609", "r610", "r611", "r612", "r613" ], "lang": { "en-us": { "role": { "documentation": "Geographical area.", "label": "Geographical [Domain]", "terseLabel": "Geographical [Domain]" } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyGeographicAreaofRisksInsuredDetails" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r160", "r161", "r291", "r293", "r530", "r580", "r582", "r583", "r584", "r585", "r586", "r587", "r588", "r589", "r590", "r603", "r605" ], "lang": { "en-us": { "role": { "documentation": "Information by geographical components.", "label": "Geographical [Axis]", "terseLabel": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyGeographicAreaofRisksInsuredDetails" ], "xbrltype": "stringItemType" }, "srt_StatementScenarioAxis": { "auth_ref": [ "r103", "r108", "r204", "r297", "r441" ], "lang": { "en-us": { "role": { "documentation": "Information by scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts.", "label": "Scenario [Axis]", "terseLabel": "Scenario [Axis]" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r166", "r433" ], "lang": { "en-us": { "role": { "documentation": "Information by title of individual or nature of relationship to individual or group of individuals.", "label": "Title of Individual [Axis]", "terseLabel": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Title of individual, or nature of relationship to individual or group of individuals.", "label": "Title of Individual [Domain]", "terseLabel": "Title of Individual [Domain]" } } }, "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]", "terseLabel": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountingStandardsUpdate202006Member": { "auth_ref": [ "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389" ], "lang": { "en-us": { "role": { "documentation": "Accounting Standards Update 2020-06 Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity's Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity's Own Equity.", "label": "Accounting Standards Update 2020-06 [Member]", "terseLabel": "Accounting Standards Update 2020-06" } } }, "localname": "AccountingStandardsUpdate202006Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingStandardsUpdateExtensibleList": { "auth_ref": [ "r0", "r1", "r2", "r3", "r4", "r95", "r96", "r97", "r98", "r171", "r172", "r182", "r183", "r184", "r185", "r186", "r187", "r211", "r323", "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r351", "r352", "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r427", "r533", "r534", "r535", "r536", "r537", "r538", "r539", "r540", "r541", "r542", "r543", "r544", "r618", "r619", "r620", "r621", "r622" ], "lang": { "en-us": { "role": { "documentation": "Indicates amendment to accounting standards.", "label": "Accounting Standards Update [Extensible Enumeration]", "terseLabel": "Accounting Standards Update [Extensible List]" } } }, "localname": "AccountingStandardsUpdateExtensibleList", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUNAUDITED" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r19", "r330", "r440" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional Paid in Capital", "verboseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r91", "r92", "r93", "r327", "r328", "r329", "r387" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUNAUDITED", "http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTESDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": { "auth_ref": [ "r0", "r1", "r2", "r3", "r4", "r95", "r96", "r97", "r98", "r108", "r171", "r172", "r182", "r183", "r184", "r185", "r186", "r187", "r211", "r323", "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r349", "r350", "r351", "r352", "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r427", "r451", "r452", "r453", "r533", "r534", "r535", "r536", "r537", "r538", "r539", "r540", "r541", "r542", "r543", "r544", "r618", "r619", "r620", "r621", "r622" ], "lang": { "en-us": { "role": { "documentation": "Information by amendment to accounting standards.", "label": "Accounting Standards Update [Axis]", "terseLabel": "Adjustments for New Accounting Pronouncements [Axis]" } } }, "localname": "AdjustmentsForNewAccountingPronouncementsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "auth_ref": [ "r299", "r301", "r332", "r333" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.", "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition", "terseLabel": "Share-based compensation expense" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net income or loss to net cash provided by\u00a0(used in)\u00a0operating activities" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "stringItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r301", "r319", "r331" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Share-based Payment Arrangement, Expense", "terseLabel": "Stock based compensation expense, net of forfeiture reversals" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivable": { "auth_ref": [ "r169", "r188", "r189", "r191" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable.", "label": "Accounts Receivable, Allowance for Credit Loss", "terseLabel": "Loss and loss adjustment expenses recoverable, allowance" } } }, "localname": "AllowanceForDoubtfulAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical", "http://www.greenlightre.ky/role/RETROCESSIONDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfFinancingCosts": { "auth_ref": [ "r52", "r70", "r249", "r417" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to debt issuance costs.", "label": "Amortization of Debt Issuance Costs", "terseLabel": "Recognized interest expense" } } }, "localname": "AmortizationOfFinancingCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r118" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "terseLabel": "Anti-dilutive stock options outstanding (in shares)" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESWeightedAverageNumberofSharesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [ "r118" ], "lang": { "en-us": { "role": { "documentation": "Information by type of antidilutive security.", "label": "Antidilutive Securities [Axis]", "terseLabel": "Antidilutive Securities [Axis]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESWeightedAverageNumberofSharesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [ "r118" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.", "label": "Antidilutive Securities, Name [Domain]", "terseLabel": "Antidilutive Securities, Name [Domain]" } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESWeightedAverageNumberofSharesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r82", "r143", "r148", "r155", "r179", "r212", "r213", "r214", "r216", "r217", "r218", "r219", "r220", "r221", "r223", "r224", "r364", "r366", "r394", "r438", "r440", "r468", "r491" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "verboseLabel": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsFairValueDisclosure": { "auth_ref": [ "r390" ], "calculation": { "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDFinancialInformationofInvestmentDetails": { "order": 1.0, "parentTag": "glre_NetAssetsFairValueDisclosure", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Fair Value Disclosure", "totalLabel": "Total assets" } } }, "localname": "AssetsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDFinancialInformationofInvestmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsFairValueDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Fair Value Disclosure [Abstract]", "terseLabel": "Assets" } } }, "localname": "AssetsFairValueDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDFinancialInformationofInvestmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AssumedPremiumsWritten": { "auth_ref": [ "r550" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED": { "order": 1.0, "parentTag": "us-gaap_PremiumsWrittenNet", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of written premiums assumed from other entities.", "label": "Assumed Premiums Written", "terseLabel": "Gross premiums written", "verboseLabel": "Gross premiums written" } } }, "localname": "AssumedPremiumsWritten", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED", "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyGeographicAreaofRisksInsuredDetails", "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyLineofBusinessDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r303", "r322" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]", "terseLabel": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedStockUnitsDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONSharebasedCompensationRestrictedStockActivityDetails", "http://www.greenlightre.ky/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by location on balance sheet (statement of financial position).", "label": "Balance Sheet Location [Axis]", "terseLabel": "Balance Sheet Location [Axis]" } } }, "localname": "BalanceSheetLocationAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/TAXATIONNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationDomain": { "auth_ref": [ "r374", "r375" ], "lang": { "en-us": { "role": { "documentation": "Location in the balance sheet (statement of financial position).", "label": "Balance Sheet Location [Domain]", "terseLabel": "Balance Sheet Location [Domain]" } } }, "localname": "BalanceSheetLocationDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/TAXATIONNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BenefitsLossesAndExpenses": { "auth_ref": [ "r512" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED": { "order": 2.0, "parentTag": "us-gaap_IncomeLossAttributableToParent", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The total amount of expense recognized during the period for future policy benefits, claims and claims adjustment costs, and for selling, general and administrative costs.", "label": "Benefits, Losses and Expenses", "totalLabel": "Total expenses" } } }, "localname": "BenefitsLossesAndExpenses", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_BenefitsLossesAndExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Benefits, Losses and Expenses [Abstract]", "terseLabel": "Expenses" } } }, "localname": "BenefitsLossesAndExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED" ], "xbrltype": "stringItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r7", "r24", "r72" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESCashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsDetails": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED", "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESCashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsFairValueDisclosure": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDFinancialInformationofInvestmentDetails": { "order": 5.0, "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash and Cash Equivalents, Fair Value Disclosure", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDFinancialInformationofInvestmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": { "auth_ref": [ "r10", "r74", "r466" ], "lang": { "en-us": { "role": { "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.", "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]", "terseLabel": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r65", "r72", "r76" ], "calculation": { "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESCashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "periodEndLabel": "Cash, cash equivalents and restricted cash at end of the period", "periodStartLabel": "Cash, cash equivalents and restricted cash at beginning of the period", "totalLabel": "Total cash, cash equivalents and restricted cash presented in the condensed consolidated statements of cash flows" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED", "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESCashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r65", "r407" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net increase (decrease) in cash, cash equivalents and restricted cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_CededCreditRiskCollateralizationAxis": { "auth_ref": [ "r560" ], "lang": { "en-us": { "role": { "documentation": "Information as to collaterization of reinsurance recoverables.", "label": "Ceded Credit Risk, Collateralization [Axis]", "terseLabel": "Ceded Credit Risk, Collateralization [Axis]" } } }, "localname": "CededCreditRiskCollateralizationAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/RETROCESSIONDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CededCreditRiskCollateralizationDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Collateralization of ceded credit risk.", "label": "Ceded Credit Risk, Collateralization [Domain]", "terseLabel": "Ceded Credit Risk, Collateralization [Domain]" } } }, "localname": "CededCreditRiskCollateralizationDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/RETROCESSIONDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CededCreditRiskLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Ceded Credit Risk [Line Items]", "terseLabel": "Ceded Credit Risk [Line Items]" } } }, "localname": "CededCreditRiskLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/RETROCESSIONDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CededCreditRiskSecuredMember": { "auth_ref": [ "r560" ], "lang": { "en-us": { "role": { "documentation": "Reinsurance recoverable that is secured by collateral.", "label": "Ceded Credit Risk, Secured [Member]", "terseLabel": "Secured" } } }, "localname": "CededCreditRiskSecuredMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/RETROCESSIONDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CededCreditRiskTable": { "auth_ref": [ "r560" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about reinsurer or group of reinsurers for whom the entity has a concentration of credit risk.", "label": "Ceded Credit Risk [Table]", "terseLabel": "Ceded Credit Risk [Table]" } } }, "localname": "CededCreditRiskTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/RETROCESSIONDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CededCreditRiskUnsecuredMember": { "auth_ref": [ "r560" ], "lang": { "en-us": { "role": { "documentation": "Reinsurance recoverable that is not secured by collateral.", "label": "Ceded Credit Risk, Unsecured [Member]", "terseLabel": "Unsecured" } } }, "localname": "CededCreditRiskUnsecuredMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/RETROCESSIONDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CededPremiumsEarned": { "auth_ref": [ "r503", "r513", "r547", "r548", "r551", "r553" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of earned premiums ceded to other entities.", "label": "Ceded Premiums Earned", "terseLabel": "Ceded premiums earned" } } }, "localname": "CededPremiumsEarned", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/RETROCESSIONDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CededPremiumsWritten": { "auth_ref": [ "r551", "r553" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED": { "order": 2.0, "parentTag": "us-gaap_PremiumsWrittenNet", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of written premiums ceded to other entities.", "label": "Ceded Premiums Written", "negatedLabel": "Gross premiums ceded" } } }, "localname": "CededPremiumsWritten", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r79", "r82", "r111", "r112", "r113", "r115", "r117", "r124", "r125", "r126", "r179", "r212", "r217", "r218", "r219", "r223", "r224", "r266", "r267", "r271", "r275", "r394", "r599" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class of Stock [Domain]", "terseLabel": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical", "http://www.greenlightre.ky/role/CoverPage", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails", "http://www.greenlightre.ky/role/SHARECAPITALNarrativeDetails", "http://www.greenlightre.ky/role/SHARECAPITALStockbyClassDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Stock [Line Items]", "terseLabel": "Class of Stock [Line Items]" } } }, "localname": "ClassOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHARECAPITALNarrativeDetails", "http://www.greenlightre.ky/role/SHARECAPITALStockbyClassDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]", "terseLabel": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r201", "r202", "r203", "r205", "r581" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "verboseLabel": "COMMITMENTS AND CONTINGENCIES" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIES" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonClassAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Classification of common stock representing ownership interest in a corporation.", "label": "Common Class A [Member]", "terseLabel": "Common Class A" } } }, "localname": "CommonClassAMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical", "http://www.greenlightre.ky/role/CoverPage", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails", "http://www.greenlightre.ky/role/SHARECAPITALNarrativeDetails", "http://www.greenlightre.ky/role/SHARECAPITALStockbyClassDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommonClassBMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation.", "label": "Common Class B [Member]", "terseLabel": "Common Class B" } } }, "localname": "CommonClassBMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical", "http://www.greenlightre.ky/role/CoverPage", "http://www.greenlightre.ky/role/SHARECAPITALNarrativeDetails", "http://www.greenlightre.ky/role/SHARECAPITALStockbyClassDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r91", "r92", "r387" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "verboseLabel": "Ordinary share capital" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUNAUDITED" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Ordinary share capital, par value (in dollars per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical", "http://www.greenlightre.ky/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Ordinary share capital, authorized (in shares)" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "verboseLabel": "Ordinary share capital, issued (in shares)" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r17", "r282" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "periodEndLabel": "Balance \u2013 end of period (in shares)", "periodStartLabel": "Balance \u2013 beginning of period (in shares)", "terseLabel": "Ordinary share capital, outstanding (in shares)" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical", "http://www.greenlightre.ky/role/SHARECAPITALStockbyClassDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r17", "r440" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Ordinary share capital (Class A: par value $0.10; authorized, 100,000,000; issued and outstanding, 27,589,731 (2020: 28,260,075): Class B: par value $0.10; authorized, 25,000,000; issued and outstanding, 6,254,715 (2020: 6,254,715))" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractualObligation": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESCommitmentsandContingenciesFiscalYearMaturityScheduleDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESCommitmentsandContingenciesFiscalYearMaturityScheduleDetails_1": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of contractual obligation, including but not limited to, long-term debt, capital lease obligations, operating lease obligations, purchase obligations, and other commitments.", "label": "Contractual Obligation", "totalLabel": "Total" } } }, "localname": "ContractualObligation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESCommitmentsandContingenciesFiscalYearMaturityScheduleDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractualObligationDueInFourthYear": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESCommitmentsandContingenciesFiscalYearMaturityScheduleDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESCommitmentsandContingenciesFiscalYearMaturityScheduleDetails_1": { "order": 3.0, "parentTag": "us-gaap_ContractualObligation", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of contractual obligation to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Contractual Obligation, to be Paid, Year Four", "totalLabel": "2025" } } }, "localname": "ContractualObligationDueInFourthYear", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESCommitmentsandContingenciesFiscalYearMaturityScheduleDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractualObligationDueInNextTwelveMonths": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESCommitmentsandContingenciesFiscalYearMaturityScheduleDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESCommitmentsandContingenciesFiscalYearMaturityScheduleDetails_1": { "order": 2.0, "parentTag": "us-gaap_ContractualObligation", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of contractual obligation to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Contractual Obligation, to be Paid, Year One", "totalLabel": "2022" } } }, "localname": "ContractualObligationDueInNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESCommitmentsandContingenciesFiscalYearMaturityScheduleDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractualObligationDueInSecondYear": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESCommitmentsandContingenciesFiscalYearMaturityScheduleDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESCommitmentsandContingenciesFiscalYearMaturityScheduleDetails_1": { "order": 6.0, "parentTag": "us-gaap_ContractualObligation", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of contractual obligation to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Contractual Obligation, to be Paid, Year Two", "totalLabel": "2023" } } }, "localname": "ContractualObligationDueInSecondYear", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESCommitmentsandContingenciesFiscalYearMaturityScheduleDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractualObligationDueInThirdYear": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESCommitmentsandContingenciesFiscalYearMaturityScheduleDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESCommitmentsandContingenciesFiscalYearMaturityScheduleDetails_1": { "order": 4.0, "parentTag": "us-gaap_ContractualObligation", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of contractual obligation to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Contractual Obligation, to be Paid, Year Three", "totalLabel": "2024" } } }, "localname": "ContractualObligationDueInThirdYear", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESCommitmentsandContingenciesFiscalYearMaturityScheduleDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractualObligationFiscalYearMaturityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Contractual Obligation, Fiscal Year Maturity [Abstract]", "terseLabel": "Total future obligations by year" } } }, "localname": "ContractualObligationFiscalYearMaturityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESCommitmentsandContingenciesFiscalYearMaturityScheduleDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESCommitmentsandContingenciesFiscalYearMaturityScheduleDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESCommitmentsandContingenciesFiscalYearMaturityScheduleDetails_1": { "order": 1.0, "parentTag": "us-gaap_ContractualObligation", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of contractual obligation to be paid in remainder of current fiscal year.", "label": "Contractual Obligation, to be Paid, Remainder of Fiscal Year", "totalLabel": "2021" } } }, "localname": "ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESCommitmentsandContingenciesFiscalYearMaturityScheduleDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleDebtMember": { "auth_ref": [ "r225", "r226", "r227", "r229", "r239", "r240", "r241", "r245", "r246", "r247", "r248", "r249", "r257", "r258", "r259", "r260" ], "lang": { "en-us": { "role": { "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.", "label": "Convertible Debt [Member]", "terseLabel": "Interest and convertible note payable" } } }, "localname": "ConvertibleDebtMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESCommitmentsandContingenciesFiscalYearMaturityScheduleDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConvertibleNotesPayable": { "auth_ref": [ "r14", "r470", "r493", "r562" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": 6.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder.", "label": "Convertible Notes Payable", "terseLabel": "Convertible senior notes payable" } } }, "localname": "ConvertibleNotesPayable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED", "http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CreditFacilityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Axis]", "terseLabel": "Credit Facility [Axis]" } } }, "localname": "CreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESLettersofCreditFacilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Domain]", "terseLabel": "Credit Facility [Domain]" } } }, "localname": "CreditFacilityDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESLettersofCreditFacilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CurrentIncomeTaxExpenseBenefit": { "auth_ref": [ "r83", "r347", "r355", "r356" ], "calculation": { "http://www.greenlightre.ky/role/TAXATIONComponentsofIncomeTaxExpenseBenefitDetails": { "order": 2.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.", "label": "Current Income Tax Expense (Benefit)", "negatedTerseLabel": "Current tax (expense) benefit" } } }, "localname": "CurrentIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/TAXATIONComponentsofIncomeTaxExpenseBenefitDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]", "terseLabel": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r78", "r232", "r233", "r234", "r235", "r236", "r237", "r238", "r243", "r250", "r251", "r253", "r261" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt Disclosure [Text Block]", "terseLabel": "SENIOR CONVERTIBLE NOTES" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTES" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r12", "r13", "r14", "r81", "r89", "r226", "r227", "r228", "r229", "r230", "r231", "r233", "r239", "r240", "r241", "r242", "r244", "r245", "r246", "r247", "r248", "r249", "r257", "r258", "r259", "r260", "r418", "r469", "r470", "r489" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]", "terseLabel": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTESDetails", "http://www.greenlightre.ky/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentConvertibleConversionPrice1": { "auth_ref": [ "r228", "r255" ], "lang": { "en-us": { "role": { "documentation": "The price per share of the conversion feature embedded in the debt instrument.", "label": "Debt Instrument, Convertible, Conversion Price", "terseLabel": "Debt conversion price (in dollars per share)" } } }, "localname": "DebtInstrumentConvertibleConversionPrice1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTESDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r226", "r257", "r258", "r416", "r418", "r419" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument, Face Amount", "terseLabel": "Convertible debt, amount" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentFairValue": { "auth_ref": [ "r241", "r257", "r258", "r393" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.", "label": "Debt Instrument, Fair Value Disclosure", "terseLabel": "Fair value of debt" } } }, "localname": "DebtInstrumentFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateEffectivePercentage": { "auth_ref": [ "r30", "r256", "r416", "r418" ], "lang": { "en-us": { "role": { "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.", "label": "Debt Instrument, Interest Rate, Effective Percentage", "terseLabel": "Effective interest rate (in percent)" } } }, "localname": "DebtInstrumentInterestRateEffectivePercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTESDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r30", "r227" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument, Interest Rate, Stated Percentage", "terseLabel": "Debt interest rate (in percent)" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTESDetails", "http://www.greenlightre.ky/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]", "terseLabel": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTESDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r31", "r81", "r89", "r226", "r227", "r228", "r229", "r230", "r231", "r233", "r239", "r240", "r241", "r242", "r244", "r245", "r246", "r247", "r248", "r249", "r257", "r258", "r259", "r260", "r418" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument, Name [Domain]", "terseLabel": "Debt Instrument, Name [Domain]" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTESDetails", "http://www.greenlightre.ky/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r31", "r81", "r89", "r226", "r227", "r228", "r229", "r230", "r231", "r233", "r239", "r240", "r241", "r242", "r244", "r245", "r246", "r247", "r248", "r249", "r252", "r257", "r258", "r259", "r260", "r283", "r286", "r287", "r288", "r415", "r416", "r418", "r419", "r483" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Schedule of Long-term Debt Instruments [Table]", "terseLabel": "Schedule of Long-term Debt Instruments [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTESDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscount": { "auth_ref": [ "r239", "r415", "r419" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt discount.", "label": "Debt Instrument, Unamortized Discount", "terseLabel": "Unamortized discount" } } }, "localname": "DebtInstrumentUnamortizedDiscount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance": { "auth_ref": [ "r305" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of shares authorized for issuance under the deferred compensation arrangement as of the balance sheet date.", "label": "Deferred Compensation Arrangement with Individual, Shares Authorized for Issuance", "terseLabel": "Shares authorized for issuance in relation to share purchase options granted to service provider (in shares)" } } }, "localname": "DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense": { "auth_ref": [ "r70", "r484", "r508", "r515", "r516", "r518", "r538" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED": { "order": 2.0, "parentTag": "us-gaap_BenefitsLossesAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense (reversal of expense) for deferred policy acquisition costs.", "label": "Deferred Policy Acquisition Costs, Amortization Expense", "terseLabel": "Acquisition costs" } } }, "localname": "DeferredPolicyAcquisitionCostAmortizationExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredPolicyAcquisitionCosts": { "auth_ref": [ "r499", "r516", "r517", "r518", "r538", "r558" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": 7.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred policy acquisition cost capitalized on contract remaining in force.", "label": "Deferred Policy Acquisition Cost", "verboseLabel": "Deferred acquisition costs" } } }, "localname": "DeferredPolicyAcquisitionCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsGross": { "auth_ref": [ "r342" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred Tax Assets, Gross", "terseLabel": "Gross deferred tax asset" } } }, "localname": "DeferredTaxAssetsGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/TAXATIONNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r343" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.", "label": "Deferred Tax Assets, Valuation Allowance", "terseLabel": "Deferred tax asset valuation allowance" } } }, "localname": "DeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/TAXATIONNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepositContractsAssets": { "auth_ref": [ "r195", "r196" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount of assets as of the balance sheet date pertaining to amounts paid by the insured (including a ceding company) under insurance or reinsurance contracts for which insurance risk is not transferred.", "label": "Deposit Contracts, Assets", "terseLabel": "Deposit contracts, assets" } } }, "localname": "DepositContractsAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepositContractsLiabilities": { "auth_ref": [ "r195", "r196" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount of liabilities as of the balance sheet date pertaining to amounts received by the insurer or reinsurer from the insured (including a ceding company) under insurance or reinsurance contracts for which insurance risk is not transferred.", "label": "Deposit Contracts, Liabilities", "terseLabel": "Deposit contracts, liabilities" } } }, "localname": "DepositContractsLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepositContractsPolicy": { "auth_ref": [ "r557" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the treatment of funds received from or paid to insureds, insurers and reinsurers on contracts for which the criteria for transferring or assuming insurance risk has not been satisfied by the insurer or reinsurer.", "label": "Deposit Contracts, Policy [Policy Text Block]", "terseLabel": "Deposit Assets and Liabilities" } } }, "localname": "DepositContractsPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DepreciationNonproduction": { "auth_ref": [ "r70", "r198" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The expense recognized in the current period that allocates the cost of nonproduction tangible assets over their useful lives.", "label": "Depreciation, Nonproduction", "terseLabel": "Depreciation expense" } } }, "localname": "DepreciationNonproduction", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAssets": { "auth_ref": [ "r34", "r35", "r38", "r393" ], "calculation": { "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDFinancialInformationofInvestmentDetails": { "order": 2.0, "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Asset", "terseLabel": "Derivative contracts, at fair value" } } }, "localname": "DerivativeAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDFinancialInformationofInvestmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilities": { "auth_ref": [ "r34", "r35", "r38", "r393" ], "calculation": { "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDFinancialInformationofInvestmentDetails": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesFairValueDisclosure", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liability", "negatedLabel": "Derivative contracts, at fair value" } } }, "localname": "DerivativeLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDFinancialInformationofInvestmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativesPolicyTextBlock": { "auth_ref": [ "r88", "r370", "r371", "r372", "r373", "r377" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.", "label": "Derivatives, Policy [Policy Text Block]", "terseLabel": "Derivative instruments" } } }, "localname": "DerivativesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [ "r334" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for share-based payment arrangement.", "label": "Share-based Payment Arrangement [Text Block]", "verboseLabel": "SHARE-BASED COMPENSATION" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATION" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Payment Arrangement [Abstract]", "terseLabel": "Share-based Payment Arrangement [Abstract]" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_DividendIncomeOperating": { "auth_ref": [ "r479" ], "calculation": { "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementofOperationsofSolasglasInvestmentsLPDetails": { "order": 2.0, "parentTag": "us-gaap_InterestAndDividendIncomeOperating", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of operating dividend income on securities.", "label": "Dividend Income, Operating", "terseLabel": "Dividend income (net of withholding taxes)" } } }, "localname": "DividendIncomeOperating", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementofOperationsofSolasglasInvestmentsLPDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Dividends": { "auth_ref": [ "r289", "r482" ], "calculation": { "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementofOperationsofSolasglasInvestmentsLPDetails": { "order": 4.0, "parentTag": "glre_InterestAndNoninterestExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of paid and unpaid cash, stock, and paid-in-kind (PIK) dividends declared, for example, but not limited to, common and preferred stock.", "label": "Dividends", "negatedLabel": "Dividends" } } }, "localname": "Dividends", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementofOperationsofSolasglasInvestmentsLPDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]", "terseLabel": "Earnings (loss) per share" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r49", "r100", "r101", "r102", "r103", "r104", "r109", "r111", "r115", "r116", "r117", "r121", "r122", "r388", "r389", "r476", "r507" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "verboseLabel": "Basic (in dollars per share)" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r49", "r100", "r101", "r102", "r103", "r104", "r111", "r115", "r116", "r117", "r121", "r122", "r388", "r389", "r476", "r507" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "verboseLabel": "Diluted (in dollars per share)" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDilutedLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]", "terseLabel": "Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]" } } }, "localname": "EarningsPerShareDilutedLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESWeightedAverageNumberofSharesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r118", "r120" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Earnings Per Share, Policy [Policy Text Block]", "terseLabel": "Earnings (Loss) Per Share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r407" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "terseLabel": "Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash" } } }, "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "auth_ref": [ "r320" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.", "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount", "terseLabel": "Restricted shares" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "auth_ref": [ "r320" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition", "terseLabel": "Weighted average period for recognition" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": { "auth_ref": [ "r320" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount", "terseLabel": "Unrecognized compensation costs related to non-vested restricted shares" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": { "auth_ref": [ "r320" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.", "label": "Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount", "terseLabel": "Total compensation cost related to non-vested options not yet recognized" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeStockOptionMember": { "auth_ref": [ "r318" ], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.", "label": "Share-based Payment Arrangement, Option [Member]", "terseLabel": "Anti-dilutive stock options outstanding", "verboseLabel": "Employee and Director Stock Options" } } }, "localname": "EmployeeStockOptionMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails", "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESWeightedAverageNumberofSharesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Revenue from External Customer [Line Items]", "terseLabel": "Revenue from External Customer [Line Items]" } } }, "localname": "EntityWideInformationRevenueFromExternalCustomerLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyGeographicAreaofRisksInsuredDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r2", "r42", "r43", "r44", "r91", "r92", "r93", "r96", "r105", "r107", "r123", "r185", "r282", "r289", "r327", "r328", "r329", "r351", "r352", "r387", "r408", "r409", "r410", "r411", "r412", "r413", "r535", "r536", "r537", "r622" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUNAUDITED", "http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTESDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis": { "auth_ref": [ "r5", "r82", "r179", "r394" ], "lang": { "en-us": { "role": { "documentation": "Information by nonconsolidated equity method investee. Excludes information consolidated by reporting entity.", "label": "Equity Method Investment, Nonconsolidated Investee [Axis]", "terseLabel": "Equity Method Investment, Nonconsolidated Investee [Axis]" } } }, "localname": "EquityMethodInvestmentNonconsolidatedInvesteeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDFinancialInformationofInvestmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain": { "auth_ref": [ "r5", "r82", "r179", "r394" ], "lang": { "en-us": { "role": { "documentation": "Nonconsolidated equity method investee. Excludes information consolidated by reporting entity.", "label": "Equity Method Investment, Nonconsolidated Investee [Domain]", "terseLabel": "Equity Method Investment, Nonconsolidated Investee [Domain]" } } }, "localname": "EquityMethodInvestmentNonconsolidatedInvesteeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDFinancialInformationofInvestmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember": { "auth_ref": [ "r5", "r82", "r179", "r394" ], "lang": { "en-us": { "role": { "documentation": "Nonconsolidated equity method investee or group of nonconsolidated investees. Excludes information consolidated by reporting entity.", "label": "Equity Method Investment, Nonconsolidated Investee or Group of Investees [Member]", "terseLabel": "Equity Method Investment, Nonconsolidated Investee or Group of Investees" } } }, "localname": "EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDFinancialInformationofInvestmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "auth_ref": [ "r177" ], "lang": { "en-us": { "role": { "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.", "label": "Equity Method Investment, Ownership Percentage", "terseLabel": "Equity method investment, ownership percentage" } } }, "localname": "EquityMethodInvestmentOwnershipPercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity Method Investments and Joint Ventures [Abstract]", "terseLabel": "Equity Method Investments and Joint Ventures [Abstract]" } } }, "localname": "EquityMethodInvestmentsAndJointVenturesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_EquityMethodInvestmentsDisclosureTextBlock": { "auth_ref": [ "r181" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.", "label": "Equity Method Investments and Joint Ventures Disclosure [Text Block]", "terseLabel": "INVESTMENT IN RELATED PARTY INVESTMENT FUND" } } }, "localname": "EquityMethodInvestmentsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUND" ], "xbrltype": "textBlockItemType" }, "us-gaap_EquityMethodInvestmentsFairValueDisclosure": { "auth_ref": [ "r175" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of investments accounted under the equity method.", "label": "Equity Method Investments, Fair Value Disclosure", "terseLabel": "Equity method investments, fair value" } } }, "localname": "EquityMethodInvestmentsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityMethodInvestmentsMember": { "auth_ref": [ "r174" ], "lang": { "en-us": { "role": { "documentation": "Investment in the stock of an investee which is adjusted for the investor's share of the earnings or losses of the investee after the date of acquisition.", "label": "Equity Method Investments [Member]", "terseLabel": "Investment accounted for under the equity method" } } }, "localname": "EquityMethodInvestmentsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSOtherInvestmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentsTextBlock": { "auth_ref": [ "r180" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.", "label": "Equity Method Investments [Table Text Block]", "terseLabel": "Schedule of Financial Information of Investment" } } }, "localname": "EquityMethodInvestmentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable": { "auth_ref": [ "r391", "r392" ], "lang": { "en-us": { "role": { "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of assets using significant unobservable inputs (level 3). Such reconciliation, separately presenting changes during the period, at a minimum, may include, but is not limited to: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income, and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.", "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]", "terseLabel": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]", "terseLabel": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_FinancialInstrumentsDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures.", "label": "Financial Instruments Disclosure [Text Block]", "verboseLabel": "FINANCIAL INSTRUMENTS" } } }, "localname": "FinancialInstrumentsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTS" ], "xbrltype": "textBlockItemType" }, "us-gaap_FinancialStandbyLetterOfCreditMember": { "auth_ref": [ "r206", "r208" ], "lang": { "en-us": { "role": { "documentation": "An irrevocable undertaking (typically by a financial institution) to guarantee payment of a specified financial obligation if defined events occur or fail to occur.", "label": "Financial Standby Letter of Credit [Member]", "terseLabel": "Facility" } } }, "localname": "FinancialStandbyLetterOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESLettersofCreditFacilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": { "auth_ref": [ "r403", "r404", "r405", "r406" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.", "label": "Foreign Currency Transaction Gain (Loss), before Tax", "negatedLabel": "Foreign exchange\u00a0(gains) losses\u00a0on investments" } } }, "localname": "ForeignCurrencyTransactionGainLossBeforeTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_FundsHeldUnderReinsuranceAgreementsLiability": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": 4.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of funds held as security for payments to be received under reinsurance contracts.", "label": "Funds Held under Reinsurance Agreements, Liability", "verboseLabel": "Funds withheld" } } }, "localname": "FundsHeldUnderReinsuranceAgreementsLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainLossOnInvestments": { "auth_ref": [ "r56", "r70", "r173" ], "calculation": { "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementofOperationsofSolasglasInvestmentsLPDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of realized and unrealized gain (loss) on investment.", "label": "Gain (Loss) on Investments", "totalLabel": "Net gain (loss) on investment transactions" } } }, "localname": "GainLossOnInvestments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementofOperationsofSolasglasInvestmentsLPDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r55" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED": { "order": 3.0, "parentTag": "us-gaap_BenefitsLossesAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and Administrative Expense", "terseLabel": "General and administrative expenses" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpenseMember": { "auth_ref": [ "r50" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing general and administrative expense.", "label": "General and Administrative Expense [Member]", "terseLabel": "General and Administrative Expense" } } }, "localname": "GeneralAndAdministrativeExpenseMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GeneralLiabilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type of business insurance which provides insurance coverage for a wide variety of liability exposures including, but not limited to, contractual liability, product liability and personal injury liability.", "label": "General Liability [Member]", "terseLabel": "General Liability" } } }, "localname": "GeneralLiabilityMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyLineofBusinessDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GeneralPartnerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Party to a partnership business who has unlimited liability.", "label": "General Partner [Member]", "terseLabel": "General Partner" } } }, "localname": "GeneralPartnerMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_HealthInsuranceProductLineMember": { "auth_ref": [ "r532" ], "lang": { "en-us": { "role": { "documentation": "Product line consisting of insurance against loss by illness or injury.", "label": "Health Insurance Product Line [Member]", "terseLabel": "Accident & Health", "verboseLabel": "Health" } } }, "localname": "HealthInsuranceProductLineMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails", "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyLineofBusinessDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncentiveFeeExpense": { "auth_ref": [ "r432" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for incentive rights held by the managing member or general partner, of limited liability company (LLC) or limited partnership (LP).", "label": "Incentive Fee Expense", "terseLabel": "Performance allocation" } } }, "localname": "IncentiveFeeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementofOperationsofSolasglasInvestmentsLPDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossAttributableToParent": { "auth_ref": [ "r44", "r54" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of income (loss) attributable to parent. Includes, but is not limited to, income (loss) from continuing operations, discontinued operations and equity method investments.", "label": "Income (Loss) Attributable to Parent, before Tax", "totalLabel": "Income (loss) before income tax" } } }, "localname": "IncomeLossAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromEquityMethodInvestments": { "auth_ref": [ "r47", "r70", "r141", "r176", "r474", "r504" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).", "label": "Income (Loss) from Equity Method Investments", "negatedTerseLabel": "Loss (income) from investment accounted for under the equity method" } } }, "localname": "IncomeLossFromEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]", "terseLabel": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r199", "r200" ], "lang": { "en-us": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]", "terseLabel": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [ "r200" ], "lang": { "en-us": { "role": { "documentation": "Location in the income statement.", "label": "Income Statement Location [Domain]", "terseLabel": "Income Statement Location [Domain]" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r84", "r338", "r340", "r346", "r353", "r357", "r359", "r360", "r361" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "terseLabel": "TAXATION" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/TAXATION" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExaminationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Income Tax Examination [Line Items]", "terseLabel": "Income Tax Examination [Line Items]" } } }, "localname": "IncomeTaxExaminationLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/TAXATIONNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxExaminationTable": { "auth_ref": [ "r339" ], "lang": { "en-us": { "role": { "documentation": "A summary of income tax examinations that an enterprise is currently subject to or that have been completed in the current period typically including a description of the examination, the jurisdiction conducting the examination, the tax year(s) under examination, the likelihood of an unfavorable settlement, the range of possible losses, the liability recorded, the Increase or Decrease in the liability from the prior period, and any penalties and interest that have been incurred or accrued.", "label": "Income Tax Examination [Table]", "terseLabel": "Income Tax Examination [Table]" } } }, "localname": "IncomeTaxExaminationTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/TAXATIONNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r85", "r106", "r107", "r142", "r337", "r354", "r358", "r509" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 }, "http://www.greenlightre.ky/role/TAXATIONComponentsofIncomeTaxExpenseBenefitDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "negatedLabel": "Income tax (expense) benefit", "negatedTotalLabel": "Income tax (expense) benefit" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED", "http://www.greenlightre.ky/role/TAXATIONComponentsofIncomeTaxExpenseBenefitDetails", "http://www.greenlightre.ky/role/TAXATIONNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r41", "r335", "r336", "r340", "r341", "r345", "r348" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Tax, Policy [Policy Text Block]", "terseLabel": "Taxation" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxesPaidNet": { "auth_ref": [ "r75" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.", "label": "Income Taxes Paid, Net", "terseLabel": "Income tax paid in cash" } } }, "localname": "IncomeTaxesPaidNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDeferredPolicyAcquisitionCosts": { "auth_ref": [ "r69" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the balance sheet value of capitalized sales costs that are associated with acquiring a new insurance customers.", "label": "Increase (Decrease) in Deferred Policy Acquisition Costs", "negatedLabel": "Deferred acquisition costs" } } }, "localname": "IncreaseDecreaseInDeferredPolicyAcquisitionCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInFundsHeldUnderReinsuranceAgreements": { "auth_ref": [ "r69" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": 19.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The change in funds held under reinsurance agreements or treaty (contract between the reinsurer and the ceding entity stipulating the manner in which insurance written on various risks is to be shared).", "label": "Increase (Decrease) in Funds Held under Reinsurance Agreements", "negatedLabel": "Funds withheld" } } }, "localname": "IncreaseDecreaseInFundsHeldUnderReinsuranceAgreements", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve": { "auth_ref": [ "r69" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in liability to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.", "label": "Increase (Decrease) in Liability for Claims and Claims Adjustment Expense Reserve", "terseLabel": "Loss and loss adjustment expense reserves" } } }, "localname": "IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInNotesReceivables": { "auth_ref": [ "r69" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period of the amounts due from borrowers for outstanding secured or unsecured loans evidenced by a note.", "label": "Increase (Decrease) in Notes Receivables", "negatedTerseLabel": "Net change in notes receivable" } } }, "localname": "IncreaseDecreaseInNotesReceivables", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Net change in" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingAssets": { "auth_ref": [ "r69" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in operating assets classified as other.", "label": "Increase (Decrease) in Other Operating Assets", "negatedLabel": "Other assets, excluding depreciation" } } }, "localname": "IncreaseDecreaseInOtherOperatingAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": { "auth_ref": [ "r69" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": 20.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in operating liabilities classified as other.", "label": "Increase (Decrease) in Other Operating Liabilities", "terseLabel": "Other liabilities" } } }, "localname": "IncreaseDecreaseInOtherOperatingLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPremiumsReceivable": { "auth_ref": [ "r69" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The change in the premium receivable balance on the balance sheet.", "label": "Increase (Decrease) in Premiums Receivable", "negatedLabel": "Reinsurance balances receivable" } } }, "localname": "IncreaseDecreaseInPremiumsReceivable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidReinsurancePremiums": { "auth_ref": [ "r69" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The change in prepaid reinsurance premiums recorded on the balance sheet, which is needed to adjust net income to arrive at net cash flows provided by or used in operations.", "label": "Increase (Decrease) in Prepaid Reinsurance Premiums", "negatedLabel": "Unearned premiums ceded" } } }, "localname": "IncreaseDecreaseInPrepaidReinsurancePremiums", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInReinsurancePayables": { "auth_ref": [ "r69" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": 18.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amount due to other insurance companies when the reporting entity has assumed a portion of the cedant's insurance risk which has resulted in insurance losses.", "label": "Increase (Decrease) in Reinsurance Payables", "terseLabel": "Reinsurance balances payable" } } }, "localname": "IncreaseDecreaseInReinsurancePayables", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInReinsuranceRecoverable": { "auth_ref": [ "r69" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amount of benefits the ceding insurer expects to recover on insurance policies ceded to other insurance entities as of the balance sheet date for all guaranteed benefit types.", "label": "Increase (Decrease) in Reinsurance Recoverable", "negatedLabel": "Loss and loss adjustment expenses recoverable" } } }, "localname": "IncreaseDecreaseInReinsuranceRecoverable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]" } } }, "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUNAUDITED", "http://www.greenlightre.ky/role/SHARECAPITALStockbyClassDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInUnearnedPremiums": { "auth_ref": [ "r69" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": 17.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) unearned premiums written. Excludes portion of unearned premiums amortized into income.", "label": "Increase (Decrease) in Unearned Premiums", "terseLabel": "Unearned premium reserves" } } }, "localname": "IncreaseDecreaseInUnearnedPremiums", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInUnearnedPremiumsNet": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED": { "order": 2.0, "parentTag": "us-gaap_PremiumsEarnedNet", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after premiums ceded to other entities and premiums assumed by the entity, of decrease (increase) in unearned premiums.", "label": "(Increase) Decrease in Unearned Premiums, Net", "terseLabel": "Change in net unearned premium reserves" } } }, "localname": "IncreaseDecreaseInUnearnedPremiumsNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_InsuranceLossReservesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Insurance Loss Reserves [Abstract]", "terseLabel": "Insurance Loss Reserves [Abstract]" } } }, "localname": "InsuranceLossReservesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_InterestAndDividendIncomeOperating": { "auth_ref": [ "r477" ], "calculation": { "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementofOperationsofSolasglasInvestmentsLPDetails": { "order": 2.0, "parentTag": "us-gaap_NetInvestmentIncome", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the total of interest and dividend income, including any amortization and accretion (as applicable) of discounts and premiums, earned from (1) loans and leases whether held-for-sale or held-in-portfolio; (2) investment securities; (3) federal funds sold; (4) securities purchased under agreements to resell; (5) investments in banker's acceptances, commercial paper, or certificates of deposit; (6) dividend income; or (7) other investments not otherwise specified herein.", "label": "Interest and Dividend Income, Operating", "totalLabel": "Total Investment income" } } }, "localname": "InterestAndDividendIncomeOperating", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementofOperationsofSolasglasInvestmentsLPDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestAndDividendIncomeOperatingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Interest and Dividend Income, Operating [Abstract]", "terseLabel": "Investment income" } } }, "localname": "InterestAndDividendIncomeOperatingAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementofOperationsofSolasglasInvestmentsLPDetails" ], "xbrltype": "stringItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r45", "r140", "r414", "r417", "r480" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED": { "order": 4.0, "parentTag": "us-gaap_BenefitsLossesAndExpenses", "weight": 1.0 }, "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementofOperationsofSolasglasInvestmentsLPDetails": { "order": 1.0, "parentTag": "glre_InterestAndNoninterestExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "negatedTerseLabel": "Interest", "verboseLabel": "Interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED", "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementofOperationsofSolasglasInvestmentsLPDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of interest income and expense, including, but not limited to, interest income and expense from investments, loans, and securities.", "label": "Interest Income and Interest Expense Disclosure [Table Text Block]", "terseLabel": "Schedule of Interest Income and Interest Expense" } } }, "localname": "InterestIncomeAndInterestExpenseDisclosureTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_InterestIncomeExpenseNet": { "auth_ref": [ "r478" ], "calculation": { "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESInterestIncomeandInterestExpenseDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net amount of operating interest income (expense).", "label": "Interest Income (Expense), Net", "totalLabel": "Deposit interest income/(expense), net" } } }, "localname": "InterestIncomeExpenseNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESInterestIncomeandInterestExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestIncomeOperating": { "auth_ref": [ "r53" ], "calculation": { "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementofOperationsofSolasglasInvestmentsLPDetails": { "order": 1.0, "parentTag": "us-gaap_InterestAndDividendIncomeOperating", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of operating interest income, including, but not limited to, amortization and accretion of premiums and discounts on securities.", "label": "Interest Income, Operating", "terseLabel": "Interest income" } } }, "localname": "InterestIncomeOperating", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementofOperationsofSolasglasInvestmentsLPDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r63", "r66", "r75" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "terseLabel": "Interest paid in cash" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPayableCurrent": { "auth_ref": [ "r8", "r9", "r29" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Interest Payable, Current", "terseLabel": "Accrued interest" } } }, "localname": "InterestPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentHoldingsOtherThanSecuritiesTextBlock": { "auth_ref": [ "r575" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the investment holdings which are represented by other than securities (for example, commodities). The investment holdings, other than securities investments table lists the long positions of non-security investments held by entity.", "label": "Investment Holdings, Other than Securities [Table Text Block]", "terseLabel": "Schedule of Other Investments" } } }, "localname": "InvestmentHoldingsOtherThanSecuritiesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_InvestmentTypeAxis": { "auth_ref": [ "r564", "r565", "r566", "r567", "r568", "r569", "r570", "r571", "r572", "r573", "r574", "r576", "r577", "r578", "r579" ], "lang": { "en-us": { "role": { "documentation": "Information by type of investments.", "label": "Investment Type [Axis]", "terseLabel": "Investment Type [Axis]" } } }, "localname": "InvestmentTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSNarrativeDetails", "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSOtherInvestmentsDetails", "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentTypeCategorizationMember": { "auth_ref": [ "r564", "r565", "r566", "r567", "r568", "r569", "r570", "r571", "r572", "r573", "r574", "r576", "r577", "r578", "r579" ], "lang": { "en-us": { "role": { "documentation": "Asset obtained to generate income or appreciate in value.", "label": "Investments [Domain]", "terseLabel": "Investments [Domain]" } } }, "localname": "InvestmentTypeCategorizationMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSNarrativeDetails", "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSOtherInvestmentsDetails", "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Investments": { "auth_ref": [ "r501" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all investments.", "label": "Investments", "totalLabel": "Total investments" } } }, "localname": "Investments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investments [Abstract]", "verboseLabel": "Investments" } } }, "localname": "InvestmentsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentsFairValueDisclosure": { "auth_ref": [ "r390" ], "calculation": { "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDFinancialInformationofInvestmentDetails": { "order": 3.0, "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.", "label": "Investments, Fair Value Disclosure", "terseLabel": "Investments, at fair value" } } }, "localname": "InvestmentsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDFinancialInformationofInvestmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures": { "auth_ref": [ "r25" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": 1.0, "parentTag": "us-gaap_Investments", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in equity method investee and investment in and advance to affiliate.", "label": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures", "terseLabel": "Investment in related party investment fund", "verboseLabel": "GLRE Limited Partners\u2019 share of Net Assets" } } }, "localname": "InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED", "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDFinancialInformationofInvestmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r425" ], "calculation": { "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESCommitmentsandContingenciesFiscalYearMaturityScheduleDetails": { "order": 1.0, "parentTag": "us-gaap_ContractualObligation", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.", "label": "Lessee, Operating Lease, Liability, to be Paid", "totalLabel": "Total" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESCommitmentsandContingenciesFiscalYearMaturityScheduleDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r425" ], "calculation": { "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESCommitmentsandContingenciesFiscalYearMaturityScheduleDetails": { "order": 4.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year One", "terseLabel": "2022" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESCommitmentsandContingenciesFiscalYearMaturityScheduleDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r425" ], "calculation": { "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESCommitmentsandContingenciesFiscalYearMaturityScheduleDetails": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four", "terseLabel": "2025" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESCommitmentsandContingenciesFiscalYearMaturityScheduleDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r425" ], "calculation": { "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESCommitmentsandContingenciesFiscalYearMaturityScheduleDetails": { "order": 6.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three", "terseLabel": "2024" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESCommitmentsandContingenciesFiscalYearMaturityScheduleDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r425" ], "calculation": { "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESCommitmentsandContingenciesFiscalYearMaturityScheduleDetails": { "order": 3.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two", "terseLabel": "2023" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESCommitmentsandContingenciesFiscalYearMaturityScheduleDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": { "auth_ref": [ "r425" ], "calculation": { "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESCommitmentsandContingenciesFiscalYearMaturityScheduleDetails": { "order": 5.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.", "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year", "terseLabel": "2021" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESCommitmentsandContingenciesFiscalYearMaturityScheduleDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LettersOfCreditOutstandingAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.", "label": "Letters of Credit Outstanding, Amount", "terseLabel": "Aggregate amount of letters of credit issued" } } }, "localname": "LettersOfCreditOutstandingAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r28", "r82", "r149", "r179", "r212", "r213", "r214", "r217", "r218", "r219", "r220", "r221", "r223", "r224", "r365", "r366", "r367", "r394", "r438", "r439" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities [Abstract]", "verboseLabel": "Liabilities" } } }, "localname": "LiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r23", "r82", "r179", "r394", "r440", "r471", "r497" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "Liabilities and equity" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesFairValueDisclosure": { "auth_ref": [ "r390" ], "calculation": { "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDFinancialInformationofInvestmentDetails": { "order": 2.0, "parentTag": "glre_NetAssetsFairValueDisclosure", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial and nonfinancial obligations.", "label": "Financial and Nonfinancial Liabilities, Fair Value Disclosure", "negatedTotalLabel": "Total liabilities" } } }, "localname": "LiabilitiesFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDFinancialInformationofInvestmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesFairValueDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Fair Value Disclosure [Abstract]", "terseLabel": "Liabilities" } } }, "localname": "LiabilitiesFairValueDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDFinancialInformationofInvestmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense": { "auth_ref": [ "r522", "r525" ], "calculation": { "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.", "label": "Liability for Claims and Claims Adjustment Expense", "periodEndLabel": "Gross balance at September 30", "periodStartLabel": "Gross balance at January 1", "totalLabel": "Total" } } }, "localname": "LiabilityForClaimsAndClaimsAdjustmentExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Liability for Claims and Claims Adjustment Expense [Line Items]", "terseLabel": "Liability for Claims and Claims Adjustment Expense [Line Items]" } } }, "localname": "LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpensePropertyCasualtyLiability": { "auth_ref": [ "r522", "r525" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount needed to reflect the estimated ultimate cost of settling claims relating to casualty insurance insured events that have occurred on or before a particular date (ordinarily, the balance sheet date) and the amount needed to provide for the estimated ultimate cost required to investigate and settle claims relating to insured events that have occurred on or before a particular date (ordinarily, the balance sheet date), whether or not reported to the insurer at that date.", "label": "Liability for Claims and Claims Adjustment Expense, Property Casualty Liability", "verboseLabel": "Loss and loss adjustment expense reserves" } } }, "localname": "LiabilityForClaimsAndClaimsAdjustmentExpensePropertyCasualtyLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about the liability for claims and claims adjustment expense.", "label": "Liability for Claims and Claims Adjustment Expense [Table]", "terseLabel": "Liability for Claims and Claims Adjustment Expense [Table]" } } }, "localname": "LiabilityForClaimsAndClaimsAdjustmentExpenseTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock": { "auth_ref": [ "r546" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for liabilities related to future policy benefits and unpaid claims and claim adjustments.", "label": "Liability for Future Policy Benefits and Unpaid Claims Disclosure [Text Block]", "terseLabel": "LOSS AND LOSS ADJUSTMENT EXPENSE RESERVES" } } }, "localname": "LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVES" ], "xbrltype": "textBlockItemType" }, "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1": { "auth_ref": [ "r524" ], "calculation": { "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails": { "order": 1.0, "parentTag": "us-gaap_PaymentsForLossesAndLossAdjustmentExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after effects of reinsurance, of payments to settle claims incurred in the current period and related claims settlement costs.", "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year", "negatedTerseLabel": "Current year" } } }, "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1": { "auth_ref": [ "r524" ], "calculation": { "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails": { "order": 2.0, "parentTag": "us-gaap_PaymentsForLossesAndLossAdjustmentExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after effects of reinsurance, of payments to settle claims incurred in prior periods and related claims settlement costs.", "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years", "negatedTerseLabel": "Prior years" } } }, "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseForeignCurrencyTranslationGainLoss": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of foreign currency gain (loss) which decreases (increases) the cost of settling unpaid claims after deduction of reinsurance recoveries. Includes, but is not limited to, claims which have been incurred but not reported.", "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Foreign Currency Translation Gain (Loss)", "terseLabel": "Foreign currency revaluation" } } }, "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseForeignCurrencyTranslationGainLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount": { "auth_ref": [ "r545" ], "calculation": { "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails": { "order": 2.0, "parentTag": "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Estimated costs as of the balance sheet date of settling insured claims and costs incurred in the claims settlement process for claims that have not yet been submitted to the insurance company for reimbursement.", "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Incurred but Not Reported (IBNR) Claims, Amount", "terseLabel": "IBNR" } } }, "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1": { "auth_ref": [ "r523" ], "calculation": { "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred and costs incurred in the claim settlement process.", "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims", "totalLabel": "Total incurred" } } }, "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet": { "auth_ref": [ "r488", "r522", "r525" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Liability as of the balance sheet date for amounts representing estimated cost of settling unpaid claims under the terms of the underlying insurance policies, less estimated reinsurance recoveries on such claims. This includes an estimate for claims which have been incurred but not reported. Claim adjustment expenses represent the costs estimated to be incurred in the settlement of unpaid claims.", "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Net", "periodEndLabel": "Net balance at September 30", "periodStartLabel": "Net balance at January 1" } } }, "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]", "terseLabel": "Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]" } } }, "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReportedClaimsAmount": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails": { "order": 1.0, "parentTag": "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Costs of settling insured claims and costs incurred in the claims settlement process for the specified year specifically for claims that have already been submitted to the insurance company for reimbursement.", "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Reported Claims, Amount", "terseLabel": "Case reserves" } } }, "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReportedClaimsAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityAxis": { "auth_ref": [ "r27", "r81" ], "lang": { "en-us": { "role": { "documentation": "Information by name of lender, which may be a single entity (for example, but not limited to, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit.", "label": "Lender Name [Axis]", "terseLabel": "Lender Name [Axis]" } } }, "localname": "LineOfCreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESLettersofCreditFacilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityLenderDomain": { "auth_ref": [ "r27", "r81" ], "lang": { "en-us": { "role": { "documentation": "Identification of the lender, which may be a single entity (for example, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit, including a letter of credit facility.", "label": "Line of Credit Facility, Lender [Domain]", "terseLabel": "Line of Credit Facility, Lender [Domain]" } } }, "localname": "LineOfCreditFacilityLenderDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESLettersofCreditFacilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LineOfCreditFacilityLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Line of Credit Facility [Line Items]", "terseLabel": "Line of Credit Facility [Line Items]" } } }, "localname": "LineOfCreditFacilityLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESLettersofCreditFacilitiesDetails", "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "auth_ref": [ "r27" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "terseLabel": "Maximum Facility Limit" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESLettersofCreditFacilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityTable": { "auth_ref": [ "r27", "r81" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.", "label": "Line of Credit Facility [Table]", "terseLabel": "Line of Credit Facility [Table]" } } }, "localname": "LineOfCreditFacilityTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESLettersofCreditFacilitiesDetails", "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongTermDebt": { "auth_ref": [ "r14", "r240", "r254", "r257", "r258", "r470", "r494" ], "calculation": { "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESCommitmentsandContingenciesFiscalYearMaturityScheduleDetails": { "order": 2.0, "parentTag": "us-gaap_ContractualObligation", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long-term Debt", "totalLabel": "Total" } } }, "localname": "LongTermDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESCommitmentsandContingenciesFiscalYearMaturityScheduleDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtByMaturityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Long-term Debt, Fiscal Year Maturity [Abstract]", "terseLabel": "Interest and convertible note payable" } } }, "localname": "LongTermDebtByMaturityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESCommitmentsandContingenciesFiscalYearMaturityScheduleDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": { "auth_ref": [ "r89", "r209", "r245" ], "calculation": { "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESCommitmentsandContingenciesFiscalYearMaturityScheduleDetails": { "order": 6.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, Year One", "terseLabel": "2022" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESCommitmentsandContingenciesFiscalYearMaturityScheduleDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": { "auth_ref": [ "r89", "r209", "r245" ], "calculation": { "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESCommitmentsandContingenciesFiscalYearMaturityScheduleDetails": { "order": 4.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, Year Four", "terseLabel": "2025" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESCommitmentsandContingenciesFiscalYearMaturityScheduleDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": { "auth_ref": [ "r89", "r209", "r245" ], "calculation": { "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESCommitmentsandContingenciesFiscalYearMaturityScheduleDetails": { "order": 2.0, "parentTag": "us-gaap_ContractualObligationDueInThirdYear", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, Year Three", "terseLabel": "2024" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESCommitmentsandContingenciesFiscalYearMaturityScheduleDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": { "auth_ref": [ "r89", "r209", "r245" ], "calculation": { "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESCommitmentsandContingenciesFiscalYearMaturityScheduleDetails": { "order": 2.0, "parentTag": "us-gaap_ContractualObligationDueInSecondYear", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, Year Two", "terseLabel": "2023" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESCommitmentsandContingenciesFiscalYearMaturityScheduleDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear": { "auth_ref": [ "r89" ], "calculation": { "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESCommitmentsandContingenciesFiscalYearMaturityScheduleDetails": { "order": 3.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year.", "label": "Long-Term Debt, Maturity, Remainder of Fiscal Year", "terseLabel": "2021" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESCommitmentsandContingenciesFiscalYearMaturityScheduleDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r31" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-term Debt, Type [Axis]", "terseLabel": "Long-term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESCommitmentsandContingenciesFiscalYearMaturityScheduleDetails", "http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTESDetails", "http://www.greenlightre.ky/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r31", "r210" ], "lang": { "en-us": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Long-term Debt, Type [Domain]", "terseLabel": "Long-term Debt, Type [Domain]" } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESCommitmentsandContingenciesFiscalYearMaturityScheduleDetails", "http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTESDetails", "http://www.greenlightre.ky/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ManagementFeeExpense": { "auth_ref": [ "r432" ], "calculation": { "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementofOperationsofSolasglasInvestmentsLPDetails": { "order": 2.0, "parentTag": "glre_InterestAndNoninterestExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses related to the managing member or general partner for management of the day-to-day business functions of the limited liability company (LLC) or limited partnership (LP).", "label": "Management Fee Expense", "negatedLabel": "Management fee", "terseLabel": "Management fee", "verboseLabel": "Management fee" } } }, "localname": "ManagementFeeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSParenthetical", "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementofOperationsofSolasglasInvestmentsLPDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r65" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": 4.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by (used in) financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r65" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash provided by (used in) investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r65", "r68", "r71" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash provided by (used in) operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Cash provided by (used in) operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r5", "r39", "r40", "r44", "r48", "r71", "r82", "r95", "r100", "r101", "r102", "r103", "r106", "r107", "r114", "r143", "r147", "r151", "r154", "r157", "r179", "r212", "r213", "r214", "r217", "r218", "r219", "r220", "r221", "r223", "r224", "r389", "r394", "r475", "r505" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "terseLabel": "Net income (loss)", "totalLabel": "Net income (loss)" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED", "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUNAUDITED", "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED", "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementofOperationsofSolasglasInvestmentsLPDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetInvestmentIncome": { "auth_ref": [ "r506" ], "calculation": { "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementofOperationsofSolasglasInvestmentsLPDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments.", "label": "Net Investment Income", "totalLabel": "Net investment income (loss)" } } }, "localname": "NetInvestmentIncome", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementofOperationsofSolasglasInvestmentsLPDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]", "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]" } } }, "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": { "auth_ref": [ "r0", "r1", "r2", "r3", "r4", "r94", "r95", "r96", "r97", "r98", "r99", "r102", "r108", "r121", "r171", "r172", "r182", "r183", "r184", "r185", "r186", "r187", "r211", "r323", "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r349", "r350", "r351", "r352", "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r427", "r451", "r452", "r453", "r533", "r534", "r535", "r536", "r537", "r538", "r539", "r540", "r541", "r542", "r543", "r544", "r618", "r619", "r620", "r621", "r622" ], "lang": { "en-us": { "role": { "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.", "label": "Accounting Standards Update and Change in Accounting Principle [Table]", "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Table]" } } }, "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Recent Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NotesReceivableNet": { "auth_ref": [ "r18", "r167", "r192" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": 8.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of financing receivable. Excludes financing receivable covered under loss sharing agreement.", "label": "Financing Receivable, after Allowance for Credit Loss", "terseLabel": "Notes receivable" } } }, "localname": "NotesReceivableNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_NumberOfOperatingSegments": { "auth_ref": [ "r135" ], "lang": { "en-us": { "role": { "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.", "label": "Number of Operating Segments", "terseLabel": "Number of operating segments" } } }, "localname": "NumberOfOperatingSegments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyLineofBusinessDetails" ], "xbrltype": "integerItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Expenses [Abstract]", "terseLabel": "Expenses" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementofOperationsofSolasglasInvestmentsLPDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLeaseCost": { "auth_ref": [ "r423", "r426" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.", "label": "Operating Lease, Cost", "terseLabel": "Operating lease cost" } } }, "localname": "OperatingLeaseCost", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseExpense": { "auth_ref": [ "r422" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating lease expense. Excludes sublease income.", "label": "Operating Lease, Expense", "terseLabel": "Operating lease expense" } } }, "localname": "OperatingLeaseExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, Payment, Due [Abstract]", "terseLabel": "Operating lease obligations" } } }, "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESCommitmentsandContingenciesFiscalYearMaturityScheduleDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r421" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Operating Lease, Liability", "terseLabel": "Operating lease liability" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r420" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating Lease, Right-of-Use Asset", "terseLabel": "Operating lease right of use asset" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasedAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Operating Leased Assets [Line Items]", "terseLabel": "Operating Leased Assets [Line Items]" } } }, "localname": "OperatingLeasedAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESCommitmentsandContingenciesFiscalYearMaturityScheduleDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]", "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "auth_ref": [ "r6", "r369" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "terseLabel": "ORGANIZATION AND BASIS OF PRESENTATION" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/ORGANIZATIONANDBASISOFPRESENTATION" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAssets": { "auth_ref": [ "r11", "r467", "r490" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": 9.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets classified as other.", "label": "Other Assets", "verboseLabel": "Other assets" } } }, "localname": "OtherAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsMember": { "auth_ref": [ "r374", "r378" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other assets.", "label": "Other Assets [Member]", "terseLabel": "Other Assets" } } }, "localname": "OtherAssetsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/TAXATIONNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherInsuranceProductLineMember": { "auth_ref": [ "r532" ], "lang": { "en-us": { "role": { "documentation": "Contract providing insurance coverage, classified as other.", "label": "Insurance, Other [Member]", "terseLabel": "Other Specialty" } } }, "localname": "OtherInsuranceProductLineMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyLineofBusinessDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherInvestments": { "auth_ref": [ "r25", "r500" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": 2.0, "parentTag": "us-gaap_Investments", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investments classified as other.", "label": "Other Investments", "terseLabel": "Other investments" } } }, "localname": "OtherInvestments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherInvestmentsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other investments.", "label": "Other Investments [Member]", "terseLabel": "Other investments" } } }, "localname": "OtherInvestmentsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSOtherInvestmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherLiabilities": { "auth_ref": [ "r472" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": 5.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other.", "label": "Other Liabilities", "verboseLabel": "Other liabilities" } } }, "localname": "OtherLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesFairValueDisclosure": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDFinancialInformationofInvestmentDetails": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesFairValueDisclosure", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of other liabilities.", "label": "Other Liabilities, Fair Value Disclosure", "negatedLabel": "Other liabilities" } } }, "localname": "OtherLiabilitiesFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDFinancialInformationofInvestmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherOperatingIncomeExpenseNet": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED": { "order": 4.0, "parentTag": "us-gaap_Revenues", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.", "label": "Other Operating Income (Expense), Net", "terseLabel": "Other income (expense), net" } } }, "localname": "OtherOperatingIncomeExpenseNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForLossesAndLossAdjustmentExpense": { "auth_ref": [ "r67", "r524" ], "calculation": { "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after effects of reinsurance, of payments to settle insured claims and pay costs incurred in the claims settlement process.", "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid", "negatedTotalLabel": "Total paid" } } }, "localname": "PaymentsForLossesAndLossAdjustmentExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "auth_ref": [ "r62" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to reacquire common stock during the period.", "label": "Payments for Repurchase of Common Stock", "negatedTerseLabel": "Repurchase of Class A ordinary shares" } } }, "localname": "PaymentsForRepurchaseOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireEquityMethodInvestments": { "auth_ref": [ "r60" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.", "label": "Payments to Acquire Equity Method Investments", "negatedTerseLabel": "Contributions to related party investment fund" } } }, "localname": "PaymentsToAcquireEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireTradingSecuritiesHeldforinvestment": { "auth_ref": [ "r61" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to acquire securities classified as trading securities and held for investment purposes. Excludes payments for trading securities purchased and held principally for the purpose of selling them in the near term (thus held for only a short period of time).", "label": "Payments to Acquire Trading Securities Held-for-investment", "negatedTerseLabel": "Purchases of investments" } } }, "localname": "PaymentsToAcquireTradingSecuritiesHeldforinvestment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_PledgedFinancialInstrumentsNotSeparatelyReportedSecuritiesForLetterOfCreditFacilities": { "auth_ref": [ "r448" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The carrying amount as of the date of the latest financial statement presented of securities which are owned but transferred to serve as collateral for letter of credit arrangements, and for which the transferee does not have the right by contract or custom to sell or re-pledge them to an unrelated party.", "label": "Pledged Financial Instruments, Not Separately Reported, Securities for Letter of Credit Facilities", "terseLabel": "Total equity securities, restricted cash, and cash and cash equivalents fair value pledged as security against the letters of credit" } } }, "localname": "PledgedFinancialInstrumentsNotSeparatelyReportedSecuritiesForLetterOfCreditFacilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PolicyholderBenefitsAndClaimsIncurredNet": { "auth_ref": [ "r485", "r511" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED": { "order": 1.0, "parentTag": "us-gaap_BenefitsLossesAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after effects of policies assumed or ceded, of expense related to the provision for policy benefits and costs incurred.", "label": "Policyholder Benefits and Claims Incurred, Net", "terseLabel": "Net loss and loss adjustment expenses incurred" } } }, "localname": "PolicyholderBenefitsAndClaimsIncurredNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r16", "r266" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred share capital, par value (in dollars per share)" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred share capital, authorized (in shares)" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r16", "r266" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued", "terseLabel": "Preferred share capital, issued (in shares)" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r16", "r440" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "terseLabel": "Preferred share capital (par value $0.10; authorized, 50,000,000; none issued)" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_PremiumsAndOtherReceivablesNet": { "auth_ref": [ "r502" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date, net of allowance for doubtful accounts, of all premiums and other types of receivables due from other persons or entities.", "label": "Premiums and Other Receivables, Net", "terseLabel": "Reinsurance balances receivable (net of allowance for expected credit losses of $89 and $89)" } } }, "localname": "PremiumsAndOtherReceivablesNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_PremiumsEarnedNet": { "auth_ref": [ "r473", "r503", "r514", "r554" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED": { "order": 1.0, "parentTag": "us-gaap_Revenues", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after premiums ceded to other entities and premiums assumed by the entity, of premiums earned.", "label": "Premiums Earned, Net", "totalLabel": "Net premiums earned" } } }, "localname": "PremiumsEarnedNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_PremiumsWrittenNet": { "auth_ref": [ "r549", "r552" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED": { "order": 1.0, "parentTag": "us-gaap_PremiumsEarnedNet", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after premiums ceded to other entities and premiums assumed by the entity, of premiums written.", "label": "Premiums Written, Net", "totalLabel": "Net premiums written" } } }, "localname": "PremiumsWrittenNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidReinsurancePremiums": { "auth_ref": [ "r521", "r559" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The unexpired portion of premiums ceded on policies in force as of the balance sheet date.", "label": "Prepaid Reinsurance Premiums", "terseLabel": "Unearned premiums ceded" } } }, "localname": "PrepaidReinsurancePremiums", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital": { "auth_ref": [ "r58", "r64" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of distribution received from equity method investee for return of investment, classified as investing activities. Excludes distribution for return on investment, classified as operating activities.", "label": "Proceeds from Equity Method Investment, Distribution, Return of Capital", "terseLabel": "Proceeds from redemptions from related party investment fund" } } }, "localname": "ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromPaymentsForTradingSecurities": { "auth_ref": [ "r57", "r59", "r73" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from sales and purchases of trading securities.", "label": "Proceeds from (Payments for) Trading Securities, Short-term", "terseLabel": "Sales of investments" } } }, "localname": "ProceedsFromPaymentsForTradingSecurities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfessionalMalpracticeLiabilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Business insurance coverage for professionals, such as doctors, lawyers, insurance agents, accountants, real estate agents, veterinarians, and others. This liability coverage insures losses for claims arising from mistakes and errors or omissions in the course of professional activities.", "label": "Professional Malpractice Liability Insurance [Member]", "terseLabel": "Professional Liability" } } }, "localname": "ProfessionalMalpracticeLiabilityMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyLineofBusinessDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyAndCasualtyCommercialInsuranceProductLineMember": { "auth_ref": [ "r532" ], "lang": { "en-us": { "role": { "documentation": "Contract providing insurance coverage to policyholder on commercial property against property-related loss. Includes, but is not limited to, damage, theft, or legal liability for personal injury.", "label": "Property and Casualty, Commercial Insurance [Member]", "terseLabel": "Commercial" } } }, "localname": "PropertyAndCasualtyCommercialInsuranceProductLineMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyLineofBusinessDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyAndCasualtyPersonalInsuranceProductLineMember": { "auth_ref": [ "r532" ], "lang": { "en-us": { "role": { "documentation": "Contract providing insurance coverage to individual against property-related loss. Includes, but is not limited to, damage, theft, or legal liability for personal injury.", "label": "Property and Casualty, Personal Insurance [Member]", "terseLabel": "Personal" } } }, "localname": "PropertyAndCasualtyPersonalInsuranceProductLineMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyLineofBusinessDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyInsuranceProductLineMember": { "auth_ref": [ "r532" ], "lang": { "en-us": { "role": { "documentation": "Contract providing insurance coverage against damage to or theft of property.", "label": "Property Insurance [Member]", "terseLabel": "Total Property" } } }, "localname": "PropertyInsuranceProductLineMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyLineofBusinessDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ProvisionForDoubtfulAccounts": { "auth_ref": [ "r51", "r190" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.", "label": "Accounts Receivable, Credit Loss Expense (Reversal)", "terseLabel": "Current expected credit losses recognized on notes receivable and reinsurance assets" } } }, "localname": "ProvisionForDoubtfulAccounts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_RealizedInvestmentGainsLosses": { "auth_ref": [ "r510" ], "calculation": { "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementofOperationsofSolasglasInvestmentsLPDetails": { "order": 2.0, "parentTag": "us-gaap_GainLossOnInvestments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of realized gain (loss) on investment.", "label": "Realized Investment Gains (Losses)", "terseLabel": "Net realized gain (loss)" } } }, "localname": "RealizedInvestmentGainsLosses", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementofOperationsofSolasglasInvestmentsLPDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReinsuranceAccountingPolicy": { "auth_ref": [ "r485", "r486", "r555", "r556" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of reinsurance accounting policy, for example, but not limited to, description of the methodologies and assumptions underlying determination of reinsurance recoverables, reinsurance payables and retention policy.", "label": "Reinsurance Accounting Policy [Policy Text Block]", "terseLabel": "Reinsurance Assets" } } }, "localname": "ReinsuranceAccountingPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ReinsuranceCostsAndRecoveriesNet": { "auth_ref": [ "r485" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of recovery (expense) related to provision for policy benefits and costs incurred for policies assumed and ceded.", "label": "Policyholder Benefits and Claims Incurred, Assumed and Ceded", "terseLabel": "Loss and loss expenses recovered and recoverable" } } }, "localname": "ReinsuranceCostsAndRecoveriesNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/RETROCESSIONDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReinsuranceDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Reinsurance Disclosures [Abstract]", "terseLabel": "Reinsurance Disclosures [Abstract]" } } }, "localname": "ReinsuranceDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_ReinsurancePayable": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying amount as of the balance sheet date of the known and estimated amounts owed to insurers under reinsurance treaties or other arrangements.", "label": "Reinsurance Payable", "verboseLabel": "Reinsurance balances payable" } } }, "localname": "ReinsurancePayable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments": { "auth_ref": [ "r487", "r520", "r522", "r525" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after valuation allowance, recoverable under reinsurance contracts for losses reported to the ceding insurer but not yet paid and amounts expected for incurred losses and settlement expenses, which have not yet been reported to the ceding insurer.", "label": "Reinsurance Recoverable for Unpaid Claims and Claims Adjustments", "terseLabel": "Loss and loss adjustment expenses recoverable (net of allowance for expected credit losses of $47 and $47)", "verboseLabel": "Add: Losses recoverable" } } }, "localname": "ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED", "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReinsuranceRecoverables": { "auth_ref": [ "r487", "r498", "r519" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after valuation allowance, recoverable under reinsurance contracts including premium paid under reinsurance contracts. Examples include, but are not limited to, settled and unsettled claims, incurred but not reported losses, loss adjustment expense, premium paid, policy benefits and policy reserves.", "label": "Reinsurance Recoverables, Including Reinsurance Premium Paid", "negatedLabel": "Less: Losses recoverable", "verboseLabel": "Loss and loss adjustment expenses recoverable" } } }, "localname": "ReinsuranceRecoverables", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails", "http://www.greenlightre.ky/role/RETROCESSIONDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReinsuranceRecoverablesAllowance": { "auth_ref": [ "r188", "r189", "r191" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on reinsurance recoverable.", "label": "Reinsurance Recoverable, Allowance for Credit Loss", "verboseLabel": "Allowance for expected credit losses" } } }, "localname": "ReinsuranceRecoverablesAllowance", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical", "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReinsuranceTextBlock": { "auth_ref": [ "r561" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure pertaining to the existence, magnitude and information about insurance that has been ceded to or assumed from another insurance company, including the methodologies and assumptions used in determining recorded amounts.", "label": "Reinsurance [Text Block]", "verboseLabel": "RETROCESSION" } } }, "localname": "ReinsuranceTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/RETROCESSION" ], "xbrltype": "textBlockItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r295", "r430", "r431" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Domain]", "terseLabel": "Related Party [Domain]" } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDNarrativeDetails", "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionAxis": { "auth_ref": [ "r295", "r430", "r431", "r434" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party transaction.", "label": "Related Party Transaction [Axis]", "terseLabel": "Related Party Transaction [Axis]" } } }, "localname": "RelatedPartyTransactionAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionDomain": { "auth_ref": [ "r295" ], "lang": { "en-us": { "role": { "documentation": "Transaction between related party.", "label": "Related Party Transaction [Domain]", "terseLabel": "Related Party Transaction [Domain]" } } }, "localname": "RelatedPartyTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty": { "auth_ref": [ "r430" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.", "label": "Related Party Transaction, Expenses from Transactions with Related Party", "terseLabel": "Investor relations monthly fee" } } }, "localname": "RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyTransactionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Related Party Transaction [Line Items]", "terseLabel": "Related Party Transaction [Line Items]" } } }, "localname": "RelatedPartyTransactionLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]", "terseLabel": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r295", "r430", "r434", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]", "terseLabel": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDNarrativeDetails", "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r428", "r429", "r431", "r435", "r436" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions Disclosure [Text Block]", "verboseLabel": "RELATED PARTY TRANSACTIONS" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONS" ], "xbrltype": "textBlockItemType" }, "us-gaap_RestrictedCashAndCashEquivalents": { "auth_ref": [ "r10", "r72", "r76", "r466", "r495" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESCashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsDetails": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Restricted Cash and Cash Equivalents", "terseLabel": "Restricted cash and cash equivalents" } } }, "localname": "RestrictedCashAndCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED", "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESCashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockMember": { "auth_ref": [ "r118" ], "lang": { "en-us": { "role": { "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.", "label": "Restricted Stock [Member]", "terseLabel": "Participating securities\u00a0excluded from calculation of loss per share", "verboseLabel": "Employee and Director Restricted Shares" } } }, "localname": "RestrictedStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONSharebasedCompensationRestrictedStockActivityDetails", "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESWeightedAverageNumberofSharesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedStockUnitsRSUMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.", "label": "Restricted Stock Units (RSUs) [Member]", "terseLabel": "RSUs" } } }, "localname": "RestrictedStockUnitsRSUMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedStockUnitsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r20", "r289", "r330", "r440", "r496", "r539", "r544" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "verboseLabel": "Retained earnings (deficit)" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r2", "r91", "r92", "r93", "r96", "r105", "r107", "r185", "r327", "r328", "r329", "r351", "r352", "r387", "r535", "r537" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Retained earnings (deficit)" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUNAUDITED" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock": { "auth_ref": [ "r162" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.", "label": "Revenue from External Customers by Geographic Areas [Table Text Block]", "terseLabel": "Schedule of Gross Premiums Written by Geographic Area of Risks Insured" } } }, "localname": "RevenueFromExternalCustomersByGeographicAreasTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueFromRelatedParties": { "auth_ref": [ "r53", "r215", "r217", "r218", "r222", "r223", "r224", "r563" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED": { "order": 2.0, "parentTag": "us-gaap_Revenues", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates.", "label": "Revenue from Related Parties", "negatedLabel": "Loss (income) from investments in related party investment fund", "netLabel": "Revenue from related parties", "terseLabel": "Income (loss) from investment in related party investment fund (net of related party expenses of $659 and $2,632 (three and nine months ended September 30, 2020: $703 and $1,981, respectively))", "verboseLabel": "GLRE limited partners\u2019 share of net income (loss)" } } }, "localname": "RevenueFromRelatedParties", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED", "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED", "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDNarrativeDetails", "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementofOperationsofSolasglasInvestmentsLPDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r46", "r82", "r138", "r139", "r146", "r152", "r153", "r159", "r160", "r164", "r179", "r212", "r213", "r214", "r217", "r218", "r219", "r220", "r221", "r223", "r224", "r394", "r481" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED": { "order": 1.0, "parentTag": "us-gaap_IncomeLossAttributableToParent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Revenues", "totalLabel": "Total revenues" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenuesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenues [Abstract]", "verboseLabel": "Revenues" } } }, "localname": "RevenuesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of cash and cash equivalents.", "label": "Schedule of Cash and Cash Equivalents [Table Text Block]", "terseLabel": "Schedule of Cash and Cash Equivalents" } } }, "localname": "ScheduleOfCashAndCashEquivalentsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "auth_ref": [ "r348" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.", "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]", "terseLabel": "Schedule of Components of Income Tax Expense (Benefit)" } } }, "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/TAXATIONTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable": { "auth_ref": [ "r111", "r112", "r115", "r117", "r122" ], "lang": { "en-us": { "role": { "documentation": "Complete disclosure pertaining to an entity's diluted earnings per share.", "label": "Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table]", "terseLabel": "Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table]" } } }, "localname": "ScheduleOfEarningsPerShareDilutedByCommonClassTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESWeightedAverageNumberofSharesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable": { "auth_ref": [ "r159" ], "lang": { "en-us": { "role": { "documentation": "Tabular presentation of the description and amount of revenues from a product or service, or a group of similar products or similar services, reported from external customers during the period, if the information is not provided as part of the reportable operating segment information.", "label": "Revenue from External Customers by Products and Services [Table]", "terseLabel": "Gross Premiums Written by Geographic Area of Risks Insured [Table]" } } }, "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyGeographicAreaofRisksInsuredDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEquityMethodInvestmentsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Schedule of Equity Method Investments [Line Items]", "terseLabel": "Schedule of Equity Method Investments [Line Items]" } } }, "localname": "ScheduleOfEquityMethodInvestmentsLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDFinancialInformationofInvestmentDetails", "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDNarrativeDetails", "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementofOperationsofSolasglasInvestmentsLPDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEquityMethodInvestmentsTable": { "auth_ref": [ "r5", "r82", "r178", "r179", "r394" ], "lang": { "en-us": { "role": { "documentation": "Summarization of information required and determined to be disclosed concerning equity method investments in common stock. The summarized information includes: (a) the name of each investee or group of investees for which combined disclosure is appropriate, (2) the percentage ownership of common stock, (3) the difference, if any, between the carrying amount of an investment and the value of the underlying equity in the net assets and the accounting treatment of difference, if any, and (4) the aggregate value of each identified investment based on its quoted market price, if available.", "label": "Schedule of Equity Method Investments [Table]", "terseLabel": "Schedule of Equity Method Investments [Table]" } } }, "localname": "ScheduleOfEquityMethodInvestmentsTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDFinancialInformationofInvestmentDetails", "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDNarrativeDetails", "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementofOperationsofSolasglasInvestmentsLPDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense": { "auth_ref": [ "r526" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the activity in the reserve for settling insured claims and expenses incurred in the claims settlement process for the period. The estimated liability includes the amount of money that will be required for future payments of (a) claims that have been reported to the insurer, (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated, and (c) claim adjustment expenses. Claim adjustment expenses include costs incurred in the claim settlement process such as legal fees; outside adjuster fees; and costs to record, process, and adjust claims.", "label": "Schedule of Liability for Unpaid Claims and Claims Adjustment Expense [Table Text Block]", "terseLabel": "Schedule of Liability for Unpaid Claims and Claims Adjustment Expense" } } }, "localname": "ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock": { "auth_ref": [ "r27" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.", "label": "Schedule of Line of Credit Facilities [Table Text Block]", "terseLabel": "Schedule of Letters of Credit Facilities" } } }, "localname": "ScheduleOfLineOfCreditFacilitiesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfOperatingLeasedAssetsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of long-lived, depreciable assets that are subject to a operating lease agreements and are used in the normal conduct of business to produce goods and services. Examples may include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Schedule of Operating Leased Assets [Table]", "terseLabel": "Schedule of Operating Leased Assets [Table]" } } }, "localname": "ScheduleOfOperatingLeasedAssetsTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESCommitmentsandContingenciesFiscalYearMaturityScheduleDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "auth_ref": [ "r432", "r434" ], "lang": { "en-us": { "role": { "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Schedule of Related Party Transactions, by Related Party [Table]", "terseLabel": "Schedule of Related Party Transactions, by Related Party [Table]" } } }, "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock": { "auth_ref": [ "r10", "r76", "r466", "r495" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage.", "label": "Restrictions on Cash and Cash Equivalents [Table Text Block]", "terseLabel": "Schedule of Restrictions on Cash and Cash Equivalents" } } }, "localname": "ScheduleOfRestrictedCashAndCashEquivalentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "auth_ref": [ "r143", "r144", "r150", "r197" ], "lang": { "en-us": { "role": { "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table]", "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyLineofBusinessDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "auth_ref": [ "r143", "r144", "r150", "r197" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]", "terseLabel": "Schedule of Gross Premiums Written by Line of Business" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r303", "r322" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]", "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedStockUnitsDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONSharebasedCompensationRestrictedStockActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.", "label": "Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]", "terseLabel": "Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity" } } }, "localname": "ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfStockByClassTable": { "auth_ref": [ "r32", "r79", "r124", "r125", "r262", "r264", "r265", "r266", "r267", "r268", "r269", "r271", "r275", "r280", "r283", "r284", "r285", "r286", "r287", "r288", "r289" ], "lang": { "en-us": { "role": { "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.", "label": "Schedule of Stock by Class [Table]", "terseLabel": "Schedule of Stock by Class [Table]" } } }, "localname": "ScheduleOfStockByClassTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHARECAPITALNarrativeDetails", "http://www.greenlightre.ky/role/SHARECAPITALStockbyClassDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfStockByClassTextBlock": { "auth_ref": [ "r15", "r16", "r17", "r263", "r264", "r265", "r283", "r284", "r285", "r286", "r287", "r288", "r289" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's stock, including par or stated value per share, number and dollar amount of share subscriptions, shares authorized, shares issued, shares outstanding, number and dollar amount of shares held in an employee trust, dividend per share, total dividends, share conversion features, par value plus additional paid in capital, the value of treasury stock and other information necessary to a fair presentation, and EPS information. Stock by class includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. Includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity. If more than one issue is outstanding, state the title of each issue and the corresponding dollar amount; dollar amount of any shares subscribed but unissued and the deduction of subscriptions receivable there from; number of shares authorized, issued, and outstanding.", "label": "Schedule of Stock by Class [Table Text Block]", "terseLabel": "Schedule of Stock by Class" } } }, "localname": "ScheduleOfStockByClassTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHARECAPITALTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt and Equity Securities, FV-NI [Line Items]", "terseLabel": "Debt and Equity Securities, FV-NI [Line Items]" } } }, "localname": "ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSOtherInvestmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security with change in fair value recognized in net income (FV-NI).", "label": "Debt Securities, Trading, and Equity Securities, FV-NI [Table]", "terseLabel": "Debt Securities, Trading, and Equity Securities, FV-NI [Table]" } } }, "localname": "ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSOtherInvestmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock": { "auth_ref": [ "r119" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit).", "label": "Schedule of Weighted Average Number of Shares [Table Text Block]", "terseLabel": "Schedule of Weighted Average Number of Shares" } } }, "localname": "ScheduleOfWeightedAverageNumberOfSharesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segment Reporting [Abstract]", "terseLabel": "Segment Reporting [Abstract]" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r134", "r136", "r137", "r143", "r145", "r151", "r155", "r156", "r157", "r158", "r159", "r163", "r164", "r165" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "Segment Reporting Disclosure [Text Block]", "verboseLabel": "SEGMENT REPORTING" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTING" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Segment Reporting Information [Line Items]", "terseLabel": "Segment Reporting Information [Line Items]" } } }, "localname": "SegmentReportingInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyLineofBusinessDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SeniorNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.", "label": "Senior Notes [Member]", "terseLabel": "Senior Notes" } } }, "localname": "SeniorNotesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTESDetails", "http://www.greenlightre.ky/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r69" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-based Payment Arrangement, Noncash Expense", "verboseLabel": "Share-based compensation expense" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "auth_ref": [ "r304" ], "lang": { "en-us": { "role": { "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period", "terseLabel": "Cliff vesting period after date of issuance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "auth_ref": [ "r309" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period", "negatedLabel": "Forfeited (in shares)", "terseLabel": "Shares forfeited (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedStockUnitsDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONSharebasedCompensationRestrictedStockActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "auth_ref": [ "r314" ], "lang": { "en-us": { "role": { "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value", "terseLabel": "Forfeited (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedStockUnitsDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONSharebasedCompensationRestrictedStockActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [ "r312" ], "lang": { "en-us": { "role": { "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period", "terseLabel": "Number of s issued to employees RSUs (in shares)", "verboseLabel": "Granted (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedStockUnitsDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONSharebasedCompensationRestrictedStockActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r312" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Granted (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedStockUnitsDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONSharebasedCompensationRestrictedStockActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "auth_ref": [ "r311" ], "lang": { "en-us": { "role": { "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "periodEndLabel": "Ending balance (in shares)", "periodStartLabel": "Beginning balance (in shares)", "terseLabel": "Unvested performance restricted shares outstanding (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedStockUnitsDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONSharebasedCompensationRestrictedStockActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]", "terseLabel": "Number of non-vested restricted \u00a0shares", "verboseLabel": "Number of non-vested RSUs" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedStockUnitsDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONSharebasedCompensationRestrictedStockActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [ "r311" ], "lang": { "en-us": { "role": { "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "periodEndLabel": "Ending balance (in dollars per share)", "periodStartLabel": "Beginning balance (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedStockUnitsDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONSharebasedCompensationRestrictedStockActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]", "terseLabel": "Weighted \u00a0average grant date fair value", "verboseLabel": "Weighted \u00a0average grant date fair value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedStockUnitsDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONSharebasedCompensationRestrictedStockActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "auth_ref": [ "r313" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period", "negatedLabel": "Vested (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedStockUnitsDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONSharebasedCompensationRestrictedStockActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": { "auth_ref": [ "r316" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value", "terseLabel": "Total fair value of restricted shares vested" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r313" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Vested (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedStockUnitsDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONSharebasedCompensationRestrictedStockActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedStockUnitsDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONSharebasedCompensationRestrictedStockActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": { "auth_ref": [ "r305" ], "lang": { "en-us": { "role": { "documentation": "Number of shares authorized for issuance under share-based payment arrangement.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized", "terseLabel": "Shares authorized for the company's stock incentive plan (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": { "auth_ref": [ "r322" ], "lang": { "en-us": { "role": { "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant", "terseLabel": "Shares available for future issuance (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": { "auth_ref": [ "r310" ], "lang": { "en-us": { "role": { "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period", "terseLabel": "Expired (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross", "terseLabel": "Granted (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r315" ], "lang": { "en-us": { "role": { "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Weighted average grant date fair value, granted (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r308", "r322" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number", "terseLabel": "Options outstanding (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r307" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "terseLabel": "Exercise price (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r300", "r306" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Award Type [Domain]", "terseLabel": "Award Type [Domain]" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedStockUnitsDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONSharebasedCompensationRestrictedStockActivityDetails", "http://www.greenlightre.ky/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r317" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term", "terseLabel": "Weighted average remaining contractual term" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of options vested.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares", "terseLabel": "Vested number of shares (in shares)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShortTermLeaseCost": { "auth_ref": [ "r424", "r426" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less.", "label": "Short-term Lease, Cost", "terseLabel": "Short term lease cost" } } }, "localname": "ShortTermLeaseCost", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r77", "r90" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "verboseLabel": "SIGNIFICANT ACCOUNTING POLICIES" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIES" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r15", "r16", "r17", "r79", "r82", "r111", "r112", "r113", "r115", "r117", "r124", "r125", "r126", "r179", "r212", "r217", "r218", "r219", "r223", "r224", "r266", "r267", "r271", "r275", "r282", "r394", "r599" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]", "terseLabel": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical", "http://www.greenlightre.ky/role/CoverPage", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails", "http://www.greenlightre.ky/role/SHARECAPITALNarrativeDetails", "http://www.greenlightre.ky/role/SHARECAPITALStockbyClassDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r2", "r33", "r42", "r43", "r44", "r91", "r92", "r93", "r96", "r105", "r107", "r123", "r185", "r282", "r289", "r327", "r328", "r329", "r351", "r352", "r387", "r408", "r409", "r410", "r411", "r412", "r413", "r535", "r536", "r537", "r622" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]", "terseLabel": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUNAUDITED", "http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTESDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical", "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUNAUDITED" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]", "terseLabel": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]", "terseLabel": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]", "terseLabel": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r91", "r92", "r93", "r123", "r450" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]", "terseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical", "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUNAUDITED" ], "xbrltype": "stringItemType" }, "us-gaap_StockCompensationPlanMember": { "auth_ref": [ "r118" ], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement in which award of equity shares are granted. Arrangement includes, but is not limited to, grantor incurring liability for product and service based on price of its shares.", "label": "Share-based Payment Arrangement [Member]", "terseLabel": "Share-based Payment Arrangement" } } }, "localname": "StockCompensationPlanMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationForfeited": { "auth_ref": [ "r321" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Value of forfeited shares granted under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Shares Granted, Value, Share-based Payment Arrangement, Forfeited", "terseLabel": "Stock-based compensation expense" } } }, "localname": "StockGrantedDuringPeriodValueSharebasedCompensationForfeited", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r16", "r17", "r282", "r289" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Stock Issued During Period, Shares, New Issues", "terseLabel": "Issue of ordinary shares, net of forfeitures (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHARECAPITALStockbyClassDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited": { "auth_ref": [ "r16", "r17", "r282", "r289" ], "lang": { "en-us": { "role": { "documentation": "Number of shares related to Restricted Stock Award forfeited during the period.", "label": "Stock Issued During Period, Shares, Restricted Stock Award, Forfeited", "terseLabel": "Restricted shares forfeited by employees who left the company prior to the vesting period (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross": { "auth_ref": [ "r282", "r289" ], "lang": { "en-us": { "role": { "documentation": "Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.", "label": "Stock Issued During Period, Shares, Restricted Stock Award, Gross", "terseLabel": "Restricted shares issued pursuant to stock incentive plan (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "auth_ref": [ "r16", "r17", "r289", "r302", "r315" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture", "terseLabel": "Issue of Class A ordinary shares, net of forfeitures" } } }, "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchasedAndRetiredDuringPeriodShares": { "auth_ref": [ "r16", "r17", "r282", "r289" ], "lang": { "en-us": { "role": { "documentation": "Number of shares that have been repurchased and retired during the period.", "label": "Stock Repurchased and Retired During Period, Shares", "negatedLabel": "Repurchase of ordinary shares (in shares)", "terseLabel": "Repurchase of ordinary shares (in shares)" } } }, "localname": "StockRepurchasedAndRetiredDuringPeriodShares", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHARECAPITALNarrativeDetails", "http://www.greenlightre.ky/role/SHARECAPITALStockbyClassDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockRepurchasedDuringPeriodValue": { "auth_ref": [ "r16", "r17", "r282", "r289" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.", "label": "Stock Repurchased During Period, Value", "negatedTerseLabel": "Repurchase of Class A ordinary shares" } } }, "localname": "StockRepurchasedDuringPeriodValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r17", "r21", "r22", "r82", "r170", "r179", "r394", "r440" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance", "totalLabel": "Total shareholders' equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED", "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "terseLabel": "Shareholders' equity" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r2", "r3", "r43", "r82", "r91", "r92", "r93", "r96", "r105", "r179", "r185", "r289", "r327", "r328", "r329", "r351", "r352", "r362", "r363", "r368", "r387", "r394", "r408", "r409", "r413", "r536", "r537", "r622" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.", "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Shareholders' equity" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r80", "r267", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r277", "r278", "r279", "r281", "r289", "r290" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "terseLabel": "SHARE CAPITAL" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHARECAPITAL" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Information [Abstract]", "terseLabel": "Supplementary information" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "stringItemType" }, "us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense": { "auth_ref": [ "r523" ], "calculation": { "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails": { "order": 1.0, "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after effects of reinsurance, of expense for claims incurred in the current reporting period and related claims settlement costs.", "label": "Current Year Claims and Claims Adjustment Expense", "terseLabel": "Current year" } } }, "localname": "SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense": { "auth_ref": [ "r523" ], "calculation": { "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails": { "order": 2.0, "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred in prior reporting periods and related claims settlement costs.", "label": "Prior Year Claims and Claims Adjustment Expense", "terseLabel": "Prior years", "verboseLabel": "Estimate of net losses" } } }, "localname": "SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TypeOfAdoptionMember": { "auth_ref": [ "r0", "r1", "r2", "r3", "r4", "r95", "r96", "r97", "r98", "r108", "r171", "r172", "r182", "r183", "r184", "r185", "r186", "r187", "r211", "r323", "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r349", "r350", "r351", "r352", "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r427", "r451", "r452", "r453", "r533", "r534", "r535", "r536", "r537", "r538", "r539", "r540", "r541", "r542", "r543", "r544", "r618", "r619", "r620", "r621", "r622" ], "lang": { "en-us": { "role": { "documentation": "Amendment to accounting standards.", "label": "Accounting Standards Update [Domain]", "terseLabel": "Type of Adoption [Domain]" } } }, "localname": "TypeOfAdoptionMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_UnamortizedDebtIssuanceExpense": { "auth_ref": [ "r26" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset.", "label": "Unamortized Debt Issuance Expense", "terseLabel": "Unamortized debt issuance expense" } } }, "localname": "UnamortizedDebtIssuanceExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnearnedPremiums": { "auth_ref": [ "r492" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount of premiums written on insurance contracts that have not been earned as of the balance sheet date.", "label": "Unearned Premiums", "verboseLabel": "Unearned premium reserves" } } }, "localname": "UnearnedPremiums", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrealizedGainLossOnInvestments": { "auth_ref": [ "r70" ], "calculation": { "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementofOperationsofSolasglasInvestmentsLPDetails": { "order": 1.0, "parentTag": "us-gaap_GainLossOnInvestments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrealized gain (loss) on investment.", "label": "Unrealized Gain (Loss) on Investments", "terseLabel": "Net change in unrealized appreciation (depreciation)" } } }, "localname": "UnrealizedGainLossOnInvestments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementofOperationsofSolasglasInvestmentsLPDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r127", "r128", "r129", "r130", "r131", "r132", "r133" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": { "auth_ref": [ "r344" ], "calculation": { "http://www.greenlightre.ky/role/TAXATIONComponentsofIncomeTaxExpenseBenefitDetails": { "order": 1.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.", "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount", "terseLabel": "Decrease (increase) in deferred tax valuation allowance" } } }, "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/TAXATIONComponentsofIncomeTaxExpenseBenefitDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Variable Interest Entities (VIE) in which the entity does not have a controlling financial interest (as defined) and of which it is therefore not the primary beneficiary. VIEs of which the entity is not the primary beneficiary because it does not have the power to direct the activities of the VIE that most significantly impact the VIE's economic performance and for which it does not have the obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE are not included in the consolidated financial statements of the entity.", "label": "Variable Interest Entity, Not Primary Beneficiary [Member]", "terseLabel": "Variable Interest Entity, Not Primary Beneficiary" } } }, "localname": "VariableInterestEntityNotPrimaryBeneficiaryMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r110", "r117" ], "calculation": { "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESWeightedAverageNumberofSharesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Diluted (in shares)", "totalLabel": "Weighted average shares outstanding - diluted (in shares)", "verboseLabel": "Weighted average shares outstanding - diluted (in shares)" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED", "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails", "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESWeightedAverageNumberofSharesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]", "terseLabel": "Weighted average number of ordinary shares used in the determination of earnings and loss per share" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED" ], "xbrltype": "stringItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r109", "r117" ], "calculation": { "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESWeightedAverageNumberofSharesDetails": { "order": 1.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Basic (in shares)", "verboseLabel": "Weighted average shares outstanding - basic (in shares)" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED", "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESWeightedAverageNumberofSharesDetails" ], "xbrltype": "sharesItemType" } }, "unitCount": 6 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M.Q2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8672-108599" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "26", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "34", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "a", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599" }, "r165": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "http://asc.fasb.org/topic&trid=2134510" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=SL6953659-111524" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27405-111563" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=123583895&loc=d3e30768-111565" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=125513658&loc=d3e32014-111567" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(b)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r181": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "323", "URI": "http://asc.fasb.org/topic&trid=2196965" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(4)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124267575&loc=SL82921842-210448" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=99383045&loc=d3e9351-108337" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=99397363&loc=d3e9420-108338" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r203": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "http://asc.fasb.org/topic&trid=2144648" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349" }, "r205": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "http://asc.fasb.org/topic&trid=2127136" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=123389529&loc=d3e10037-110241" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(4)", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12069-110248" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=123408193&loc=d3e12803-110250" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S65", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359872&loc=SL124427846-239511" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466302&loc=d3e4852-112606" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.12)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.17)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612" }, "r261": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "http://asc.fasb.org/topic&trid=2208564" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(CFRR 211.02)", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21553-112644" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21484-112644" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21488-112644" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "http://asc.fasb.org/topic&trid=2208762" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4534-113899" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)-(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(4)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)-(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.28,29)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "c(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.F)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11149-113907" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11178-113907" }, "r334": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "http://asc.fasb.org/topic&trid=2228938" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331" }, "r361": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "http://asc.fasb.org/topic&trid=2144680" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568447-111683" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568740-111683" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "4I", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686" }, "r369": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "http://asc.fasb.org/topic&trid=2197479" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(4)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5708775-113959" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "182", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123421605&loc=SL5629052-113961" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)(2)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)(3)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)(2)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(2)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=120253306&loc=d3e28228-110885" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=123602790&loc=d3e30226-110892" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=125521441&loc=d3e30690-110894" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=124440516&loc=d3e30840-110895" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "848", "URI": "http://asc.fasb.org/extlink&oid=122150657&loc=SL122150809-237846" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864" }, "r436": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "http://asc.fasb.org/topic&trid=2122745" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124437977&loc=d3e55792-112764" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(1)(i)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL6224234-111729" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(1)(a))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(12))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(13)(c))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(13)(f))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.1-5)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.10)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.2)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "405", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=6480726&loc=d3e6691-158385" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=99397103&loc=d3e6811-158387" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=99397103&loc=d3e6816-158387" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=99397103&loc=d3e6824-158387" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(13)(a))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(10))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(13)(a)(2))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16)(a))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(2))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(6))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(7))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(4))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.1(f,g))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.1(h))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.5)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(1))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(10))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(2))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(7)(a))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(5))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04.3(a))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04.5)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04.5,6,7)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-17(Column C))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120401096&loc=d3e574992-122915" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-17(Column E))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120401096&loc=d3e574992-122915" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=35755530&loc=d3e11264-158415" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "2B", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124505477&loc=SL117422543-158416" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "2B", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124505477&loc=SL117422543-158416" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504731&loc=d3e11522-158419" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=99404803&loc=d3e21409-158489" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(8))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=99404803&loc=d3e21412-158489" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "340", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=6485982&loc=d3e22818-158507" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(cc)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1(e))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "9C", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=122147696&loc=SL65671395-207642" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.20)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iv)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "40", "Subparagraph": "(SAB TOPIC 5.W)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=27015833&loc=d3e570705-122907" }, "r546": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/subtopic&trid=2560295" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "605", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=84167274&loc=d3e27175-158546" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "605", "Subparagraph": "(a)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=6486672&loc=d3e27261-158547" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "605", "Subparagraph": "(b)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=6486672&loc=d3e27261-158547" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "605", "Subparagraph": "(b)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=6486672&loc=d3e27261-158547" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "605", "Subparagraph": "(b)(3)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=6486672&loc=d3e27261-158547" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "605", "Subparagraph": "(c)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=6486672&loc=d3e27261-158547" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "605", "Subparagraph": "(c)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=6486672&loc=d3e27261-158547" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "605", "Subparagraph": "(c)(3)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=6486672&loc=d3e27261-158547" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "605", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=99379264&loc=d3e27758-158548" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "605", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=99379264&loc=d3e27830-158548" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "05", "SubTopic": "825", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=6487483&loc=d3e32239-158577" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "825", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124506110&loc=d3e32546-158582" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(c),9(a))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195" }, "r561": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "944", "URI": "http://asc.fasb.org/topic&trid=2303980" }, "r562": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996" }, "r563": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07.1(c))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401555&loc=SL114874292-224272" }, "r564": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r565": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r566": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r567": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r568": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r569": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585" }, "r570": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r571": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r572": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r573": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010" }, "r574": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010" }, "r575": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13D)", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010" }, "r576": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column A))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010" }, "r577": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column B))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010" }, "r578": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column C))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010" }, "r579": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column D))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585" }, "r580": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014" }, "r581": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629" }, "r582": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column B))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r583": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column C))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r584": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column D))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r585": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column E))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r586": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column F))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r587": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column G))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r588": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column H))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r589": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column I))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585" }, "r590": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r591": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 4))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r592": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663" }, "r593": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691" }, "r594": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r595": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r596": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r597": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r598": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r599": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402" }, "r6": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "http://asc.fasb.org/topic&trid=2122149" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585" }, "r600": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "303", "Subparagraph": "(5)" }, "r601": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r602": { "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "11", "Subsection": "03" }, "r603": { "Footnote": "2", "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r604": { "Footnote": "4", "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r605": { "Footnote": "4", "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "29" }, "r606": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column B", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r607": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column C", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r608": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column D", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r609": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column E", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585" }, "r610": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column F", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r611": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column G", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r612": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column H", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r613": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column I", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r614": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(i)", "Subsection": "01" }, "r615": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(iv)", "Subsection": "01" }, "r616": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(iv)", "Subsection": "02" }, "r617": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(m)", "Publisher": "SEC", "Section": "4", "Subparagraph": "(1)(iii)", "Subsection": "08" }, "r618": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "848" }, "r619": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "848" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585" }, "r620": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "848" }, "r621": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(01)", "Topic": "848" }, "r622": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "21D", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=SL94080555-108585" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3098-108585" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(2)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(n))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e7018-107765" }, "r90": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "http://asc.fasb.org/topic&trid=2122369" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(4)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" } }, "version": "2.1" } ZIP 76 0001385613-21-000120-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001385613-21-000120-xbrl.zip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�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end